data_2km7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2km7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.61 0.243 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.52 ' HD2' ' HD2' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -126.43 167.54 15.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.03 140.14 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.72 145.03 45.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.601 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.28 99.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 110.671 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.71 -27.8 68.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.684 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.46 ' CG ' ' HZ3' ' A' ' 45' ' ' LYS . 1.5 t70 -72.2 -41.27 67.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.725 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.741 ' HA ' HD23 ' A' ' 59' ' ' LEU . 11.3 t -68.22 -23.73 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 110.433 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 m -77.0 -5.87 50.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' HZ3' ' CG ' ' A' ' 42' ' ' ASP . 25.7 mtmt -68.07 -35.43 78.18 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.731 0.3 . . . . 0.0 111.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.2 pp -84.87 -177.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.402 -175.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.0 175.74 13.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.159 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.521 HG23 HD13 ' A' ' 104' ' ' ILE . 2.8 t -73.05 143.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.665 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.57 ' HA2' ' CG1' ' A' ' 100' ' ' VAL . . . 84.06 -11.13 58.57 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.342 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.85 133.67 47.64 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -77.42 156.73 30.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.362 -175.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.423 ' H ' ' HG3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.94 -44.57 14.89 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.624 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.494 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.87 -37.64 58.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.926 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.451 ' HA ' HG21 ' A' ' 46' ' ' ILE . 78.0 t -60.91 -46.93 95.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 109.983 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -67.67 -35.2 78.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.731 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -43.54 97.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.32 -46.47 20.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 43' ' ' VAL . 7.0 mt -84.05 -16.41 43.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -173.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 17.79 65.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -68.9 141.05 91.83 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 122.534 0.333 . . . . 0.0 111.457 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.14 158.81 53.98 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.481 2.121 . . . . 0.0 111.417 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.67 135.1 57.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.1 128.6 24.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.536 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -149.78 71.33 1.09 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.541 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.16 121.36 84.91 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.36 -2.93 12.94 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.075 2.517 . . . . 0.0 112.358 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -90.0 -20.05 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.447 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.8 4.66 34.0 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.02 85.29 6.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.344 0.592 . . . . 0.0 110.18 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -101.25 49.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.052 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -112.99 128.11 56.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.714 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -103.62 132.47 49.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.54 125.63 52.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.73 154.57 49.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.63 128.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.995 0.426 . . . . 0.0 110.659 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.516 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 6.7 p90 -127.19 173.47 9.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.606 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD2' ' HD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -94.07 131.21 39.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.034 0.445 . . . . 0.0 111.115 -177.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.6 -30.74 0.19 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.867 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.445 HE21 ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -125.74 83.26 62.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.72 -42.42 9.07 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.951 2.434 . . . . 0.0 113.469 -172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.18 138.4 4.76 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.884 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -175.2 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.166 0.586 . . . . 0.0 109.581 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -128.11 -2.25 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.539 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.98 -38.35 2.54 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.53 87.64 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.8 m -159.58 98.27 1.37 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.608 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.97 154.96 22.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.012 -175.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -111.54 131.51 55.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.061 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.24 114.18 25.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.967 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.516 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -84.52 105.43 15.33 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.97 124.1 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.592 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -99.68 139.3 35.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.05 108.1 9.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.77 ' HB3' HD23 ' A' ' 101' ' ' LEU . 36.0 p90 -115.35 133.22 56.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.963 0.411 . . . . 0.0 109.976 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.48 ' HB3' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -73.91 162.26 29.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.972 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.29 -22.38 2.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.24 -10.2 59.51 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.776 -0.577 . . . . 0.0 110.94 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 98.83 10.05 50.72 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.213 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.57 ' CG1' ' HA2' ' A' ' 49' ' ' GLY . 18.0 t -98.93 119.53 47.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 122.343 0.257 . . . . 0.0 110.709 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.77 HD23 ' HB3' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -55.14 105.48 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.423 0.452 . . . . 0.0 109.785 174.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -91.4 -31.95 15.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -175.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -150.34 138.02 19.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.888 0.375 . . . . 0.0 110.923 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.521 HD13 HG23 ' A' ' 48' ' ' VAL . 3.8 mt -110.78 133.05 57.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 174.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.515 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -96.04 99.95 11.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.546 174.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.411 ' C ' ' HG3' ' A' ' 107' ' ' LYS . 28.3 t30 -144.47 101.92 3.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 110.591 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -142.5 133.75 12.93 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.09 158.61 50.95 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.918 2.412 . . . . 0.0 112.781 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.08 42.79 0.82 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.02 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.589 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -159.3 148.63 18.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -75.2 174.03 10.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.233 0.54 . . . . 0.0 111.216 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -128.05 153.05 47.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.677 176.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.44 -21.23 66.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.974 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -74.17 -34.77 63.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.684 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -70.84 -20.58 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 -176.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.31 -17.1 21.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.224 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -90.73 -8.4 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.684 ' HG3' ' HA ' ' A' ' 42' ' ' ASP . 2.0 mtmt -83.22 -30.6 27.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.217 0.532 . . . . 0.0 110.048 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.496 ' H ' HG12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -86.31 144.83 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.859 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -127.57 154.35 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.418 -178.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.575 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -74.36 148.12 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 1.023 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 80.15 -4.42 67.03 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.084 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 16.1 mmt -74.86 138.6 42.59 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 6.0 t -79.41 154.72 28.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.571 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -53.04 -36.18 60.3 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.866 -177.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -60.51 -42.64 96.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.088 0.47 . . . . 0.0 110.579 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -77.0 -34.92 57.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.55 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.51 -45.94 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.032 0.444 . . . . 0.0 109.826 175.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -66.02 -36.36 83.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.738 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.87 -28.03 65.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.355 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.68 -54.48 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.66 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.07 -29.82 34.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.75 0.31 . . . . 0.0 111.812 -174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.24 24.0 9.98 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.179 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.554 HG21 ' HH ' ' A' ' 75' ' ' TYR . 2.5 m -62.35 131.23 93.72 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.431 -0.385 . . . . 0.0 111.336 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.2 165.36 32.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.627 2.218 . . . . 0.0 111.508 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.09 116.82 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.36 119.75 40.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.47 -172.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.27 104.09 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.083 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 134.79 19.92 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.3 -5.65 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.44 2.093 . . . . 0.0 113.46 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.17 -26.24 12.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.1 32.23 7.2 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -73.31 114.92 12.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.895 -0.652 . . . . 0.0 111.249 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.586 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 2.2 m120 -92.41 45.77 1.22 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.262 0.553 . . . . 0.0 110.488 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -148.14 137.08 21.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.618 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.405 ' HE1' HG11 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -105.51 133.11 50.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.067 0.461 . . . . 0.0 110.592 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.554 ' HH ' HG21 ' A' ' 61' ' ' THR . 21.4 m-85 -133.78 149.55 51.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.993 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG11 ' HE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -128.54 133.87 65.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 54.5 p90 -163.13 149.8 12.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.53 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.505 ' HD2' ' HB3' ' A' ' 81' ' ' PRO . 2.0 ttm180 -77.58 104.06 7.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.593 HE22 ' HA ' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -67.96 -44.84 75.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.557 -174.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.49 79.23 74.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.505 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 92.6 Cg_endo -83.7 -3.28 10.57 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.729 2.286 . . . . 0.0 112.337 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.23 126.95 8.33 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.735 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.37 -65.72 0.33 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.732 0.813 . . . . 0.0 112.401 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.64 -56.79 8.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.139 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 -36.52 2.95 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.682 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.1 87.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.369 0.604 . . . . 0.0 109.82 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 109' ' ' ALA . 5.3 m -162.81 115.31 1.6 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.709 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.44 ' O ' ' HB1' ' A' ' 109' ' ' ALA . 12.9 tp60 -136.13 124.7 23.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.852 0.358 . . . . 0.0 111.687 -169.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 161.56 14.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.803 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.226 175.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.441 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -83.26 105.04 13.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.32 108.45 13.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.499 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 72' ' ' THR . 4.8 mp -80.9 121.87 26.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.239 175.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.3 124.88 53.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.695 ' HB3' HD22 ' A' ' 101' ' ' LEU . 30.9 p90 -135.86 160.18 39.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 111.265 -175.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.36 165.01 18.59 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.3 m -64.43 -4.13 3.65 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -7.37 58.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.578 . . . . 0.0 109.853 172.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 86.84 16.27 61.73 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.407 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 1.023 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -103.66 116.61 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.187 0.195 . . . . 0.0 110.477 -173.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 95' ' ' PHE . 19.4 mt -55.24 114.98 2.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.345 0.403 . . . . 0.0 110.971 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.57 -35.3 21.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 109.754 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -162.18 153.76 18.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.111 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.433 HD13 HG12 ' A' ' 48' ' ' VAL . 3.2 mt -110.15 136.12 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.415 ' N ' HG22 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -88.21 101.58 13.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 172.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -140.55 100.76 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 0.0 110.537 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -144.61 169.05 10.77 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.593 ' HA ' HE22 ' A' ' 79' ' ' GLN . 82.6 Cg_endo -81.5 166.56 17.75 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.831 1.688 . . . . 0.0 111.8 171.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 87' ' ' THR . . . -68.38 67.7 0.13 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 110.499 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.514 ' HA ' HD11 ' A' ' 110' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.863 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.514 0.197 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -113.7 165.64 12.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.64 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.041 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.39 143.52 27.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HA ' HG22 ' A' ' 43' ' ' VAL . . . -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.642 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -21.73 64.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.28 -29.37 31.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.575 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 40' ' ' ALA . 3.5 t -66.99 -17.06 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.154 0.502 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -69.69 -6.37 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.235 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -75.77 -23.29 55.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.188 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.615 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pt -104.91 -179.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.484 0.183 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.9 OUTLIER -154.33 168.4 26.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.543 0.211 . . . . 0.0 110.755 -177.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.61 140.48 18.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.291 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.709 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 81.34 1.74 90.19 Favored Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.999 -0.441 . . . . 0.0 111.999 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.512 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.99 149.05 30.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -75.35 145.63 41.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.717 0.294 . . . . 0.0 110.693 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HG2' ' N ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -58.97 -26.93 64.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.853 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.431 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 10.8 mp0 -63.86 -48.31 77.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.195 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -69.46 -35.55 75.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.383 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.615 ' HA ' HG21 ' A' ' 46' ' ' ILE . 89.0 t -61.28 -47.81 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.39 70.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.082 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.96 -43.23 96.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.551 . . . . 0.0 110.677 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.48 -53.09 8.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.941 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 43' ' ' VAL . 50.4 mt -81.64 -20.42 39.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.18 26.83 35.42 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.405 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -72.11 133.45 83.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.388 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.1 Cg_exo -68.29 152.47 75.74 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.93 2.42 . . . . 0.0 111.515 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.495 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.83 116.44 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 0.0 110.159 -179.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 105.25 7.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.798 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.26 69.16 3.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.731 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 75.07 80.72 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -1.78 11.83 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.161 2.574 . . . . 0.0 112.414 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -67.67 -15.32 63.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.751 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.96 16.37 12.74 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.15 83.74 4.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.863 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 50.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.684 0.754 . . . . 0.0 110.125 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.37 128.82 50.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.976 176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 122.71 45.44 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -106.44 121.66 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -116.91 137.82 51.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.375 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.76 118.37 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.66 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 65.3 m-85 -117.91 163.22 16.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.883 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -122.85 103.49 8.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 110.342 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -155.25 164.9 38.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.449 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 55.01 74.29 0.75 Allowed Pre-proline 0 C--O 1.234 0.271 0 O-C-N 123.781 0.676 . . . . 0.0 111.365 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.28 86.16 1.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.309 2.006 . . . . 0.0 111.362 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.11 -104.56 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.702 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -134.27 155.86 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.563 -0.375 . . . . 0.0 111.142 -176.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.0 mp0 76.6 -45.64 0.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.771 0.828 . . . . 0.0 111.803 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.1 -36.44 4.22 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.988 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 p -85.04 85.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.417 1.103 . . . . 0.0 109.434 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.667 HG21 ' HB2' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -175.53 138.84 0.41 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.175 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.494 ' CA ' ' HB3' ' A' ' 109' ' ' ALA . 2.0 tp60 -161.1 168.91 23.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.355 . . . . 0.0 111.091 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -84.3 124.23 31.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.236 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.02 104.73 16.69 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.04 0.447 . . . . 0.0 110.56 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.66 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -84.66 104.83 14.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -103.11 104.19 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.56 HD23 HD21 ' A' ' 101' ' ' LEU . 1.8 tp -94.33 119.6 33.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.481 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 116.0 25.95 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.64 -171.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.838 ' HB3' HD22 ' A' ' 101' ' ' LEU . 1.3 p90 -123.62 142.77 50.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.995 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.536 ' HB3' HG23 ' A' ' 102' ' ' THR . 0.4 OUTLIER -78.45 164.16 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.54 -22.32 3.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -169.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -6.27 45.42 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.991 -0.443 . . . . 0.0 111.252 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 88.0 21.3 46.69 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.425 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.545 HG13 ' HA2' ' A' ' 49' ' ' GLY . 24.6 t -112.18 120.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.838 HD22 ' HB3' ' A' ' 95' ' ' PHE . 9.1 mt -55.44 110.36 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.367 0.417 . . . . 0.0 110.383 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -76.53 -32.05 58.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.83 153.32 10.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.624 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 105' ' ' ASP . 5.0 mt -110.54 135.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 170.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -107.96 102.7 11.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -121.85 114.42 21.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.928 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 153.72 78.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.558 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.28 171.43 3.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.111 2.541 . . . . 0.0 111.71 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.667 ' HB2' HG21 ' A' ' 87' ' ' THR . . . -74.5 6.54 3.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 120.712 0.291 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -90.3 156.23 18.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.195 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.3 tp -80.15 142.58 34.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 110.281 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.84 145.96 28.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.92 86.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.787 0.327 . . . . 0.0 111.392 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.98 -30.01 70.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -20.0 62.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.153 0.501 . . . . 0.0 111.084 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 t -84.06 -17.03 10.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.871 0.367 . . . . 0.0 111.529 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.7 -8.28 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -8.47 56.04 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.378 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -109.85 158.92 9.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.9 mtt85 -135.88 160.39 38.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 111.158 -173.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.5 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 3.4 m -73.62 147.54 9.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.473 171.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.793 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 82.05 -8.48 60.33 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.556 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.6 mmt -79.29 141.36 37.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -68.0 150.37 48.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.48 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -59.59 -28.11 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.009 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -68.23 -38.96 82.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -70.14 -38.69 75.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.992 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.552 ' HA ' HG22 ' A' ' 46' ' ' ILE . 52.2 t -59.57 -45.5 93.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.703 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.436 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -66.57 -33.28 75.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.012 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -70.04 -34.45 73.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.915 0.388 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.07 -35.08 24.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.219 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -98.17 -34.82 10.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.58 30.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.25 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -58.87 139.22 86.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 123.23 0.612 . . . . 0.0 112.118 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.78 140.76 29.58 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.672 2.248 . . . . 0.0 111.501 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.21 108.58 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.2 tpp -75.88 118.32 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.595 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.61 106.36 11.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.913 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.24 115.2 18.58 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-O 120.928 0.394 . . . . 0.0 109.94 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -91.54 -2.66 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.953 2.435 . . . . 0.0 112.26 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -26.19 15.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.007 -170.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.44 15.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.48 85.43 3.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.227 0.537 . . . . 0.0 109.893 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.14 55.1 1.27 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.443 0.639 . . . . 0.0 110.772 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.463 HG21 HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -132.15 146.16 51.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.84 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 2.0 m0 -124.01 130.6 52.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -120.37 124.58 45.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.309 0.575 . . . . 0.0 111.079 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -124.53 153.92 41.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.453 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.74 130.34 55.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.288 0.566 . . . . 0.0 110.905 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -93.78 -175.61 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.7 ptt85 -128.14 119.47 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 111.451 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HB2' ' HA ' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -105.61 -114.82 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.938 174.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -126.92 81.41 69.67 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.52 135.04 32.4 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.141 2.561 . . . . 0.0 112.57 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.55 162.18 28.66 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.37 121.88 18.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.366 0.083 . . . . 0.0 110.78 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 69.38 108.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.002 0.814 . . . . 0.0 110.128 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.67 53.73 0.55 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 t -82.93 87.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.488 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . 0.9 OUTLIER -127.77 113.56 16.13 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.56 -169.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.735 ' H ' ' HB3' ' A' ' 109' ' ' ALA . 2.8 mm100 -150.58 168.68 23.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.087 -168.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.442 ' CD ' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -122.14 136.15 54.88 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 173.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.3 133.15 56.34 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.493 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.18 104.56 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 105.39 15.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.658 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.5 mp -94.96 127.88 41.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.66 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.463 HG21 HG21 ' A' ' 72' ' ' THR . 0.2 OUTLIER -123.02 127.84 49.35 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.528 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -126.21 148.92 49.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.418 ' HB2' HG22 ' A' ' 102' ' ' THR . 6.0 t-20 -76.73 160.48 29.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -0.37 0.64 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.464 0.478 . . . . 0.0 112.237 -175.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -8.57 58.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.558 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.18 15.53 55.6 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.254 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.793 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -111.52 123.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.765 0.426 . . . . 0.0 110.34 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.542 HD11 HG21 ' A' ' 55' ' ' VAL . 6.5 mt -54.32 110.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.741 0.305 . . . . 0.0 110.486 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.418 HG22 ' HB2' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -75.51 -42.19 53.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.465 ' HA ' HG13 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -163.07 153.61 16.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.708 178.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.614 HG23 ' N ' ' A' ' 105' ' ' ASP . 2.4 mt -107.88 136.31 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.614 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -115.04 101.65 9.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.873 0.368 . . . . 0.0 110.728 177.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -114.09 100.74 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 116.62 11.02 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.286 -174.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.7 146.09 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.805 2.336 . . . . 0.0 112.117 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.735 ' HB3' ' H ' ' A' ' 88' ' ' GLN . . . -71.61 70.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.186 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.066 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 t30 . . . . . 0 N--CA 1.465 0.277 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 172.14 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.07 128.13 34.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.232 176.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -109.96 177.49 4.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.947 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.87 90.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.308 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -59.29 -38.21 79.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -38.96 91.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.1 t -70.64 -30.9 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.272 0.558 . . . . 0.0 110.385 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 m -75.15 -9.25 58.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.815 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.581 ' HE2' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -86.7 -20.39 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.507 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.595 HD13 HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -87.11 173.85 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.114 177.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.1 mmp_? -131.56 153.6 49.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.938 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.54 ' H ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -72.92 136.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.909 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 92.95 -4.08 74.51 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.791 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.39 144.19 49.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -81.16 145.05 31.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.759 0.314 . . . . 0.0 110.603 -175.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -54.65 -36.13 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.675 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -68.75 -43.02 76.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.138 0.494 . . . . 0.0 110.426 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -74.9 -34.84 62.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.9 -46.32 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.634 ' HA ' ' HB ' ' A' ' 61' ' ' THR . . . -64.52 -41.59 96.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.705 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.55 -35.93 81.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.632 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.86 -43.71 35.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.203 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.595 HD11 HD13 ' A' ' 46' ' ' ILE . 19.9 mt -94.54 1.83 55.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.81 46.25 90.2 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.293 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.634 ' HB ' ' HA ' ' A' ' 56' ' ' ALA . 13.6 m -102.87 136.58 19.24 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.48 -0.36 . . . . 0.0 111.068 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.557 ' HD2' HG22 ' A' ' 61' ' ' THR . 26.8 Cg_exo -63.56 132.29 34.95 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.605 2.203 . . . . 0.0 111.46 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.92 87.88 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 110.545 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.7 tpt -79.98 93.68 5.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.205 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.12 109.32 22.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.0 152.45 40.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.465 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.63 -3.27 9.94 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.737 2.291 . . . . 0.0 113.78 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -98.79 -26.22 14.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.829 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.64 27.76 5.35 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.22 83.52 6.94 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.272 0.558 . . . . 0.0 109.755 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -82.34 63.61 6.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.496 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.67 126.65 20.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.012 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 7.1 m0 -105.89 135.53 47.17 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.498 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -111.2 122.07 46.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.548 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 159.89 20.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.15 125.08 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.493 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 1.7 m-30 -97.64 162.97 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.51 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -139.7 105.12 5.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 175.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.83 11.18 0.65 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.122 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.658 HE22 ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -134.54 144.73 52.11 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.005 -173.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 3.0 Cg_exo -76.39 -165.41 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.192 2.594 . . . . 0.0 112.149 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.76 -14.33 12.64 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.138 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -75.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.944 0.372 . . . . 0.0 111.125 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -115.41 145.17 42.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.61 34.67 13.12 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.523 ' H ' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -78.2 88.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 -177.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -172.23 176.2 3.48 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 -172.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.456 ' CA ' ' HB3' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -151.18 178.96 8.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.765 0.317 . . . . 0.0 110.366 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.558 ' NE2' ' H ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -128.68 164.06 23.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 -176.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 104.92 15.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.493 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -82.46 105.03 13.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 109.94 19.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.031 -171.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.2 mt -89.51 120.36 30.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.55 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -110.2 123.96 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.608 0.242 . . . . 0.0 110.356 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 0.8 OUTLIER -119.2 148.0 43.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.88 168.29 18.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 m -58.42 -16.37 14.62 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.661 0.384 . . . . 0.0 111.985 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -5.29 42.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.547 175.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 80.15 21.89 64.28 Favored Glycine 0 C--O 1.219 -0.826 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.909 HG12 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -106.26 127.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 -172.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.438 HD13 HG13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -54.66 101.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.799 175.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -39.44 30.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.087 0.47 . . . . 0.0 110.015 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -161.19 153.21 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.255 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 105' ' ' ASP . 2.4 mp -118.59 133.24 66.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.489 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -95.18 101.93 13.71 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.417 ' HA ' HD21 ' A' ' 91' ' ' LEU . 16.5 p-10 -135.38 100.88 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 0.0 111.139 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.84 111.52 6.23 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.189 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 54.3 Cg_exo -54.58 121.53 9.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.511 2.14 . . . . 0.0 112.443 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.658 ' HB2' HE22 ' A' ' 80' ' ' GLN . . . -6.43 77.11 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.514 1.759 . . . . 0.0 114.123 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.24 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--O 1.232 0.163 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -109.57 -171.33 1.82 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.475 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.98 134.66 54.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.841 0.353 . . . . 0.0 110.444 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 145.23 44.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.22 96.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.38 -27.88 68.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.989 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -72.72 -39.05 67.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.652 HG22 HD23 ' A' ' 59' ' ' LEU . 61.1 t -67.62 -25.15 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.38 0.609 . . . . 0.0 109.952 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -74.59 -6.48 48.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.091 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 16.7 mtpt -71.0 -33.45 70.4 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.531 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.499 HG22 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pp -93.84 -178.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.4 OUTLIER -157.31 172.27 18.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.737 0.304 . . . . 0.0 111.08 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 1.4 m -66.31 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.279 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.601 ' HA2' ' CG1' ' A' ' 100' ' ' VAL . . . 90.27 -10.59 73.75 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.095 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -75.03 137.45 41.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -73.89 146.5 43.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.328 -175.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -52.52 -32.43 40.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.721 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 mp0 -62.46 -44.21 96.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.165 0.507 . . . . 0.0 109.837 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -73.57 -36.37 65.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 46' ' ' ILE . 93.9 t -61.04 -48.76 87.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.539 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -71.45 -30.62 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.012 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -37.91 87.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.81 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.11 -39.51 17.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.999 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.652 HD23 HG22 ' A' ' 43' ' ' VAL . 6.9 mp -86.23 -49.5 7.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 0.0 111.939 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.18 29.25 5.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.224 -172.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.594 HG21 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -60.89 141.75 92.97 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.247 -0.476 . . . . 0.0 111.293 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.594 ' HD2' HG21 ' A' ' 61' ' ' THR . 50.1 Cg_exo -57.31 165.57 5.46 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.15 2.567 . . . . 0.0 113.351 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 104.58 2.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.365 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.25 93.17 5.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.108 0.48 . . . . 0.0 110.594 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.87 62.12 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.196 0.522 . . . . 0.0 109.865 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -127.88 80.22 72.43 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.48 -175.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.98 -1.5 11.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.339 2.693 . . . . 0.0 112.497 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -74.43 13.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.323 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.84 13.28 20.5 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.344 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 66' ' ' ASP . 8.7 m -83.99 87.22 7.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.261 0.553 . . . . 0.0 110.619 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -113.73 24.04 12.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.742 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.38 55.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.101 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.41 ' CE2' HG22 ' A' ' 61' ' ' THR . 0.2 OUTLIER -112.79 121.92 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.088 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.0 p90 -111.22 147.25 35.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 111.569 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.665 ' HB2' HD11 ' A' ' 91' ' ' LEU . 1.5 m-85 -147.96 160.75 42.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.066 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.29 115.99 50.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.311 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' HZ ' HG21 ' A' ' 43' ' ' VAL . 12.2 m-30 -94.0 124.75 38.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -78.4 106.09 10.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.178 0.513 . . . . 0.0 109.815 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.534 HE22 ' HB3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -158.24 41.91 0.27 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.117 -178.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.445 ' NE2' HE21 ' A' ' 88' ' ' GLN . 27.7 mp0 -107.99 120.39 47.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.821 -171.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.1 Cg_exo -69.72 176.06 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 123.084 2.523 . . . . 0.0 112.523 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.85 11.31 72.46 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.746 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -86.67 109.75 19.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.9 mp0 72.34 -52.62 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.16 0.912 . . . . 0.0 111.144 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.94 76.58 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.936 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.93 84.84 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.4 m -171.44 101.43 0.2 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.908 -174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.449 ' CA ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -132.33 169.0 17.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.93 0.395 . . . . 0.0 111.16 -173.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.453 ' HB3' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -130.04 166.31 20.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.799 -175.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 117.57 17.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.849 0.357 . . . . 0.0 111.429 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.806 HD22 ' HB2' ' A' ' 106' ' ' ASN . 0.9 OUTLIER -84.26 112.02 19.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.28 118.95 32.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.333 0.587 . . . . 0.0 111.277 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.581 HD11 HD12 ' A' ' 91' ' ' LEU . 2.2 mp -102.93 142.55 33.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.447 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.56 123.17 27.4 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 102' ' ' THR . 11.1 p90 -131.3 145.38 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.895 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -69.15 159.79 32.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.359 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -19.04 12.72 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -174.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -15.67 61.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.708 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 101.56 11.73 37.42 Favored Glycine 0 C--O 1.221 -0.706 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.754 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.601 ' CG1' ' HA2' ' A' ' 49' ' ' GLY . 43.0 t -94.32 114.0 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.856 -0.202 . . . . 0.0 110.733 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . 0.8 OUTLIER -54.77 102.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.393 0.433 . . . . 0.0 110.542 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.403 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -85.37 -29.43 24.45 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.99 -176.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -156.7 143.41 18.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.676 HG21 ' N ' ' A' ' 105' ' ' ASP . 18.7 mt -121.07 141.74 40.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.676 ' N ' HG21 ' A' ' 104' ' ' ILE . 10.5 t0 -129.6 102.89 6.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.623 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.806 ' HB2' HD22 ' A' ' 91' ' ' LEU . 34.8 t30 -135.45 100.13 4.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 110.137 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -121.01 131.6 24.44 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.428 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.534 ' HB3' HE22 ' A' ' 79' ' ' GLN . 46.0 Cg_exo -56.42 146.25 74.84 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.067 2.511 . . . . 0.0 112.983 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.453 ' N ' ' HB3' ' A' ' 89' ' ' GLN . . . -45.93 -41.98 12.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.244 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.529 ' HA ' HD11 ' A' ' 110' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 121.067 0.46 . . . . 0.0 110.15 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 t30 . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -104.61 166.76 10.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.48 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.459 HD13 HD22 ' A' ' 59' ' ' LEU . 7.5 tp -74.52 137.62 42.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.556 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.68 144.99 25.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.87 75.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -74.11 -29.91 62.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 111.194 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -72.96 -20.26 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.408 -175.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 46' ' ' ILE . 2.2 t -74.54 -16.47 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.166 0.507 . . . . 0.0 110.654 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -83.91 -6.94 59.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.778 ' HE3' ' HB1' ' A' ' 58' ' ' ALA . 4.6 pttt -82.23 -8.0 59.64 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.377 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -102.87 162.41 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.555 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -132.81 168.79 17.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.145 0.498 . . . . 0.0 112.241 -169.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.549 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -76.96 137.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.38 171.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.966 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 83.49 5.36 88.59 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.555 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -89.15 136.35 33.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.25 145.17 51.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.849 0.356 . . . . 0.0 111.272 -176.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.41 -29.3 61.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.639 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.17 -42.15 89.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.2 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.124 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.56 HG22 HD23 ' A' ' 101' ' ' LEU . 72.3 t -60.43 -46.58 95.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.223 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.99 78.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -45.71 93.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.211 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.778 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -80.43 -39.39 28.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.144 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.495 HD23 ' HE2' ' A' ' 45' ' ' LYS . 70.0 mt -86.09 -18.67 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.22 40.71 13.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.46 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.4 m -95.58 133.84 25.12 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.104 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.4 Cg_exo -69.68 157.48 60.39 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.904 2.403 . . . . 0.0 111.111 173.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 tp -86.47 87.64 7.48 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.248 0.546 . . . . 0.0 110.367 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.3 115.06 29.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.669 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 140.07 47.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.498 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -91.46 123.74 63.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.96 -2.16 12.28 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.822 2.348 . . . . 0.0 113.284 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -99.61 -20.59 16.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.77 10.66 26.3 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.94 90.15 5.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.111 0.481 . . . . 0.0 109.796 177.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -80.24 61.35 4.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -174.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -126.01 123.04 37.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 177.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.56 ' HB2' ' HZ ' ' A' ' 95' ' ' PHE . 1.5 m0 -103.89 122.57 45.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -108.37 121.91 45.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.703 0.763 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.38 153.66 21.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.057 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.9 t -123.48 107.67 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.785 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 55.1 p90 -142.17 146.97 35.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.76 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 106.45 18.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.547 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -113.7 -0.3 14.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.485 HE21 ' HB3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -105.4 138.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.303 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 23.6 Cg_exo -63.78 145.04 90.35 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.828 2.352 . . . . 0.0 111.996 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.23 71.43 1.49 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.836 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.454 ' C ' ' H ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -119.49 136.73 54.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.3 mt-10 74.41 -17.37 0.47 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.946 0.779 . . . . 0.0 111.016 -176.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 83' ' ' HIS . . . 89.88 -36.39 3.55 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.924 169.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.512 ' H ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -105.08 88.82 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.374 -0.486 . . . . 0.0 110.309 -176.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -157.69 121.61 4.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.406 0.622 . . . . 0.0 111.197 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.463 ' H ' ' HB1' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -170.58 150.49 3.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.421 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.77 156.2 44.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.997 0.427 . . . . 0.0 111.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -93.71 129.04 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.969 174.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.785 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -85.62 103.96 14.92 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -102.0 105.9 16.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -174.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.3 mt -93.79 125.25 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.677 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.7 123.45 48.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.56 ' HZ ' ' HB2' ' A' ' 73' ' ' TRP . 0.1 OUTLIER -118.88 151.67 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.72 ' HB2' HG22 ' A' ' 102' ' ' THR . 8.1 t-20 -88.93 167.78 12.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 171.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -23.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -171.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -3.64 47.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.32 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 84.16 28.17 34.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.296 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.966 HG12 ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -112.85 130.75 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 122.274 0.229 . . . . 0.0 110.436 -177.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.56 HD23 HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -55.72 103.06 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.632 0.583 . . . . 0.0 111.263 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.72 HG22 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -91.37 -18.5 24.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.0 110.643 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -162.67 138.72 7.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.632 HG23 ' N ' ' A' ' 105' ' ' ASP . 3.0 mt -113.61 136.48 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.693 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 28.7 t70 -117.79 103.34 9.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.673 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -131.38 100.65 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.145 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.02 119.54 10.58 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.756 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.74 155.96 20.44 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.436 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.463 ' HB1' ' H ' ' A' ' 88' ' ' GLN . . . -64.7 92.31 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.033 0.444 . . . . 0.0 110.561 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.1 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 121.514 0.673 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -131.86 -169.48 2.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.966 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.601 HD13 ' HE1' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -112.02 155.36 23.91 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.68 142.56 49.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.915 0.388 . . . . 0.0 111.569 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.64 -38.44 23.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.404 0.621 . . . . 0.0 110.192 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.37 -17.78 64.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 1.2 t0 -77.65 -20.38 53.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.33 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.448 ' HA ' HD11 ' A' ' 59' ' ' LEU . 14.5 t -71.29 -28.1 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.935 0.397 . . . . 0.0 111.147 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -7.21 22.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.696 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -77.92 -15.32 59.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.089 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.564 HG22 HD21 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -100.87 172.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.161 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.5 160.86 39.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.875 -178.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.55 152.03 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.873 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 79.42 -4.72 62.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.211 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.456 ' HB3' ' HE3' ' A' ' 50' ' ' MET . 1.9 mtp -85.1 141.84 29.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.56 146.43 50.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.802 -175.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -31.9 62.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.984 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -69.31 -39.52 78.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.032 0.444 . . . . 0.0 110.043 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.03 -34.74 64.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.199 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.621 HG21 HD22 ' A' ' 101' ' ' LEU . 76.1 t -61.71 -48.03 90.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.763 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.87 -29.66 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.151 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -41.8 72.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.094 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.05 -59.6 2.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -91.51 -2.18 57.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.277 0.561 . . . . 0.0 111.39 -171.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 46.27 9.86 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.753 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 73' ' ' TRP . 0.2 OUTLIER -89.9 136.41 29.19 Favored Pre-proline 0 C--N 1.317 -0.81 0 O-C-N 122.818 -0.225 . . . . 0.0 111.121 177.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.2 Cg_exo -68.58 132.02 24.32 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.37 2.047 . . . . 0.0 111.284 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.86 118.16 19.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.0 ttp -92.15 119.98 32.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.389 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.13 109.35 13.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -114.46 93.19 31.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.615 0.722 . . . . 0.0 111.066 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.92 -9.12 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.04 1.827 . . . . 0.0 111.22 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -96.31 -21.99 17.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.115 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 12.07 25.81 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.19 83.4 2.37 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.146 0.498 . . . . 0.0 110.757 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -94.51 67.57 3.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.236 -177.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -135.61 147.28 48.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.721 -178.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.422 ' CE2' HG21 ' A' ' 61' ' ' THR . 0.3 OUTLIER -127.44 148.49 50.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.965 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -133.82 133.59 41.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 0.0 110.594 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.601 ' HE1' HD13 ' A' ' 38' ' ' LEU . 2.4 m-85 -117.2 134.6 54.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.523 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.98 107.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.93 114.29 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -91.17 103.01 15.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.518 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 1.7 pt20 -127.34 37.65 4.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 8.4 pm0 -116.23 136.68 23.07 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.418 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 4.5 Cg_exo -78.11 165.21 26.28 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.788 2.326 . . . . 0.0 111.631 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.23 67.08 3.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.122 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.486 ' HB3' ' H ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -168.71 -99.5 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 mp0 -93.94 149.74 20.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.797 0.332 . . . . 0.0 110.445 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.746 ' HA2' HD21 ' A' ' 110' ' ' LEU . . . 75.85 45.32 17.11 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.275 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -95.81 88.44 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.812 HG21 ' HB1' ' A' ' 109' ' ' ALA . 1.9 t -164.72 176.18 9.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.6 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -114.07 109.99 19.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.535 1.061 . . . . 0.0 113.67 -162.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.679 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -76.58 128.87 35.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.76 172.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 120.7 22.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -174.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.15 112.26 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.719 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.52 111.11 23.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 72' ' ' THR . 11.2 mp -94.83 134.55 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.811 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -131.23 117.76 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -124.8 136.21 53.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.932 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.486 ' HB2' HG23 ' A' ' 102' ' ' THR . 1.3 t30 -73.24 165.68 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.863 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.32 -13.89 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -5.85 42.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 175.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.695 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 83.99 12.77 76.19 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.873 HG12 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -105.54 122.47 58.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.995 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.621 HD22 HG21 ' A' ' 55' ' ' VAL . 1.6 mm? -55.42 107.27 0.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.098 174.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.486 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -97.67 -36.04 10.38 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.956 0.408 . . . . 0.0 110.879 -177.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.415 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 41.2 t30 -137.06 135.97 37.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.654 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -122.28 132.2 71.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.53 ' N ' HG22 ' A' ' 104' ' ' ILE . 1.4 t70 -100.81 100.94 11.68 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -116.7 99.6 7.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 1.3 mtmt -156.4 141.6 12.42 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.079 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 16.9 Cg_exo -68.25 169.46 16.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.664 2.243 . . . . 0.0 111.536 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.812 ' HB1' HG21 ' A' ' 87' ' ' THR . . . -71.66 -22.22 61.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.578 0.704 . . . . 0.0 110.257 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.746 HD21 ' HA2' ' A' ' 85' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.258 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -162.72 154.96 18.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.078 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.7 127.13 32.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.958 0.408 . . . . 0.0 110.234 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 m -87.4 144.72 26.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.48 93.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.211 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -60.64 -33.58 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.241 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.568 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -71.48 -25.43 62.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 -176.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 46' ' ' ILE . 46.7 t -74.49 -32.3 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.209 0.528 . . . . 0.0 110.27 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -6.82 47.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.111 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -74.82 -20.23 59.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -110.71 -173.43 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 176.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.58 171.52 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.794 0.33 . . . . 0.0 111.018 -174.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.472 ' H ' HG21 ' A' ' 48' ' ' VAL . 1.1 m -71.58 149.6 9.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.598 ' HA2' ' CG1' ' A' ' 100' ' ' VAL . . . 72.35 6.64 65.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.206 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.33 148.05 24.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -74.82 142.87 44.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.85 0.357 . . . . 0.0 110.731 -175.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -27.43 69.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.612 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.423 HE21 ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -71.81 -35.31 69.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.362 -178.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.11 -36.35 48.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.299 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 83.0 t -58.41 -47.85 86.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.613 ' HB1' ' OG1' ' A' ' 61' ' ' THR . . . -61.42 -39.14 89.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.326 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.92 55.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.585 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.74 -58.66 3.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.595 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -95.26 -16.58 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 95.31 0.77 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.748 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.613 ' OG1' ' HB1' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -78.51 155.2 78.91 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.82 148.33 40.88 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.566 2.177 . . . . 0.0 110.585 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 87.11 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.298 0.57 . . . . 0.0 110.624 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -104.93 120.39 41.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.806 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.61 133.18 34.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.31 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -160.26 94.79 1.56 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 110.482 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.45 -3.03 7.66 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.812 2.341 . . . . 0.0 111.919 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.67 -27.52 22.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.213 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.14 35.25 4.55 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.451 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.0 m -76.2 89.62 3.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.355 0.597 . . . . 0.0 110.021 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 8.5 m120 -88.09 51.76 2.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.335 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.71 13.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.71 176.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.6 m0 -103.56 121.63 43.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.917 0.389 . . . . 0.0 110.299 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -104.88 115.06 29.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.885 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -119.39 140.81 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.889 0.376 . . . . 0.0 110.609 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.82 129.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.505 ' HZ ' HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -112.95 -176.14 2.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.186 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.4 123.65 36.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.983 0.42 . . . . 0.0 110.375 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.76 ' HG3' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -77.82 167.29 21.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.793 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -102.23 93.82 4.23 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 92.7 Cg_endo -93.44 164.77 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.048 2.499 . . . . 0.0 114.22 -169.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.65 -107.85 1.02 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -107.59 -7.36 16.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.214 0.531 . . . . 0.0 109.651 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -178.88 5.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.916 172.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.45 36.95 11.35 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.516 ' H ' HG23 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -92.21 86.58 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -176.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.3 m -164.95 170.02 15.74 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -170.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -123.35 129.06 50.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.774 0.715 . . . . 0.0 112.119 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 4.1 pm0 -94.84 137.97 33.22 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.96 129.41 56.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.99 104.61 14.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 m -105.2 109.37 21.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.279 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 3.0 mp -88.31 130.7 35.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.498 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.16 118.4 26.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.667 ' HB3' ' HA ' ' A' ' 101' ' ' LEU . 40.6 p90 -144.04 151.99 40.4 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.645 -173.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -77.81 154.55 31.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.672 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.26 -14.23 24.64 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.868 0.467 . . . . 0.0 111.936 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -73.49 -3.38 27.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.166 0.507 . . . . 0.0 110.577 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.59 6.26 59.73 Favored Glycine 0 C--O 1.22 -0.774 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.551 175.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.598 ' CG1' ' HA2' ' A' ' 49' ' ' GLY . 93.9 t -97.42 112.1 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.666 0.233 . . . . 0.0 111.097 -172.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.667 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -55.34 103.35 0.09 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.584 0.552 . . . . 0.0 110.016 174.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.616 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -75.71 -30.98 59.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.727 0.298 . . . . 0.0 110.587 -175.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.05 152.71 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.368 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 105' ' ' ASP . 3.4 mt -112.7 134.11 56.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.521 ' N ' HG22 ' A' ' 104' ' ' ILE . 2.1 t70 -91.53 101.36 14.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.157 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -119.08 100.32 7.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -142.61 146.94 40.51 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.178 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.07 166.97 28.04 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.507 2.138 . . . . 0.0 112.31 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.76 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . . . -72.81 66.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.672 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.351 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.9 t30 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -100.13 -174.72 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.407 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.524 HD13 ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -90.53 127.42 36.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.114 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 41' ' ' ASN . 72.5 m -96.93 144.67 26.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.437 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 39' ' ' THR . . . -63.94 -24.52 67.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.27 0.557 . . . . 0.0 110.881 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.715 ' H ' HG22 ' A' ' 39' ' ' THR . 12.9 t-20 -74.01 -20.95 60.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.43 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 39' ' ' THR . 7.5 m-20 -74.66 -31.28 61.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.533 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.677 HG22 ' HZ ' ' A' ' 77' ' ' PHE . 2.0 t -64.85 -24.97 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.824 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -10.8 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.724 0.297 . . . . 0.0 111.46 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -73.87 -34.35 64.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.188 0.518 . . . . 0.0 109.841 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.624 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pp -108.97 -178.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.91 157.3 31.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.72 0.295 . . . . 0.0 110.758 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.29 130.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.149 0.5 . . . . 0.0 109.818 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.771 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 96.93 -8.79 65.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.902 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 148.72 39.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.694 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.99 146.18 37.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.084 -175.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.39 -40.29 17.34 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.851 0.72 . . . . 0.0 111.999 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.428 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 7.1 mp0 -67.77 -42.29 81.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.546 -175.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -78.39 -33.33 48.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.393 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.624 ' HA ' HG21 ' A' ' 46' ' ' ILE . 39.5 t -60.47 -46.96 94.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 61' ' ' THR . . . -68.9 -38.74 79.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.726 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -40.12 83.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.66 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -40.61 55.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.582 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.501 HD12 HG12 ' A' ' 46' ' ' ILE . 1.4 mt -82.25 -38.93 23.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.665 0.269 . . . . 0.0 111.659 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.21 19.87 11.09 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.5 m -80.5 135.19 53.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.956 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.55 131.68 32.59 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.481 2.121 . . . . 0.0 111.074 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mt -72.83 125.04 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.813 0.339 . . . . 0.0 110.526 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.9 ttm -102.23 148.16 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.634 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.475 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -84.18 -177.11 6.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.868 176.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.567 ' N ' ' HD3' ' A' ' 67' ' ' PRO . 11.0 p-10 -134.87 49.79 4.14 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 66' ' ' ASP . 13.3 Cg_exo -68.16 -27.42 35.34 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.822 1.681 . . . . 0.0 111.072 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.23 -2.08 24.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.25 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.41 37.57 5.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.225 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.49 103.79 3.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.029 0.442 . . . . 0.0 111.585 -172.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -115.18 12.88 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.956 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.521 HG21 HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -134.68 145.31 48.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 -178.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.3 m0 -123.72 140.26 53.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -112.32 111.45 22.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.21 141.84 42.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.632 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -89.07 111.96 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.483 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.677 ' HZ ' HG22 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -96.68 170.98 8.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.156 -177.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -155.66 151.35 27.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.096 175.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB2' ' H ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -129.2 -138.87 0.23 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.536 ' H ' ' HB2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.3 104.89 25.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 24.0 Cg_exo -63.59 137.26 58.46 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.254 2.636 . . . . 0.0 112.669 -176.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.79 150.14 16.93 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -64.84 115.96 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 73.11 134.66 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.045 0.841 . . . . 0.0 110.315 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.82 54.15 1.15 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -170.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.67 100.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.407 0.622 . . . . 0.0 110.093 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 88' ' ' GLN . 0.9 OUTLIER -162.64 158.96 23.93 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.463 -175.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.562 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . 2.8 tp60 -136.03 170.07 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 111.275 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.42 130.97 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.036 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -99.86 115.05 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.465 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -83.52 104.85 13.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 109.884 -176.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -97.93 110.55 23.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.646 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -98.79 130.93 45.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.957 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.521 HG22 HG21 ' A' ' 72' ' ' THR . 0.3 OUTLIER -121.81 129.31 52.54 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -127.38 132.37 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 0.0 110.29 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.527 ' HB2' HG21 ' A' ' 102' ' ' THR . 20.3 t-20 -74.68 163.61 27.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.809 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -14.7 9.24 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.591 0.557 . . . . 0.0 112.137 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -10.96 60.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.243 0.544 . . . . 0.0 110.65 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.49 15.2 55.75 Favored Glycine 0 C--O 1.22 -0.743 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.862 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.764 HG11 ' HA2' ' A' ' 49' ' ' GLY . 2.4 t -112.42 130.2 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 122.432 0.293 . . . . 0.0 110.712 -172.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.771 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 2.3 mt -55.21 115.14 2.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -84.98 -33.19 22.64 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.033 0.444 . . . . 0.0 110.538 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -168.13 144.8 4.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.088 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 105' ' ' ASP . 1.8 mp -111.36 134.46 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 169.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.552 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -104.73 103.03 12.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.776 0.322 . . . . 0.0 110.386 176.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -125.31 104.81 8.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.262 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' HZ1' ' CG ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -118.75 133.84 23.59 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.11 132.87 38.32 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.943 2.429 . . . . 0.0 113.182 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.562 ' HB1' ' HA ' ' A' ' 88' ' ' GLN . . . -52.38 -41.47 63.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.235 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 111.097 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.42 ' HB3' ' H ' ' A' ' 37' ' ' TYR . 49.3 t30 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.42 ' H ' ' HB3' ' A' ' 36' ' ' ASN . 1.3 p90 -163.48 -177.78 5.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tp -75.0 158.71 32.79 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 41' ' ' ASN . 11.0 t -129.15 -179.85 5.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.603 0.239 . . . . 0.0 110.384 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.49 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.071 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.429 ' H ' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.9 -31.99 73.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.787 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -68.08 -34.29 76.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 110.371 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG12 HD21 ' A' ' 91' ' ' LEU . 6.8 t -63.19 -34.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.34 0.591 . . . . 0.0 110.33 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -6.79 59.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.196 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -29.93 45.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.404 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.585 HG23 ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -96.84 -177.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.056 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -140.44 144.96 36.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.599 0.238 . . . . 0.0 110.699 -175.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.519 HG12 HD13 ' A' ' 104' ' ' ILE . 3.1 m -68.23 138.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.502 175.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.76 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 85.34 3.17 87.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.975 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.525 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -82.25 154.36 25.42 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.693 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.53 145.99 38.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.505 ' H ' ' HG3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -53.98 -31.78 51.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.424 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -59.57 -44.72 93.21 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 110.426 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -76.65 -35.58 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.228 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.585 ' HA ' HG23 ' A' ' 46' ' ' ILE . 84.1 t -61.03 -43.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.973 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.833 ' HA ' HG21 ' A' ' 61' ' ' THR . . . -71.66 -34.49 69.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.834 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -37.48 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.85 -52.44 7.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.96 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 46' ' ' ILE . 48.1 mt -79.97 -12.28 59.73 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.08 32.44 69.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.833 HG21 ' HA ' ' A' ' 56' ' ' ALA . 3.2 t -100.95 146.4 32.06 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.8 Cg_exo -64.32 132.71 34.69 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.462 2.108 . . . . 0.0 112.009 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.3 mt -70.15 99.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.096 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.1 ttp -136.71 100.29 4.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -104.01 146.32 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.96 126.1 75.87 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.429 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.42 -5.42 9.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.402 2.735 . . . . 0.0 113.658 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.53 -12.82 55.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.156 0.503 . . . . 0.0 110.184 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.76 2.19 34.55 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 104.46 4.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.249 0.547 . . . . 0.0 110.437 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -108.39 53.89 0.67 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.727 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.432 HG23 HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -128.08 140.89 51.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.46 176.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.677 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 6.8 m0 -117.29 142.86 46.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.695 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 38.6 p90 -129.73 119.62 23.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.356 0.598 . . . . 0.0 110.428 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.99 159.17 26.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.54 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.0 121.86 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.0 0.429 . . . . 0.0 110.82 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.527 ' HZ ' ' ND2' ' A' ' 106' ' ' ASN . 3.6 p90 -118.39 -174.95 2.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.93 138.74 48.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.864 0.364 . . . . 0.0 111.362 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.54 HE21 ' NE2' ' A' ' 80' ' ' GLN . 1.6 mt-30 -91.85 -128.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.245 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.54 ' NE2' HE21 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -116.92 105.25 49.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.53 143.34 87.58 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.865 2.377 . . . . 0.0 112.396 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.02 -136.22 2.37 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.41 15.0 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.553 0.216 . . . . 0.0 111.083 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 76.01 -60.01 0.5 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.785 0.834 . . . . 0.0 111.119 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.98 -13.32 61.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.026 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 t -109.33 88.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.74 HG21 ' HB3' ' A' ' 109' ' ' ALA . 7.0 m -165.67 112.85 0.93 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.275 -174.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.54 117.49 1.56 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.271 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 13.5 pt20 -80.28 131.56 35.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.863 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.96 157.45 16.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.395 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.507 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -98.05 104.02 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -104.01 107.8 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.677 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.1 mp -101.24 124.18 46.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.432 HG22 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -117.76 122.23 42.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.464 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -127.14 148.07 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.964 0.412 . . . . 0.0 110.362 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -81.15 161.61 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -8.45 1.85 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.72 -13.34 60.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.27 14.39 48.37 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.915 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.572 HG12 ' HA2' ' A' ' 49' ' ' GLY . 2.5 t -112.16 126.94 69.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.59 0.356 . . . . 0.0 110.43 -173.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.76 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 8.2 mt -56.76 108.42 0.5 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.321 0.388 . . . . 0.0 110.179 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.464 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -74.71 -32.97 62.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.49 140.06 4.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.974 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 105' ' ' ASP . 53.6 mt -102.38 134.51 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 104' ' ' ILE . 3.2 t70 -111.04 101.8 10.31 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.394 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.527 ' ND2' ' HZ ' ' A' ' 77' ' ' PHE . 9.4 t-20 -133.32 102.17 5.45 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.06 0.457 . . . . 0.0 109.779 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.22 131.56 24.39 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.763 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.07 146.01 13.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.363 2.708 . . . . 0.0 112.361 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.74 ' HB3' HG21 ' A' ' 87' ' ' THR . . . -74.55 51.58 0.47 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.164 0.506 . . . . 0.0 111.485 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.628 0.252 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.788 ' HE2' ' HA ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -159.12 179.35 9.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.59 151.45 40.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.953 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.3 145.97 43.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.126 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.85 80.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.75 -18.54 63.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.154 0.502 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.73 -23.35 45.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.437 HG13 HD11 ' A' ' 46' ' ' ILE . 10.6 t -67.77 -18.38 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.045 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -7.4 51.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.669 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -17.23 38.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.42 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.547 HG12 HD13 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -115.02 165.6 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 0.0 111.471 -177.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -142.08 166.17 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.014 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.436 ' H ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -72.47 145.44 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.88 0.372 . . . . 0.0 110.189 176.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.707 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 79.16 1.84 86.25 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.261 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.4 mmt -82.09 137.31 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.82 146.09 53.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.624 0.249 . . . . 0.0 111.051 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.664 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 4.6 pt20 -57.28 -26.84 61.47 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.286 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -43.04 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 0.0 109.983 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -76.02 -32.72 59.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.52 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.418 ' HA ' HG22 ' A' ' 46' ' ' ILE . 59.0 t -64.59 -44.33 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.57 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -65.96 -38.02 87.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.668 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.3 -49.5 75.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.495 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.38 -47.34 34.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.3 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.547 HD13 HG12 ' A' ' 46' ' ' ILE . 5.0 mp -76.17 -43.53 42.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -175.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.13 50.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.935 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 56' ' ' ALA . 18.9 m -77.19 134.3 67.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 120.679 0.275 . . . . 0.0 111.151 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.3 Cg_exo -66.66 146.47 79.19 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.888 2.392 . . . . 0.0 111.578 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.557 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -69.66 123.97 22.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.217 0.532 . . . . 0.0 110.179 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.75 157.54 44.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.289 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.74 126.97 47.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.125 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.93 121.54 21.94 Favored Pre-proline 0 N--CA 1.447 -0.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -86.47 -3.5 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.672 2.248 . . . . 0.0 113.522 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -102.3 -27.0 13.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.91 34.04 3.88 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.063 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -77.17 84.81 3.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.36 52.94 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.886 0.85 . . . . 0.0 110.3 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -137.54 119.87 15.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.548 175.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 m0 -104.26 128.33 52.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.762 -174.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.78 131.66 55.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.776 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.426 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 23.1 m-85 -136.47 139.84 42.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.931 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 121.44 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.788 ' HA ' ' HE2' ' A' ' 37' ' ' TYR . 7.4 p90 -140.29 150.37 43.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.302 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.69 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -105.35 114.21 28.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.9 0.857 . . . . 0.0 110.137 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -107.94 -130.15 0.29 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.259 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -65.81 129.99 94.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 5.9 Cg_exo -75.61 -161.86 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.261 2.641 . . . . 0.0 112.381 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.91 -67.33 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.565 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -163.55 158.11 20.36 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -178.09 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.6 OUTLIER 81.36 -19.83 0.4 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.064 0.852 . . . . 0.0 111.915 172.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 -37.09 1.56 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.238 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.53 86.07 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.644 0.735 . . . . 0.0 109.18 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.409 HG22 ' HB1' ' A' ' 109' ' ' ALA . 11.4 m -167.66 119.37 0.87 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.524 HE22 ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -131.48 172.44 12.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -165.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.437 ' H ' ' HG2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -117.71 137.8 52.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.103 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.11 136.97 54.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.925 0.393 . . . . 0.0 111.766 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -86.98 105.68 17.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.356 174.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.8 104.71 14.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.952 0.406 . . . . 0.0 110.311 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.2 mp -98.32 118.43 34.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.438 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.89 111.96 23.28 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.689 ' HB3' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -126.28 146.09 50.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.247 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 168.03 18.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -20.54 8.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -171.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.66 -5.18 56.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.971 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.664 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 87.93 22.19 43.27 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.164 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.707 HG12 ' HA2' ' A' ' 49' ' ' GLY . 53.2 t -100.28 111.52 30.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.689 HD22 ' HB3' ' A' ' 95' ' ' PHE . 13.9 mt -54.88 101.85 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.054 0.454 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.72 42.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.454 0.645 . . . . 0.0 109.728 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 136.19 6.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.023 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 105' ' ' ASP . 29.7 mt -106.84 134.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 104' ' ' ILE . 1.9 t0 -109.01 101.18 10.28 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -133.91 104.44 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.924 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 145.03 54.08 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.422 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 31.1 Cg_exo -59.63 162.16 16.04 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.376 2.05 . . . . 0.0 111.08 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -58.9 -21.45 57.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.198 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 . . . . . 0 CA--C 1.519 -0.241 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -79.83 -174.89 4.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -72.61 155.46 40.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.976 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 162.95 25.68 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.87 69.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.998 0.428 . . . . 0.0 110.637 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -68.19 -23.62 64.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.059 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.694 ' HB3' HD12 ' A' ' 38' ' ' LEU . 1.8 t70 -84.61 -22.35 30.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.74 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG11 HD12 ' A' ' 91' ' ' LEU . 39.6 t -71.02 -27.16 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.309 0.576 . . . . 0.0 110.436 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -5.05 12.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.797 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HB2' ' HE2' ' A' ' 45' ' ' LYS . 9.1 mtmt -78.24 -13.25 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.84 -176.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.689 ' HB2' ' HG3' ' A' ' 50' ' ' MET . 84.3 mmt-85 -141.64 159.03 43.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.446 -173.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.9 121.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.916 174.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.791 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 103.22 -2.68 47.19 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -175.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.689 ' HG3' ' HB2' ' A' ' 47' ' ' ARG . 5.6 mtt -65.98 147.11 53.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -79.16 151.72 31.13 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -49.65 -43.24 46.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.596 0.56 . . . . 0.0 111.435 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -68.86 -37.29 78.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.28 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -73.23 -33.34 65.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -61.77 -51.11 76.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.572 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.95 82.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.715 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -45.66 88.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.391 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.74 -51.97 10.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 -177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.5 -35.37 65.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.298 -175.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.1 27.42 10.96 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.439 HG21 ' HD2' ' A' ' 62' ' ' PRO . 1.3 m -71.64 135.95 83.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.311 -0.445 . . . . 0.0 111.769 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD2' HG21 ' A' ' 61' ' ' THR . 22.2 Cg_exo -65.64 137.97 52.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 110.917 171.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.65 134.24 53.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.51 155.53 16.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.102 0.477 . . . . 0.0 111.319 -172.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.91 81.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.254 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.79 75.14 68.32 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.189 0.518 . . . . 0.0 110.003 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.92 -3.44 13.86 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.696 2.931 . . . . 0.0 112.208 -173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -19.68 63.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.38 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.6 18.76 10.47 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.016 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.09 105.64 4.63 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.705 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 5.4 m-80 -92.13 36.14 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.435 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.98 128.49 34.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.301 177.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.1 m0 -103.7 141.39 36.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.759 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -113.49 111.38 21.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.458 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.55 129.12 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.994 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 t -108.77 107.26 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.686 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 20.7 p90 -123.52 153.71 40.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.057 0.456 . . . . 0.0 110.645 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 139.24 58.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.946 -172.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -169.52 2.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.515 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.435 ' N ' HE21 ' A' ' 80' ' ' GLN . 0.0 OUTLIER -74.83 139.2 73.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 16.9 Cg_exo -68.03 68.44 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.196 2.598 . . . . 0.0 113.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 161.2 -96.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.829 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.525 ' HB3' ' OG1' ' A' ' 87' ' ' THR . 0.4 OUTLIER 57.43 -100.7 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.861 0.465 . . . . 0.0 111.527 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.439 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 8.3 tp10 -123.27 -14.66 7.41 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.19 -37.75 3.32 Favored Glycine 0 C--N 1.322 -0.218 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.4 89.02 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 164.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 83' ' ' HIS . 3.5 m -156.03 113.62 3.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.896 -161.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.745 ' H ' ' HB1' ' A' ' 109' ' ' ALA . 4.1 tp-100 -170.19 -178.43 2.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -161.71 155.08 21.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.546 0.612 . . . . 0.0 111.198 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -126.72 125.51 41.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.875 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.795 HD21 ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -84.75 111.17 19.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.138 -177.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -89.64 107.04 18.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.651 176.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.4 mp -100.63 121.46 41.65 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -113.59 127.57 56.12 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -127.17 158.08 38.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -88.73 171.75 9.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.33 -25.49 24.35 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -13.13 60.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.007 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.06 22.79 24.34 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.791 HG12 ' HA2' ' A' ' 49' ' ' GLY . 42.0 t -99.42 115.87 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.109 0.164 . . . . 0.0 110.674 -174.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -53.96 107.38 0.26 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 110.606 177.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.45 -13.77 17.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.771 -176.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.546 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 22.3 t-20 -159.85 127.84 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.237 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.715 HG21 ' N ' ' A' ' 105' ' ' ASP . 5.0 mt -108.44 142.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.715 ' N ' HG21 ' A' ' 104' ' ' ILE . 6.7 t70 -144.53 103.05 3.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.848 0.356 . . . . 0.0 111.143 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.795 ' HB2' HD21 ' A' ' 91' ' ' LEU . 21.9 t30 -115.51 109.31 17.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 2.2 mmtt -121.94 107.0 36.0 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.279 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.436 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 8.3 Cg_exo -72.22 143.45 39.67 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.021 2.48 . . . . 0.0 112.352 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.745 ' HB1' ' H ' ' A' ' 88' ' ' GLN . . . -60.08 92.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.552 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.559 177.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.5 t30 . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -169.35 0.49 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -86.71 159.03 19.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.189 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 t -127.78 170.57 12.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 0.0 110.597 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.82 -23.71 67.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.169 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -65.17 -30.12 71.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.986 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.934 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 42.3 m-20 -74.87 -31.15 61.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.04 -27.64 38.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.24 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -12.09 60.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.769 0.318 . . . . 0.0 111.289 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.934 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 mttt -78.01 -46.23 21.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.748 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pp -70.25 154.39 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.989 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.622 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -123.75 156.64 35.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -174.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -68.36 131.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.66 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 85.18 4.09 86.82 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.195 -176.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.622 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -72.21 142.45 49.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.527 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -83.93 151.1 25.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 111.121 -176.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.639 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 1.1 pt20 -51.37 -35.3 37.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.055 -172.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.527 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 2.3 mp0 -64.66 -50.32 67.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.841 0.353 . . . . 0.0 110.106 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -68.37 -36.56 79.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.9 t -59.59 -47.32 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.288 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.551 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -74.68 -23.94 58.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.149 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 -41.85 10.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.543 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.37 -10.94 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.764 0.316 . . . . 0.0 111.549 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.85 40.83 57.14 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.412 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 1.7 m -67.98 128.6 93.32 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.507 0.194 . . . . 0.0 111.217 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.85 173.93 7.44 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.266 2.644 . . . . 0.0 112.289 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.88 116.66 2.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.06 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.59 127.19 46.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.375 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.38 81.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.01 115.16 64.53 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 109.268 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 -2.44 12.61 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.7 2.266 . . . . 0.0 112.647 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -100.71 -26.9 13.64 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.5 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.49 4.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.348 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -71.28 99.26 1.89 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.387 0.613 . . . . 0.0 110.546 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 95' ' ' PHE . 5.4 p30 -90.88 43.24 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.258 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.03 129.38 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.87 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 13.5 m0 -116.81 142.76 46.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -120.8 127.06 51.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.992 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.83 153.85 49.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.823 0.344 . . . . 0.0 110.305 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.89 132.76 29.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.444 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 2.6 p90 -125.81 138.1 53.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.996 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.12 116.95 13.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.793 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.415 ' HB3' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -120.39 -92.5 0.54 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.543 -171.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -128.03 117.78 20.65 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.836 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.488 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 8.1 Cg_exo -71.97 -95.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.871 2.381 . . . . 0.0 111.992 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 111.17 157.36 14.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.081 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -101.85 -40.33 6.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -110.81 119.96 40.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.795 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.68 55.21 0.95 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.999 -172.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -74.88 89.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.422 0.63 . . . . 0.0 109.456 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -159.54 162.33 35.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.801 -171.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 88' ' ' GLN . 1.4 tp60 -136.35 179.82 6.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.439 0.638 . . . . 0.0 111.976 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 108' ' ' PRO . 3.5 mp0 -78.94 148.23 32.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.258 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.94 118.36 27.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.444 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -112.46 105.37 13.6 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 110.406 178.015 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -115.55 126.35 54.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.641 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.1 mp -111.43 131.04 55.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.975 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.89 131.24 53.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.633 ' HE1' HD23 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -118.73 130.46 55.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.919 0.39 . . . . 0.0 110.784 -174.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.416 ' HB2' HG21 ' A' ' 102' ' ' THR . 66.1 t30 -77.54 162.4 27.15 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.18 45.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -2.51 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.639 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 85.05 22.3 52.85 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.66 HG12 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -94.15 130.16 43.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.516 0.198 . . . . 0.0 110.919 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.633 HD23 ' HE1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -58.96 96.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.506 174.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.416 HG21 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.52 -32.9 58.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.179 0.514 . . . . 0.0 110.762 -178.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -164.38 142.57 6.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.838 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.503 HG13 HD12 ' A' ' 101' ' ' LEU . 3.3 mt -111.54 129.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.479 ' N ' HG22 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -97.34 101.14 12.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.68 115.39 18.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.12 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -145.56 136.93 12.72 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.613 -177.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.675 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . 18.0 Cg_exo -66.84 169.88 13.85 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.154 2.569 . . . . 0.0 112.114 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.403 ' HB3' ' CA ' ' A' ' 88' ' ' GLN . . . -74.08 -28.11 61.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.085 0.469 . . . . 0.0 110.606 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.738 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -102.81 175.08 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.999 0.428 . . . . 0.0 110.93 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.6 152.37 49.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.884 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -125.27 174.09 8.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.696 0.284 . . . . 0.0 110.331 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.36 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.966 0.412 . . . . 0.0 111.337 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.42 -29.12 70.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.21 -27.4 68.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.716 HG21 HD23 ' A' ' 91' ' ' LEU . 2.3 t -79.98 -18.65 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -75.99 -12.21 60.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.161 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -82.11 -29.29 31.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.612 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.25 -167.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 50' ' ' MET . 1.4 ptt85 -154.85 164.52 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.385 . . . . 0.0 111.601 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.28 141.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.793 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.663 ' H ' ' HB3' ' A' ' 101' ' ' LEU . . . 86.4 -5.3 84.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.761 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.619 ' HE2' ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -68.22 131.37 45.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -69.59 146.64 51.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.519 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -50.04 -37.5 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.48 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -68.53 -38.5 80.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.525 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.619 ' HB3' ' HE2' ' A' ' 50' ' ' MET . 3.5 mp0 -77.46 -31.54 53.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.359 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.09 -49.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.675 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.73 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -57.26 8.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.0 -42.66 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.26 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.1 tp -85.88 -28.97 24.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 0.0 110.696 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.06 79.67 1.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.724 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 m -105.62 134.32 19.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.458 0.171 . . . . 0.0 111.28 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.42 134.96 54.53 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.833 2.355 . . . . 0.0 112.05 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 138.11 51.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.159 -175.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -140.27 170.81 15.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.277 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.7 13.32 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -155.92 90.27 2.79 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.83 -8.15 5.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.948 2.432 . . . . 0.0 112.325 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.25 -27.36 11.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -173.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.2 31.0 6.72 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -83.89 88.5 7.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.657 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.94 64.63 7.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.369 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.67 HG23 HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -141.36 137.35 32.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.455 176.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -125.43 155.41 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.381 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.55 134.42 33.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.725 0.298 . . . . 0.0 110.468 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -122.38 146.63 47.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.272 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.68 114.38 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.52 ' HE1' HD21 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -94.13 128.44 40.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.114 -170.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -77.66 103.42 7.59 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.58 ' HB3' HE21 ' A' ' 89' ' ' GLN . 1.5 tp-100 -140.84 168.17 20.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 -171.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -70.87 127.47 91.73 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.246 0.546 . . . . 0.0 110.923 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 36.7 Cg_endo -93.35 -37.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.012 2.474 . . . . 0.0 113.495 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.89 -149.15 27.95 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.999 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.96 52.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.528 0.664 . . . . 0.0 111.665 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.44 -30.67 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.171 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.29 -33.64 6.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.69 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.72 86.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -161.32 98.37 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.748 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.437 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -147.0 107.36 4.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.943 178.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.58 HE21 ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -90.88 123.64 34.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.485 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.55 44.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.716 HD23 HG21 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -84.13 115.31 22.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -106.08 132.78 51.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.177 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.5 mp -111.41 122.15 47.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.881 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.67 HG22 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -114.6 114.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -176.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.46 ' CD1' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -113.34 158.57 20.41 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -86.99 169.07 12.76 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.2 -23.42 47.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -173.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -11.63 60.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.5 27.05 12.2 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.246 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.549 HG12 ' HA2' ' A' ' 49' ' ' GLY . 30.7 t -111.78 125.1 69.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.865 0.333 . . . . 0.0 111.127 -174.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.663 ' HB3' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -53.68 111.11 0.67 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -24.74 13.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.915 0.388 . . . . 0.0 110.343 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -155.5 131.49 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.641 HG21 ' N ' ' A' ' 105' ' ' ASP . 1.4 mp -105.95 140.17 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 170.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.641 ' N ' HG21 ' A' ' 104' ' ' ILE . 10.7 t70 -117.04 109.97 17.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.9 101.35 3.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.157 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 140.9 29.67 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.648 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.446 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 11.3 Cg_endo -56.14 133.37 57.59 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.514 2.143 . . . . 0.0 111.815 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.437 ' CB ' ' H ' ' A' ' 88' ' ' GLN . . . -60.67 -24.92 65.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.129 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 CA--C 1.519 -0.233 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -123.78 -169.47 1.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.51 150.98 32.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.909 0.385 . . . . 0.0 111.528 -175.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.05 145.25 35.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.52 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HA ' ' CE2' ' A' ' 77' ' ' PHE . . . -74.27 -41.89 60.52 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.012 0.434 . . . . 0.0 110.329 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.04 -22.44 66.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.661 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 8.1 m-20 -69.49 -37.22 77.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.977 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.578 HG22 ' HZ ' ' A' ' 77' ' ' PHE . 9.2 t -76.1 -16.9 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.529 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 -7.38 56.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 4.7 mtpt -82.49 -34.03 28.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.2 pp -80.5 160.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.579 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -136.92 165.51 25.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.85 -171.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -72.3 145.38 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.615 ' HA2' ' CG1' ' A' ' 100' ' ' VAL . . . 75.93 2.77 72.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.38 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.1 mmm -83.9 137.06 33.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.2 OUTLIER -78.17 152.39 32.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 -176.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -32.74 62.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.313 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -64.66 -45.34 87.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -72.63 -33.74 66.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.051 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 59' ' ' LEU . 56.0 t -62.23 -49.68 83.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.632 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.5 69.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.78 -54.43 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.815 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.83 34.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.814 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' A' ' 55' ' ' VAL . 8.3 tp -84.79 -40.27 17.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.22 -176.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.08 63.47 0.81 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.178 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 5.7 m -101.81 133.37 20.79 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -80.19 172.45 13.78 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.136 2.557 . . . . 0.0 111.649 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 138.94 56.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.818 0.342 . . . . 0.0 110.657 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.1 ttp -142.21 178.7 7.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.052 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -121.51 152.34 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.76 0.314 . . . . 0.0 111.418 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.75 46.13 0.35 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.172 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.24 -34.08 88.93 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.0 113.449 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -104.26 7.73 35.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.797 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.03 21.13 9.18 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.425 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.84 85.61 3.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.247 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' A' ' 71' ' ' ASN . 4.0 m120 -108.86 27.87 9.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.298 0.57 . . . . 0.0 111.374 -172.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.76 129.57 49.45 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.258 170.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -103.46 121.58 43.13 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.53 114.67 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.365 -176.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -106.12 130.99 53.91 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.884 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.05 108.76 16.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.578 ' HZ ' HG22 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -115.28 116.47 28.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 102.35 11.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.923 165.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -118.9 -37.68 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.184 0.516 . . . . 0.0 110.697 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -147.57 141.47 15.76 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.572 175.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.504 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 1.3 Cg_endo -85.4 -104.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.136 2.557 . . . . 0.0 111.987 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 116.19 165.94 14.39 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.9 97.2 9.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.929 0.365 . . . . 0.0 110.787 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -159.23 -63.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.02 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 -35.76 4.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.453 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -106.42 87.18 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.511 HG23 ' HB1' ' A' ' 109' ' ' ALA . 27.2 m -159.41 101.24 1.53 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.559 -168.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.517 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 19.2 tp60 -151.69 144.48 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.55 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.71 147.01 44.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.482 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.05 127.98 47.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.389 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.02 114.73 21.93 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.97 105.41 14.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.331 0.586 . . . . 0.0 111.515 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 6.6 mp -87.34 148.04 25.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.815 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.19 116.24 12.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.616 ' HB3' HD22 ' A' ' 101' ' ' LEU . 26.6 p90 -129.2 145.03 51.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.63 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.41 163.01 28.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.892 177.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.08 -38.49 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -3.51 25.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.63 17.82 47.36 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.182 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.615 ' CG1' ' HA2' ' A' ' 49' ' ' GLY . 14.3 t -97.08 114.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 95' ' ' PHE . 1.4 mm? -54.82 106.21 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.552 0.533 . . . . 0.0 110.837 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.41 -28.22 19.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.146 0.498 . . . . 0.0 110.891 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -158.8 149.65 20.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.696 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.505 HG22 ' N ' ' A' ' 105' ' ' ASP . 1.7 mp -124.02 130.03 73.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 171.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -98.13 101.65 13.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.599 174.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -125.11 106.53 9.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.223 0.535 . . . . 0.0 110.376 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 144.59 35.68 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 159.64 40.71 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.299 1.999 . . . . 0.0 111.274 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.517 ' HB2' ' C ' ' A' ' 88' ' ' GLN . . . -66.37 -34.92 79.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.18 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.4 t30 . . . . . 0 C--O 1.23 0.07 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 -179.74 3.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.649 HD23 ' HE1' ' A' ' 77' ' ' PHE . 12.4 tp -78.87 131.81 36.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.414 . . . . 0.0 110.772 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 145.84 27.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.302 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.01 81.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.969 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.91 -22.15 65.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.493 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -42.3 89.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.866 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.589 HG21 ' HZ ' ' A' ' 77' ' ' PHE . 6.3 t -74.98 -17.06 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.747 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -73.86 -7.36 51.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.854 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -76.06 -37.9 57.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.061 0.457 . . . . 0.0 110.165 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -91.0 179.13 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.874 177.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.587 ' O ' ' HB2' ' A' ' 50' ' ' MET . 7.7 ptp180 -157.81 167.66 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.769 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 101' ' ' LEU . 61.9 t -66.36 128.96 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.785 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.612 ' HA2' HG11 ' A' ' 100' ' ' VAL . . . 95.51 -4.7 66.84 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.01 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -81.26 161.84 23.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -79.29 144.67 34.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.069 0.462 . . . . 0.0 111.518 -169.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -61.31 -36.32 79.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.728 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.67 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -79.52 -30.54 41.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.154 -172.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 54' ' ' GLN . 2.3 tt0 -75.26 -37.68 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 51' ' ' THR . 38.4 t -60.44 -46.24 95.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.796 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -68.5 -31.88 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.873 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -37.62 83.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.153 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.7 -44.8 13.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.989 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 59' ' ' LEU . 88.0 mt -88.93 -6.74 57.06 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 55.8 17.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.464 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.565 HG22 ' HD2' ' A' ' 62' ' ' PRO . 2.0 m -79.02 130.95 68.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.477 0.179 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.565 ' HD2' HG22 ' A' ' 61' ' ' THR . 52.9 Cg_exo -55.89 148.84 54.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.143 2.562 . . . . 0.0 112.588 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.56 113.74 13.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.374 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.78 131.29 47.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.142 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.53 102.6 8.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.07 115.36 38.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 120.911 0.386 . . . . 0.0 110.571 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.43 -2.03 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.063 2.508 . . . . 0.0 112.183 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -81.55 -26.73 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.642 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.82 30.17 4.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.839 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -80.43 108.99 14.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.983 0.421 . . . . 0.0 110.59 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -112.49 39.16 2.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.427 0.632 . . . . 0.0 110.229 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.69 141.45 52.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.52 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.691 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 3.0 m0 -116.31 142.96 46.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -124.9 111.56 15.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.138 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.469 ' HD2' HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -107.57 140.78 40.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.436 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.487 ' H ' HG21 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -90.96 114.74 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.076 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.649 ' HE1' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -102.89 142.25 34.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.28 148.41 47.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.733 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -129.57 167.66 17.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.2 mm-40 -88.1 115.77 64.17 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.2 Cg_exo -70.36 70.09 1.93 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.158 2.572 . . . . 0.0 111.978 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.36 -150.0 17.51 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.444 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.61 3.04 30.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.0 111.871 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.9 -48.23 16.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.31 0.576 . . . . 0.0 110.095 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.66 -39.2 1.51 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.727 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.41 88.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 117.108 0.454 . . . . 0.0 110.798 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.571 HG21 ' HB1' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -169.69 136.1 1.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.89 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 29.5 tp60 -154.76 130.9 10.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.095 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -75.14 124.56 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 110.536 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.6 110.44 20.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.954 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.457 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.91 106.93 15.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.974 0.416 . . . . 0.0 110.537 -175.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 111.3 22.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.853 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.691 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 4.1 mp -106.66 142.6 36.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.002 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.512 ' O ' HD11 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -139.74 133.85 31.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -132.2 141.65 49.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.88 0.371 . . . . 0.0 110.442 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.627 ' HB2' HG21 ' A' ' 102' ' ' THR . 5.5 t-20 -78.1 156.56 29.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.247 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -14.14 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.766 0.666 . . . . 0.0 112.245 -176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -15.01 61.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 0.0 110.496 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 97.36 19.55 25.27 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.164 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.612 HG11 ' HA2' ' A' ' 49' ' ' GLY . 2.2 t -113.47 126.4 70.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 122.877 0.471 . . . . 0.0 110.564 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 94' ' ' THR . 2.9 mm? -55.46 108.23 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 173.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.627 HG21 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.08 -31.99 59.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.838 0.351 . . . . 0.0 110.627 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -167.43 149.7 5.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.146 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.614 HG23 ' N ' ' A' ' 105' ' ' ASP . 6.1 mt -127.7 138.33 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.614 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -115.73 102.82 10.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.171 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.06 101.45 9.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.27 153.71 44.9 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.188 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.508 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 52.2 Cg_exo -56.73 151.49 47.39 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.87 2.38 . . . . 0.0 112.396 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' A' ' 87' ' ' THR . . . -60.6 -79.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.208 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.34 0 O-C-N 123.272 0.357 . . . . 0.0 110.817 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 t30 . . . . . 0 CA--C 1.521 -0.153 0 CA-C-O 121.391 0.615 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -154.43 157.34 38.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.535 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 38' ' ' LEU . 8.9 tp -127.03 141.62 51.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.0 110.72 177.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.15 145.21 25.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.974 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.94 78.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.59 -35.54 76.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -63.37 -40.68 97.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.434 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.38 -26.4 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 110.382 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m -75.8 -10.65 59.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.315 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -34.02 41.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.493 ' HB ' ' H ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -81.1 -150.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.711 0.291 . . . . 0.0 110.786 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.892 ' HB3' ' HG3' ' A' ' 50' ' ' MET . 0.6 OUTLIER -156.59 134.47 11.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.651 0.262 . . . . 0.0 110.665 -173.12 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 48' ' ' VAL . 1.9 p -71.43 122.26 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.87 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 106.98 2.87 36.41 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.449 -175.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.892 ' HG3' ' HB3' ' A' ' 47' ' ' ARG . 3.9 mtt -78.87 151.61 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.78 154.1 36.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.919 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -48.72 -39.33 24.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.708 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -59.91 -46.18 90.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.074 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.53 -40.25 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.717 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.486 HG11 HD12 ' A' ' 59' ' ' LEU . 84.4 t -58.29 -45.85 89.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.236 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -29.93 68.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 111.087 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.18 -57.72 2.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.844 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.486 HD12 HG11 ' A' ' 55' ' ' VAL . 26.8 mt -81.36 -20.56 40.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -172.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.2 31.01 32.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.318 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.704 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -65.52 136.41 96.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.689 -178.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.704 ' HD2' HG23 ' A' ' 61' ' ' THR . 57.7 Cg_endo -73.96 151.22 44.78 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.515 2.144 . . . . 0.0 111.945 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.6 106.43 15.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.001 0.429 . . . . 0.0 110.225 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.4 tpt -95.08 120.6 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.735 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.86 117.53 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.735 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.28 112.31 13.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.448 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.89 -2.99 12.89 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.721 2.281 . . . . 0.0 112.574 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.411 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -85.61 -25.69 26.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.923 -176.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.78 29.34 4.7 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.948 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -72.92 107.82 5.51 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.165 0.507 . . . . 0.0 110.644 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -103.6 25.89 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.124 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -131.01 127.17 37.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.531 178.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.432 ' CZ3' HG21 ' A' ' 61' ' ' THR . 3.8 m0 -104.01 124.74 49.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -103.78 135.7 44.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.81 151.24 50.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 178.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.58 115.34 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.367 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.521 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -93.56 160.26 14.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.693 -178.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 78' ' ' ARG . 4.4 ptm180 -126.16 132.93 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.687 0.279 . . . . 0.0 110.329 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.1 -44.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.854 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.43 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -90.62 120.21 68.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -54.28 4.54 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.885 2.39 . . . . 0.0 112.563 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.79 127.82 1.04 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.864 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 179.24 149.66 0.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.836 0.454 . . . . 0.0 110.137 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 72.62 -41.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.856 0.862 . . . . 0.0 112.321 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.17 -37.78 3.55 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 t -115.2 86.74 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 m -164.37 99.96 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 -174.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.593 ' N ' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -165.48 168.36 16.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.877 171.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -82.47 142.81 31.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -176.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 122.85 47.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.322 175.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.521 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -110.03 119.47 39.42 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.12 138.57 50.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 110.652 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -116.59 139.18 50.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.304 177.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -102.78 146.79 27.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -125.18 125.37 43.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 111.805 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.78 ' HB2' HG21 ' A' ' 102' ' ' THR . 47.5 t-20 -73.61 157.02 37.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 170.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -19.69 37.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -7.75 57.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 87.06 29.64 22.35 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.455 ' CG1' ' HA2' ' A' ' 49' ' ' GLY . 1.6 t -111.88 135.6 50.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -174.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.87 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 17.6 mt -60.91 105.77 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.341 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.78 HG21 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -75.56 -30.51 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.186 0.517 . . . . 0.0 110.631 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -168.25 140.82 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.904 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.642 HG21 ' N ' ' A' ' 105' ' ' ASP . 14.2 mt -103.48 139.11 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.642 ' N ' HG21 ' A' ' 104' ' ' ILE . 4.9 t0 -117.52 101.9 8.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.089 175.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 121.48 33.95 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -143.31 129.85 10.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.362 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.88 170.26 2.85 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.273 2.649 . . . . 0.0 112.262 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.593 ' HB3' ' N ' ' A' ' 88' ' ' GLN . . . -63.87 -39.28 93.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.76 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.611 -177.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.275 0.56 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -164.42 177.63 8.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.278 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.652 HD22 HD23 ' A' ' 59' ' ' LEU . 11.9 tp -118.01 140.71 49.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.77 0.319 . . . . 0.0 110.568 175.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.13 145.97 39.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.072 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -63.49 -42.32 98.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.92 -21.77 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.897 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.619 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -73.45 -34.2 65.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.126 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.548 HG22 ' HG ' ' A' ' 91' ' ' LEU . 96.2 t -75.8 -30.77 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 110.091 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.3 m -66.72 -6.56 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.45 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.619 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 13.5 mtpt -70.6 -32.97 70.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.525 HG22 HD13 ' A' ' 59' ' ' LEU . 1.1 pp -93.58 179.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.391 . . . . 0.0 111.151 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -144.3 160.03 41.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.89 -175.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.457 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 2.8 m -69.55 146.25 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.951 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 84.67 -15.77 39.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.291 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.538 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -70.52 141.08 51.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.18 145.92 41.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.898 0.38 . . . . 0.0 111.78 -172.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -35.4 29.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.827 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -64.89 -53.87 39.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.625 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.5 72.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 21.6 t -61.39 -42.19 92.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . -67.13 -37.94 84.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.691 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.21 -34.19 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.645 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.1 -41.07 16.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.507 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.652 HD23 HD22 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -69.73 -43.25 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 111.378 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.9 59.74 0.81 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -71.99 147.33 91.11 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.737 0.303 . . . . 0.0 110.792 -177.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.83 164.64 35.05 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.2 2.6 . . . . 0.0 111.547 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.34 85.31 3.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.346 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mtm -143.77 171.24 14.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.453 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -119.9 -178.05 3.55 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -128.85 53.28 10.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 78.9 Cg_endo -78.23 -4.99 14.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.066 1.844 . . . . 0.0 112.085 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -93.41 -4.59 51.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.262 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.24 35.79 7.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 86.85 2.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.314 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.549 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 17.5 m120 -102.35 7.72 40.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.263 0.554 . . . . 0.0 110.208 176.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.11 123.37 41.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.176 176.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.758 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 11.7 m0 -104.79 137.12 43.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.181 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -118.78 115.27 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.051 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 22.6 m-85 -118.44 148.25 42.76 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.08 117.97 31.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.121 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -104.8 114.46 28.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.05 0.453 . . . . 0.0 111.359 -175.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -93.28 103.87 16.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -151.3 147.27 26.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 -176.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.585 HE22 ' HB3' ' A' ' 108' ' ' PRO . 31.5 mt-30 73.13 147.79 0.12 Allowed Pre-proline 0 N--CA 1.466 0.371 0 O-C-N 123.984 0.803 . . . . 0.0 111.485 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.3 Cg_exo -71.85 -2.35 11.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 112.572 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' HA2' HG22 ' A' ' 87' ' ' THR . . . 95.95 148.59 24.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.967 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.425 ' H ' ' CB ' ' A' ' 87' ' ' THR . 3.0 t-80 -118.89 117.76 29.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 60.98 20.56 10.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.99 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.44 -9.29 42.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.023 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.38 87.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.022 0.411 . . . . 0.0 110.0 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.48 HG22 ' HA2' ' A' ' 82' ' ' GLY . 11.7 m -163.26 121.53 1.99 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.39 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.534 ' NE2' ' HA ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -176.61 112.26 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.22 0.95 . . . . 0.0 109.156 170.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.583 ' NE2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -78.47 165.98 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.283 0.563 . . . . 0.0 111.842 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.9 t -123.54 127.21 48.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.726 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.548 ' HG ' HG22 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -84.56 110.9 19.05 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 1.9 m -109.37 110.99 22.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.353 -177.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.758 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -91.79 142.15 27.9 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.585 177.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -135.22 117.79 15.91 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 1.1 p90 -132.2 157.62 43.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.085 0.469 . . . . 0.0 110.936 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.31 161.73 22.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.17 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -20.0 24.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -9.0 58.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.493 0.663 . . . . 0.0 110.314 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.82 8.73 57.96 Favored Glycine 0 C--O 1.219 -0.783 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.636 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.951 HG12 ' HA2' ' A' ' 49' ' ' GLY . 55.1 t -89.2 110.0 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 122.894 -0.18 . . . . 0.0 111.15 -172.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 0.6 OUTLIER -55.22 107.5 0.32 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.593 0.558 . . . . 0.0 110.101 174.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.36 -25.82 14.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.776 0.322 . . . . 0.0 111.142 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.56 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 18.1 t30 -150.29 143.84 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 105' ' ' ASP . 4.2 mt -127.87 133.78 66.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.528 ' N ' HG22 ' A' ' 104' ' ' ILE . 6.4 t70 -103.28 101.87 11.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.278 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -132.33 102.0 5.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.229 0.538 . . . . 0.0 110.149 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 165.6 21.73 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.585 ' HB3' HE22 ' A' ' 80' ' ' GLN . 23.2 Cg_exo -65.78 158.22 54.81 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.223 1.949 . . . . 0.0 110.778 169.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.33 59.53 0.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 111.467 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.513 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.1 179.48 7.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.753 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 43' ' ' VAL . 5.6 tp -75.05 145.12 42.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.638 0.732 . . . . 0.0 112.968 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.43 ' HB ' ' OD1' ' A' ' 42' ' ' ASP . 4.7 m -116.14 152.6 33.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.187 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -54.84 -38.96 68.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.17 -47.05 87.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.384 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.43 ' OD1' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -68.35 -20.4 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.603 -176.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.508 HG21 HD21 ' A' ' 38' ' ' LEU . 1.2 t -78.8 -27.01 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.748 0.308 . . . . 0.0 111.256 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.9 -7.14 32.02 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 3.36 55.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.21 -169.03 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.236 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -147.79 143.2 27.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.07 0.462 . . . . 0.0 112.018 -174.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.1 t -76.05 137.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.87 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.746 ' HA2' HG11 ' A' ' 100' ' ' VAL . . . 89.26 -6.46 83.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.902 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.2 mmm -71.04 153.24 42.76 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -77.78 145.66 36.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.89 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -36.31 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.298 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 1.6 mp0 -70.15 -40.81 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.279 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.64 -34.76 60.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.754 -177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.51 -46.49 94.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.548 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -62.67 -41.14 98.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.574 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -60.22 -49.2 78.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.6 -36.35 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.232 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -80.08 -37.62 33.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.4 . . . . 0.0 111.54 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.44 52.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -173.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -122.08 139.85 31.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.45 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.41 138.7 82.34 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.323 2.015 . . . . 0.0 110.716 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.3 mt -74.07 87.92 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.151 0.501 . . . . 0.0 110.649 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 109.12 12.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.776 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.64 142.05 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.969 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.34 131.64 24.37 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -92.54 -2.97 3.75 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.932 2.422 . . . . 0.0 112.996 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.473 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -103.01 -26.16 13.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.12 5.54 32.7 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.46 7.34 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.957 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 71' ' ' ASN . 3.1 m120 -99.73 51.71 0.92 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.225 -174.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.88 128.85 55.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.373 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.548 ' HH2' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -103.4 141.07 36.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -123.12 119.8 31.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 144.14 47.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.232 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.468 ' H ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -84.94 117.13 29.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -94.18 116.88 29.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -175.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.15 104.35 12.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.616 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.73 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -165.31 129.15 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.402 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -142.47 117.74 6.7 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.77 0.319 . . . . 0.0 110.801 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.39 -3.19 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.472 2.115 . . . . 0.0 111.927 176.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -11.77 60.11 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.092 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.11 132.79 47.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.671 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER 75.98 -67.44 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 124.106 0.879 . . . . 0.0 112.294 172.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 -36.52 4.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.71 86.74 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 m -170.37 131.81 0.97 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.303 -174.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.472 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 28.0 tp60 -143.86 114.01 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.366 0.603 . . . . 0.0 110.782 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.73 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -75.83 135.14 40.21 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.074 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.32 132.5 56.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.635 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.506 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -95.93 110.31 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.482 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -108.95 138.65 44.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.106 0.479 . . . . 0.0 110.996 -177.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 72' ' ' THR . 3.4 mp -117.32 131.05 56.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.68 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.88 105.4 9.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.884 0.373 . . . . 0.0 110.087 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.427 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -116.09 135.71 53.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.78 -178.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.404 ' ND2' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -72.69 164.89 25.81 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.77 -31.4 2.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -170.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -4.51 33.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 111.295 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 93.61 9.86 59.66 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.021 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.746 HG11 ' HA2' ' A' ' 49' ' ' GLY . 21.0 t -93.49 116.22 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -174.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.49 HD11 HG13 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -54.28 97.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.773 0.671 . . . . 0.0 110.464 176.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.427 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -76.99 -31.51 56.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.909 0.385 . . . . 0.0 110.449 -176.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.68 140.66 9.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.147 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.595 HG21 ' N ' ' A' ' 105' ' ' ASP . 1.7 mp -103.45 139.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 171.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.595 ' N ' HG21 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -107.39 102.03 11.34 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -113.8 102.84 10.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 127.34 10.96 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.039 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.638 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 13.6 Cg_exo -70.9 150.95 62.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.923 2.415 . . . . 0.0 110.554 171.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.472 ' CB ' ' H ' ' A' ' 88' ' ' GLN . . . -81.44 38.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 110.842 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.531 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.957 0.408 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.47 137.51 33.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.156 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.24 106.04 16.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.266 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.54 93.01 9.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.376 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -108.53 103.96 13.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.961 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.1 85.36 2.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.14 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.8 p -89.53 146.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.635 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.32 121.04 59.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.97 0.414 . . . . 0.0 111.085 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.454 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 3.8 t80 -99.05 139.29 34.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.93 113.02 55.51 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.597 0.237 . . . . 0.0 111.46 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 28' ' ' TYR . 5.4 Cg_exo -77.52 45.36 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.285 2.657 . . . . 0.0 111.269 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -136.95 23.68 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.305 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.0 140.45 37.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.296 -173.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -114.89 96.77 5.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.389 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -106.93 67.5 0.71 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.985 0.422 . . . . 0.0 110.972 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.53 -160.56 16.97 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.972 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.2 t30 67.98 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.628 0.771 . . . . 0.0 111.358 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.52 ' HD2' ' HD2' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -126.43 167.54 15.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.03 140.14 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.72 145.03 45.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.601 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.28 99.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 110.671 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.71 -27.8 68.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.684 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.46 ' CG ' ' HZ3' ' A' ' 45' ' ' LYS . 1.5 t70 -72.2 -41.27 67.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.725 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.741 ' HA ' HD23 ' A' ' 59' ' ' LEU . 11.3 t -68.22 -23.73 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 110.433 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 m -77.0 -5.87 50.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' HZ3' ' CG ' ' A' ' 42' ' ' ASP . 25.7 mtmt -68.07 -35.43 78.18 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.731 0.3 . . . . 0.0 111.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.2 pp -84.87 -177.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.402 -175.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.0 175.74 13.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.159 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.521 HG23 HD13 ' A' ' 104' ' ' ILE . 2.8 t -73.05 143.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.665 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.57 ' HA2' ' CG1' ' A' ' 100' ' ' VAL . . . 84.06 -11.13 58.57 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.342 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.85 133.67 47.64 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -77.42 156.73 30.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.362 -175.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.423 ' H ' ' HG3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.94 -44.57 14.89 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.624 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.494 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.87 -37.64 58.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.926 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.451 ' HA ' HG21 ' A' ' 46' ' ' ILE . 78.0 t -60.91 -46.93 95.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 109.983 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -67.67 -35.2 78.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.731 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -43.54 97.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.32 -46.47 20.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 43' ' ' VAL . 7.0 mt -84.05 -16.41 43.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -173.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 17.79 65.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -68.9 141.05 91.83 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 122.534 0.333 . . . . 0.0 111.457 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.14 158.81 53.98 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.481 2.121 . . . . 0.0 111.417 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.67 135.1 57.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.1 128.6 24.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.536 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -149.78 71.33 1.09 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.541 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.16 121.36 84.91 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.36 -2.93 12.94 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.075 2.517 . . . . 0.0 112.358 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -90.0 -20.05 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.447 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.8 4.66 34.0 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.02 85.29 6.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.344 0.592 . . . . 0.0 110.18 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -101.25 49.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.052 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -112.99 128.11 56.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.714 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -103.62 132.47 49.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.54 125.63 52.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.73 154.57 49.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.63 128.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.995 0.426 . . . . 0.0 110.659 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.516 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 6.7 p90 -127.19 173.47 9.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.606 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD2' ' HD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -94.07 131.21 39.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.034 0.445 . . . . 0.0 111.115 -177.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.6 -30.74 0.19 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.867 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.445 HE21 ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -125.74 83.26 62.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.72 -42.42 9.07 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.951 2.434 . . . . 0.0 113.469 -172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.18 138.4 4.76 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.884 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -175.2 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.166 0.586 . . . . 0.0 109.581 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -128.11 -2.25 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.539 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.98 -38.35 2.54 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.53 87.64 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.8 m -159.58 98.27 1.37 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.608 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.97 154.96 22.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.012 -175.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -111.54 131.51 55.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.061 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.24 114.18 25.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.967 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.516 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -84.52 105.43 15.33 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.97 124.1 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.592 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -99.68 139.3 35.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.05 108.1 9.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.77 ' HB3' HD23 ' A' ' 101' ' ' LEU . 36.0 p90 -115.35 133.22 56.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.963 0.411 . . . . 0.0 109.976 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.48 ' HB3' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -73.91 162.26 29.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.972 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.29 -22.38 2.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.24 -10.2 59.51 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.776 -0.577 . . . . 0.0 110.94 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 98.83 10.05 50.72 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.213 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.57 ' CG1' ' HA2' ' A' ' 49' ' ' GLY . 18.0 t -98.93 119.53 47.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 122.343 0.257 . . . . 0.0 110.709 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.77 HD23 ' HB3' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -55.14 105.48 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.423 0.452 . . . . 0.0 109.785 174.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -91.4 -31.95 15.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -175.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -150.34 138.02 19.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.888 0.375 . . . . 0.0 110.923 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.521 HD13 HG23 ' A' ' 48' ' ' VAL . 3.8 mt -110.78 133.05 57.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 174.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.515 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -96.04 99.95 11.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.546 174.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.411 ' C ' ' HG3' ' A' ' 107' ' ' LYS . 28.3 t30 -144.47 101.92 3.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 110.591 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.014 ' HB2' ' HB2' ' A' ' 113' ' ' ASN . 0.7 OUTLIER -142.5 133.75 12.93 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.09 158.61 50.95 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.918 2.412 . . . . 0.0 112.781 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.485 ' HB1' HD23 ' A' ' 114' ' ' LEU . . . -83.08 42.79 0.82 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.02 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.34 59.63 1.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.589 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.485 ' H ' ' HA ' ' A' ' 115' ' ' GLU . 4.6 m 68.95 96.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.312 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.83 -90.38 0.11 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.912 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 1.014 ' HB2' ' HB2' ' A' ' 107' ' ' LYS . 28.2 t30 -77.14 -33.17 56.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.485 HD23 ' HB1' ' A' ' 109' ' ' ALA . 5.3 tp -157.38 155.49 30.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.156 -1.384 . . . . 0.0 107.823 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.485 ' HA ' ' H ' ' A' ' 111' ' ' SER . 0.1 OUTLIER -125.73 -177.52 3.95 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 133.9 56.52 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -69.97 125.28 26.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.304 0.573 . . . . 0.0 112.239 -166.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.34 122.56 0.03 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.535 -1.212 . . . . 0.0 112.547 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -76.62 74.28 3.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.211 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.3 122.24 35.5 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.3 t60 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.687 -176.433 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.808 0.337 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.43 86.36 5.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.179 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 108.35 1.26 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.904 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 tp -155.04 28.55 0.41 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.11 0.481 . . . . 0.0 110.668 -176.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -79.11 92.45 5.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.894 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -169.95 74.89 0.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.731 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.6 t -106.73 109.23 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.148 0.499 . . . . 0.0 110.932 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.04 114.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.823 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -114.12 136.97 52.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.087 0.47 . . . . 0.0 111.002 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -116.12 138.37 24.12 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.092 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.61 60.07 2.73 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.059 2.506 . . . . 0.0 112.091 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 9.3 t70 -159.47 -133.15 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.103 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 31' ' ' ASP . 7.2 mt 75.56 134.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.306 0.574 . . . . 0.0 111.308 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.34 94.53 2.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.145 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.87 -167.33 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.93 88.47 0.91 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.371 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -118.46 -68.38 0.92 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -159.3 148.63 18.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -75.2 174.03 10.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.233 0.54 . . . . 0.0 111.216 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -128.05 153.05 47.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.677 176.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.44 -21.23 66.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.974 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -74.17 -34.77 63.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.684 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -70.84 -20.58 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 -176.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.31 -17.1 21.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.224 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -90.73 -8.4 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.684 ' HG3' ' HA ' ' A' ' 42' ' ' ASP . 2.0 mtmt -83.22 -30.6 27.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.217 0.532 . . . . 0.0 110.048 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.496 ' H ' HG12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -86.31 144.83 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.859 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -127.57 154.35 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.418 -178.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.575 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -74.36 148.12 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 1.023 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 80.15 -4.42 67.03 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.084 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 16.1 mmt -74.86 138.6 42.59 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 6.0 t -79.41 154.72 28.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.571 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -53.04 -36.18 60.3 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.866 -177.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -60.51 -42.64 96.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.088 0.47 . . . . 0.0 110.579 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -77.0 -34.92 57.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.55 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.51 -45.94 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.032 0.444 . . . . 0.0 109.826 175.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -66.02 -36.36 83.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.738 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.87 -28.03 65.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.355 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.68 -54.48 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.66 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.07 -29.82 34.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.75 0.31 . . . . 0.0 111.812 -174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.24 24.0 9.98 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.179 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.554 HG21 ' HH ' ' A' ' 75' ' ' TYR . 2.5 m -62.35 131.23 93.72 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.431 -0.385 . . . . 0.0 111.336 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.2 165.36 32.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.627 2.218 . . . . 0.0 111.508 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.09 116.82 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.36 119.75 40.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.47 -172.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.27 104.09 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.083 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 134.79 19.92 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.3 -5.65 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.44 2.093 . . . . 0.0 113.46 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.17 -26.24 12.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.1 32.23 7.2 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -73.31 114.92 12.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.895 -0.652 . . . . 0.0 111.249 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.586 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 2.2 m120 -92.41 45.77 1.22 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.262 0.553 . . . . 0.0 110.488 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -148.14 137.08 21.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.618 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.405 ' HE1' HG11 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -105.51 133.11 50.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.067 0.461 . . . . 0.0 110.592 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.554 ' HH ' HG21 ' A' ' 61' ' ' THR . 21.4 m-85 -133.78 149.55 51.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.993 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG11 ' HE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -128.54 133.87 65.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 54.5 p90 -163.13 149.8 12.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.53 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.505 ' HD2' ' HB3' ' A' ' 81' ' ' PRO . 2.0 ttm180 -77.58 104.06 7.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.593 HE22 ' HA ' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -67.96 -44.84 75.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.557 -174.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.49 79.23 74.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.505 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 92.6 Cg_endo -83.7 -3.28 10.57 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.729 2.286 . . . . 0.0 112.337 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.23 126.95 8.33 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.735 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.37 -65.72 0.33 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.732 0.813 . . . . 0.0 112.401 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.64 -56.79 8.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.139 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 -36.52 2.95 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.682 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.1 87.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.369 0.604 . . . . 0.0 109.82 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 109' ' ' ALA . 5.3 m -162.81 115.31 1.6 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.709 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.44 ' O ' ' HB1' ' A' ' 109' ' ' ALA . 12.9 tp60 -136.13 124.7 23.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.852 0.358 . . . . 0.0 111.687 -169.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 161.56 14.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.803 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.226 175.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.441 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -83.26 105.04 13.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.32 108.45 13.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.499 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 72' ' ' THR . 4.8 mp -80.9 121.87 26.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.239 175.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.3 124.88 53.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.695 ' HB3' HD22 ' A' ' 101' ' ' LEU . 30.9 p90 -135.86 160.18 39.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 111.265 -175.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.36 165.01 18.59 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.3 m -64.43 -4.13 3.65 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -7.37 58.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.578 . . . . 0.0 109.853 172.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 86.84 16.27 61.73 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.407 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 1.023 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -103.66 116.61 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.187 0.195 . . . . 0.0 110.477 -173.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 95' ' ' PHE . 19.4 mt -55.24 114.98 2.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.345 0.403 . . . . 0.0 110.971 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.57 -35.3 21.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 109.754 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -162.18 153.76 18.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.111 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.433 HD13 HG12 ' A' ' 48' ' ' VAL . 3.2 mt -110.15 136.12 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.415 ' N ' HG22 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -88.21 101.58 13.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 172.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -140.55 100.76 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 0.0 110.537 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -144.61 169.05 10.77 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.593 ' HA ' HE22 ' A' ' 79' ' ' GLN . 82.6 Cg_endo -81.5 166.56 17.75 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.831 1.688 . . . . 0.0 111.8 171.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 87' ' ' THR . . . -68.38 67.7 0.13 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 110.499 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.514 ' HA ' HD11 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -138.57 28.38 2.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.863 -177.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.69 10.28 2.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.882 -173.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.42 -105.5 1.58 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.491 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -135.51 -60.75 0.74 Allowed 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.652 -0.322 . . . . 0.0 111.593 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.5 ' HG ' ' HG3' ' A' ' 115' ' ' GLU . 0.4 OUTLIER -69.98 -32.62 70.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.848 0.356 . . . . 0.0 111.282 -174.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.5 ' HG3' ' HG ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -81.86 -162.26 0.52 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.258 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.8 p80 39.16 51.91 2.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.691 0.758 . . . . 0.0 111.719 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 56.25 28.98 14.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.866 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 50.19 57.19 6.84 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.95 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.89 114.81 3.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.258 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -97.11 156.54 16.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.961 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 . . . . . 0 C--O 1.243 0.734 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.297 173.061 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.11 90.05 6.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.984 0.421 . . . . 0.0 110.122 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.26 95.44 4.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.303 0.573 . . . . 0.0 110.548 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.08 147.66 27.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.542 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 143.64 26.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.68 109.07 21.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.321 -174.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' H ' HG11 ' A' ' 26' ' ' VAL . 2.4 p -74.91 116.81 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.215 0.531 . . . . 0.0 109.837 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -114.61 166.1 8.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.995 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -62.93 112.19 2.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 110.196 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HE ' ' HB2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -98.29 116.76 65.46 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.766 177.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.92 60.13 2.95 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.849 2.366 . . . . 0.0 111.11 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.487 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -88.18 39.06 0.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.722 -176.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.68 171.04 17.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.938 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -85.64 48.41 1.59 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.029 0.442 . . . . 0.0 110.893 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.85 152.89 22.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.101 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.05 -124.26 8.18 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.051 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 69.11 -79.65 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.242 0.617 . . . . 0.0 111.157 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -113.7 165.64 12.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.64 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.041 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.39 143.52 27.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HA ' HG22 ' A' ' 43' ' ' VAL . . . -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.642 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -21.73 64.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.28 -29.37 31.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.575 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 40' ' ' ALA . 3.5 t -66.99 -17.06 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.154 0.502 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -69.69 -6.37 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.235 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -75.77 -23.29 55.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.188 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.615 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pt -104.91 -179.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.484 0.183 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.9 OUTLIER -154.33 168.4 26.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.543 0.211 . . . . 0.0 110.755 -177.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.61 140.48 18.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.291 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.709 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 81.34 1.74 90.19 Favored Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.999 -0.441 . . . . 0.0 111.999 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.512 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.99 149.05 30.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -75.35 145.63 41.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.717 0.294 . . . . 0.0 110.693 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HG2' ' N ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -58.97 -26.93 64.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.853 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.431 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 10.8 mp0 -63.86 -48.31 77.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.195 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -69.46 -35.55 75.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.383 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.615 ' HA ' HG21 ' A' ' 46' ' ' ILE . 89.0 t -61.28 -47.81 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.39 70.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.082 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.96 -43.23 96.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.551 . . . . 0.0 110.677 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.48 -53.09 8.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.941 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 43' ' ' VAL . 50.4 mt -81.64 -20.42 39.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.18 26.83 35.42 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.405 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -72.11 133.45 83.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.388 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.1 Cg_exo -68.29 152.47 75.74 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.93 2.42 . . . . 0.0 111.515 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.495 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.83 116.44 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 0.0 110.159 -179.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 105.25 7.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.798 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.26 69.16 3.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.731 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 75.07 80.72 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -1.78 11.83 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.161 2.574 . . . . 0.0 112.414 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -67.67 -15.32 63.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.751 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.96 16.37 12.74 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.15 83.74 4.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.863 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 50.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.684 0.754 . . . . 0.0 110.125 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.37 128.82 50.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.976 176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 122.71 45.44 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -106.44 121.66 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -116.91 137.82 51.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.375 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.76 118.37 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.66 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 65.3 m-85 -117.91 163.22 16.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.883 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -122.85 103.49 8.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 110.342 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -155.25 164.9 38.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.449 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 55.01 74.29 0.75 Allowed Pre-proline 0 C--O 1.234 0.271 0 O-C-N 123.781 0.676 . . . . 0.0 111.365 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.28 86.16 1.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.309 2.006 . . . . 0.0 111.362 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.11 -104.56 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.702 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -134.27 155.86 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.563 -0.375 . . . . 0.0 111.142 -176.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.0 mp0 76.6 -45.64 0.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.771 0.828 . . . . 0.0 111.803 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.1 -36.44 4.22 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.988 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 p -85.04 85.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.417 1.103 . . . . 0.0 109.434 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.667 HG21 ' HB2' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -175.53 138.84 0.41 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.175 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.494 ' CA ' ' HB3' ' A' ' 109' ' ' ALA . 2.0 tp60 -161.1 168.91 23.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.355 . . . . 0.0 111.091 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -84.3 124.23 31.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.236 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.02 104.73 16.69 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.04 0.447 . . . . 0.0 110.56 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.66 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -84.66 104.83 14.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -103.11 104.19 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.56 HD23 HD21 ' A' ' 101' ' ' LEU . 1.8 tp -94.33 119.6 33.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.481 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 116.0 25.95 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.64 -171.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.838 ' HB3' HD22 ' A' ' 101' ' ' LEU . 1.3 p90 -123.62 142.77 50.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.995 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.536 ' HB3' HG23 ' A' ' 102' ' ' THR . 0.4 OUTLIER -78.45 164.16 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.54 -22.32 3.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -169.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -6.27 45.42 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.991 -0.443 . . . . 0.0 111.252 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 88.0 21.3 46.69 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.425 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.545 HG13 ' HA2' ' A' ' 49' ' ' GLY . 24.6 t -112.18 120.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.838 HD22 ' HB3' ' A' ' 95' ' ' PHE . 9.1 mt -55.44 110.36 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.367 0.417 . . . . 0.0 110.383 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -76.53 -32.05 58.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.83 153.32 10.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.624 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 105' ' ' ASP . 5.0 mt -110.54 135.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 170.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -107.96 102.7 11.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -121.85 114.42 21.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.928 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 153.72 78.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.558 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.28 171.43 3.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.111 2.541 . . . . 0.0 111.71 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.667 ' HB2' HG21 ' A' ' 87' ' ' THR . . . -74.5 6.54 3.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.81 113.44 12.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.72 129.68 45.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 172.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.65 149.12 34.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.776 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 t30 71.57 -64.42 0.39 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.638 0.775 . . . . 0.0 112.191 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -23.87 58.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.659 0.266 . . . . 0.0 110.481 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 69.78 160.3 0.2 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.08 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.45 24.37 2.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -89.27 -38.99 13.8 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 172.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -156.52 -57.34 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.345 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 175.57 171.24 0.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.889 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -72.73 -80.35 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.268 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.503 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.703 0.287 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.49 78.77 2.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.481 0.658 . . . . 0.0 112.409 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -150.2 118.48 6.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.835 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.47 80.96 1.4 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.006 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.59 101.79 6.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.859 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.68 79.55 1.68 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.469 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.92 121.93 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.311 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.7 m -107.23 152.71 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.688 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -85.28 115.88 23.3 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' C ' ' H ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -80.45 120.02 78.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.56 35.88 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.244 2.629 . . . . 0.0 112.611 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 29' ' ' ARG . 1.5 m-20 -85.27 128.29 34.63 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 31' ' ' ASP . 90.4 mt 72.11 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -171.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.14 84.11 1.01 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.843 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -71.56 168.95 16.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.67 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.34 53.21 5.7 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.6 -178.39 5.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.712 0.291 . . . . 0.0 110.81 -174.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -90.3 156.23 18.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.195 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.3 tp -80.15 142.58 34.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 110.281 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.84 145.96 28.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.92 86.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.787 0.327 . . . . 0.0 111.392 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.98 -30.01 70.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -20.0 62.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.153 0.501 . . . . 0.0 111.084 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 t -84.06 -17.03 10.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.871 0.367 . . . . 0.0 111.529 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.7 -8.28 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -8.47 56.04 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.378 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -109.85 158.92 9.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.9 mtt85 -135.88 160.39 38.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 111.158 -173.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.5 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 3.4 m -73.62 147.54 9.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.473 171.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.793 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 82.05 -8.48 60.33 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.556 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.6 mmt -79.29 141.36 37.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -68.0 150.37 48.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.48 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -59.59 -28.11 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.009 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -68.23 -38.96 82.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -70.14 -38.69 75.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.992 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.552 ' HA ' HG22 ' A' ' 46' ' ' ILE . 52.2 t -59.57 -45.5 93.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.703 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.436 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -66.57 -33.28 75.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.012 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -70.04 -34.45 73.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.915 0.388 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.07 -35.08 24.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.219 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -98.17 -34.82 10.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.58 30.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.25 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -58.87 139.22 86.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 123.23 0.612 . . . . 0.0 112.118 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.78 140.76 29.58 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.672 2.248 . . . . 0.0 111.501 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.21 108.58 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.2 tpp -75.88 118.32 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.595 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.61 106.36 11.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.913 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.24 115.2 18.58 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-O 120.928 0.394 . . . . 0.0 109.94 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -91.54 -2.66 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.953 2.435 . . . . 0.0 112.26 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -26.19 15.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.007 -170.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.44 15.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.48 85.43 3.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.227 0.537 . . . . 0.0 109.893 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.14 55.1 1.27 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.443 0.639 . . . . 0.0 110.772 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.463 HG21 HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -132.15 146.16 51.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.84 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 2.0 m0 -124.01 130.6 52.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -120.37 124.58 45.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.309 0.575 . . . . 0.0 111.079 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -124.53 153.92 41.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.453 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.74 130.34 55.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.288 0.566 . . . . 0.0 110.905 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -93.78 -175.61 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.7 ptt85 -128.14 119.47 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 111.451 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HB2' ' HA ' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -105.61 -114.82 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.938 174.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -126.92 81.41 69.67 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.52 135.04 32.4 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.141 2.561 . . . . 0.0 112.57 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.55 162.18 28.66 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.37 121.88 18.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.366 0.083 . . . . 0.0 110.78 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 69.38 108.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.002 0.814 . . . . 0.0 110.128 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.67 53.73 0.55 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 t -82.93 87.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.488 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . 0.9 OUTLIER -127.77 113.56 16.13 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.56 -169.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.735 ' H ' ' HB3' ' A' ' 109' ' ' ALA . 2.8 mm100 -150.58 168.68 23.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.087 -168.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.442 ' CD ' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -122.14 136.15 54.88 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 173.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.3 133.15 56.34 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.493 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.18 104.56 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 105.39 15.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.658 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.5 mp -94.96 127.88 41.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.66 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.463 HG21 HG21 ' A' ' 72' ' ' THR . 0.2 OUTLIER -123.02 127.84 49.35 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.528 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -126.21 148.92 49.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.418 ' HB2' HG22 ' A' ' 102' ' ' THR . 6.0 t-20 -76.73 160.48 29.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -0.37 0.64 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.464 0.478 . . . . 0.0 112.237 -175.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -8.57 58.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.558 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.18 15.53 55.6 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.254 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.793 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -111.52 123.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.765 0.426 . . . . 0.0 110.34 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.542 HD11 HG21 ' A' ' 55' ' ' VAL . 6.5 mt -54.32 110.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.741 0.305 . . . . 0.0 110.486 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.418 HG22 ' HB2' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -75.51 -42.19 53.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.465 ' HA ' HG13 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -163.07 153.61 16.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.708 178.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.614 HG23 ' N ' ' A' ' 105' ' ' ASP . 2.4 mt -107.88 136.31 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.614 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -115.04 101.65 9.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.873 0.368 . . . . 0.0 110.728 177.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -114.09 100.74 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 116.62 11.02 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.286 -174.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.7 146.09 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.805 2.336 . . . . 0.0 112.117 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.735 ' HB3' ' H ' ' A' ' 88' ' ' GLN . . . -71.61 70.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.186 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.471 ' HB3' ' H ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -152.26 -120.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.066 -178.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.471 ' H ' ' HB3' ' A' ' 110' ' ' LEU . 1.0 OUTLIER 66.75 -66.8 0.17 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.404 0.682 . . . . 0.0 111.629 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 137.9 63.36 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.02 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -122.41 -42.6 2.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.882 0.372 . . . . 0.0 110.908 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 tp -129.18 -65.76 0.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.343 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.401 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -71.74 -50.34 30.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.478 -174.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 56.91 66.79 1.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.674 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.468 ' HB2' HD11 ' A' ' 110' ' ' LEU . 13.3 m80 -63.22 101.21 0.28 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -87.23 133.66 33.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.345 0.593 . . . . 0.0 110.988 -174.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -101.62 -39.73 7.34 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -149.18 -70.9 0.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.879 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.247 0.93 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.25 173.55 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 120.812 0.339 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.78 104.64 17.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.17 -176.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.21 97.11 6.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.289 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.28 140.47 52.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.292 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.0 93.47 4.52 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.84 87.71 2.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.023 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.67 99.12 8.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.42 ' H ' HG13 ' A' ' 27' ' ' VAL . 1.4 p -98.68 -45.51 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.225 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -160.0 119.54 2.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.874 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 2.1 ptp180 -99.19 115.59 65.65 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 7.3 Cg_exo -74.1 43.48 0.86 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.508 2.805 . . . . 0.0 112.13 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.99 -1.82 38.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.442 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.486 HG22 HD11 ' A' ' 32' ' ' ILE . 7.1 mm -93.34 136.28 25.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.787 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.9 134.54 46.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -144.5 171.53 14.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.723 0.296 . . . . 0.0 110.652 -175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.21 -83.34 0.32 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.108 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 t30 59.86 -133.43 0.85 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 172.14 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.07 128.13 34.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.232 176.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -109.96 177.49 4.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.947 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.87 90.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.308 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -59.29 -38.21 79.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -38.96 91.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.1 t -70.64 -30.9 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.272 0.558 . . . . 0.0 110.385 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 m -75.15 -9.25 58.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.815 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.581 ' HE2' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -86.7 -20.39 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.507 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.595 HD13 HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -87.11 173.85 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.114 177.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.1 mmp_? -131.56 153.6 49.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.938 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.54 ' H ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -72.92 136.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.909 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 92.95 -4.08 74.51 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.791 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.39 144.19 49.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -81.16 145.05 31.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.759 0.314 . . . . 0.0 110.603 -175.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -54.65 -36.13 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.675 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -68.75 -43.02 76.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.138 0.494 . . . . 0.0 110.426 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -74.9 -34.84 62.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.9 -46.32 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.634 ' HA ' ' HB ' ' A' ' 61' ' ' THR . . . -64.52 -41.59 96.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.705 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.55 -35.93 81.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.632 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.86 -43.71 35.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.203 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.595 HD11 HD13 ' A' ' 46' ' ' ILE . 19.9 mt -94.54 1.83 55.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.81 46.25 90.2 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.293 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.634 ' HB ' ' HA ' ' A' ' 56' ' ' ALA . 13.6 m -102.87 136.58 19.24 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.48 -0.36 . . . . 0.0 111.068 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.557 ' HD2' HG22 ' A' ' 61' ' ' THR . 26.8 Cg_exo -63.56 132.29 34.95 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.605 2.203 . . . . 0.0 111.46 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.92 87.88 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 110.545 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.7 tpt -79.98 93.68 5.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.205 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.12 109.32 22.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.0 152.45 40.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.465 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.63 -3.27 9.94 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.737 2.291 . . . . 0.0 113.78 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -98.79 -26.22 14.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.829 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.64 27.76 5.35 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.22 83.52 6.94 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.272 0.558 . . . . 0.0 109.755 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -82.34 63.61 6.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.496 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.67 126.65 20.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.012 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 7.1 m0 -105.89 135.53 47.17 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.498 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -111.2 122.07 46.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.548 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 159.89 20.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.15 125.08 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.493 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 1.7 m-30 -97.64 162.97 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.51 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -139.7 105.12 5.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 175.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.83 11.18 0.65 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.122 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.658 HE22 ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -134.54 144.73 52.11 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.005 -173.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 3.0 Cg_exo -76.39 -165.41 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.192 2.594 . . . . 0.0 112.149 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.76 -14.33 12.64 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.138 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -75.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.944 0.372 . . . . 0.0 111.125 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 2.3 mm-40 -115.41 145.17 42.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.61 34.67 13.12 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.523 ' H ' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -78.2 88.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 -177.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 115' ' ' GLU . 10.5 t -172.23 176.2 3.48 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.456 ' CA ' ' HB3' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -151.18 178.96 8.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.765 0.317 . . . . 0.0 110.366 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.558 ' NE2' ' H ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -128.68 164.06 23.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 -176.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 104.92 15.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.493 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -82.46 105.03 13.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 109.94 19.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.031 -171.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.2 mt -89.51 120.36 30.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.55 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -110.2 123.96 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.608 0.242 . . . . 0.0 110.356 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 0.8 OUTLIER -119.2 148.0 43.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.88 168.29 18.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 m -58.42 -16.37 14.62 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.661 0.384 . . . . 0.0 111.985 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -5.29 42.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.547 175.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 80.15 21.89 64.28 Favored Glycine 0 C--O 1.219 -0.826 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.909 HG12 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -106.26 127.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 -172.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.438 HD13 HG13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -54.66 101.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.799 175.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -39.44 30.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.087 0.47 . . . . 0.0 110.015 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -161.19 153.21 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.255 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 105' ' ' ASP . 2.4 mp -118.59 133.24 66.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.489 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -95.18 101.93 13.71 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.417 ' HA ' HD21 ' A' ' 91' ' ' LEU . 16.5 p-10 -135.38 100.88 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 0.0 111.139 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.84 111.52 6.23 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.189 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 54.3 Cg_exo -54.58 121.53 9.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.511 2.14 . . . . 0.0 112.443 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.658 ' HB2' HE22 ' A' ' 80' ' ' GLN . . . -6.43 77.11 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.514 1.759 . . . . 0.0 114.123 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER 174.93 59.69 0.0 OUTLIER 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -175.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.23 45.01 1.24 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.405 -174.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 129.21 -152.12 19.37 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.404 175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -87.73 69.4 9.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.222 -0.489 . . . . 0.0 111.396 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.4 tp -160.9 -72.46 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 110' ' ' LEU . 11.9 mp0 -40.72 -66.35 0.33 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -170.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 68.2 t60 -144.11 59.4 1.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.525 0.679 . . . . 0.0 109.898 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.33 140.58 15.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.017 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 60.69 55.33 3.34 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.728 0.642 . . . . 0.0 110.21 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -98.51 112.17 24.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.791 -176.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -83.57 141.68 31.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.074 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.763 177.265 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.59 49.0 2.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.13 0.491 . . . . 0.0 110.178 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.37 88.78 7.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.639 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.79 145.14 24.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.216 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.37 150.29 36.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.469 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -153.24 -12.26 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.91 62.91 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.327 0.584 . . . . 0.0 110.759 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.98 148.75 33.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.612 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -63.29 121.74 14.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.877 0.37 . . . . 0.0 110.668 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HG3' ' H ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -83.16 127.1 70.39 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.378 172.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 19.1 Cg_exo -67.86 60.98 0.91 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.391 2.727 . . . . 0.0 112.756 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -133.91 150.45 51.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.835 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt 56.73 80.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 123.492 0.495 . . . . 0.0 109.915 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -54.71 -39.23 67.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.288 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 72.45 -72.14 0.12 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.267 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.43 136.42 13.37 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.473 -172.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -119.42 -40.32 2.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -109.57 -171.33 1.82 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.475 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.98 134.66 54.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.841 0.353 . . . . 0.0 110.444 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 145.23 44.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.22 96.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.38 -27.88 68.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.989 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -72.72 -39.05 67.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.652 HG22 HD23 ' A' ' 59' ' ' LEU . 61.1 t -67.62 -25.15 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.38 0.609 . . . . 0.0 109.952 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -74.59 -6.48 48.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.091 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 16.7 mtpt -71.0 -33.45 70.4 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.531 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.499 HG22 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pp -93.84 -178.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.4 OUTLIER -157.31 172.27 18.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.737 0.304 . . . . 0.0 111.08 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 1.4 m -66.31 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.279 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.601 ' HA2' ' CG1' ' A' ' 100' ' ' VAL . . . 90.27 -10.59 73.75 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.095 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -75.03 137.45 41.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -73.89 146.5 43.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.328 -175.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -52.52 -32.43 40.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.721 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 mp0 -62.46 -44.21 96.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.165 0.507 . . . . 0.0 109.837 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -73.57 -36.37 65.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 46' ' ' ILE . 93.9 t -61.04 -48.76 87.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.539 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -71.45 -30.62 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.012 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -37.91 87.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.81 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.11 -39.51 17.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.999 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.652 HD23 HG22 ' A' ' 43' ' ' VAL . 6.9 mp -86.23 -49.5 7.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 0.0 111.939 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.18 29.25 5.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.224 -172.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.594 HG21 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -60.89 141.75 92.97 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.247 -0.476 . . . . 0.0 111.293 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.594 ' HD2' HG21 ' A' ' 61' ' ' THR . 50.1 Cg_exo -57.31 165.57 5.46 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.15 2.567 . . . . 0.0 113.351 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 104.58 2.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.365 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.25 93.17 5.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.108 0.48 . . . . 0.0 110.594 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.87 62.12 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.196 0.522 . . . . 0.0 109.865 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -127.88 80.22 72.43 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.48 -175.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.98 -1.5 11.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.339 2.693 . . . . 0.0 112.497 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -74.43 13.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.323 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.84 13.28 20.5 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.344 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 66' ' ' ASP . 8.7 m -83.99 87.22 7.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.261 0.553 . . . . 0.0 110.619 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -113.73 24.04 12.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.742 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.38 55.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.101 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.41 ' CE2' HG22 ' A' ' 61' ' ' THR . 0.2 OUTLIER -112.79 121.92 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.088 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.0 p90 -111.22 147.25 35.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 111.569 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.665 ' HB2' HD11 ' A' ' 91' ' ' LEU . 1.5 m-85 -147.96 160.75 42.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.066 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.29 115.99 50.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.311 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' HZ ' HG21 ' A' ' 43' ' ' VAL . 12.2 m-30 -94.0 124.75 38.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -78.4 106.09 10.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.178 0.513 . . . . 0.0 109.815 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.534 HE22 ' HB3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -158.24 41.91 0.27 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.117 -178.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.445 ' NE2' HE21 ' A' ' 88' ' ' GLN . 27.7 mp0 -107.99 120.39 47.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.821 -171.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.1 Cg_exo -69.72 176.06 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 123.084 2.523 . . . . 0.0 112.523 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.85 11.31 72.46 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.746 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -86.67 109.75 19.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.9 mp0 72.34 -52.62 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.16 0.912 . . . . 0.0 111.144 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.94 76.58 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.936 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -111.93 84.84 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.4 m -171.44 101.43 0.2 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.908 -174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.449 ' CA ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -132.33 169.0 17.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.93 0.395 . . . . 0.0 111.16 -173.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.453 ' HB3' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -130.04 166.31 20.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.799 -175.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 117.57 17.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.849 0.357 . . . . 0.0 111.429 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.806 HD22 ' HB2' ' A' ' 106' ' ' ASN . 0.9 OUTLIER -84.26 112.02 19.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.28 118.95 32.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.333 0.587 . . . . 0.0 111.277 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.581 HD11 HD12 ' A' ' 91' ' ' LEU . 2.2 mp -102.93 142.55 33.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.447 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.56 123.17 27.4 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 102' ' ' THR . 11.1 p90 -131.3 145.38 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.895 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -69.15 159.79 32.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.359 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -19.04 12.72 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -174.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -15.67 61.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.708 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 101.56 11.73 37.42 Favored Glycine 0 C--O 1.221 -0.706 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.754 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.601 ' CG1' ' HA2' ' A' ' 49' ' ' GLY . 43.0 t -94.32 114.0 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.856 -0.202 . . . . 0.0 110.733 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . 0.8 OUTLIER -54.77 102.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.393 0.433 . . . . 0.0 110.542 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.403 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -85.37 -29.43 24.45 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.99 -176.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -156.7 143.41 18.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.676 HG21 ' N ' ' A' ' 105' ' ' ASP . 18.7 mt -121.07 141.74 40.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.676 ' N ' HG21 ' A' ' 104' ' ' ILE . 10.5 t0 -129.6 102.89 6.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.623 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.806 ' HB2' HD22 ' A' ' 91' ' ' LEU . 34.8 t30 -135.45 100.13 4.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 110.137 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -121.01 131.6 24.44 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.428 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.534 ' HB3' HE22 ' A' ' 79' ' ' GLN . 46.0 Cg_exo -56.42 146.25 74.84 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.067 2.511 . . . . 0.0 112.983 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.453 ' N ' ' HB3' ' A' ' 89' ' ' GLN . . . -45.93 -41.98 12.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.244 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.529 ' HA ' HD11 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -78.56 90.36 4.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.067 0.46 . . . . 0.0 110.15 178.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -71.4 148.04 47.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.483 178.18 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.12 -65.72 1.98 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.57 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -66.45 -67.87 0.42 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.762 0.315 . . . . 0.0 110.675 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 111' ' ' SER . 0.1 OUTLIER -112.45 116.29 30.06 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -89.79 157.83 17.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.205 0.526 . . . . 0.0 111.695 -171.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.52 47.81 0.98 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.034 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -88.6 60.18 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.057 -170.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 16.7 t60 55.67 85.75 0.07 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.267 0.556 . . . . 0.0 111.654 174.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -107.61 91.2 3.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.003 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -89.52 63.75 6.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.681 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 117.892 -1.052 . . . . 0.0 109.574 176.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.82 0.343 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -78.75 69.03 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.178 0.513 . . . . 0.0 110.656 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 80.47 9.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.682 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.71 116.89 10.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.622 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.91 150.4 26.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.141 0.496 . . . . 0.0 111.011 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.78 67.82 1.35 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.087 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 p -70.37 -57.54 7.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.421 -173.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t 47.2 72.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.09 0.472 . . . . 0.0 110.982 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -89.41 126.86 35.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.123 0.487 . . . . 0.0 110.967 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -132.52 131.76 22.4 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 8.6 Cg_exo -72.54 51.63 1.88 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 123.011 2.474 . . . . 0.0 111.682 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.06 -30.2 17.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.009 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.506 HG12 ' HG2' ' A' ' 34' ' ' GLN . 0.1 OUTLIER -77.92 148.66 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.591 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.89 62.74 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.331 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.506 ' HG2' HG12 ' A' ' 32' ' ' ILE . 5.4 pt20 -104.36 132.29 50.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.721 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.72 38.0 92.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.99 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -94.5 122.98 37.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.694 0.283 . . . . 0.0 110.679 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -104.61 166.76 10.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.48 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 HD13 HD22 ' A' ' 59' ' ' LEU . 7.5 tp -74.52 137.62 42.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.556 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.68 144.99 25.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.87 75.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -74.11 -29.91 62.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 111.194 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -72.96 -20.26 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.408 -175.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 46' ' ' ILE . 2.2 t -74.54 -16.47 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.166 0.507 . . . . 0.0 110.654 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -83.91 -6.94 59.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.778 ' HE3' ' HB1' ' A' ' 58' ' ' ALA . 4.6 pttt -82.23 -8.0 59.64 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.377 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -102.87 162.41 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.555 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -132.81 168.79 17.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.145 0.498 . . . . 0.0 112.241 -169.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.549 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -76.96 137.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.38 171.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.966 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 83.49 5.36 88.59 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.555 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -89.15 136.35 33.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.25 145.17 51.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.849 0.356 . . . . 0.0 111.272 -176.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.41 -29.3 61.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.639 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.17 -42.15 89.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.2 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.124 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.56 HG22 HD23 ' A' ' 101' ' ' LEU . 72.3 t -60.43 -46.58 95.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.223 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.99 78.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -45.71 93.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.211 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.778 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -80.43 -39.39 28.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.144 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.495 HD23 ' HE2' ' A' ' 45' ' ' LYS . 70.0 mt -86.09 -18.67 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.22 40.71 13.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.46 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.4 m -95.58 133.84 25.12 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.104 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.4 Cg_exo -69.68 157.48 60.39 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.904 2.403 . . . . 0.0 111.111 173.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 tp -86.47 87.64 7.48 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.248 0.546 . . . . 0.0 110.367 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.3 115.06 29.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.669 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 140.07 47.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.498 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -91.46 123.74 63.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.96 -2.16 12.28 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.822 2.348 . . . . 0.0 113.284 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -99.61 -20.59 16.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.77 10.66 26.3 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.94 90.15 5.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.111 0.481 . . . . 0.0 109.796 177.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -80.24 61.35 4.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -174.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -126.01 123.04 37.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 177.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.56 ' HB2' ' HZ ' ' A' ' 95' ' ' PHE . 1.5 m0 -103.89 122.57 45.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -108.37 121.91 45.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.703 0.763 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.38 153.66 21.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.057 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.9 t -123.48 107.67 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.785 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 55.1 p90 -142.17 146.97 35.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.76 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 106.45 18.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.547 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -113.7 -0.3 14.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.485 HE21 ' HB3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -105.4 138.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.303 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 23.6 Cg_exo -63.78 145.04 90.35 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.828 2.352 . . . . 0.0 111.996 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.23 71.43 1.49 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.836 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.454 ' C ' ' H ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -119.49 136.73 54.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.3 mt-10 74.41 -17.37 0.47 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.946 0.779 . . . . 0.0 111.016 -176.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 83' ' ' HIS . . . 89.88 -36.39 3.55 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.924 169.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.512 ' H ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -105.08 88.82 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.374 -0.486 . . . . 0.0 110.309 -176.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -157.69 121.61 4.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.406 0.622 . . . . 0.0 111.197 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.463 ' H ' ' HB1' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -170.58 150.49 3.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.421 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.77 156.2 44.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.997 0.427 . . . . 0.0 111.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -93.71 129.04 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.969 174.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.785 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -85.62 103.96 14.92 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -102.0 105.9 16.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -174.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.3 mt -93.79 125.25 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.677 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.7 123.45 48.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' HZ ' ' HB2' ' A' ' 73' ' ' TRP . 0.1 OUTLIER -118.88 151.67 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.72 ' HB2' HG22 ' A' ' 102' ' ' THR . 8.1 t-20 -88.93 167.78 12.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 171.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -23.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -171.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -3.64 47.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.32 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 84.16 28.17 34.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.296 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.966 HG12 ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -112.85 130.75 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 122.274 0.229 . . . . 0.0 110.436 -177.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.56 HD23 HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -55.72 103.06 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.632 0.583 . . . . 0.0 111.263 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.72 HG22 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -91.37 -18.5 24.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.0 110.643 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -162.67 138.72 7.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.632 HG23 ' N ' ' A' ' 105' ' ' ASP . 3.0 mt -113.61 136.48 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.693 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 28.7 t70 -117.79 103.34 9.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.673 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -131.38 100.65 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.145 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.02 119.54 10.58 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.756 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.74 155.96 20.44 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.436 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.463 ' HB1' ' H ' ' A' ' 88' ' ' GLN . . . -64.7 92.31 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.033 0.444 . . . . 0.0 110.561 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.33 136.16 11.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.1 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.8 m 73.88 148.57 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 124.208 0.942 . . . . 0.0 112.303 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.2 -99.65 1.83 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.933 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -64.05 -34.1 77.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.071 0.462 . . . . 0.0 110.235 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -139.78 107.78 5.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.328 177.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -81.3 111.09 17.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -71.84 104.87 3.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.696 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.52 -58.8 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.388 -174.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.18 59.29 0.65 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.695 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -101.46 126.67 48.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.4 -5.55 6.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.315 0.579 . . . . 0.0 109.933 172.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.574 179.344 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.838 0.351 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.77 73.65 2.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.412 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.98 94.74 4.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.484 174.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 mt -81.41 152.01 27.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.58 -171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.46 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -83.71 133.93 34.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 -178.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -105.35 125.55 51.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.949 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.8 143.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.836 0.351 . . . . 0.0 111.063 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -93.54 -168.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.985 176.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.81 ' HE2' ' HG3' ' A' ' 34' ' ' GLN . 2.1 p90 -96.95 163.31 13.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.814 0.34 . . . . 0.0 110.783 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.632 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 1.4 ptp180 -123.21 138.53 30.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.96 51.61 1.65 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.766 2.311 . . . . 0.0 112.656 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.632 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 19.5 t70 -97.82 37.48 1.4 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.632 0.73 . . . . 0.0 110.303 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.49 -66.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.909 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.37 -70.91 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.414 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.81 ' HG3' ' HE2' ' A' ' 28' ' ' TYR . 6.6 mm100 46.3 53.6 9.36 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.972 0.795 . . . . 0.0 112.335 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.7 166.44 22.5 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.652 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.72 -19.16 45.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.514 0.673 . . . . 0.0 109.591 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -131.86 -169.48 2.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.966 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.601 HD13 ' HE1' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -112.02 155.36 23.91 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.68 142.56 49.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.915 0.388 . . . . 0.0 111.569 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.64 -38.44 23.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.404 0.621 . . . . 0.0 110.192 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.37 -17.78 64.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 1.2 t0 -77.65 -20.38 53.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.33 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.448 ' HA ' HD11 ' A' ' 59' ' ' LEU . 14.5 t -71.29 -28.1 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.935 0.397 . . . . 0.0 111.147 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -7.21 22.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.696 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -77.92 -15.32 59.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.089 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.564 HG22 HD21 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -100.87 172.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.161 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.5 160.86 39.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.875 -178.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.55 152.03 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.873 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 79.42 -4.72 62.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.211 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.456 ' HB3' ' HE3' ' A' ' 50' ' ' MET . 1.9 mtp -85.1 141.84 29.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.56 146.43 50.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.802 -175.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -31.9 62.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.984 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -69.31 -39.52 78.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.032 0.444 . . . . 0.0 110.043 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.03 -34.74 64.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.199 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.621 HG21 HD22 ' A' ' 101' ' ' LEU . 76.1 t -61.71 -48.03 90.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.763 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.87 -29.66 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.151 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -41.8 72.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.094 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.05 -59.6 2.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -91.51 -2.18 57.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.277 0.561 . . . . 0.0 111.39 -171.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 46.27 9.86 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.753 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 73' ' ' TRP . 0.2 OUTLIER -89.9 136.41 29.19 Favored Pre-proline 0 C--N 1.317 -0.81 0 O-C-N 122.818 -0.225 . . . . 0.0 111.121 177.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.2 Cg_exo -68.58 132.02 24.32 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.37 2.047 . . . . 0.0 111.284 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.86 118.16 19.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.0 ttp -92.15 119.98 32.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.389 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.13 109.35 13.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -114.46 93.19 31.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.615 0.722 . . . . 0.0 111.066 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.92 -9.12 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.04 1.827 . . . . 0.0 111.22 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -96.31 -21.99 17.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.115 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 12.07 25.81 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.19 83.4 2.37 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.146 0.498 . . . . 0.0 110.757 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -94.51 67.57 3.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.236 -177.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -135.61 147.28 48.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.721 -178.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.422 ' CE2' HG21 ' A' ' 61' ' ' THR . 0.3 OUTLIER -127.44 148.49 50.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.965 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -133.82 133.59 41.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 0.0 110.594 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.601 ' HE1' HD13 ' A' ' 38' ' ' LEU . 2.4 m-85 -117.2 134.6 54.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.523 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.98 107.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.93 114.29 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -91.17 103.01 15.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.518 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 1.7 pt20 -127.34 37.65 4.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 8.4 pm0 -116.23 136.68 23.07 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.418 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 4.5 Cg_exo -78.11 165.21 26.28 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.788 2.326 . . . . 0.0 111.631 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.23 67.08 3.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.122 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.486 ' HB3' ' H ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -168.71 -99.5 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 mp0 -93.94 149.74 20.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.797 0.332 . . . . 0.0 110.445 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.746 ' HA2' HD21 ' A' ' 110' ' ' LEU . . . 75.85 45.32 17.11 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.275 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -95.81 88.44 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.812 HG21 ' HB1' ' A' ' 109' ' ' ALA . 1.9 t -164.72 176.18 9.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.6 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -114.07 109.99 19.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.535 1.061 . . . . 0.0 113.67 -162.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.679 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -76.58 128.87 35.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.76 172.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 120.7 22.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -174.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.15 112.26 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.719 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.52 111.11 23.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 72' ' ' THR . 11.2 mp -94.83 134.55 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.811 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -131.23 117.76 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -124.8 136.21 53.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.932 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.486 ' HB2' HG23 ' A' ' 102' ' ' THR . 1.3 t30 -73.24 165.68 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.863 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.32 -13.89 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -5.85 42.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 175.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.695 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 83.99 12.77 76.19 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.873 HG12 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -105.54 122.47 58.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.995 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.621 HD22 HG21 ' A' ' 55' ' ' VAL . 1.6 mm? -55.42 107.27 0.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.098 174.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.486 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -97.67 -36.04 10.38 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.956 0.408 . . . . 0.0 110.879 -177.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.415 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 41.2 t30 -137.06 135.97 37.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.654 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -122.28 132.2 71.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.53 ' N ' HG22 ' A' ' 104' ' ' ILE . 1.4 t70 -100.81 100.94 11.68 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -116.7 99.6 7.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 1.3 mtmt -156.4 141.6 12.42 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.079 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 16.9 Cg_exo -68.25 169.46 16.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.664 2.243 . . . . 0.0 111.536 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.812 ' HB1' HG21 ' A' ' 87' ' ' THR . . . -71.66 -22.22 61.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.578 0.704 . . . . 0.0 110.257 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.746 HD21 ' HA2' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -96.74 92.17 6.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.258 -177.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -86.78 163.54 17.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.86 172.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.51 -48.01 56.06 Favored Glycine 0 C--N 1.332 0.318 0 O-C-N 123.485 0.49 . . . . 0.0 113.487 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -127.91 56.74 1.57 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.28 0.562 . . . . 0.0 110.722 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 6.5 tp -122.07 -134.86 0.3 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.944 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -60.71 -51.57 68.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.555 ' HA ' HD22 ' A' ' 110' ' ' LEU . 30.7 m80 61.84 -131.5 0.64 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -147.44 18.8 1.19 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.677 0.751 . . . . 0.0 109.114 169.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.52 103.96 0.94 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.357 -174.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -78.04 106.78 10.14 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -79.45 52.21 1.35 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.023 0.44 . . . . 0.0 110.87 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.881 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 120.802 0.334 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.01 160.69 15.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.724 0.297 . . . . 0.0 110.958 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 t -127.77 150.56 49.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.982 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.16 -94.48 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.592 0.234 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.72 69.42 1.07 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.701 0.286 . . . . 0.0 111.18 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 9.7 ptp180 -174.97 172.49 2.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.066 177.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 25' ' ' ARG . 73.3 t 79.28 108.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 124.086 0.867 . . . . 0.0 111.293 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.66 94.18 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.064 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.15 137.64 56.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.659 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -87.27 116.23 65.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.256 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 23.2 Cg_exo -65.19 -21.76 61.93 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.916 2.411 . . . . 0.0 112.377 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -124.21 118.67 27.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.218 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.27 -171.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.428 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -120.6 81.38 1.75 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -115.6 146.27 41.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.038 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.71 130.71 5.61 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.09 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -89.18 46.75 1.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -162.72 154.96 18.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.078 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.7 127.13 32.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.958 0.408 . . . . 0.0 110.234 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 m -87.4 144.72 26.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.48 93.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.211 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -60.64 -33.58 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.241 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.568 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -71.48 -25.43 62.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 -176.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 46' ' ' ILE . 46.7 t -74.49 -32.3 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.209 0.528 . . . . 0.0 110.27 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -6.82 47.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.111 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -74.82 -20.23 59.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -110.71 -173.43 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 176.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.58 171.52 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.794 0.33 . . . . 0.0 111.018 -174.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.472 ' H ' HG21 ' A' ' 48' ' ' VAL . 1.1 m -71.58 149.6 9.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.598 ' HA2' ' CG1' ' A' ' 100' ' ' VAL . . . 72.35 6.64 65.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.206 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.33 148.05 24.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -74.82 142.87 44.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.85 0.357 . . . . 0.0 110.731 -175.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -27.43 69.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.612 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.423 HE21 ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -71.81 -35.31 69.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.362 -178.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.11 -36.35 48.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.299 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 83.0 t -58.41 -47.85 86.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.613 ' HB1' ' OG1' ' A' ' 61' ' ' THR . . . -61.42 -39.14 89.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.326 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.92 55.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.585 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.74 -58.66 3.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.595 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -95.26 -16.58 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 95.31 0.77 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.748 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.613 ' OG1' ' HB1' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -78.51 155.2 78.91 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.82 148.33 40.88 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.566 2.177 . . . . 0.0 110.585 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 87.11 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.298 0.57 . . . . 0.0 110.624 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -104.93 120.39 41.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.806 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.61 133.18 34.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.31 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -160.26 94.79 1.56 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 110.482 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.45 -3.03 7.66 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.812 2.341 . . . . 0.0 111.919 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.67 -27.52 22.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.213 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.14 35.25 4.55 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.451 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.0 m -76.2 89.62 3.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.355 0.597 . . . . 0.0 110.021 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 8.5 m120 -88.09 51.76 2.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.335 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.71 13.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.71 176.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.6 m0 -103.56 121.63 43.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.917 0.389 . . . . 0.0 110.299 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -104.88 115.06 29.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.885 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -119.39 140.81 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.889 0.376 . . . . 0.0 110.609 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.82 129.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.505 ' HZ ' HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -112.95 -176.14 2.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.186 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.4 123.65 36.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.983 0.42 . . . . 0.0 110.375 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.76 ' HG3' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -77.82 167.29 21.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.793 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -102.23 93.82 4.23 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 92.7 Cg_endo -93.44 164.77 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.048 2.499 . . . . 0.0 114.22 -169.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.65 -107.85 1.02 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -107.59 -7.36 16.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.214 0.531 . . . . 0.0 109.651 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -178.88 5.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.916 172.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.45 36.95 11.35 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.516 ' H ' HG23 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -92.21 86.58 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -176.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.3 m -164.95 170.02 15.74 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -170.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -123.35 129.06 50.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.774 0.715 . . . . 0.0 112.119 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 4.1 pm0 -94.84 137.97 33.22 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.96 129.41 56.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.99 104.61 14.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 m -105.2 109.37 21.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.279 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 3.0 mp -88.31 130.7 35.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.498 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.16 118.4 26.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.667 ' HB3' ' HA ' ' A' ' 101' ' ' LEU . 40.6 p90 -144.04 151.99 40.4 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.645 -173.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -77.81 154.55 31.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.672 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.26 -14.23 24.64 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.868 0.467 . . . . 0.0 111.936 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -73.49 -3.38 27.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.166 0.507 . . . . 0.0 110.577 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.59 6.26 59.73 Favored Glycine 0 C--O 1.22 -0.774 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.551 175.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.598 ' CG1' ' HA2' ' A' ' 49' ' ' GLY . 93.9 t -97.42 112.1 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.666 0.233 . . . . 0.0 111.097 -172.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.667 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -55.34 103.35 0.09 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.584 0.552 . . . . 0.0 110.016 174.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.616 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -75.71 -30.98 59.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.727 0.298 . . . . 0.0 110.587 -175.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.05 152.71 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.368 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 105' ' ' ASP . 3.4 mt -112.7 134.11 56.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.521 ' N ' HG22 ' A' ' 104' ' ' ILE . 2.1 t70 -91.53 101.36 14.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.157 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -119.08 100.32 7.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -142.61 146.94 40.51 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.178 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.07 166.97 28.04 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.507 2.138 . . . . 0.0 112.31 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.76 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . . . -72.81 66.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.672 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 115' ' ' GLU . 0.3 OUTLIER -156.81 108.93 2.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.351 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.79 144.33 56.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.775 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.96 64.2 3.41 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.467 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 17.4 t30 -159.09 83.54 0.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER 73.28 -73.75 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.994 0.809 . . . . 0.0 110.84 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.459 ' N ' ' HG ' ' A' ' 114' ' ' LEU . 1.4 tt0 179.48 170.78 1.02 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -67.44 -20.16 65.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 110.52 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -137.87 172.0 13.59 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -17.87 26.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.763 0.316 . . . . 0.0 110.4 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 m80 61.19 -89.15 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.297 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -147.78 47.04 1.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.017 0.437 . . . . 0.0 111.599 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.962 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.613 -0.143 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m 64.09 179.29 0.17 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.833 0.708 . . . . 0.0 111.176 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.51 130.61 40.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.678 0.275 . . . . 0.0 110.828 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.483 ' HB2' HH21 ' A' ' 25' ' ' ARG . 1.4 mp -120.64 99.83 6.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.891 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.14 131.69 41.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.512 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.483 HH21 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -101.04 141.31 34.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.197 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -75.01 88.46 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.025 0.44 . . . . 0.0 110.507 178.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.636 HG21 ' H ' ' A' ' 28' ' ' TYR . 2.6 p -89.51 178.38 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.393 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.636 ' H ' HG21 ' A' ' 27' ' ' VAL . 23.7 t80 -55.14 131.11 44.41 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.737 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.519 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -97.57 132.33 25.39 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HD2' ' HG2' ' A' ' 29' ' ' ARG . 11.9 Cg_endo -55.35 99.3 0.07 OUTLIER 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.016 2.477 . . . . 0.0 111.989 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.625 ' HB3' ' HG2' ' A' ' 34' ' ' GLN . 30.0 t0 -65.8 155.47 36.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.535 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.15 142.24 14.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.348 -173.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 t30 69.62 -67.06 0.24 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.428 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.625 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 13.7 mm-40 56.48 36.54 27.73 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.588 0.555 . . . . 0.0 111.948 173.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.92 70.93 3.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.517 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -119.35 141.63 48.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.835 0.35 . . . . 0.0 111.256 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -100.13 -174.72 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.407 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.524 HD13 ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -90.53 127.42 36.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.114 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 41' ' ' ASN . 72.5 m -96.93 144.67 26.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.437 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 39' ' ' THR . . . -63.94 -24.52 67.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.27 0.557 . . . . 0.0 110.881 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.715 ' H ' HG22 ' A' ' 39' ' ' THR . 12.9 t-20 -74.01 -20.95 60.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.43 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 39' ' ' THR . 7.5 m-20 -74.66 -31.28 61.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.533 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.677 HG22 ' HZ ' ' A' ' 77' ' ' PHE . 2.0 t -64.85 -24.97 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.824 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -10.8 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.724 0.297 . . . . 0.0 111.46 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -73.87 -34.35 64.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.188 0.518 . . . . 0.0 109.841 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.624 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pp -108.97 -178.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.91 157.3 31.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.72 0.295 . . . . 0.0 110.758 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.29 130.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.149 0.5 . . . . 0.0 109.818 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.771 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 96.93 -8.79 65.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.902 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 148.72 39.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.694 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.99 146.18 37.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.084 -175.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.39 -40.29 17.34 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.851 0.72 . . . . 0.0 111.999 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.428 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 7.1 mp0 -67.77 -42.29 81.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.546 -175.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -78.39 -33.33 48.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.393 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.624 ' HA ' HG21 ' A' ' 46' ' ' ILE . 39.5 t -60.47 -46.96 94.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 61' ' ' THR . . . -68.9 -38.74 79.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.726 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -40.12 83.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.66 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -40.61 55.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.582 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.501 HD12 HG12 ' A' ' 46' ' ' ILE . 1.4 mt -82.25 -38.93 23.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.665 0.269 . . . . 0.0 111.659 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.21 19.87 11.09 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.5 m -80.5 135.19 53.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.956 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.55 131.68 32.59 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.481 2.121 . . . . 0.0 111.074 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mt -72.83 125.04 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.813 0.339 . . . . 0.0 110.526 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.9 ttm -102.23 148.16 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.634 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.475 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -84.18 -177.11 6.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.868 176.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.567 ' N ' ' HD3' ' A' ' 67' ' ' PRO . 11.0 p-10 -134.87 49.79 4.14 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 66' ' ' ASP . 13.3 Cg_exo -68.16 -27.42 35.34 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.822 1.681 . . . . 0.0 111.072 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.23 -2.08 24.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.25 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.41 37.57 5.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.225 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.49 103.79 3.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.029 0.442 . . . . 0.0 111.585 -172.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -115.18 12.88 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.956 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.521 HG21 HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -134.68 145.31 48.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 -178.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.3 m0 -123.72 140.26 53.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -112.32 111.45 22.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.21 141.84 42.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.632 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -89.07 111.96 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.483 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.677 ' HZ ' HG22 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -96.68 170.98 8.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.156 -177.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -155.66 151.35 27.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.096 175.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB2' ' H ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -129.2 -138.87 0.23 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.536 ' H ' ' HB2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.3 104.89 25.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 24.0 Cg_exo -63.59 137.26 58.46 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.254 2.636 . . . . 0.0 112.669 -176.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.79 150.14 16.93 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -64.84 115.96 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 73.11 134.66 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.045 0.841 . . . . 0.0 110.315 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.82 54.15 1.15 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -170.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.67 100.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.407 0.622 . . . . 0.0 110.093 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 88' ' ' GLN . 0.9 OUTLIER -162.64 158.96 23.93 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.463 -175.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.562 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . 2.8 tp60 -136.03 170.07 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 111.275 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.42 130.97 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.036 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -99.86 115.05 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.465 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -83.52 104.85 13.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 109.884 -176.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -97.93 110.55 23.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.646 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -98.79 130.93 45.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.957 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.521 HG22 HG21 ' A' ' 72' ' ' THR . 0.3 OUTLIER -121.81 129.31 52.54 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -127.38 132.37 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 0.0 110.29 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.527 ' HB2' HG21 ' A' ' 102' ' ' THR . 20.3 t-20 -74.68 163.61 27.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.809 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -14.7 9.24 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.591 0.557 . . . . 0.0 112.137 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -10.96 60.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.243 0.544 . . . . 0.0 110.65 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.49 15.2 55.75 Favored Glycine 0 C--O 1.22 -0.743 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.862 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.764 HG11 ' HA2' ' A' ' 49' ' ' GLY . 2.4 t -112.42 130.2 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 122.432 0.293 . . . . 0.0 110.712 -172.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.771 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 2.3 mt -55.21 115.14 2.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -84.98 -33.19 22.64 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.033 0.444 . . . . 0.0 110.538 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -168.13 144.8 4.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.088 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 105' ' ' ASP . 1.8 mp -111.36 134.46 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 169.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.552 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -104.73 103.03 12.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.776 0.322 . . . . 0.0 110.386 176.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -125.31 104.81 8.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.262 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' HZ1' ' CG ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -118.75 133.84 23.59 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.11 132.87 38.32 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.943 2.429 . . . . 0.0 113.182 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.562 ' HB1' ' HA ' ' A' ' 88' ' ' GLN . . . -52.38 -41.47 63.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.235 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -79.61 41.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 111.097 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -165.3 -60.76 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 58.49 -119.32 16.84 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.048 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -102.78 -37.51 7.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.074 0.464 . . . . 0.0 110.574 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.2 26.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.949 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -86.87 -112.74 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.094 -174.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 115' ' ' GLU . 1.0 OUTLIER 71.7 -51.04 0.69 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -172.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 177.48 93.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.308 0.643 . . . . 0.0 110.204 171.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -55.43 144.83 24.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.088 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.47 55.75 0.9 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -81.25 114.01 19.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.311 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.511 0.196 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.74 74.04 0.44 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.12 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.2 m -74.7 109.94 8.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.412 175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.31 162.93 17.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.877 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.2 163.99 12.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.35 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.36 116.17 29.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.426 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 26' ' ' VAL . 1.4 t -78.25 83.91 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.42 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 t -74.6 138.94 20.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -110.92 148.97 31.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -89.26 109.76 33.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.639 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 28' ' ' TYR . 3.3 Cg_exo -76.75 52.82 3.84 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.241 2.627 . . . . 0.0 111.951 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -95.05 -159.98 0.75 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.883 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.524 ' HB ' ' H ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER 37.67 -117.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 124.015 0.822 . . . . 0.0 111.35 -177.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.524 ' H ' ' HB ' ' A' ' 32' ' ' ILE . 37.7 t-20 -167.97 -57.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.513 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 21.7 mm-40 61.23 -148.16 0.42 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.386 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' H ' ' HB3' ' A' ' 34' ' ' GLN . . . 77.11 13.56 83.53 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.249 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.42 ' HB3' ' H ' ' A' ' 37' ' ' TYR . 49.3 t30 -84.36 -109.49 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.42 ' H ' ' HB3' ' A' ' 36' ' ' ASN . 1.3 p90 -163.48 -177.78 5.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tp -75.0 158.71 32.79 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 41' ' ' ASN . 11.0 t -129.15 -179.85 5.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.603 0.239 . . . . 0.0 110.384 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.49 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.071 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.429 ' H ' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.9 -31.99 73.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.787 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -68.08 -34.29 76.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 110.371 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.442 HG12 HD21 ' A' ' 91' ' ' LEU . 6.8 t -63.19 -34.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.34 0.591 . . . . 0.0 110.33 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -6.79 59.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.196 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -29.93 45.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.404 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.585 HG23 ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -96.84 -177.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.056 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -140.44 144.96 36.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.599 0.238 . . . . 0.0 110.699 -175.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.519 HG12 HD13 ' A' ' 104' ' ' ILE . 3.1 m -68.23 138.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.502 175.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.76 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 85.34 3.17 87.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.975 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.525 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -82.25 154.36 25.42 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.693 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.53 145.99 38.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.505 ' H ' ' HG3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -53.98 -31.78 51.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.424 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -59.57 -44.72 93.21 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 110.426 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -76.65 -35.58 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.228 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.585 ' HA ' HG23 ' A' ' 46' ' ' ILE . 84.1 t -61.03 -43.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.973 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.833 ' HA ' HG21 ' A' ' 61' ' ' THR . . . -71.66 -34.49 69.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.834 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -37.48 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.85 -52.44 7.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.96 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 46' ' ' ILE . 48.1 mt -79.97 -12.28 59.73 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.08 32.44 69.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.833 HG21 ' HA ' ' A' ' 56' ' ' ALA . 3.2 t -100.95 146.4 32.06 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.8 Cg_exo -64.32 132.71 34.69 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.462 2.108 . . . . 0.0 112.009 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.3 mt -70.15 99.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.096 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.1 ttp -136.71 100.29 4.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -104.01 146.32 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.96 126.1 75.87 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.429 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.42 -5.42 9.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.402 2.735 . . . . 0.0 113.658 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.53 -12.82 55.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.156 0.503 . . . . 0.0 110.184 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.76 2.19 34.55 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 104.46 4.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.249 0.547 . . . . 0.0 110.437 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -108.39 53.89 0.67 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.727 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.432 HG23 HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -128.08 140.89 51.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.46 176.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.677 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 6.8 m0 -117.29 142.86 46.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.695 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 38.6 p90 -129.73 119.62 23.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.356 0.598 . . . . 0.0 110.428 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.99 159.17 26.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.54 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.0 121.86 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.0 0.429 . . . . 0.0 110.82 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.527 ' HZ ' ' ND2' ' A' ' 106' ' ' ASN . 3.6 p90 -118.39 -174.95 2.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.93 138.74 48.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.864 0.364 . . . . 0.0 111.362 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.54 HE21 ' NE2' ' A' ' 80' ' ' GLN . 1.6 mt-30 -91.85 -128.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.245 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.54 ' NE2' HE21 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -116.92 105.25 49.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.53 143.34 87.58 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.865 2.377 . . . . 0.0 112.396 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.02 -136.22 2.37 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.41 15.0 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.553 0.216 . . . . 0.0 111.083 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 76.01 -60.01 0.5 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.785 0.834 . . . . 0.0 111.119 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.98 -13.32 61.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.026 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 t -109.33 88.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.74 HG21 ' HB3' ' A' ' 109' ' ' ALA . 7.0 m -165.67 112.85 0.93 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.275 -174.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.54 117.49 1.56 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.271 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 13.5 pt20 -80.28 131.56 35.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.863 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.96 157.45 16.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.395 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.507 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -98.05 104.02 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -104.01 107.8 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.677 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.1 mp -101.24 124.18 46.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.432 HG22 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -117.76 122.23 42.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -127.14 148.07 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.964 0.412 . . . . 0.0 110.362 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -81.15 161.61 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -8.45 1.85 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.72 -13.34 60.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.27 14.39 48.37 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.915 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.572 HG12 ' HA2' ' A' ' 49' ' ' GLY . 2.5 t -112.16 126.94 69.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.59 0.356 . . . . 0.0 110.43 -173.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.76 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 8.2 mt -56.76 108.42 0.5 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.321 0.388 . . . . 0.0 110.179 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.464 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -74.71 -32.97 62.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.49 140.06 4.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.974 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 105' ' ' ASP . 53.6 mt -102.38 134.51 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 104' ' ' ILE . 3.2 t70 -111.04 101.8 10.31 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.394 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.527 ' ND2' ' HZ ' ' A' ' 77' ' ' PHE . 9.4 t-20 -133.32 102.17 5.45 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.06 0.457 . . . . 0.0 109.779 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.22 131.56 24.39 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.763 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.07 146.01 13.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.363 2.708 . . . . 0.0 112.361 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.74 ' HB3' HG21 ' A' ' 87' ' ' THR . . . -74.55 51.58 0.47 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.164 0.506 . . . . 0.0 111.485 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -15.94 60.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -19.25 63.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.116 173.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 113' ' ' ASN . . . -67.57 113.44 5.5 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 173.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 112' ' ' GLY . 11.8 t-20 72.64 -71.31 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 tp 156.64 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.681 1.192 . . . . 0.0 108.601 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -135.88 81.95 1.92 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.667 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -65.08 -39.49 93.27 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -149.74 74.59 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -175.35 159.52 2.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.937 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.35 137.72 52.04 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.34 173.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -63.63 136.16 57.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.592 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 34.7 t60 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.719 176.645 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 121.194 0.521 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.7 m -143.17 33.5 1.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 109.685 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.09 125.11 25.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.482 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.7 tp -145.98 81.26 1.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.004 0.431 . . . . 0.0 110.744 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.36 71.48 8.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.432 0.634 . . . . 0.0 110.155 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.97 63.35 1.31 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.228 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.15 132.78 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.778 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.85 93.66 4.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.808 0.814 . . . . 0.0 110.953 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -91.56 115.98 28.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.381 174.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -120.55 139.03 28.16 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 7.9 Cg_exo -72.33 54.09 2.25 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.916 2.411 . . . . 0.0 111.105 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -127.42 7.29 6.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.106 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -85.31 143.82 10.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.651 -176.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -87.0 75.2 9.56 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.463 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -133.11 114.01 13.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.29 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.5 32.19 67.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.047 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -103.14 155.12 18.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.628 0.252 . . . . 0.0 110.429 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.788 ' HE2' ' HA ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -159.12 179.35 9.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.59 151.45 40.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.953 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.3 145.97 43.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.126 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.85 80.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.75 -18.54 63.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.154 0.502 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.73 -23.35 45.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.437 HG13 HD11 ' A' ' 46' ' ' ILE . 10.6 t -67.77 -18.38 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.045 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -7.4 51.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.669 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -17.23 38.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.42 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.547 HG12 HD13 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -115.02 165.6 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 0.0 111.471 -177.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -142.08 166.17 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.014 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.436 ' H ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -72.47 145.44 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.88 0.372 . . . . 0.0 110.189 176.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.707 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 79.16 1.84 86.25 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.261 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.4 mmt -82.09 137.31 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.82 146.09 53.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.624 0.249 . . . . 0.0 111.051 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.664 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 4.6 pt20 -57.28 -26.84 61.47 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.286 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -43.04 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 0.0 109.983 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -76.02 -32.72 59.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.52 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.418 ' HA ' HG22 ' A' ' 46' ' ' ILE . 59.0 t -64.59 -44.33 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.57 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -65.96 -38.02 87.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.668 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.3 -49.5 75.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.495 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.38 -47.34 34.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.3 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.547 HD13 HG12 ' A' ' 46' ' ' ILE . 5.0 mp -76.17 -43.53 42.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -175.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.13 50.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.935 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 56' ' ' ALA . 18.9 m -77.19 134.3 67.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 120.679 0.275 . . . . 0.0 111.151 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.3 Cg_exo -66.66 146.47 79.19 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.888 2.392 . . . . 0.0 111.578 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.557 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -69.66 123.97 22.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.217 0.532 . . . . 0.0 110.179 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.75 157.54 44.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.289 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.74 126.97 47.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.125 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.93 121.54 21.94 Favored Pre-proline 0 N--CA 1.447 -0.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -86.47 -3.5 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.672 2.248 . . . . 0.0 113.522 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -102.3 -27.0 13.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.91 34.04 3.88 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.063 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -77.17 84.81 3.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.36 52.94 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.886 0.85 . . . . 0.0 110.3 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -137.54 119.87 15.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.548 175.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 m0 -104.26 128.33 52.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.762 -174.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.78 131.66 55.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.776 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.426 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 23.1 m-85 -136.47 139.84 42.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.931 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 121.44 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.788 ' HA ' ' HE2' ' A' ' 37' ' ' TYR . 7.4 p90 -140.29 150.37 43.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.302 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.69 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -105.35 114.21 28.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.9 0.857 . . . . 0.0 110.137 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -107.94 -130.15 0.29 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.259 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -65.81 129.99 94.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 5.9 Cg_exo -75.61 -161.86 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.261 2.641 . . . . 0.0 112.381 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.91 -67.33 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.565 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -163.55 158.11 20.36 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -178.09 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.6 OUTLIER 81.36 -19.83 0.4 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.064 0.852 . . . . 0.0 111.915 172.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 -37.09 1.56 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.238 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.53 86.07 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.644 0.735 . . . . 0.0 109.18 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.409 HG22 ' HB1' ' A' ' 109' ' ' ALA . 11.4 m -167.66 119.37 0.87 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.524 HE22 ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -131.48 172.44 12.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -165.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.437 ' H ' ' HG2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -117.71 137.8 52.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.103 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.11 136.97 54.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.925 0.393 . . . . 0.0 111.766 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -86.98 105.68 17.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.356 174.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.8 104.71 14.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.952 0.406 . . . . 0.0 110.311 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.2 mp -98.32 118.43 34.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.438 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.89 111.96 23.28 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.689 ' HB3' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -126.28 146.09 50.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.247 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 168.03 18.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -20.54 8.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -171.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.66 -5.18 56.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.971 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.664 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 87.93 22.19 43.27 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.164 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.707 HG12 ' HA2' ' A' ' 49' ' ' GLY . 53.2 t -100.28 111.52 30.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.689 HD22 ' HB3' ' A' ' 95' ' ' PHE . 13.9 mt -54.88 101.85 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.054 0.454 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.72 42.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.454 0.645 . . . . 0.0 109.728 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 136.19 6.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.023 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 105' ' ' ASP . 29.7 mt -106.84 134.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 104' ' ' ILE . 1.9 t0 -109.01 101.18 10.28 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -133.91 104.44 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.924 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 145.03 54.08 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.422 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 31.1 Cg_exo -59.63 162.16 16.04 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.376 2.05 . . . . 0.0 111.08 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -58.9 -21.45 57.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.508 HD23 ' HG3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -86.41 -9.34 56.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.198 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.554 ' HB2' HD21 ' A' ' 114' ' ' LEU . 3.1 m 68.26 -56.95 0.49 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.373 0.669 . . . . 0.0 112.245 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -168.25 -132.93 1.48 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.02 58.57 5.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.962 0.41 . . . . 0.0 110.528 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 111' ' ' SER . 0.7 OUTLIER -163.09 140.63 7.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.942 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.508 ' HG3' HD23 ' A' ' 110' ' ' LEU . 2.4 mp0 -102.0 117.44 34.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.347 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.52 179.46 0.21 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.777 0.673 . . . . 0.0 110.797 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.31 91.87 0.18 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -37.01 77.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 110.427 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -103.8 113.97 27.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 170.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -67.82 129.38 39.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.836 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.757 -1.116 . . . . 0.0 108.718 173.287 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.778 0.323 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.92 133.41 46.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.062 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.2 m -116.22 111.63 20.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.235 0.54 . . . . 0.0 111.298 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 120.73 40.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.35 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.2 150.7 25.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.84 0.352 . . . . 0.0 110.408 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -108.04 132.7 53.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.132 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.53 66.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.374 0.607 . . . . 0.0 109.563 175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.4 p -104.08 177.56 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.311 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.46 ' H ' HG22 ' A' ' 27' ' ' VAL . 29.8 t80 -61.94 120.34 10.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.092 0.472 . . . . 0.0 110.801 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -105.64 137.55 19.34 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 173.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 4.5 Cg_exo -75.88 18.99 0.59 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 123.048 2.499 . . . . 0.0 113.192 -177.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -125.06 81.61 1.98 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.872 0.368 . . . . 0.0 110.785 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.573 HD13 ' HG3' ' A' ' 34' ' ' GLN . 0.3 OUTLIER -153.0 162.4 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.014 -179.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -85.48 61.84 7.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.159 0.504 . . . . 0.0 111.107 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.573 ' HG3' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -148.18 13.6 0.99 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.295 175.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.76 170.31 13.6 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.232 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 179.89 -179.26 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -79.83 -174.89 4.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -72.61 155.46 40.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.976 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 162.95 25.68 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.87 69.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.998 0.428 . . . . 0.0 110.637 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -68.19 -23.62 64.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.059 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.694 ' HB3' HD12 ' A' ' 38' ' ' LEU . 1.8 t70 -84.61 -22.35 30.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.74 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG11 HD12 ' A' ' 91' ' ' LEU . 39.6 t -71.02 -27.16 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.309 0.576 . . . . 0.0 110.436 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -5.05 12.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.797 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HB2' ' HE2' ' A' ' 45' ' ' LYS . 9.1 mtmt -78.24 -13.25 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.84 -176.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.689 ' HB2' ' HG3' ' A' ' 50' ' ' MET . 84.3 mmt-85 -141.64 159.03 43.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.446 -173.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.9 121.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.916 174.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.791 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 103.22 -2.68 47.19 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -175.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.689 ' HG3' ' HB2' ' A' ' 47' ' ' ARG . 5.6 mtt -65.98 147.11 53.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -79.16 151.72 31.13 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -49.65 -43.24 46.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.596 0.56 . . . . 0.0 111.435 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -68.86 -37.29 78.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.28 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -73.23 -33.34 65.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -61.77 -51.11 76.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.572 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.95 82.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.715 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -45.66 88.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.391 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.74 -51.97 10.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 -177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.5 -35.37 65.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.298 -175.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.1 27.42 10.96 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.439 HG21 ' HD2' ' A' ' 62' ' ' PRO . 1.3 m -71.64 135.95 83.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.311 -0.445 . . . . 0.0 111.769 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD2' HG21 ' A' ' 61' ' ' THR . 22.2 Cg_exo -65.64 137.97 52.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 110.917 171.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.65 134.24 53.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.51 155.53 16.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.102 0.477 . . . . 0.0 111.319 -172.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.91 81.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.254 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.79 75.14 68.32 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.189 0.518 . . . . 0.0 110.003 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.92 -3.44 13.86 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.696 2.931 . . . . 0.0 112.208 -173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -19.68 63.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.38 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.6 18.76 10.47 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.016 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.09 105.64 4.63 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.705 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 5.4 m-80 -92.13 36.14 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.435 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.98 128.49 34.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.301 177.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.1 m0 -103.7 141.39 36.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.759 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -113.49 111.38 21.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.458 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.55 129.12 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.994 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 t -108.77 107.26 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.686 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 20.7 p90 -123.52 153.71 40.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.057 0.456 . . . . 0.0 110.645 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 139.24 58.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.946 -172.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -169.52 2.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.515 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.435 ' N ' HE21 ' A' ' 80' ' ' GLN . 0.0 OUTLIER -74.83 139.2 73.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 16.9 Cg_exo -68.03 68.44 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.196 2.598 . . . . 0.0 113.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 161.2 -96.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.829 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.525 ' HB3' ' OG1' ' A' ' 87' ' ' THR . 0.4 OUTLIER 57.43 -100.7 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.861 0.465 . . . . 0.0 111.527 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.439 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 8.3 tp10 -123.27 -14.66 7.41 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.19 -37.75 3.32 Favored Glycine 0 C--N 1.322 -0.218 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.4 89.02 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 164.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 83' ' ' HIS . 3.5 m -156.03 113.62 3.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.896 -161.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.745 ' H ' ' HB1' ' A' ' 109' ' ' ALA . 4.1 tp-100 -170.19 -178.43 2.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -161.71 155.08 21.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.546 0.612 . . . . 0.0 111.198 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -126.72 125.51 41.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.875 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.795 HD21 ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -84.75 111.17 19.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.138 -177.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -89.64 107.04 18.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.651 176.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.4 mp -100.63 121.46 41.65 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -113.59 127.57 56.12 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -127.17 158.08 38.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -88.73 171.75 9.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.33 -25.49 24.35 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -13.13 60.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.007 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.06 22.79 24.34 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.791 HG12 ' HA2' ' A' ' 49' ' ' GLY . 42.0 t -99.42 115.87 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.109 0.164 . . . . 0.0 110.674 -174.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -53.96 107.38 0.26 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 110.606 177.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.45 -13.77 17.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.771 -176.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.546 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 22.3 t-20 -159.85 127.84 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.237 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.715 HG21 ' N ' ' A' ' 105' ' ' ASP . 5.0 mt -108.44 142.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.715 ' N ' HG21 ' A' ' 104' ' ' ILE . 6.7 t70 -144.53 103.05 3.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.848 0.356 . . . . 0.0 111.143 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.795 ' HB2' HD21 ' A' ' 91' ' ' LEU . 21.9 t30 -115.51 109.31 17.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 2.2 mmtt -121.94 107.0 36.0 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.279 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.436 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 8.3 Cg_exo -72.22 143.45 39.67 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.021 2.48 . . . . 0.0 112.352 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.745 ' HB1' ' H ' ' A' ' 88' ' ' GLN . . . -60.08 92.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.552 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER 177.21 -47.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.559 177.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.25 133.53 48.18 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.23 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.81 -49.28 0.52 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -177.04 -33.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -20.1 63.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.771 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 18.02 77.83 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.822 1.249 . . . . 0.0 113.748 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 68.8 -80.28 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.215 0.606 . . . . 0.0 110.776 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -141.64 70.68 1.34 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.492 0.663 . . . . 0.0 109.395 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.88 120.33 42.21 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.88 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -96.68 -153.95 0.43 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.22 -155.47 0.64 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.393 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.749 179.902 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.916 0.389 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -140.06 48.59 1.78 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.064 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.52 109.18 16.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.835 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.86 116.01 21.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.114 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -95.71 117.9 31.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.638 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.68 118.72 3.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.29 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.6 144.72 20.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.31 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.93 89.92 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.163 0.506 . . . . 0.0 110.276 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -107.94 135.74 48.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.828 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.4 108.55 59.51 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.935 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.75 63.47 7.44 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.487 2.125 . . . . 0.0 111.508 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 1.1 t0 -153.51 169.8 22.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.945 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 31' ' ' ASP . 1.3 mp 76.92 138.06 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 123.906 0.754 . . . . 0.0 111.252 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.458 ' N ' HG23 ' A' ' 32' ' ' ILE . 48.5 t-20 -75.52 82.63 2.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.129 176.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.93 74.89 7.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.767 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.13 -143.93 5.33 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.324 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.5 t30 71.25 -94.22 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.233 0.613 . . . . 0.0 110.62 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -169.35 0.49 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -86.71 159.03 19.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.189 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 t -127.78 170.57 12.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 0.0 110.597 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.82 -23.71 67.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.169 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -65.17 -30.12 71.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.986 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.934 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 42.3 m-20 -74.87 -31.15 61.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.04 -27.64 38.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.24 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -12.09 60.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.769 0.318 . . . . 0.0 111.289 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.934 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 mttt -78.01 -46.23 21.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.748 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pp -70.25 154.39 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.989 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.622 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -123.75 156.64 35.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -174.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -68.36 131.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.66 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 85.18 4.09 86.82 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.195 -176.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.622 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -72.21 142.45 49.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.527 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -83.93 151.1 25.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 111.121 -176.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.639 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 1.1 pt20 -51.37 -35.3 37.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.055 -172.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.527 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 2.3 mp0 -64.66 -50.32 67.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.841 0.353 . . . . 0.0 110.106 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -68.37 -36.56 79.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.9 t -59.59 -47.32 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.288 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.551 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -74.68 -23.94 58.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.149 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 -41.85 10.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.543 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.37 -10.94 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.764 0.316 . . . . 0.0 111.549 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.85 40.83 57.14 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.412 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 1.7 m -67.98 128.6 93.32 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.507 0.194 . . . . 0.0 111.217 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.85 173.93 7.44 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.266 2.644 . . . . 0.0 112.289 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.88 116.66 2.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.06 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.59 127.19 46.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.375 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.38 81.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.01 115.16 64.53 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 109.268 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 -2.44 12.61 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.7 2.266 . . . . 0.0 112.647 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -100.71 -26.9 13.64 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.5 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.49 4.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.348 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -71.28 99.26 1.89 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.387 0.613 . . . . 0.0 110.546 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 95' ' ' PHE . 5.4 p30 -90.88 43.24 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.258 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.03 129.38 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.87 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 13.5 m0 -116.81 142.76 46.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -120.8 127.06 51.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.992 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.83 153.85 49.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.823 0.344 . . . . 0.0 110.305 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.89 132.76 29.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.444 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 2.6 p90 -125.81 138.1 53.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.996 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.12 116.95 13.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.793 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.415 ' HB3' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -120.39 -92.5 0.54 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.543 -171.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -128.03 117.78 20.65 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.836 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.488 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 8.1 Cg_exo -71.97 -95.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.871 2.381 . . . . 0.0 111.992 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 111.17 157.36 14.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.081 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -101.85 -40.33 6.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -110.81 119.96 40.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.795 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.68 55.21 0.95 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.999 -172.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -74.88 89.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.422 0.63 . . . . 0.0 109.456 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -159.54 162.33 35.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.801 -171.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 88' ' ' GLN . 1.4 tp60 -136.35 179.82 6.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.439 0.638 . . . . 0.0 111.976 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 108' ' ' PRO . 3.5 mp0 -78.94 148.23 32.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.258 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.94 118.36 27.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.444 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -112.46 105.37 13.6 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 110.406 178.015 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -115.55 126.35 54.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.641 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.1 mp -111.43 131.04 55.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.975 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.89 131.24 53.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.633 ' HE1' HD23 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -118.73 130.46 55.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.919 0.39 . . . . 0.0 110.784 -174.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.416 ' HB2' HG21 ' A' ' 102' ' ' THR . 66.1 t30 -77.54 162.4 27.15 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.18 45.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -2.51 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.639 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 85.05 22.3 52.85 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.66 HG12 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -94.15 130.16 43.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.516 0.198 . . . . 0.0 110.919 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.633 HD23 ' HE1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -58.96 96.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.506 174.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.416 HG21 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.52 -32.9 58.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.179 0.514 . . . . 0.0 110.762 -178.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -164.38 142.57 6.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.838 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.503 HG13 HD12 ' A' ' 101' ' ' LEU . 3.3 mt -111.54 129.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.479 ' N ' HG22 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -97.34 101.14 12.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.68 115.39 18.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.12 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -145.56 136.93 12.72 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.613 -177.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.675 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . 18.0 Cg_exo -66.84 169.88 13.85 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.154 2.569 . . . . 0.0 112.114 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' HB3' ' CA ' ' A' ' 88' ' ' GLN . . . -74.08 -28.11 61.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.085 0.469 . . . . 0.0 110.606 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -94.41 115.28 27.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.738 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 m -90.35 175.24 7.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.791 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.79 -28.3 67.33 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.681 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 114' ' ' LEU . 9.8 t-20 -64.94 -84.07 0.02 OUTLIER 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.449 ' H ' ' HB3' ' A' ' 113' ' ' ASN . 0.5 OUTLIER -175.63 123.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.744 175.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 60.04 15.41 5.08 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 170.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 70.01 -54.8 0.61 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.953 0.501 . . . . 0.0 110.174 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -92.33 106.47 18.46 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -65.13 122.47 17.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.527 -177.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -134.41 116.21 14.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.66 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.27 -175.14 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.821 -173.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.656 -0.687 . . . . 0.0 109.457 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.549 0.214 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 m -74.23 116.97 15.49 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.35 129.54 34.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.226 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -142.97 46.5 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.513 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -71.82 104.17 3.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.753 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.65 92.4 3.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.112 0.482 . . . . 0.0 111.383 -176.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.82 69.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.88 126.39 40.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.767 -171.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -92.8 131.52 37.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.221 -0.899 . . . . 0.0 108.901 171.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' H ' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -102.92 122.38 45.86 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.155 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 8.8 Cg_exo -72.58 43.36 0.64 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 123.33 2.686 . . . . 0.0 112.223 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.68 28.14 1.59 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.494 0.664 . . . . 0.0 110.002 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.19 144.43 31.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.428 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.97 108.01 3.85 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -142.0 108.78 5.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.01 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.93 -142.17 15.97 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.775 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.7 t30 71.45 -86.64 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.309 0.644 . . . . 0.0 111.673 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -102.81 175.08 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.999 0.428 . . . . 0.0 110.93 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.6 152.37 49.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.884 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -125.27 174.09 8.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.696 0.284 . . . . 0.0 110.331 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.36 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.966 0.412 . . . . 0.0 111.337 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.42 -29.12 70.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.21 -27.4 68.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.716 HG21 HD23 ' A' ' 91' ' ' LEU . 2.3 t -79.98 -18.65 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -75.99 -12.21 60.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.161 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -82.11 -29.29 31.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.612 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.25 -167.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 50' ' ' MET . 1.4 ptt85 -154.85 164.52 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.385 . . . . 0.0 111.601 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.28 141.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.793 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.663 ' H ' ' HB3' ' A' ' 101' ' ' LEU . . . 86.4 -5.3 84.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.761 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.619 ' HE2' ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -68.22 131.37 45.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -69.59 146.64 51.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.519 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -50.04 -37.5 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.48 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -68.53 -38.5 80.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.525 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.619 ' HB3' ' HE2' ' A' ' 50' ' ' MET . 3.5 mp0 -77.46 -31.54 53.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.359 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.09 -49.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.675 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.73 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -57.26 8.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.0 -42.66 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.26 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.1 tp -85.88 -28.97 24.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 0.0 110.696 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.06 79.67 1.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.724 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 m -105.62 134.32 19.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.458 0.171 . . . . 0.0 111.28 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.42 134.96 54.53 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.833 2.355 . . . . 0.0 112.05 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 138.11 51.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.159 -175.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -140.27 170.81 15.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.277 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.7 13.32 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -155.92 90.27 2.79 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.83 -8.15 5.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.948 2.432 . . . . 0.0 112.325 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.25 -27.36 11.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -173.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.2 31.0 6.72 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -83.89 88.5 7.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.657 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.94 64.63 7.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.369 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.67 HG23 HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -141.36 137.35 32.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.455 176.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -125.43 155.41 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.381 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.55 134.42 33.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.725 0.298 . . . . 0.0 110.468 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -122.38 146.63 47.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.272 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.68 114.38 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.52 ' HE1' HD21 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -94.13 128.44 40.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.114 -170.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -77.66 103.42 7.59 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.58 ' HB3' HE21 ' A' ' 89' ' ' GLN . 1.5 tp-100 -140.84 168.17 20.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 -171.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -70.87 127.47 91.73 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.246 0.546 . . . . 0.0 110.923 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 36.7 Cg_endo -93.35 -37.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.012 2.474 . . . . 0.0 113.495 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.89 -149.15 27.95 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.999 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.96 52.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.528 0.664 . . . . 0.0 111.665 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.44 -30.67 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.171 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.29 -33.64 6.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.69 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.72 86.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -161.32 98.37 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.748 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.437 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -147.0 107.36 4.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.943 178.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.58 HE21 ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -90.88 123.64 34.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.485 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.55 44.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.716 HD23 HG21 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -84.13 115.31 22.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -106.08 132.78 51.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.177 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.5 mp -111.41 122.15 47.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.881 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.67 HG22 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -114.6 114.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -176.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.46 ' CD1' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -113.34 158.57 20.41 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -86.99 169.07 12.76 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.2 -23.42 47.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -173.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -11.63 60.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.5 27.05 12.2 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.246 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.549 HG12 ' HA2' ' A' ' 49' ' ' GLY . 30.7 t -111.78 125.1 69.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.865 0.333 . . . . 0.0 111.127 -174.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.663 ' HB3' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -53.68 111.11 0.67 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -24.74 13.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.915 0.388 . . . . 0.0 110.343 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -155.5 131.49 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.641 HG21 ' N ' ' A' ' 105' ' ' ASP . 1.4 mp -105.95 140.17 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 170.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.641 ' N ' HG21 ' A' ' 104' ' ' ILE . 10.7 t70 -117.04 109.97 17.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.9 101.35 3.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.157 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 140.9 29.67 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.648 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.446 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 11.3 Cg_endo -56.14 133.37 57.59 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.514 2.143 . . . . 0.0 111.815 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.437 ' CB ' ' H ' ' A' ' 88' ' ' GLN . . . -60.67 -24.92 65.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.129 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.22 10.76 9.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.2 m -126.24 -173.03 2.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.159 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 117.87 109.56 2.48 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 71.32 -49.46 0.68 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.319 0.647 . . . . 0.0 110.697 -174.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.518 ' HG ' ' HG3' ' A' ' 115' ' ' GLU . 6.7 tp -168.71 -74.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.518 ' HG3' ' HG ' ' A' ' 114' ' ' LEU . 92.4 mt-10 -131.3 149.38 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.778 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -102.95 -36.29 8.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.42 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -169.33 99.06 0.35 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.261 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -166.56 -42.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.869 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 74.79 74.03 0.1 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 124.11 0.881 . . . . 0.0 111.38 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -56.85 -43.98 81.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.665 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 . . . . . 0 C--O 1.243 0.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.01 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m 58.84 37.44 24.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.37 0.605 . . . . 0.0 110.699 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 76.81 5.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.362 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -126.83 143.42 51.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.592 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -134.15 118.87 18.16 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.971 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.462 ' HB3' ' H ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -152.28 -96.88 0.05 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.109 178.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.462 ' H ' ' HB3' ' A' ' 25' ' ' ARG . 2.2 t 47.94 59.55 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 O-C-N 123.606 0.566 . . . . 0.0 111.126 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 27' ' ' VAL . 2.3 m -112.79 163.66 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.812 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -78.76 135.51 37.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.855 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -109.36 128.93 24.53 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.454 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.69 -29.0 69.02 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.655 2.237 . . . . 0.0 111.867 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -103.8 103.42 13.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.587 HG12 ' HB2' ' A' ' 34' ' ' GLN . 0.1 OUTLIER -136.57 -158.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.698 178.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -81.44 47.58 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.726 0.774 . . . . 0.0 110.196 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.587 ' HB2' HG12 ' A' ' 32' ' ' ILE . 1.2 tp-100 -90.54 90.41 7.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.918 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.08 175.82 14.64 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.663 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -127.7 -59.53 1.2 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -123.78 -169.47 1.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.51 150.98 32.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.909 0.385 . . . . 0.0 111.528 -175.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.05 145.25 35.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.52 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HA ' ' CE2' ' A' ' 77' ' ' PHE . . . -74.27 -41.89 60.52 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.012 0.434 . . . . 0.0 110.329 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.04 -22.44 66.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.661 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 8.1 m-20 -69.49 -37.22 77.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.977 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.578 HG22 ' HZ ' ' A' ' 77' ' ' PHE . 9.2 t -76.1 -16.9 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.529 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 -7.38 56.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 4.7 mtpt -82.49 -34.03 28.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.2 pp -80.5 160.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.579 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -136.92 165.51 25.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.85 -171.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -72.3 145.38 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.615 ' HA2' ' CG1' ' A' ' 100' ' ' VAL . . . 75.93 2.77 72.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.38 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.1 mmm -83.9 137.06 33.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.2 OUTLIER -78.17 152.39 32.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 -176.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -32.74 62.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.313 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -64.66 -45.34 87.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -72.63 -33.74 66.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.051 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 59' ' ' LEU . 56.0 t -62.23 -49.68 83.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.632 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.5 69.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.78 -54.43 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.815 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.83 34.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.814 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' A' ' 55' ' ' VAL . 8.3 tp -84.79 -40.27 17.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.22 -176.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.08 63.47 0.81 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.178 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 5.7 m -101.81 133.37 20.79 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -80.19 172.45 13.78 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.136 2.557 . . . . 0.0 111.649 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 138.94 56.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.818 0.342 . . . . 0.0 110.657 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.1 ttp -142.21 178.7 7.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.052 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -121.51 152.34 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.76 0.314 . . . . 0.0 111.418 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.75 46.13 0.35 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.172 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.24 -34.08 88.93 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.0 113.449 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -104.26 7.73 35.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.797 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.03 21.13 9.18 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.425 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.84 85.61 3.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.247 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' A' ' 71' ' ' ASN . 4.0 m120 -108.86 27.87 9.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.298 0.57 . . . . 0.0 111.374 -172.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.76 129.57 49.45 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.258 170.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -103.46 121.58 43.13 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.53 114.67 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.365 -176.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -106.12 130.99 53.91 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.884 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.05 108.76 16.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.578 ' HZ ' HG22 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -115.28 116.47 28.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 102.35 11.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.923 165.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -118.9 -37.68 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.184 0.516 . . . . 0.0 110.697 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -147.57 141.47 15.76 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.572 175.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.504 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 1.3 Cg_endo -85.4 -104.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.136 2.557 . . . . 0.0 111.987 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 116.19 165.94 14.39 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.9 97.2 9.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.929 0.365 . . . . 0.0 110.787 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -159.23 -63.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.02 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 -35.76 4.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.453 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -106.42 87.18 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.511 HG23 ' HB1' ' A' ' 109' ' ' ALA . 27.2 m -159.41 101.24 1.53 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.559 -168.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 19.2 tp60 -151.69 144.48 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.55 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.71 147.01 44.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.482 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.05 127.98 47.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.389 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.02 114.73 21.93 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.97 105.41 14.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.331 0.586 . . . . 0.0 111.515 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 6.6 mp -87.34 148.04 25.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.815 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.19 116.24 12.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.616 ' HB3' HD22 ' A' ' 101' ' ' LEU . 26.6 p90 -129.2 145.03 51.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.63 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.41 163.01 28.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.892 177.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.08 -38.49 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -3.51 25.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.63 17.82 47.36 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.182 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.615 ' CG1' ' HA2' ' A' ' 49' ' ' GLY . 14.3 t -97.08 114.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 95' ' ' PHE . 1.4 mm? -54.82 106.21 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.552 0.533 . . . . 0.0 110.837 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.41 -28.22 19.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.146 0.498 . . . . 0.0 110.891 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -158.8 149.65 20.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.696 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.505 HG22 ' N ' ' A' ' 105' ' ' ASP . 1.7 mp -124.02 130.03 73.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 171.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -98.13 101.65 13.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.599 174.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -125.11 106.53 9.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.223 0.535 . . . . 0.0 110.376 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 144.59 35.68 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 159.64 40.71 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.299 1.999 . . . . 0.0 111.274 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.517 ' HB2' ' C ' ' A' ' 88' ' ' GLN . . . -66.37 -34.92 79.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 116.54 31.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.18 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m 69.92 124.44 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.076 0.86 . . . . 0.0 110.935 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.27 -77.86 0.23 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.442 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -73.4 -35.69 65.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.46 0.648 . . . . 0.0 109.703 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.0 132.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.35 176.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -80.55 148.37 30.39 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.235 175.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -49.62 127.56 15.92 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.746 0.654 . . . . 0.0 112.263 -176.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 75.47 161.13 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.454 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -69.61 120.32 15.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.787 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -67.04 103.26 1.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.469 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.54 144.44 25.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.377 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.5 p80 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.426 -176.68 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.592 0.234 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.4 156.11 40.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.948 0.404 . . . . 0.0 110.997 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.1 133.13 34.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.873 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -85.6 49.66 1.81 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.419 0.628 . . . . 0.0 110.267 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -131.97 126.42 33.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.549 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -174.43 126.41 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.57 123.54 19.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.177 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.7 p -146.05 -47.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.759 0.314 . . . . 0.0 111.138 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -159.09 139.64 12.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.918 0.39 . . . . 0.0 110.742 -176.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.9 ttt85 -111.11 113.05 54.86 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.676 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.54 75.86 0.77 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.564 2.176 . . . . 0.0 110.855 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.32 -133.95 0.34 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.221 -173.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.539 HD11 ' N ' ' A' ' 33' ' ' ASN . 2.1 pp -92.08 -20.39 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.619 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.539 ' N ' HD11 ' A' ' 32' ' ' ILE . 17.2 t-20 -77.21 67.5 3.18 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.353 0.597 . . . . 0.0 110.477 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.98 -35.3 0.09 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.369 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.33 84.87 0.38 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.08 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -118.26 169.32 9.81 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 -179.74 3.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.649 HD23 ' HE1' ' A' ' 77' ' ' PHE . 12.4 tp -78.87 131.81 36.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.414 . . . . 0.0 110.772 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 145.84 27.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.302 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.01 81.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.969 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.91 -22.15 65.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.493 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -42.3 89.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.866 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.589 HG21 ' HZ ' ' A' ' 77' ' ' PHE . 6.3 t -74.98 -17.06 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.747 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -73.86 -7.36 51.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.854 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -76.06 -37.9 57.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.061 0.457 . . . . 0.0 110.165 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -91.0 179.13 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.874 177.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.587 ' O ' ' HB2' ' A' ' 50' ' ' MET . 7.7 ptp180 -157.81 167.66 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.769 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 101' ' ' LEU . 61.9 t -66.36 128.96 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.785 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.612 ' HA2' HG11 ' A' ' 100' ' ' VAL . . . 95.51 -4.7 66.84 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.01 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -81.26 161.84 23.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -79.29 144.67 34.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.069 0.462 . . . . 0.0 111.518 -169.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -61.31 -36.32 79.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.728 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.67 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -79.52 -30.54 41.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.154 -172.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 54' ' ' GLN . 2.3 tt0 -75.26 -37.68 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 51' ' ' THR . 38.4 t -60.44 -46.24 95.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.796 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -68.5 -31.88 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.873 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -37.62 83.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.153 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.7 -44.8 13.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.989 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 59' ' ' LEU . 88.0 mt -88.93 -6.74 57.06 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 55.8 17.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.464 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.565 HG22 ' HD2' ' A' ' 62' ' ' PRO . 2.0 m -79.02 130.95 68.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.477 0.179 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.565 ' HD2' HG22 ' A' ' 61' ' ' THR . 52.9 Cg_exo -55.89 148.84 54.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.143 2.562 . . . . 0.0 112.588 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.56 113.74 13.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.374 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.78 131.29 47.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.142 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.53 102.6 8.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.07 115.36 38.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 120.911 0.386 . . . . 0.0 110.571 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.43 -2.03 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.063 2.508 . . . . 0.0 112.183 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -81.55 -26.73 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.642 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.82 30.17 4.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.839 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -80.43 108.99 14.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.983 0.421 . . . . 0.0 110.59 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -112.49 39.16 2.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.427 0.632 . . . . 0.0 110.229 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.69 141.45 52.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.52 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.691 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 3.0 m0 -116.31 142.96 46.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -124.9 111.56 15.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.138 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.469 ' HD2' HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -107.57 140.78 40.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.436 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.487 ' H ' HG21 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -90.96 114.74 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.076 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.649 ' HE1' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -102.89 142.25 34.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.28 148.41 47.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.733 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -129.57 167.66 17.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.2 mm-40 -88.1 115.77 64.17 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.2 Cg_exo -70.36 70.09 1.93 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.158 2.572 . . . . 0.0 111.978 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.36 -150.0 17.51 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.444 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.61 3.04 30.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.0 111.871 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.9 -48.23 16.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.31 0.576 . . . . 0.0 110.095 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.66 -39.2 1.51 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.727 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.41 88.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 117.108 0.454 . . . . 0.0 110.798 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.571 HG21 ' HB1' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -169.69 136.1 1.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.89 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 29.5 tp60 -154.76 130.9 10.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.095 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -75.14 124.56 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 110.536 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.6 110.44 20.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.954 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.457 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.91 106.93 15.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.974 0.416 . . . . 0.0 110.537 -175.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 111.3 22.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.853 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.691 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 4.1 mp -106.66 142.6 36.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.002 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.512 ' O ' HD11 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -139.74 133.85 31.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -132.2 141.65 49.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.88 0.371 . . . . 0.0 110.442 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.627 ' HB2' HG21 ' A' ' 102' ' ' THR . 5.5 t-20 -78.1 156.56 29.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.247 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -14.14 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.766 0.666 . . . . 0.0 112.245 -176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -15.01 61.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 0.0 110.496 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 97.36 19.55 25.27 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.164 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.612 HG11 ' HA2' ' A' ' 49' ' ' GLY . 2.2 t -113.47 126.4 70.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 122.877 0.471 . . . . 0.0 110.564 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 94' ' ' THR . 2.9 mm? -55.46 108.23 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 173.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.627 HG21 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.08 -31.99 59.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.838 0.351 . . . . 0.0 110.627 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -167.43 149.7 5.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.146 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.614 HG23 ' N ' ' A' ' 105' ' ' ASP . 6.1 mt -127.7 138.33 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.614 ' N ' HG23 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -115.73 102.82 10.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.171 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.06 101.45 9.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.27 153.71 44.9 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.188 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.508 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 52.2 Cg_exo -56.73 151.49 47.39 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.87 2.38 . . . . 0.0 112.396 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' A' ' 87' ' ' THR . . . -60.6 -79.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.208 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER 55.42 -99.66 0.1 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.272 0.357 . . . . 0.0 110.817 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' ' 110' ' ' LEU . 1.2 m 57.72 57.71 4.09 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.278 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.42 -167.56 14.55 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.965 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.96 7.24 43.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.095 0.474 . . . . 0.0 110.712 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tp -171.97 -56.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.82 -149.84 0.44 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.085 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -57.01 148.58 21.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -44.25 131.23 6.22 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.816 0.698 . . . . 0.0 111.771 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -130.15 85.58 2.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.566 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -110.82 122.78 48.68 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.878 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -142.76 126.33 16.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.371 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 C--O 1.246 0.875 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.323 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m 54.54 52.93 11.46 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.534 0.521 . . . . 0.0 111.184 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.62 147.84 27.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.789 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.11 134.07 36.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.953 0.406 . . . . 0.0 111.066 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.84 123.42 4.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.387 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -168.72 110.38 0.52 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.76 0.314 . . . . 0.0 111.347 -178.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.97 83.93 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 171.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.49 126.83 40.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.195 -175.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -69.05 123.22 20.46 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.88 115.37 57.35 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.722 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.13 51.11 2.37 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.749 2.299 . . . . 0.0 111.574 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.76 9.89 41.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.712 -175.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.647 ' HB ' ' HG2' ' A' ' 34' ' ' GLN . 0.3 OUTLIER -132.05 144.98 35.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.334 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -98.49 51.15 1.0 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.286 0.565 . . . . 0.0 110.976 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.647 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 7.1 mm100 -78.36 -7.9 57.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.174 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.89 90.0 0.28 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.665 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -128.38 38.46 3.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.391 0.615 . . . . 0.0 109.714 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -154.43 157.34 38.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.535 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 38' ' ' LEU . 8.9 tp -127.03 141.62 51.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.0 110.72 177.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.15 145.21 25.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.974 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.94 78.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.59 -35.54 76.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -63.37 -40.68 97.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.434 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.38 -26.4 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 110.382 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m -75.8 -10.65 59.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.315 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -34.02 41.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.493 ' HB ' ' H ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -81.1 -150.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.711 0.291 . . . . 0.0 110.786 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.892 ' HB3' ' HG3' ' A' ' 50' ' ' MET . 0.6 OUTLIER -156.59 134.47 11.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.651 0.262 . . . . 0.0 110.665 -173.12 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 48' ' ' VAL . 1.9 p -71.43 122.26 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.87 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 106.98 2.87 36.41 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.449 -175.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.892 ' HG3' ' HB3' ' A' ' 47' ' ' ARG . 3.9 mtt -78.87 151.61 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.78 154.1 36.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.919 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -48.72 -39.33 24.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.708 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -59.91 -46.18 90.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.074 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.53 -40.25 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.717 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.486 HG11 HD12 ' A' ' 59' ' ' LEU . 84.4 t -58.29 -45.85 89.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.236 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -29.93 68.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 111.087 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.18 -57.72 2.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.844 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.486 HD12 HG11 ' A' ' 55' ' ' VAL . 26.8 mt -81.36 -20.56 40.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -172.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.2 31.01 32.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.318 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.704 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -65.52 136.41 96.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.689 -178.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.704 ' HD2' HG23 ' A' ' 61' ' ' THR . 57.7 Cg_endo -73.96 151.22 44.78 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.515 2.144 . . . . 0.0 111.945 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.6 106.43 15.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.001 0.429 . . . . 0.0 110.225 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.4 tpt -95.08 120.6 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.735 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.86 117.53 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.735 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.28 112.31 13.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.448 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.89 -2.99 12.89 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.721 2.281 . . . . 0.0 112.574 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.411 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -85.61 -25.69 26.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.923 -176.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.78 29.34 4.7 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.948 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -72.92 107.82 5.51 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.165 0.507 . . . . 0.0 110.644 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -103.6 25.89 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.124 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -131.01 127.17 37.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.531 178.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.432 ' CZ3' HG21 ' A' ' 61' ' ' THR . 3.8 m0 -104.01 124.74 49.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -103.78 135.7 44.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.81 151.24 50.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 178.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.58 115.34 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.367 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.521 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -93.56 160.26 14.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.693 -178.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 78' ' ' ARG . 4.4 ptm180 -126.16 132.93 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.687 0.279 . . . . 0.0 110.329 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.1 -44.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.854 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.43 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -90.62 120.21 68.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -54.28 4.54 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.885 2.39 . . . . 0.0 112.563 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.79 127.82 1.04 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.864 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 179.24 149.66 0.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.836 0.454 . . . . 0.0 110.137 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 72.62 -41.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.856 0.862 . . . . 0.0 112.321 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.17 -37.78 3.55 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 t -115.2 86.74 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 m -164.37 99.96 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 -174.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.593 ' N ' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -165.48 168.36 16.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.877 171.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -82.47 142.81 31.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -176.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 122.85 47.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.322 175.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.521 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -110.03 119.47 39.42 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.12 138.57 50.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 110.652 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -116.59 139.18 50.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.304 177.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -102.78 146.79 27.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -125.18 125.37 43.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 111.805 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.78 ' HB2' HG21 ' A' ' 102' ' ' THR . 47.5 t-20 -73.61 157.02 37.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 170.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -19.69 37.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -7.75 57.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 87.06 29.64 22.35 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.455 ' CG1' ' HA2' ' A' ' 49' ' ' GLY . 1.6 t -111.88 135.6 50.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -174.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.87 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 17.6 mt -60.91 105.77 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.341 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.78 HG21 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -75.56 -30.51 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.186 0.517 . . . . 0.0 110.631 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -168.25 140.82 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.904 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.642 HG21 ' N ' ' A' ' 105' ' ' ASP . 14.2 mt -103.48 139.11 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.642 ' N ' HG21 ' A' ' 104' ' ' ILE . 4.9 t0 -117.52 101.9 8.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.089 175.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 121.48 33.95 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -143.31 129.85 10.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.362 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.88 170.26 2.85 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.273 2.649 . . . . 0.0 112.262 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.593 ' HB3' ' N ' ' A' ' 88' ' ' GLN . . . -63.87 -39.28 93.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.76 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.24 97.82 8.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.611 -177.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.95 172.21 11.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.236 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.85 -60.59 6.35 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.952 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 8.7 t30 -99.37 109.69 22.27 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 115' ' ' GLU . 2.9 tp 70.21 144.16 0.05 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.736 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.471 ' N ' ' HG ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -79.17 171.97 14.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.361 178.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -78.53 72.85 5.08 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -30.19 15.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.64 147.45 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.465 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.03 -45.2 10.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.734 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -177.39 -33.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 38.8 t60 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 117.958 -1.02 . . . . 0.0 108.834 175.243 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 121.278 0.561 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.6 74.02 9.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.134 -176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -120.18 58.15 0.92 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.987 0.898 . . . . 0.0 109.489 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.1 39.22 2.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.187 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -71.96 111.91 7.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.144 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.25 91.66 3.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.231 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.44 112.84 37.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.214 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.96 126.38 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.517 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -116.5 126.58 53.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.818 0.342 . . . . 0.0 110.355 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.468 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 4.0 ptm180 -117.42 112.0 39.61 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.73 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.38 55.38 4.65 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.161 2.574 . . . . 0.0 112.161 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 29' ' ' ARG . 2.7 p-10 -132.59 -10.79 3.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.593 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.73 131.51 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.987 0.423 . . . . 0.0 111.909 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 69.4 11.22 8.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.963 170.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.66 87.1 3.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.539 0.685 . . . . 0.0 110.274 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.08 131.55 1.56 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.117 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.34 18.07 12.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.275 0.56 . . . . 0.0 109.919 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -164.42 177.63 8.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.278 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.652 HD22 HD23 ' A' ' 59' ' ' LEU . 11.9 tp -118.01 140.71 49.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.77 0.319 . . . . 0.0 110.568 175.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.13 145.97 39.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.072 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -63.49 -42.32 98.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.92 -21.77 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.897 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.619 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -73.45 -34.2 65.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.126 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.548 HG22 ' HG ' ' A' ' 91' ' ' LEU . 96.2 t -75.8 -30.77 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 110.091 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.3 m -66.72 -6.56 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.45 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.619 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 13.5 mtpt -70.6 -32.97 70.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.525 HG22 HD13 ' A' ' 59' ' ' LEU . 1.1 pp -93.58 179.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.391 . . . . 0.0 111.151 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -144.3 160.03 41.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.89 -175.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.457 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 2.8 m -69.55 146.25 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.951 ' HA2' HG12 ' A' ' 100' ' ' VAL . . . 84.67 -15.77 39.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.291 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.538 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -70.52 141.08 51.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.18 145.92 41.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.898 0.38 . . . . 0.0 111.78 -172.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -35.4 29.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.827 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -64.89 -53.87 39.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.625 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.5 72.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 21.6 t -61.39 -42.19 92.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . -67.13 -37.94 84.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.691 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.21 -34.19 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.645 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.1 -41.07 16.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.507 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.652 HD23 HD22 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -69.73 -43.25 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 111.378 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.9 59.74 0.81 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -71.99 147.33 91.11 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.737 0.303 . . . . 0.0 110.792 -177.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.83 164.64 35.05 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.2 2.6 . . . . 0.0 111.547 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.34 85.31 3.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.346 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mtm -143.77 171.24 14.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.453 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -119.9 -178.05 3.55 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -128.85 53.28 10.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 78.9 Cg_endo -78.23 -4.99 14.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.066 1.844 . . . . 0.0 112.085 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -93.41 -4.59 51.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.262 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.24 35.79 7.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 86.85 2.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.314 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.549 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 17.5 m120 -102.35 7.72 40.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.263 0.554 . . . . 0.0 110.208 176.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.11 123.37 41.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.176 176.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.758 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 11.7 m0 -104.79 137.12 43.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.181 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -118.78 115.27 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.051 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 22.6 m-85 -118.44 148.25 42.76 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.08 117.97 31.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.121 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -104.8 114.46 28.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.05 0.453 . . . . 0.0 111.359 -175.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -93.28 103.87 16.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -151.3 147.27 26.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 -176.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.585 HE22 ' HB3' ' A' ' 108' ' ' PRO . 31.5 mt-30 73.13 147.79 0.12 Allowed Pre-proline 0 N--CA 1.466 0.371 0 O-C-N 123.984 0.803 . . . . 0.0 111.485 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.3 Cg_exo -71.85 -2.35 11.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 112.572 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' HA2' HG22 ' A' ' 87' ' ' THR . . . 95.95 148.59 24.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.967 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.425 ' H ' ' CB ' ' A' ' 87' ' ' THR . 3.0 t-80 -118.89 117.76 29.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 60.98 20.56 10.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.99 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.44 -9.29 42.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.023 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.38 87.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.022 0.411 . . . . 0.0 110.0 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.48 HG22 ' HA2' ' A' ' 82' ' ' GLY . 11.7 m -163.26 121.53 1.99 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.39 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.534 ' NE2' ' HA ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -176.61 112.26 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.22 0.95 . . . . 0.0 109.156 170.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.583 ' NE2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -78.47 165.98 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.283 0.563 . . . . 0.0 111.842 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.9 t -123.54 127.21 48.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.726 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.548 ' HG ' HG22 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -84.56 110.9 19.05 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 1.9 m -109.37 110.99 22.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.353 -177.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.758 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -91.79 142.15 27.9 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.585 177.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -135.22 117.79 15.91 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 1.1 p90 -132.2 157.62 43.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.085 0.469 . . . . 0.0 110.936 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.31 161.73 22.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.17 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -20.0 24.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -9.0 58.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.493 0.663 . . . . 0.0 110.314 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.82 8.73 57.96 Favored Glycine 0 C--O 1.219 -0.783 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.636 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.951 HG12 ' HA2' ' A' ' 49' ' ' GLY . 55.1 t -89.2 110.0 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 122.894 -0.18 . . . . 0.0 111.15 -172.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 0.6 OUTLIER -55.22 107.5 0.32 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.593 0.558 . . . . 0.0 110.101 174.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.36 -25.82 14.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.776 0.322 . . . . 0.0 111.142 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.56 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 18.1 t30 -150.29 143.84 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 105' ' ' ASP . 4.2 mt -127.87 133.78 66.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.528 ' N ' HG22 ' A' ' 104' ' ' ILE . 6.4 t70 -103.28 101.87 11.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.278 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -132.33 102.0 5.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.229 0.538 . . . . 0.0 110.149 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 165.6 21.73 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.585 ' HB3' HE22 ' A' ' 80' ' ' GLN . 23.2 Cg_exo -65.78 158.22 54.81 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.223 1.949 . . . . 0.0 110.778 169.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.33 59.53 0.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 111.467 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.81 ' HA ' ' HG2' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -163.55 82.85 0.46 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.513 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m -81.63 63.56 5.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.155 0.502 . . . . 0.0 110.731 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.79 -157.18 41.37 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.634 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -74.61 -11.16 60.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 14.8 tp -77.7 -10.21 59.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.772 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.81 ' HG2' ' HA ' ' A' ' 110' ' ' LEU . 4.3 tp10 -89.17 -127.25 0.06 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.801 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 64.74 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.019 0.528 . . . . 0.0 109.595 -173.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -164.27 111.14 1.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.21 109.73 0.21 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.939 0.775 . . . . 0.0 111.155 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -165.71 148.44 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.26 -176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -138.53 115.75 11.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.242 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.777 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.959 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.867 0.365 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -109.59 132.92 53.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.393 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 143.42 53.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.592 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.85 116.07 21.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.399 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.88 132.41 49.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.145 0.498 . . . . 0.0 109.977 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -96.44 82.51 3.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.498 -176.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p -71.79 123.81 26.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.388 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.38 156.61 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.562 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -76.01 135.24 39.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.122 0.487 . . . . 0.0 110.715 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.82 131.87 24.13 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.283 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.32 98.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.588 2.192 . . . . 0.0 111.247 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -135.79 -44.9 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.419 -172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.477 ' H ' HG12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -75.31 -32.43 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.229 -173.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.7 t30 56.64 57.73 4.6 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.801 0.81 . . . . 0.0 109.983 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -95.66 156.62 16.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.629 -175.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.85 39.48 7.53 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.558 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -154.08 140.56 18.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.1 179.48 7.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.753 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 43' ' ' VAL . 5.6 tp -75.05 145.12 42.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.638 0.732 . . . . 0.0 112.968 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.43 ' HB ' ' OD1' ' A' ' 42' ' ' ASP . 4.7 m -116.14 152.6 33.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.187 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -54.84 -38.96 68.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.17 -47.05 87.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.384 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.43 ' OD1' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -68.35 -20.4 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.603 -176.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG21 HD21 ' A' ' 38' ' ' LEU . 1.2 t -78.8 -27.01 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.748 0.308 . . . . 0.0 111.256 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.9 -7.14 32.02 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 3.36 55.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.21 -169.03 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.236 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -147.79 143.2 27.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.07 0.462 . . . . 0.0 112.018 -174.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.1 t -76.05 137.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.87 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.746 ' HA2' HG11 ' A' ' 100' ' ' VAL . . . 89.26 -6.46 83.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.902 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.2 mmm -71.04 153.24 42.76 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -77.78 145.66 36.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.89 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -36.31 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.298 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 1.6 mp0 -70.15 -40.81 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.279 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.64 -34.76 60.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.754 -177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.51 -46.49 94.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.548 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -62.67 -41.14 98.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.574 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -60.22 -49.2 78.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.6 -36.35 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.232 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -80.08 -37.62 33.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.4 . . . . 0.0 111.54 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.44 52.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -173.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -122.08 139.85 31.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.45 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.41 138.7 82.34 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.323 2.015 . . . . 0.0 110.716 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.3 mt -74.07 87.92 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.151 0.501 . . . . 0.0 110.649 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 109.12 12.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.776 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.64 142.05 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.969 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.34 131.64 24.37 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -92.54 -2.97 3.75 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.932 2.422 . . . . 0.0 112.996 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.473 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -103.01 -26.16 13.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.12 5.54 32.7 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.46 7.34 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.957 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 71' ' ' ASN . 3.1 m120 -99.73 51.71 0.92 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.225 -174.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.88 128.85 55.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.373 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.548 ' HH2' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -103.4 141.07 36.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -123.12 119.8 31.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 144.14 47.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.232 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.468 ' H ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -84.94 117.13 29.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -94.18 116.88 29.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -175.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.15 104.35 12.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.616 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.73 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -165.31 129.15 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.402 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -142.47 117.74 6.7 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.77 0.319 . . . . 0.0 110.801 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.39 -3.19 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.472 2.115 . . . . 0.0 111.927 176.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -11.77 60.11 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.092 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.11 132.79 47.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.671 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.805 ' HG2' ' HB3' ' A' ' 116' ' ' HIS . 0.3 OUTLIER 75.98 -67.44 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 124.106 0.879 . . . . 0.0 112.294 172.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 -36.52 4.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.71 86.74 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 m -170.37 131.81 0.97 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.303 -174.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.472 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 28.0 tp60 -143.86 114.01 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.366 0.603 . . . . 0.0 110.782 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.73 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -75.83 135.14 40.21 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.074 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.32 132.5 56.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.635 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.506 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -95.93 110.31 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.482 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -108.95 138.65 44.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.106 0.479 . . . . 0.0 110.996 -177.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 72' ' ' THR . 3.4 mp -117.32 131.05 56.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.68 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.88 105.4 9.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.884 0.373 . . . . 0.0 110.087 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.427 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -116.09 135.71 53.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.78 -178.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.404 ' ND2' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -72.69 164.89 25.81 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.77 -31.4 2.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -170.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -4.51 33.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 111.295 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 93.61 9.86 59.66 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.021 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.746 HG11 ' HA2' ' A' ' 49' ' ' GLY . 21.0 t -93.49 116.22 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -174.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.49 HD11 HG13 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -54.28 97.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.773 0.671 . . . . 0.0 110.464 176.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.427 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -76.99 -31.51 56.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.909 0.385 . . . . 0.0 110.449 -176.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.68 140.66 9.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.147 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.595 HG21 ' N ' ' A' ' 105' ' ' ASP . 1.7 mp -103.45 139.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 171.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.595 ' N ' HG21 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -107.39 102.03 11.34 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -113.8 102.84 10.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 127.34 10.96 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.039 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.638 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 13.6 Cg_exo -70.9 150.95 62.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.923 2.415 . . . . 0.0 110.554 171.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.472 ' CB ' ' H ' ' A' ' 88' ' ' GLN . . . -81.44 38.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 110.842 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.41 141.97 25.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.531 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.0 m -125.55 131.71 52.71 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.77 -52.68 50.9 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.862 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -85.68 55.3 3.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.096 0.474 . . . . 0.0 110.63 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.99 -57.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.86 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.28 112.45 0.03 OUTLIER 'General case' 0 C--O 1.233 0.188 0 O-C-N 124.135 0.897 . . . . 0.0 110.992 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.805 ' HB3' ' HG2' ' A' ' 84' ' ' GLU . 6.0 t-160 -72.88 -6.34 44.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.802 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.79 -39.24 77.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.768 174.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -90.18 122.79 33.44 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.167 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -70.52 -33.79 71.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 173.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.76 168.99 15.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.185 175.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.278 175.892 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.61 0.243 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' HD2' ' HD2' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -126.43 167.54 15.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -89.03 140.14 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -73.72 145.03 45.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.601 178.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.28 99.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 110.671 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.71 -27.8 68.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.684 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.2 -41.27 67.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.725 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.718 ' HA ' HD21 ' A' ' 59' ' ' LEU . 11.3 t -68.22 -23.73 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 110.433 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 m -77.0 -5.87 50.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HE3' ' HB1' ' A' ' 58' ' ' ALA . 25.7 mtmt -68.07 -35.43 78.18 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.731 0.3 . . . . 0.0 111.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 pp -84.87 -177.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.402 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.0 175.74 13.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.159 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 104' ' ' ILE . 2.8 t -73.05 143.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.665 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.96 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 84.06 -11.13 58.57 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.342 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.85 133.67 47.64 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -77.42 156.73 30.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.362 -175.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.445 ' HG3' ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.94 -44.57 14.89 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.624 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.494 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.87 -37.64 58.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.926 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 HD23 ' A' ' 101' ' ' LEU . 78.0 t -60.91 -46.93 95.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 109.983 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -67.67 -35.2 78.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.731 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -43.54 97.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.502 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -78.32 -46.47 20.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.718 HD21 ' HA ' ' A' ' 43' ' ' VAL . 7.0 mt -84.05 -16.41 43.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -173.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 17.79 65.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.518 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -68.9 141.05 91.83 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 122.534 0.333 . . . . 0.0 111.457 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.14 158.81 53.98 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.481 2.121 . . . . 0.0 111.417 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.67 135.1 57.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.1 128.6 24.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.536 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -149.78 71.33 1.09 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.541 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.16 121.36 84.91 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.36 -2.93 12.94 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.075 2.517 . . . . 0.0 112.358 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -90.0 -20.05 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.447 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.8 4.66 34.0 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.02 85.29 6.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.344 0.592 . . . . 0.0 110.18 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -101.25 49.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.052 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -112.99 128.11 56.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.714 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -103.62 132.47 49.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.54 125.63 52.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.73 154.57 49.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.63 128.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.995 0.426 . . . . 0.0 110.659 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.53 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 6.7 p90 -127.19 173.47 9.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.606 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HD2' ' HD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -94.07 131.21 39.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.034 0.445 . . . . 0.0 111.115 -177.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.6 -30.74 0.19 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.867 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -125.74 83.26 62.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.72 -42.42 9.07 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.951 2.434 . . . . 0.0 113.469 -172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.18 138.4 4.76 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.884 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -175.2 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.166 0.586 . . . . 0.0 109.581 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -128.11 -2.25 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.539 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.98 -38.35 2.54 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.53 87.64 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.8 m -159.58 98.27 1.37 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.608 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.97 154.96 22.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.012 -175.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.55 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -111.54 131.51 55.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.061 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.24 114.18 25.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.967 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.53 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -84.52 105.43 15.33 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.97 124.1 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.592 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -99.68 139.3 35.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.462 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -130.05 108.1 9.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.79 ' HB3' HD22 ' A' ' 101' ' ' LEU . 36.0 p90 -115.35 133.22 56.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.963 0.411 . . . . 0.0 109.976 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.91 162.26 29.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.972 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.29 -22.38 2.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.24 -10.2 59.51 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.776 -0.577 . . . . 0.0 110.94 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 98.83 10.05 50.72 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.213 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.96 HG13 ' HA2' ' A' ' 49' ' ' GLY . 18.0 t -98.93 119.53 47.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 122.343 0.257 . . . . 0.0 110.709 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.79 HD22 ' HB3' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -55.14 105.48 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.423 0.452 . . . . 0.0 109.785 174.268 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.4 -31.95 15.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -150.34 138.02 19.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.888 0.375 . . . . 0.0 110.923 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 HG23 ' A' ' 48' ' ' VAL . 3.8 mt -110.78 133.05 57.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 174.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.04 99.95 11.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.546 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.412 ' C ' ' HG3' ' A' ' 107' ' ' LYS . 28.3 t30 -144.47 101.92 3.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 110.591 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -142.5 133.75 12.93 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.09 158.61 50.95 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.918 2.412 . . . . 0.0 112.781 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.08 42.79 0.82 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.02 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.589 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -159.3 148.63 18.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -75.2 174.03 10.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.233 0.54 . . . . 0.0 111.216 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -128.05 153.05 47.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.677 176.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.44 -21.23 66.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.974 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -74.17 -34.77 63.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.703 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -70.84 -20.58 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 -176.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.31 -17.1 21.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.224 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -90.73 -8.4 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.703 ' HG3' ' HA ' ' A' ' 42' ' ' ASP . 2.0 mtmt -83.22 -30.6 27.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.217 0.532 . . . . 0.0 110.048 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.636 HD12 HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -86.31 144.83 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.859 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.51 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -127.57 154.35 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.418 -178.33 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -74.36 148.12 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.195 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.984 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 80.15 -4.42 67.03 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.084 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 16.1 mmt -74.86 138.6 42.59 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 6.0 t -79.41 154.72 28.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.571 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -36.18 60.3 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.866 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -60.51 -42.64 96.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.088 0.47 . . . . 0.0 110.579 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -77.0 -34.92 57.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.55 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.51 -45.94 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.032 0.444 . . . . 0.0 109.826 175.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.36 83.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.738 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.87 -28.03 65.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.355 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.68 -54.48 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.66 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 46' ' ' ILE . 12.9 mt -81.07 -29.82 34.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.75 0.31 . . . . 0.0 111.812 -174.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.24 24.0 9.98 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.179 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 2.5 m -62.35 131.23 93.72 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.431 -0.385 . . . . 0.0 111.336 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 9.6 Cg_exo -71.2 165.36 32.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.627 2.218 . . . . 0.0 111.508 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.09 116.82 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.36 119.75 40.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.47 -172.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.27 104.09 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.083 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 134.79 19.92 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.3 -5.65 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.44 2.093 . . . . 0.0 113.46 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.17 -26.24 12.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.1 32.23 7.2 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -73.31 114.92 12.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.895 -0.652 . . . . 0.0 111.249 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.596 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 34.2 m-20 -92.41 45.77 1.22 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.262 0.553 . . . . 0.0 110.488 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -148.14 137.08 21.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.618 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -105.51 133.11 50.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.067 0.461 . . . . 0.0 110.592 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -133.78 149.55 51.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.993 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.54 133.87 65.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.454 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 54.5 p90 -163.13 149.8 12.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.53 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 81' ' ' PRO . 2.0 ttm180 -77.58 104.06 7.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.548 HE22 ' HA ' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -67.96 -44.84 75.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.557 -174.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' A' ' 87' ' ' THR . 0.0 OUTLIER -129.49 79.23 74.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 92.6 Cg_endo -83.7 -3.28 10.57 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.729 2.286 . . . . 0.0 112.337 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.23 126.95 8.33 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.735 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.37 -65.72 0.33 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.732 0.813 . . . . 0.0 112.401 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.64 -56.79 8.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.139 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 -36.52 2.95 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.682 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.1 87.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.369 0.604 . . . . 0.0 109.82 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.598 HG23 ' HB3' ' A' ' 109' ' ' ALA . 5.3 m -162.81 115.31 1.6 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.709 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -136.13 124.7 23.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.852 0.358 . . . . 0.0 111.687 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 161.56 14.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.803 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.226 175.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.26 105.04 13.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.32 108.45 13.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.499 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.636 HD21 HD12 ' A' ' 46' ' ' ILE . 4.8 mp -80.9 121.87 26.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.239 175.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 72' ' ' THR . 1.0 OUTLIER -111.3 124.88 53.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.654 ' HB3' HD23 ' A' ' 101' ' ' LEU . 30.9 p90 -135.86 160.18 39.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 111.265 -175.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.36 165.01 18.59 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.3 m -64.43 -4.13 3.65 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -7.37 58.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.578 . . . . 0.0 109.853 172.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 86.84 16.27 61.73 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.407 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.984 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -103.66 116.61 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.187 0.195 . . . . 0.0 110.477 -173.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 95' ' ' PHE . 19.4 mt -55.24 114.98 2.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.345 0.403 . . . . 0.0 110.971 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.57 -35.3 21.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 109.754 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -162.18 153.76 18.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.111 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mt -110.15 136.12 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.21 101.58 13.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -140.55 100.76 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 0.0 110.537 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -144.61 169.05 10.77 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.548 ' HA ' HE22 ' A' ' 79' ' ' GLN . 82.6 Cg_endo -81.5 166.56 17.75 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.831 1.688 . . . . 0.0 111.8 171.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.598 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -68.38 67.7 0.13 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 110.499 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.436 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.863 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.514 0.197 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -113.7 165.64 12.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.64 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.041 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.39 143.52 27.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.642 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -21.73 64.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.28 -29.37 31.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.575 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.54 ' HA ' HD21 ' A' ' 59' ' ' LEU . 3.5 t -66.99 -17.06 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.154 0.502 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -69.69 -6.37 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.235 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HE3' ' HB1' ' A' ' 58' ' ' ALA . 11.6 mtmt -75.77 -23.29 55.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.188 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pt -104.91 -179.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.484 0.183 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.9 OUTLIER -154.33 168.4 26.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.543 0.211 . . . . 0.0 110.755 -177.276 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.61 140.48 18.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.291 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.709 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 81.34 1.74 90.19 Favored Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.999 -0.441 . . . . 0.0 111.999 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.53 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.99 149.05 30.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -75.35 145.63 41.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.717 0.294 . . . . 0.0 110.693 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -58.97 -26.93 64.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.853 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.44 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 10.8 mp0 -63.86 -48.31 77.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.195 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -69.46 -35.55 75.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.383 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.588 ' HA ' HG21 ' A' ' 46' ' ' ILE . 89.0 t -61.28 -47.81 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.39 70.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.082 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.96 -43.23 96.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.551 . . . . 0.0 110.677 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.502 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -76.48 -53.09 8.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.941 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 43' ' ' VAL . 50.4 mt -81.64 -20.42 39.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.18 26.83 35.42 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.405 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -72.11 133.45 83.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.388 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.1 Cg_exo -68.29 152.47 75.74 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.93 2.42 . . . . 0.0 111.515 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.462 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.83 116.44 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 0.0 110.159 -179.424 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 105.25 7.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.798 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.26 69.16 3.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.731 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 75.07 80.72 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -1.78 11.83 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.161 2.574 . . . . 0.0 112.414 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -67.67 -15.32 63.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.751 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.96 16.37 12.74 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.15 83.74 4.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.863 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 50.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.684 0.754 . . . . 0.0 110.125 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 94' ' ' THR . 0.1 OUTLIER -123.37 128.82 50.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.976 176.238 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 122.71 45.44 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -106.44 121.66 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.5 ' HB2' HD12 ' A' ' 91' ' ' LEU . 1.2 m-85 -116.91 137.82 51.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.375 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.76 118.37 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.673 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 65.3 m-85 -117.91 163.22 16.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.883 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -122.85 103.49 8.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 110.342 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -155.25 164.9 38.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.449 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 55.01 74.29 0.75 Allowed Pre-proline 0 C--O 1.234 0.271 0 O-C-N 123.781 0.676 . . . . 0.0 111.365 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.28 86.16 1.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.309 2.006 . . . . 0.0 111.362 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.11 -104.56 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.702 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -134.27 155.86 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.563 -0.375 . . . . 0.0 111.142 -176.219 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.0 mp0 76.6 -45.64 0.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.771 0.828 . . . . 0.0 111.803 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.1 -36.44 4.22 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.988 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 p -85.04 85.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.417 1.103 . . . . 0.0 109.434 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.808 HG23 ' HB1' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -175.53 138.84 0.41 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.175 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -161.1 168.91 23.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.355 . . . . 0.0 111.091 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -84.3 124.23 31.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.236 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.02 104.73 16.69 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.04 0.447 . . . . 0.0 110.56 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.673 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -84.66 104.83 14.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -103.11 104.19 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.588 HD12 HG12 ' A' ' 104' ' ' ILE . 1.8 tp -94.33 119.6 33.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.481 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -118.15 116.0 25.95 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.64 -171.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.709 ' HB3' HD23 ' A' ' 101' ' ' LEU . 1.3 p90 -123.62 142.77 50.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.995 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.45 164.16 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.54 -22.32 3.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -169.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -6.27 45.42 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.991 -0.443 . . . . 0.0 111.252 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 88.0 21.3 46.69 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.425 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG13 ' HA2' ' A' ' 49' ' ' GLY . 24.6 t -112.18 120.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 9.1 mt -55.44 110.36 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.367 0.417 . . . . 0.0 110.383 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.53 -32.05 58.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.83 153.32 10.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.624 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.588 HG12 HD12 ' A' ' 93' ' ' LEU . 5.0 mt -110.54 135.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 170.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -107.96 102.7 11.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -121.85 114.42 21.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.928 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 153.72 78.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.558 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.28 171.43 3.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.111 2.541 . . . . 0.0 111.71 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.808 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -74.5 6.54 3.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 120.712 0.291 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -90.3 156.23 18.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.195 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.517 HD23 ' HE1' ' A' ' 77' ' ' PHE . 15.3 tp -80.15 142.58 34.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 110.281 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -101.84 145.96 28.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 -179.077 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.92 86.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.787 0.327 . . . . 0.0 111.392 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.98 -30.01 70.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -20.0 62.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.153 0.501 . . . . 0.0 111.084 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 39' ' ' THR . 8.2 t -84.06 -17.03 10.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.871 0.367 . . . . 0.0 111.529 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.7 -8.28 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -87.71 -8.47 56.04 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.378 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.85 158.92 9.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.9 mtt85 -135.88 160.39 38.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 111.158 -173.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 3.4 m -73.62 147.54 9.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.473 171.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 1.006 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 82.05 -8.48 60.33 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.559 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.6 mmt -79.29 141.36 37.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -68.0 150.37 48.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.48 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -59.59 -28.11 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.009 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -68.23 -38.96 82.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -70.14 -38.69 75.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.992 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.2 t -59.57 -45.5 93.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.703 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.44 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -66.57 -33.28 75.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.012 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -70.04 -34.45 73.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.915 0.388 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.07 -35.08 24.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.219 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -98.17 -34.82 10.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.58 30.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.25 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -58.87 139.22 86.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 123.23 0.612 . . . . 0.0 112.118 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 7.7 Cg_exo -73.78 140.76 29.58 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.672 2.248 . . . . 0.0 111.501 174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.21 108.58 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.2 tpp -75.88 118.32 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.595 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.61 106.36 11.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.913 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.24 115.2 18.58 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-O 120.928 0.394 . . . . 0.0 109.94 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -91.54 -2.66 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.953 2.435 . . . . 0.0 112.26 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -26.19 15.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.007 -170.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.44 15.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.48 85.43 3.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.227 0.537 . . . . 0.0 109.893 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.14 55.1 1.27 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.443 0.639 . . . . 0.0 110.772 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -132.15 146.16 51.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.84 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 2.0 m0 -124.01 130.6 52.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -120.37 124.58 45.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.309 0.575 . . . . 0.0 111.079 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -124.53 153.92 41.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.453 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.74 130.34 55.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.288 0.566 . . . . 0.0 110.905 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.517 ' HE1' HD23 ' A' ' 38' ' ' LEU . 2.6 m-30 -93.78 -175.61 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.7 ptt85 -128.14 119.47 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 111.451 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB2' ' HA ' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -105.61 -114.82 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.938 174.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.524 ' H ' ' HB3' ' A' ' 79' ' ' GLN . 3.8 mm-40 -126.92 81.41 69.67 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.52 135.04 32.4 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.141 2.561 . . . . 0.0 112.57 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.55 162.18 28.66 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.37 121.88 18.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.366 0.083 . . . . 0.0 110.78 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 69.38 108.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.002 0.814 . . . . 0.0 110.128 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.67 53.73 0.55 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 t -82.93 87.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 0.9 OUTLIER -127.77 113.56 16.13 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.56 -169.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.594 ' H ' ' HB3' ' A' ' 109' ' ' ALA . 2.8 mm100 -150.58 168.68 23.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.087 -168.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.457 ' CD ' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -122.14 136.15 54.88 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 173.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.3 133.15 56.34 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.18 104.56 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 105.39 15.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.658 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.5 mp -94.96 127.88 41.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.66 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -123.02 127.84 49.35 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.55 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -126.21 148.92 49.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.452 ' HB2' HG23 ' A' ' 102' ' ' THR . 6.0 t-20 -76.73 160.48 29.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -0.37 0.64 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.464 0.478 . . . . 0.0 112.237 -175.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -8.57 58.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.558 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.18 15.53 55.6 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.254 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.006 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -111.52 123.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.765 0.426 . . . . 0.0 110.34 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 95' ' ' PHE . 6.5 mt -54.32 110.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.741 0.305 . . . . 0.0 110.486 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -75.51 -42.19 53.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.07 153.61 16.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.708 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.478 HD12 HG13 ' A' ' 48' ' ' VAL . 2.4 mt -107.88 136.31 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.04 101.65 9.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.873 0.368 . . . . 0.0 110.728 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -114.09 100.74 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 116.62 11.02 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.286 -174.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.7 146.09 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.805 2.336 . . . . 0.0 112.117 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.594 ' HB3' ' H ' ' A' ' 88' ' ' GLN . . . -71.61 70.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.186 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.066 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 t30 . . . . . 0 N--CA 1.465 0.277 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 172.14 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.07 128.13 34.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.232 176.239 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -109.96 177.49 4.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.947 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.87 90.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.308 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -59.29 -38.21 79.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -38.96 91.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.485 ' HA ' HD11 ' A' ' 46' ' ' ILE . 43.1 t -70.64 -30.9 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.272 0.558 . . . . 0.0 110.385 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 m -75.15 -9.25 58.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.815 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.7 -20.39 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.507 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.558 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -87.11 173.85 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.114 177.204 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.1 mmp_? -131.56 153.6 49.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.938 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.92 136.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.988 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 92.95 -4.08 74.51 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.791 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.535 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.39 144.19 49.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -81.16 145.05 31.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.759 0.314 . . . . 0.0 110.603 -175.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -54.65 -36.13 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.675 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -68.75 -43.02 76.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.138 0.494 . . . . 0.0 110.426 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -74.9 -34.84 62.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.9 -46.32 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.65 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -64.52 -41.59 96.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.705 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.55 -35.93 81.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.632 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.86 -43.71 35.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.203 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.54 1.83 55.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.81 46.25 90.2 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.293 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' A' ' 56' ' ' ALA . 13.6 m -102.87 136.58 19.24 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.48 -0.36 . . . . 0.0 111.068 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.56 132.29 34.95 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.605 2.203 . . . . 0.0 111.46 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.92 87.88 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 110.545 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.7 tpt -79.98 93.68 5.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.205 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.12 109.32 22.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.0 152.45 40.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.465 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.63 -3.27 9.94 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.737 2.291 . . . . 0.0 113.78 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -98.79 -26.22 14.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.829 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.64 27.76 5.35 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.22 83.52 6.94 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.272 0.558 . . . . 0.0 109.755 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -82.34 63.61 6.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.496 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.67 126.65 20.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.012 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.65 ' HH2' ' HB2' ' A' ' 56' ' ' ALA . 7.1 m0 -105.89 135.53 47.17 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.498 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -111.2 122.07 46.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.548 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 159.89 20.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.15 125.08 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 1.7 m-30 -97.64 162.97 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.51 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -139.7 105.12 5.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 175.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.427 HE22 ' HD2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -150.83 11.18 0.65 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.122 -176.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -134.54 144.73 52.11 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.005 -173.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 3.0 Cg_exo -76.39 -165.41 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.192 2.594 . . . . 0.0 112.149 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.76 -14.33 12.64 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.138 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -75.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.944 0.372 . . . . 0.0 111.125 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -115.41 145.17 42.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.61 34.67 13.12 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.2 88.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.974 HG23 ' HB1' ' A' ' 109' ' ' ALA . 10.5 t -172.23 176.2 3.48 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -151.18 178.96 8.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.765 0.317 . . . . 0.0 110.366 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -128.68 164.06 23.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 -176.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 104.92 15.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.497 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -82.46 105.03 13.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 109.94 19.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.031 -171.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.2 mt -89.51 120.36 30.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.55 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.486 HG23 HG23 ' A' ' 72' ' ' THR . 1.3 m -110.2 123.96 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.608 0.242 . . . . 0.0 110.356 -175.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 0.8 OUTLIER -119.2 148.0 43.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.88 168.29 18.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 m -58.42 -16.37 14.62 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.661 0.384 . . . . 0.0 111.985 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -5.29 42.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.547 175.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 80.15 21.89 64.28 Favored Glycine 0 C--O 1.219 -0.826 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.988 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -106.26 127.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 -172.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HA ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -54.66 101.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.799 175.171 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -39.44 30.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.087 0.47 . . . . 0.0 110.015 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -161.19 153.21 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.255 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.402 HD11 ' HG ' ' A' ' 101' ' ' LEU . 2.4 mp -118.59 133.24 66.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.18 101.93 13.71 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -135.38 100.88 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 0.0 111.139 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.84 111.52 6.23 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.189 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 54.3 Cg_exo -54.58 121.53 9.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.511 2.14 . . . . 0.0 112.443 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.974 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -6.43 77.11 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.514 1.759 . . . . 0.0 114.123 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.24 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--O 1.232 0.163 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -109.57 -171.33 1.82 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.475 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -116.98 134.66 54.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.841 0.353 . . . . 0.0 110.444 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 145.23 44.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.22 96.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.38 -27.88 68.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.989 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -72.72 -39.05 67.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.532 ' HA ' HD11 ' A' ' 59' ' ' LEU . 61.1 t -67.62 -25.15 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.38 0.609 . . . . 0.0 109.952 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -74.59 -6.48 48.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.091 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 16.7 mtpt -71.0 -33.45 70.4 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.531 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.81 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pp -93.84 -178.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.4 OUTLIER -157.31 172.27 18.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.737 0.304 . . . . 0.0 111.08 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 1.4 m -66.31 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.279 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.915 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 90.27 -10.59 73.75 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.095 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -75.03 137.45 41.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.334 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -73.89 146.5 43.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.328 -175.065 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -52.52 -32.43 40.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.721 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 mp0 -62.46 -44.21 96.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.165 0.507 . . . . 0.0 109.837 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -73.57 -36.37 65.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.81 ' HA ' HG21 ' A' ' 46' ' ' ILE . 93.9 t -61.04 -48.76 87.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -71.45 -30.62 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.012 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -37.91 87.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.81 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.11 -39.51 17.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.999 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.532 HD11 ' HA ' ' A' ' 43' ' ' VAL . 6.9 mp -86.23 -49.5 7.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 0.0 111.939 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.18 29.25 5.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.224 -172.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -60.89 141.75 92.97 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.247 -0.476 . . . . 0.0 111.293 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.54 ' HD2' HG22 ' A' ' 61' ' ' THR . 50.1 Cg_exo -57.31 165.57 5.46 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.15 2.567 . . . . 0.0 113.351 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 104.58 2.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.365 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.25 93.17 5.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.108 0.48 . . . . 0.0 110.594 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.87 62.12 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.196 0.522 . . . . 0.0 109.865 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -127.88 80.22 72.43 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.48 -175.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.98 -1.5 11.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.339 2.693 . . . . 0.0 112.497 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -74.43 13.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.323 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.84 13.28 20.5 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.344 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 66' ' ' ASP . 8.7 m -83.99 87.22 7.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.261 0.553 . . . . 0.0 110.619 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -113.73 24.04 12.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.742 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.38 55.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.101 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -112.79 121.92 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.0 p90 -111.22 147.25 35.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 111.569 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.836 ' HB2' HD12 ' A' ' 91' ' ' LEU . 1.5 m-85 -147.96 160.75 42.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.066 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.29 115.99 50.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.311 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.417 ' HZ ' HG21 ' A' ' 43' ' ' VAL . 12.2 m-30 -94.0 124.75 38.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -78.4 106.09 10.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.178 0.513 . . . . 0.0 109.815 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.579 HE22 ' HB3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -158.24 41.91 0.27 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.117 -178.672 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 27.7 mp0 -107.99 120.39 47.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.821 -171.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.1 Cg_exo -69.72 176.06 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 123.084 2.523 . . . . 0.0 112.523 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.85 11.31 72.46 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.746 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -86.67 109.75 19.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.9 mp0 72.34 -52.62 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.16 0.912 . . . . 0.0 111.144 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.94 76.58 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.936 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.93 84.84 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.616 HG22 ' HB1' ' A' ' 109' ' ' ALA . 55.4 m -171.44 101.43 0.2 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.908 -174.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.33 169.0 17.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.93 0.395 . . . . 0.0 111.16 -173.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.463 ' HB3' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -130.04 166.31 20.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.799 -175.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 117.57 17.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.849 0.357 . . . . 0.0 111.429 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.836 HD12 ' HB2' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -84.26 112.02 19.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.28 118.95 32.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.333 0.587 . . . . 0.0 111.277 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.728 ' HG ' HD11 ' A' ' 101' ' ' LEU . 2.2 mp -102.93 142.55 33.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.447 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.56 123.17 27.4 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.708 ' HB3' HD22 ' A' ' 101' ' ' LEU . 11.1 p90 -131.3 145.38 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.895 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -69.15 159.79 32.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.359 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -19.04 12.72 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -174.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -15.67 61.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.708 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 101.56 11.73 37.42 Favored Glycine 0 C--O 1.221 -0.706 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.754 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.915 HG13 ' HA2' ' A' ' 49' ' ' GLY . 43.0 t -94.32 114.0 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.856 -0.202 . . . . 0.0 110.733 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -54.77 102.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.393 0.433 . . . . 0.0 110.542 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.37 -29.43 24.45 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.99 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -156.7 143.41 18.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.415 HG13 HD12 ' A' ' 101' ' ' LEU . 18.7 mt -121.07 141.74 40.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -129.6 102.89 6.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.623 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.729 ' HB2' HD23 ' A' ' 91' ' ' LEU . 34.8 t30 -135.45 100.13 4.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 110.137 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -121.01 131.6 24.44 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.428 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.579 ' HB3' HE22 ' A' ' 79' ' ' GLN . 46.0 Cg_exo -56.42 146.25 74.84 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.067 2.511 . . . . 0.0 112.983 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -45.93 -41.98 12.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.244 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 87' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 121.067 0.46 . . . . 0.0 110.15 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 t30 . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -104.61 166.76 10.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.48 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD11 HD22 ' A' ' 59' ' ' LEU . 7.5 tp -74.52 137.62 42.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.556 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -90.68 144.99 25.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 178.055 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.87 75.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -74.11 -29.91 62.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 111.194 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -72.96 -20.26 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.408 -175.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 39' ' ' THR . 2.2 t -74.54 -16.47 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.166 0.507 . . . . 0.0 110.654 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -83.91 -6.94 59.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' A' ' 42' ' ' ASP . 4.6 pttt -82.23 -8.0 59.64 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.377 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -102.87 162.41 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -132.81 168.79 17.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.145 0.498 . . . . 0.0 112.241 -169.207 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -76.96 137.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.38 171.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.921 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 83.49 5.36 88.59 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.56 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -89.15 136.35 33.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.25 145.17 51.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.849 0.356 . . . . 0.0 111.272 -176.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.41 -29.3 61.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.639 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.17 -42.15 89.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.2 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.124 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.416 HG21 HD23 ' A' ' 101' ' ' LEU . 72.3 t -60.43 -46.58 95.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.223 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.99 78.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -45.71 93.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.211 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.69 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -80.43 -39.39 28.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.144 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 38' ' ' LEU . 70.0 mt -86.09 -18.67 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.22 40.71 13.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.46 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.4 m -95.58 133.84 25.12 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.104 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.4 Cg_exo -69.68 157.48 60.39 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.904 2.403 . . . . 0.0 111.111 173.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 tp -86.47 87.64 7.48 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.248 0.546 . . . . 0.0 110.367 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.3 115.06 29.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.669 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 140.07 47.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.498 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -91.46 123.74 63.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.96 -2.16 12.28 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.822 2.348 . . . . 0.0 113.284 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -99.61 -20.59 16.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.77 10.66 26.3 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.94 90.15 5.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.111 0.481 . . . . 0.0 109.796 177.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.24 61.35 4.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.484 HG23 HG23 ' A' ' 94' ' ' THR . 0.2 OUTLIER -126.01 123.04 37.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 177.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.551 ' HB2' ' HZ ' ' A' ' 95' ' ' PHE . 1.5 m0 -103.89 122.57 45.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -108.37 121.91 45.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.703 0.763 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.38 153.66 21.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.057 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.9 t -123.48 107.67 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.801 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 55.1 p90 -142.17 146.97 35.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.76 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 106.45 18.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.547 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -113.7 -0.3 14.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -105.4 138.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.303 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 23.6 Cg_exo -63.78 145.04 90.35 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.828 2.352 . . . . 0.0 111.996 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.23 71.43 1.49 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.836 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -119.49 136.73 54.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.3 mt-10 74.41 -17.37 0.47 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.946 0.779 . . . . 0.0 111.016 -176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 83' ' ' HIS . . . 89.88 -36.39 3.55 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.924 169.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.08 88.82 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.374 -0.486 . . . . 0.0 110.309 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -157.69 121.61 4.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.406 0.622 . . . . 0.0 111.197 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -170.58 150.49 3.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.421 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.77 156.2 44.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.997 0.427 . . . . 0.0 111.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -93.71 129.04 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.969 174.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.801 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -85.62 103.96 14.92 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.708 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -102.0 105.9 16.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -174.277 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.3 mt -93.79 125.25 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.677 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.484 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -115.7 123.45 48.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.113 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.551 ' HZ ' ' HB2' ' A' ' 73' ' ' TRP . 0.1 OUTLIER -118.88 151.67 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -88.93 167.78 12.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -23.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -171.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -3.64 47.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.32 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 84.16 28.17 34.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.296 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.921 HG13 ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -112.85 130.75 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 122.274 0.229 . . . . 0.0 110.436 -177.011 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -55.72 103.06 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.632 0.583 . . . . 0.0 111.263 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.37 -18.5 24.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.0 110.643 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -162.67 138.72 7.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.562 HD12 HG13 ' A' ' 48' ' ' VAL . 3.0 mt -113.61 136.48 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.708 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 28.7 t70 -117.79 103.34 9.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.673 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -131.38 100.65 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.145 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.02 119.54 10.58 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.756 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.74 155.96 20.44 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.436 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 88' ' ' GLN . . . -64.7 92.31 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.033 0.444 . . . . 0.0 110.561 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.1 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 121.514 0.673 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -131.86 -169.48 2.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.966 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.718 HD13 ' HE1' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -112.02 155.36 23.91 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.045 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.68 142.56 49.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.915 0.388 . . . . 0.0 111.569 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.64 -38.44 23.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.404 0.621 . . . . 0.0 110.192 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.37 -17.78 64.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 1.2 t0 -77.65 -20.38 53.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.33 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.48 ' HA ' HD13 ' A' ' 59' ' ' LEU . 14.5 t -71.29 -28.1 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.935 0.397 . . . . 0.0 111.147 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -7.21 22.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.696 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -77.92 -15.32 59.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.089 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.474 HG21 HG13 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -100.87 172.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.161 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.5 160.86 39.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.875 -178.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.55 152.03 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 1.008 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 79.42 -4.72 62.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.211 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.9 mtp -85.1 141.84 29.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.56 146.43 50.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.802 -175.346 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -31.9 62.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.984 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -69.31 -39.52 78.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.032 0.444 . . . . 0.0 110.043 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.03 -34.74 64.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.199 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG13 HG21 ' A' ' 46' ' ' ILE . 76.1 t -61.71 -48.03 90.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.763 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HB2' ' CH2' ' A' ' 73' ' ' TRP . . . -67.87 -29.66 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.151 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -41.8 72.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.094 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.05 -59.6 2.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -91.51 -2.18 57.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.277 0.561 . . . . 0.0 111.39 -171.304 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 46.27 9.86 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.753 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -89.9 136.41 29.19 Favored Pre-proline 0 C--N 1.317 -0.81 0 O-C-N 122.818 -0.225 . . . . 0.0 111.121 177.532 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.2 Cg_exo -68.58 132.02 24.32 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.37 2.047 . . . . 0.0 111.284 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.86 118.16 19.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.0 ttp -92.15 119.98 32.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.389 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.13 109.35 13.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -114.46 93.19 31.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.615 0.722 . . . . 0.0 111.066 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.92 -9.12 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.04 1.827 . . . . 0.0 111.22 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -96.31 -21.99 17.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.115 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 12.07 25.81 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.19 83.4 2.37 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.146 0.498 . . . . 0.0 110.757 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -94.51 67.57 3.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.236 -177.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -135.61 147.28 48.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.721 -178.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -127.44 148.49 50.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.965 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -133.82 133.59 41.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 0.0 110.594 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.718 ' HE1' HD13 ' A' ' 38' ' ' LEU . 2.4 m-85 -117.2 134.6 54.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.523 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.98 107.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.93 114.29 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -91.17 103.01 15.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.523 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 1.7 pt20 -127.34 37.65 4.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 8.4 pm0 -116.23 136.68 23.07 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.418 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 4.5 Cg_exo -78.11 165.21 26.28 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.788 2.326 . . . . 0.0 111.631 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.23 67.08 3.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.122 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.413 ' HB3' ' H ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -168.71 -99.5 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 mp0 -93.94 149.74 20.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.797 0.332 . . . . 0.0 110.445 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.85 45.32 17.11 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.275 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.81 88.44 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 109' ' ' ALA . 1.9 t -164.72 176.18 9.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.572 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -114.07 109.99 19.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.535 1.061 . . . . 0.0 113.67 -162.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.722 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -76.58 128.87 35.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.76 172.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 120.7 22.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -174.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.15 112.26 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.719 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.52 111.11 23.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.83 134.55 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.811 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -131.23 117.76 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -124.8 136.21 53.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.932 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -73.24 165.68 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.863 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.32 -13.89 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -5.85 42.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 175.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 83.99 12.77 76.19 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.008 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -105.54 122.47 58.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.995 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 55' ' ' VAL . 1.6 mm? -55.42 107.27 0.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.098 174.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.67 -36.04 10.38 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.956 0.408 . . . . 0.0 110.879 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 41.2 t30 -137.06 135.97 37.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.654 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.28 132.2 71.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.81 100.94 11.68 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.7 99.6 7.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 1.3 mtmt -156.4 141.6 12.42 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.079 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.722 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 16.9 Cg_exo -68.25 169.46 16.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.664 2.243 . . . . 0.0 111.536 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.651 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -71.66 -22.22 61.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.578 0.704 . . . . 0.0 110.257 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.258 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -162.72 154.96 18.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.078 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 38' ' ' LEU . 13.6 tp -76.7 127.13 32.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.958 0.408 . . . . 0.0 110.234 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 m -87.4 144.72 26.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.48 93.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.211 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -60.64 -33.58 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.241 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.603 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -71.48 -25.43 62.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 -176.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 46' ' ' ILE . 46.7 t -74.49 -32.3 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.209 0.528 . . . . 0.0 110.27 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -6.82 47.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.111 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.603 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -74.82 -20.23 59.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -110.71 -173.43 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 176.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.58 171.52 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.794 0.33 . . . . 0.0 111.018 -174.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 48' ' ' VAL . 1.1 m -71.58 149.6 9.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.739 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 72.35 6.64 65.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.206 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.33 148.05 24.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.766 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -74.82 142.87 44.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.85 0.357 . . . . 0.0 110.731 -175.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -27.43 69.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.612 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -71.81 -35.31 69.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.362 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.11 -36.35 48.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.299 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 83.0 t -58.41 -47.85 86.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB1' ' OG1' ' A' ' 61' ' ' THR . . . -61.42 -39.14 89.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.326 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.92 55.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.585 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.74 -58.66 3.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.595 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -95.26 -16.58 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 95.31 0.77 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.748 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' HB1' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -78.51 155.2 78.91 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.82 148.33 40.88 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.566 2.177 . . . . 0.0 110.585 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 87.11 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.298 0.57 . . . . 0.0 110.624 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -104.93 120.39 41.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.806 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.61 133.18 34.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.31 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -160.26 94.79 1.56 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 110.482 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.45 -3.03 7.66 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.812 2.341 . . . . 0.0 111.919 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.67 -27.52 22.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.213 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.14 35.25 4.55 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.451 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.0 m -76.2 89.62 3.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.355 0.597 . . . . 0.0 110.021 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 8.5 m120 -88.09 51.76 2.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.335 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.71 13.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.71 176.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.6 m0 -103.56 121.63 43.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.917 0.389 . . . . 0.0 110.299 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -104.88 115.06 29.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.885 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -119.39 140.81 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.889 0.376 . . . . 0.0 110.609 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.82 129.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.95 -176.14 2.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.186 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.4 123.65 36.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.983 0.42 . . . . 0.0 110.375 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.519 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -77.82 167.29 21.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.793 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -102.23 93.82 4.23 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 92.7 Cg_endo -93.44 164.77 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.048 2.499 . . . . 0.0 114.22 -169.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.65 -107.85 1.02 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -107.59 -7.36 16.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.214 0.531 . . . . 0.0 109.651 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -178.88 5.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.916 172.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.45 36.95 11.35 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.21 86.58 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.652 HG22 ' HB1' ' A' ' 109' ' ' ALA . 53.3 m -164.95 170.02 15.74 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -170.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.412 ' N ' HG22 ' A' ' 87' ' ' THR . 22.9 tp60 -123.35 129.06 50.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.774 0.715 . . . . 0.0 112.119 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 4.1 pm0 -94.84 137.97 33.22 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.96 129.41 56.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.99 104.61 14.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 m -105.2 109.37 21.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.279 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 3.0 mp -88.31 130.7 35.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.498 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.16 118.4 26.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.686 ' HB3' ' HA ' ' A' ' 101' ' ' LEU . 40.6 p90 -144.04 151.99 40.4 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.645 -173.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -77.81 154.55 31.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.672 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.26 -14.23 24.64 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.868 0.467 . . . . 0.0 111.936 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -73.49 -3.38 27.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.166 0.507 . . . . 0.0 110.577 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.59 6.26 59.73 Favored Glycine 0 C--O 1.22 -0.774 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.551 175.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 49' ' ' GLY . 93.9 t -97.42 112.1 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.666 0.233 . . . . 0.0 111.097 -172.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.686 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -55.34 103.35 0.09 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.584 0.552 . . . . 0.0 110.016 174.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.643 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -75.71 -30.98 59.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.727 0.298 . . . . 0.0 110.587 -175.395 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.05 152.71 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.368 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.4 mt -112.7 134.11 56.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -91.53 101.36 14.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.157 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -119.08 100.32 7.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -142.61 146.94 40.51 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.178 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 10.3 Cg_exo -72.07 166.97 28.04 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.507 2.138 . . . . 0.0 112.31 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.652 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -72.81 66.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.672 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.351 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.9 t30 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -100.13 -174.72 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.407 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.622 HD12 ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -90.53 127.42 36.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.114 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' H ' ' A' ' 41' ' ' ASN . 72.5 m -96.93 144.67 26.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.437 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.94 -24.52 67.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.27 0.557 . . . . 0.0 110.881 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.93 ' H ' HG22 ' A' ' 39' ' ' THR . 12.9 t-20 -74.01 -20.95 60.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.43 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 39' ' ' THR . 7.5 m-20 -74.66 -31.28 61.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.533 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.574 HG21 ' HZ ' ' A' ' 77' ' ' PHE . 2.0 t -64.85 -24.97 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.824 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -10.8 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.724 0.297 . . . . 0.0 111.46 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -73.87 -34.35 64.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.188 0.518 . . . . 0.0 109.841 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -108.97 -178.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.91 157.3 31.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.72 0.295 . . . . 0.0 110.758 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.29 130.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.149 0.5 . . . . 0.0 109.818 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.908 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 96.93 -8.79 65.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.902 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 148.72 39.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.99 146.18 37.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.084 -175.361 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.39 -40.29 17.34 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.851 0.72 . . . . 0.0 111.999 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.444 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 7.1 mp0 -67.77 -42.29 81.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.546 -175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -78.39 -33.33 48.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.393 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.47 -46.96 94.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 61' ' ' THR . . . -68.9 -38.74 79.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.726 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -40.12 83.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.66 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -40.61 55.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.582 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.25 -38.93 23.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.665 0.269 . . . . 0.0 111.659 -176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.21 19.87 11.09 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.48 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 2.5 m -80.5 135.19 53.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.956 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.55 131.68 32.59 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.481 2.121 . . . . 0.0 111.074 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mt -72.83 125.04 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.813 0.339 . . . . 0.0 110.526 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.401 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 4.9 ttm -102.23 148.16 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.634 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.483 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -84.18 -177.11 6.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.868 176.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.574 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 11.0 p-10 -134.87 49.79 4.14 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 66' ' ' ASP . 13.3 Cg_exo -68.16 -27.42 35.34 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.822 1.681 . . . . 0.0 111.072 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.23 -2.08 24.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.25 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.41 37.57 5.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.225 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.574 ' OG1' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.49 103.79 3.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.029 0.442 . . . . 0.0 111.585 -172.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -115.18 12.88 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.956 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -134.68 145.31 48.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 -178.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.3 m0 -123.72 140.26 53.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -112.32 111.45 22.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.21 141.84 42.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.632 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -89.07 111.96 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.483 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.622 ' HE1' HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -96.68 170.98 8.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.156 -177.414 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -155.66 151.35 27.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.096 175.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HB2' ' H ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -129.2 -138.87 0.23 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.128 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.466 ' H ' ' HB2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.3 104.89 25.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.368 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 24.0 Cg_exo -63.59 137.26 58.46 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.254 2.636 . . . . 0.0 112.669 -176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.79 150.14 16.93 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -64.84 115.96 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 73.11 134.66 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.045 0.841 . . . . 0.0 110.315 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.82 54.15 1.15 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -170.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.67 100.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.407 0.622 . . . . 0.0 110.093 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -162.64 158.96 23.93 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.463 -175.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -136.03 170.07 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 111.275 -172.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' OE1' ' HG3' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -95.42 130.97 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.036 177.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -99.86 115.05 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.48 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -83.52 104.85 13.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 109.884 -176.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -97.93 110.55 23.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.646 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -98.79 130.93 45.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.957 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -121.81 129.31 52.54 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.475 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -127.38 132.37 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 0.0 110.29 177.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB2' HG23 ' A' ' 102' ' ' THR . 20.3 t-20 -74.68 163.61 27.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.809 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -14.7 9.24 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.591 0.557 . . . . 0.0 112.137 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -10.96 60.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.243 0.544 . . . . 0.0 110.65 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.49 15.2 55.75 Favored Glycine 0 C--O 1.22 -0.743 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.862 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.908 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.4 t -112.42 130.2 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 122.432 0.293 . . . . 0.0 110.712 -172.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.805 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 2.3 mt -55.21 115.14 2.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -84.98 -33.19 22.64 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.033 0.444 . . . . 0.0 110.538 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -168.13 144.8 4.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.088 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.36 134.46 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 169.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.73 103.03 12.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.776 0.322 . . . . 0.0 110.386 176.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -125.31 104.81 8.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.262 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.75 133.84 23.59 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.11 132.87 38.32 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.943 2.429 . . . . 0.0 113.182 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.38 -41.47 63.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.235 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 111.097 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.3 t30 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -163.48 -177.78 5.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 38' ' ' LEU . 2.0 tp -75.0 158.71 32.79 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 41' ' ' ASN . 11.0 t -129.15 -179.85 5.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.603 0.239 . . . . 0.0 110.384 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.49 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.071 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.501 ' H ' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.9 -31.99 73.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.787 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -68.08 -34.29 76.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 110.371 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.408 HG13 HD21 ' A' ' 91' ' ' LEU . 6.8 t -63.19 -34.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.34 0.591 . . . . 0.0 110.33 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -6.79 59.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.196 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -29.93 45.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.404 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.47 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -96.84 -177.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.056 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -140.44 144.96 36.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.599 0.238 . . . . 0.0 110.699 -175.239 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 m -68.23 138.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.502 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.807 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 85.34 3.17 87.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.975 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.534 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -82.25 154.36 25.42 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.011 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.53 145.99 38.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HG3' ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -53.98 -31.78 51.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.424 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.546 ' HA ' HD21 ' A' ' 63' ' ' LEU . 23.7 mm-40 -59.57 -44.72 93.21 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 110.426 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -76.65 -35.58 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.228 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 101' ' ' LEU . 84.1 t -61.03 -43.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.973 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 61' ' ' THR . . . -71.66 -34.49 69.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.834 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -37.48 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.85 -52.44 7.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.96 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.1 mt -79.97 -12.28 59.73 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.08 32.44 69.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.519 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 3.2 t -100.95 146.4 32.06 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.8 Cg_exo -64.32 132.71 34.69 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.462 2.108 . . . . 0.0 112.009 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 53' ' ' GLN . 13.3 mt -70.15 99.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.096 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.1 ttp -136.71 100.29 4.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -104.01 146.32 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.96 126.1 75.87 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.429 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.42 -5.42 9.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.402 2.735 . . . . 0.0 113.658 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.53 -12.82 55.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.156 0.503 . . . . 0.0 110.184 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.76 2.19 34.55 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 104.46 4.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.249 0.547 . . . . 0.0 110.437 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -108.39 53.89 0.67 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.727 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -128.08 140.89 51.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.46 176.362 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.71 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 6.8 m0 -117.29 142.86 46.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.695 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 38.6 p90 -129.73 119.62 23.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.356 0.598 . . . . 0.0 110.428 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.99 159.17 26.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.54 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.0 121.86 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.0 0.429 . . . . 0.0 110.82 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.519 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 3.6 p90 -118.39 -174.95 2.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HD2' ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.93 138.74 48.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.864 0.364 . . . . 0.0 111.362 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HG3' ' HG2' ' A' ' 89' ' ' GLN . 1.6 mt-30 -91.85 -128.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.245 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.416 ' H ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -116.92 105.25 49.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.53 143.34 87.58 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.865 2.377 . . . . 0.0 112.396 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.02 -136.22 2.37 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.41 15.0 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.553 0.216 . . . . 0.0 111.083 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 76.01 -60.01 0.5 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.785 0.834 . . . . 0.0 111.119 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.98 -13.32 61.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.026 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 t -109.33 88.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 109' ' ' ALA . 7.0 m -165.67 112.85 0.93 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.275 -174.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.4 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -163.54 117.49 1.56 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.271 176.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 13.5 pt20 -80.28 131.56 35.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.863 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.96 157.45 16.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.395 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -98.05 104.02 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -104.01 107.8 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.1 mp -101.24 124.18 46.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -117.76 122.23 42.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.46 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -127.14 148.07 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.964 0.412 . . . . 0.0 110.362 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -81.15 161.61 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -8.45 1.85 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.72 -13.34 60.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.27 14.39 48.37 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.915 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.5 t -112.16 126.94 69.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.59 0.356 . . . . 0.0 110.43 -173.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.807 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 8.2 mt -56.76 108.42 0.5 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.321 0.388 . . . . 0.0 110.179 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.46 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -74.71 -32.97 62.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.49 140.06 4.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.974 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.6 mt -102.38 134.51 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 3.2 t70 -111.04 101.8 10.31 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.394 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -133.32 102.17 5.45 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.06 0.457 . . . . 0.0 109.779 175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.22 131.56 24.39 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.763 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.07 146.01 13.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.363 2.708 . . . . 0.0 112.361 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.582 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -74.55 51.58 0.47 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.164 0.506 . . . . 0.0 111.485 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.628 0.252 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.8 ' HE2' ' HA ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -159.12 179.35 9.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.59 151.45 40.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.953 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.3 145.97 43.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.126 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.85 80.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.75 -18.54 63.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.154 0.502 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.73 -23.35 45.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 t -67.77 -18.38 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.045 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -7.4 51.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.669 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -17.23 38.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.42 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.516 HG21 HG13 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -115.02 165.6 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 0.0 111.471 -177.208 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.506 ' O ' HD12 ' A' ' 101' ' ' LEU . 15.4 mmt-85 -142.08 166.17 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.014 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.47 145.44 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.88 0.372 . . . . 0.0 110.189 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.652 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 79.16 1.84 86.25 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.261 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.404 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 28.4 mmt -82.09 137.31 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.82 146.09 53.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.624 0.249 . . . . 0.0 111.051 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.699 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 4.6 pt20 -57.28 -26.84 61.47 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.286 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -43.04 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 0.0 109.983 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -76.02 -32.72 59.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.52 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG13 HG21 ' A' ' 46' ' ' ILE . 59.0 t -64.59 -44.33 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.443 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -65.96 -38.02 87.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.668 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.3 -49.5 75.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.495 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.38 -47.34 34.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.3 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 5.0 mp -76.17 -43.53 42.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -175.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.13 50.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.935 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 18.9 m -77.19 134.3 67.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 120.679 0.275 . . . . 0.0 111.151 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.3 Cg_exo -66.66 146.47 79.19 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.888 2.392 . . . . 0.0 111.578 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -69.66 123.97 22.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.217 0.532 . . . . 0.0 110.179 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.75 157.54 44.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.289 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.74 126.97 47.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.125 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.93 121.54 21.94 Favored Pre-proline 0 N--CA 1.447 -0.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -86.47 -3.5 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.672 2.248 . . . . 0.0 113.522 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -102.3 -27.0 13.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.91 34.04 3.88 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.063 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -77.17 84.81 3.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.36 52.94 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.886 0.85 . . . . 0.0 110.3 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.54 119.87 15.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.548 175.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 m0 -104.26 128.33 52.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.762 -174.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.78 131.66 55.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.776 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 23.1 m-85 -136.47 139.84 42.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.931 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 121.44 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.8 ' HA ' ' HE2' ' A' ' 37' ' ' TYR . 7.4 p90 -140.29 150.37 43.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.302 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.684 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -105.35 114.21 28.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.9 0.857 . . . . 0.0 110.137 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -107.94 -130.15 0.29 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.259 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -65.81 129.99 94.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 5.9 Cg_exo -75.61 -161.86 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.261 2.641 . . . . 0.0 112.381 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.91 -67.33 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.565 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 1.4 t-80 -163.55 158.11 20.36 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.6 OUTLIER 81.36 -19.83 0.4 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.064 0.852 . . . . 0.0 111.915 172.202 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 -37.09 1.56 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.238 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.53 86.07 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.644 0.735 . . . . 0.0 109.18 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.912 HG22 ' HB1' ' A' ' 109' ' ' ALA . 11.4 m -167.66 119.37 0.87 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.48 172.44 12.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -165.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -117.71 137.8 52.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.103 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.11 136.97 54.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.925 0.393 . . . . 0.0 111.766 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.559 HD13 HD11 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -86.98 105.68 17.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.356 174.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.8 104.71 14.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.952 0.406 . . . . 0.0 110.311 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.559 HD11 HD13 ' A' ' 91' ' ' LEU . 1.2 mp -98.32 118.43 34.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.438 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.89 111.96 23.28 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.739 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -126.28 146.09 50.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.247 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 168.03 18.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -20.54 8.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -171.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.66 -5.18 56.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.971 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.699 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 87.93 22.19 43.27 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.164 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.652 HG13 ' HA2' ' A' ' 49' ' ' GLY . 53.2 t -100.28 111.52 30.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 95' ' ' PHE . 13.9 mt -54.88 101.85 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.054 0.454 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.72 42.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.454 0.645 . . . . 0.0 109.728 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 136.19 6.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.023 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.7 mt -106.84 134.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -109.01 101.18 10.28 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -133.91 104.44 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.924 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 145.03 54.08 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 31.1 Cg_exo -59.63 162.16 16.04 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.376 2.05 . . . . 0.0 111.08 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.912 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -58.9 -21.45 57.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.198 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.241 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -79.83 -174.89 4.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -72.61 155.46 40.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.976 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 162.95 25.68 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.87 69.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.998 0.428 . . . . 0.0 110.637 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -68.19 -23.62 64.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.059 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -84.61 -22.35 30.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.74 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 46' ' ' ILE . 39.6 t -71.02 -27.16 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.309 0.576 . . . . 0.0 110.436 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -5.05 12.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.797 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HB2' ' HE2' ' A' ' 45' ' ' LYS . 9.1 mtmt -78.24 -13.25 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.533 HG21 HG13 ' A' ' 55' ' ' VAL . 1.1 pp -110.84 -176.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.7 ' HB2' ' HG3' ' A' ' 50' ' ' MET . 84.3 mmt-85 -141.64 159.03 43.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.446 -173.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.9 121.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.916 174.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.624 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 103.22 -2.68 47.19 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -175.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.7 ' HG3' ' HB2' ' A' ' 47' ' ' ARG . 5.6 mtt -65.98 147.11 53.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -79.16 151.72 31.13 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.286 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -49.65 -43.24 46.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.596 0.56 . . . . 0.0 111.435 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -68.86 -37.29 78.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.28 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -73.23 -33.34 65.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.533 HG13 HG21 ' A' ' 46' ' ' ILE . 59.0 t -61.77 -51.11 76.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.572 174.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.95 82.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.715 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -45.66 88.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.391 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . -76.74 -51.97 10.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.506 HD21 HD11 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -73.5 -35.37 65.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.298 -175.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.1 27.42 10.96 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -71.64 135.95 83.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.311 -0.445 . . . . 0.0 111.769 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.64 137.97 52.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 110.917 171.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.65 134.24 53.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.51 155.53 16.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.102 0.477 . . . . 0.0 111.319 -172.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.91 81.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.254 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.79 75.14 68.32 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.189 0.518 . . . . 0.0 110.003 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.92 -3.44 13.86 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.696 2.931 . . . . 0.0 112.208 -173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -19.68 63.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.38 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.6 18.76 10.47 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.016 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.09 105.64 4.63 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.705 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 5.4 m-80 -92.13 36.14 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.435 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.98 128.49 34.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.301 177.523 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.1 m0 -103.7 141.39 36.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.759 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -113.49 111.38 21.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.458 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.4 ' CE1' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -106.55 129.12 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.994 178.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 t -108.77 107.26 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 20.7 p90 -123.52 153.71 40.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.057 0.456 . . . . 0.0 110.645 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 139.24 58.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.946 -172.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.422 ' CD ' HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.18 -169.52 2.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.515 174.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -74.83 139.2 73.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 16.9 Cg_exo -68.03 68.44 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.196 2.598 . . . . 0.0 113.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 161.2 -96.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.829 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 87' ' ' THR . 0.4 OUTLIER 57.43 -100.7 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.861 0.465 . . . . 0.0 111.527 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.501 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 8.3 tp10 -123.27 -14.66 7.41 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.19 -37.75 3.32 Favored Glycine 0 C--N 1.322 -0.218 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.4 89.02 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 164.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 83' ' ' HIS . 3.5 m -156.03 113.62 3.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.896 -161.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.632 ' H ' ' HB3' ' A' ' 109' ' ' ALA . 4.1 tp-100 -170.19 -178.43 2.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -161.71 155.08 21.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.546 0.612 . . . . 0.0 111.198 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -126.72 125.51 41.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.875 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.517 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -84.75 111.17 19.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.138 -177.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.64 107.04 18.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.651 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.4 mp -100.63 121.46 41.65 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -113.59 127.57 56.12 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -127.17 158.08 38.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -88.73 171.75 9.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.33 -25.49 24.35 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -13.13 60.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.007 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.606 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.06 22.79 24.34 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.624 HG13 ' HA2' ' A' ' 49' ' ' GLY . 42.0 t -99.42 115.87 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.109 0.164 . . . . 0.0 110.674 -174.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.4 HD12 HG13 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -53.96 107.38 0.26 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 110.606 177.537 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.45 -13.77 17.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.771 -176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.554 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 22.3 t-20 -159.85 127.84 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.237 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.4 HG13 HD12 ' A' ' 101' ' ' LEU . 5.0 mt -108.44 142.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -144.53 103.05 3.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.848 0.356 . . . . 0.0 111.143 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.408 ' HB2' HD23 ' A' ' 91' ' ' LEU . 21.9 t30 -115.51 109.31 17.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 2.2 mmtt -121.94 107.0 36.0 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.279 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 8.3 Cg_exo -72.22 143.45 39.67 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.021 2.48 . . . . 0.0 112.352 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.632 ' HB3' ' H ' ' A' ' 88' ' ' GLN . . . -60.08 92.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.552 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.485 ' HG ' ' NE2' ' A' ' 83' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.559 177.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.5 t30 . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -169.35 0.49 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.71 159.03 19.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 41' ' ' ASN . 12.3 t -127.78 170.57 12.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 0.0 110.597 175.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.82 -23.71 67.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.169 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.44 ' H ' HG23 ' A' ' 39' ' ' THR . 35.1 t30 -65.17 -30.12 71.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.986 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.95 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 42.3 m-20 -74.87 -31.15 61.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.04 -27.64 38.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.24 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -12.09 60.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.769 0.318 . . . . 0.0 111.289 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.95 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 mttt -78.01 -46.23 21.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.748 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pp -70.25 154.39 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.989 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.635 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -123.75 156.64 35.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -174.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG13 HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -68.36 131.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 1.007 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 85.18 4.09 86.82 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.195 -176.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -72.21 142.45 49.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.535 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -83.93 151.1 25.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 111.121 -176.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.662 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 1.1 pt20 -51.37 -35.3 37.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.055 -172.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.535 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 2.3 mp0 -64.66 -50.32 67.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.841 0.353 . . . . 0.0 110.106 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -68.37 -36.56 79.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 51' ' ' THR . 96.9 t -59.59 -47.32 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.288 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.551 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -74.68 -23.94 58.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.149 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 -41.85 10.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.543 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.37 -10.94 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.764 0.316 . . . . 0.0 111.549 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.85 40.83 57.14 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.412 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.7 m -67.98 128.6 93.32 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.507 0.194 . . . . 0.0 111.217 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 20.9 Cg_exo -66.85 173.93 7.44 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.266 2.644 . . . . 0.0 112.289 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.88 116.66 2.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.06 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.59 127.19 46.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.375 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.38 81.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.01 115.16 64.53 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 109.268 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 -2.44 12.61 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.7 2.266 . . . . 0.0 112.647 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -100.71 -26.9 13.64 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.5 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.49 4.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.348 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -71.28 99.26 1.89 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.387 0.613 . . . . 0.0 110.546 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 95' ' ' PHE . 5.4 p30 -90.88 43.24 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.258 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.03 129.38 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.87 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 13.5 m0 -116.81 142.76 46.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -120.8 127.06 51.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.992 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.83 153.85 49.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.823 0.344 . . . . 0.0 110.305 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.89 132.76 29.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 2.6 p90 -125.81 138.1 53.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.996 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.12 116.95 13.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.793 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HB3' ' H ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -120.39 -92.5 0.54 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.543 -171.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.461 ' H ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -128.03 117.78 20.65 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.836 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 8.1 Cg_exo -71.97 -95.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.871 2.381 . . . . 0.0 111.992 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 111.17 157.36 14.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.081 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -101.85 -40.33 6.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -110.81 119.96 40.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.795 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.68 55.21 0.95 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.999 -172.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -74.88 89.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.422 0.63 . . . . 0.0 109.456 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.825 HG23 ' HB1' ' A' ' 109' ' ' ALA . 14.2 t -159.54 162.33 35.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.801 -171.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 88' ' ' GLN . 1.4 tp60 -136.35 179.82 6.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.439 0.638 . . . . 0.0 111.976 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.715 ' HG3' ' HA ' ' A' ' 108' ' ' PRO . 3.5 mp0 -78.94 148.23 32.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.258 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.94 118.36 27.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -112.46 105.37 13.6 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 110.406 178.015 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -115.55 126.35 54.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.641 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.1 mp -111.43 131.04 55.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.975 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.89 131.24 53.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.767 ' HE1' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -118.73 130.46 55.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.919 0.39 . . . . 0.0 110.784 -174.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.499 ' HB2' HG23 ' A' ' 102' ' ' THR . 66.1 t30 -77.54 162.4 27.15 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.18 45.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -2.51 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.662 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 85.05 22.3 52.85 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.007 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -94.15 130.16 43.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.516 0.198 . . . . 0.0 110.919 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.767 HD22 ' HE1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -58.96 96.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.506 174.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.52 -32.9 58.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.179 0.514 . . . . 0.0 110.762 -178.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -164.38 142.57 6.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.838 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.456 HD12 HG13 ' A' ' 48' ' ' VAL . 3.3 mt -111.54 129.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.34 101.14 12.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.68 115.39 18.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.12 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -145.56 136.93 12.72 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.613 -177.184 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.715 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . 18.0 Cg_exo -66.84 169.88 13.85 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.154 2.569 . . . . 0.0 112.114 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.825 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -74.08 -28.11 61.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.085 0.469 . . . . 0.0 110.606 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.738 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -102.81 175.08 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.999 0.428 . . . . 0.0 110.93 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -129.6 152.37 49.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.884 175.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -125.27 174.09 8.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.696 0.284 . . . . 0.0 110.331 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.36 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.966 0.412 . . . . 0.0 111.337 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.42 -29.12 70.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.21 -27.4 68.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.508 ' CG2' ' HZ ' ' A' ' 77' ' ' PHE . 2.3 t -79.98 -18.65 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -75.99 -12.21 60.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.161 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -82.11 -29.29 31.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.612 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.25 -167.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 50' ' ' MET . 1.4 ptt85 -154.85 164.52 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.385 . . . . 0.0 111.601 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.28 141.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.793 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.677 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 86.4 -5.3 84.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.761 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -68.22 131.37 45.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.702 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -69.59 146.64 51.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.519 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -50.04 -37.5 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.48 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -68.53 -38.5 80.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.525 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -77.46 -31.54 53.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.359 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.09 -49.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.675 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.73 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -57.26 8.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.0 -42.66 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.26 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 38' ' ' LEU . 26.1 tp -85.88 -28.97 24.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 0.0 110.696 -175.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.06 79.67 1.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.724 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.2 m -105.62 134.32 19.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.458 0.171 . . . . 0.0 111.28 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 36.0 Cg_exo -61.42 134.96 54.53 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.833 2.355 . . . . 0.0 112.05 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 138.11 51.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.159 -175.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -140.27 170.81 15.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.277 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.7 13.32 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -155.92 90.27 2.79 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.83 -8.15 5.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.948 2.432 . . . . 0.0 112.325 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.25 -27.36 11.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -173.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.2 31.0 6.72 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -83.89 88.5 7.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.657 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.94 64.63 7.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.369 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.536 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -141.36 137.35 32.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.455 176.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -125.43 155.41 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.381 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.55 134.42 33.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.725 0.298 . . . . 0.0 110.468 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -122.38 146.63 47.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.272 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.68 114.38 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HZ ' ' CG2' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -94.13 128.44 40.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.114 -170.478 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 78' ' ' ARG . 2.8 mmt85 -77.66 103.42 7.59 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 169.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HB3' HE21 ' A' ' 89' ' ' GLN . 1.5 tp-100 -140.84 168.17 20.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 -171.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.516 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -70.87 127.47 91.73 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.246 0.546 . . . . 0.0 110.923 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 36.7 Cg_endo -93.35 -37.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.012 2.474 . . . . 0.0 113.495 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.89 -149.15 27.95 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.999 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.96 52.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.528 0.664 . . . . 0.0 111.665 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.44 -30.67 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.171 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.29 -33.64 6.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.69 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.72 86.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -161.32 98.37 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.748 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.438 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -147.0 107.36 4.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.943 178.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.613 HE21 ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -90.88 123.64 34.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.485 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.55 44.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -84.13 115.31 22.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -106.08 132.78 51.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.177 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.5 mp -111.41 122.15 47.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.881 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.536 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -114.6 114.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -176.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.34 158.57 20.41 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.401 ' OD1' ' HB ' ' A' ' 100' ' ' VAL . 24.2 p30 -86.99 169.07 12.76 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.2 -23.42 47.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -173.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -11.63 60.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.5 27.05 12.2 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.246 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.677 HG13 ' HA2' ' A' ' 49' ' ' GLY . 30.7 t -111.78 125.1 69.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.865 0.333 . . . . 0.0 111.127 -174.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.667 ' HB3' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -53.68 111.11 0.67 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -24.74 13.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.915 0.388 . . . . 0.0 110.343 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -155.5 131.49 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.95 140.17 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 170.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 10.7 t70 -117.04 109.97 17.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.9 101.35 3.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.157 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 140.9 29.67 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.648 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 11.3 Cg_endo -56.14 133.37 57.59 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.514 2.143 . . . . 0.0 111.815 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.438 ' CB ' ' H ' ' A' ' 88' ' ' GLN . . . -60.67 -24.92 65.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.129 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 CA--C 1.519 -0.233 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -123.78 -169.47 1.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.84 HD21 HD11 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -113.51 150.98 32.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.909 0.385 . . . . 0.0 111.528 -175.002 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.05 145.25 35.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.52 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -74.27 -41.89 60.52 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.012 0.434 . . . . 0.0 110.329 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.04 -22.44 66.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.661 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 8.1 m-20 -69.49 -37.22 77.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.977 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' HA ' HD13 ' A' ' 59' ' ' LEU . 9.2 t -76.1 -16.9 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.529 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 -7.38 56.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 4.7 mtpt -82.49 -34.03 28.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.625 HG21 HG13 ' A' ' 55' ' ' VAL . 1.2 pp -80.5 160.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.579 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -136.92 165.51 25.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.85 -171.439 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -72.3 145.38 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.997 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 75.93 2.77 72.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.38 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.532 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.1 mmm -83.9 137.06 33.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.2 OUTLIER -78.17 152.39 32.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 -176.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -32.74 62.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.313 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -64.66 -45.34 87.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -72.63 -33.74 66.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.051 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.625 HG13 HG21 ' A' ' 46' ' ' ILE . 56.0 t -62.23 -49.68 83.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.632 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.5 69.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.78 -54.43 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.815 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.83 34.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.814 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.84 HD11 HD21 ' A' ' 38' ' ' LEU . 8.3 tp -84.79 -40.27 17.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.22 -176.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.08 63.47 0.81 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.178 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 5.7 m -101.81 133.37 20.79 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -80.19 172.45 13.78 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.136 2.557 . . . . 0.0 111.649 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 138.94 56.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.818 0.342 . . . . 0.0 110.657 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.1 ttp -142.21 178.7 7.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.052 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -121.51 152.34 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.76 0.314 . . . . 0.0 111.418 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.75 46.13 0.35 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.172 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.24 -34.08 88.93 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.0 113.449 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -104.26 7.73 35.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.797 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.03 21.13 9.18 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.425 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.84 85.61 3.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.247 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.86 27.87 9.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.298 0.57 . . . . 0.0 111.374 -172.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -102.76 129.57 49.45 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.258 170.529 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -103.46 121.58 43.13 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.53 114.67 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.365 -176.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.513 ' HE2' HD13 ' A' ' 38' ' ' LEU . 11.1 m-85 -106.12 130.99 53.91 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.884 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.05 108.76 16.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.545 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -115.28 116.47 28.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 102.35 11.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.923 165.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -118.9 -37.68 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.184 0.516 . . . . 0.0 110.697 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.477 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -147.57 141.47 15.76 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.572 175.239 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 1.3 Cg_endo -85.4 -104.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.136 2.557 . . . . 0.0 111.987 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 116.19 165.94 14.39 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.9 97.2 9.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.929 0.365 . . . . 0.0 110.787 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -159.23 -63.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.02 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 -35.76 4.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.453 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -106.42 87.18 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.555 HG23 ' HB3' ' A' ' 109' ' ' ALA . 27.2 m -159.41 101.24 1.53 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.559 -168.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -151.69 144.48 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.55 173.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.71 147.01 44.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.482 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.05 127.98 47.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.389 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.02 114.73 21.93 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.97 105.41 14.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.331 0.586 . . . . 0.0 111.515 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 6.6 mp -87.34 148.04 25.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.815 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -137.19 116.24 12.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.616 ' HB3' HD22 ' A' ' 101' ' ' LEU . 26.6 p90 -129.2 145.03 51.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.63 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.528 ' ND2' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.41 163.01 28.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.892 177.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.08 -38.49 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -3.51 25.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.63 17.82 47.36 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.182 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.997 HG13 ' HA2' ' A' ' 49' ' ' GLY . 14.3 t -97.08 114.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 95' ' ' PHE . 1.4 mm? -54.82 106.21 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.552 0.533 . . . . 0.0 110.837 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.41 -28.22 19.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.146 0.498 . . . . 0.0 110.891 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -158.8 149.65 20.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.696 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 mp -124.02 130.03 73.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.13 101.65 13.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.599 174.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -125.11 106.53 9.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.223 0.535 . . . . 0.0 110.376 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 144.59 35.68 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 159.64 40.71 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.299 1.999 . . . . 0.0 111.274 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -66.37 -34.92 79.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.18 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.4 t30 . . . . . 0 C--O 1.23 0.07 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 -179.74 3.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.658 HD23 ' HE1' ' A' ' 77' ' ' PHE . 12.4 tp -78.87 131.81 36.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.414 . . . . 0.0 110.772 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 145.84 27.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.302 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.01 81.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.969 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.91 -22.15 65.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.493 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -42.3 89.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.866 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' HG13 ' A' ' 46' ' ' ILE . 6.3 t -74.98 -17.06 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.747 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -73.86 -7.36 51.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.854 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -76.06 -37.9 57.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.061 0.457 . . . . 0.0 110.165 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -91.0 179.13 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.874 177.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.602 ' O ' ' HB2' ' A' ' 50' ' ' MET . 7.7 ptp180 -157.81 167.66 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.769 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.36 128.96 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.785 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.957 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 95.51 -4.7 66.84 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.01 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.602 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -81.26 161.84 23.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.273 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -79.29 144.67 34.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.069 0.462 . . . . 0.0 111.518 -169.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -61.31 -36.32 79.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.728 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.686 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -79.52 -30.54 41.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.154 -172.426 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.26 -37.68 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HA ' HG21 ' A' ' 46' ' ' ILE . 38.4 t -60.44 -46.24 95.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.796 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -68.5 -31.88 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.873 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -37.62 83.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.153 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.7 -44.8 13.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.989 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.419 HD21 ' HA ' ' A' ' 43' ' ' VAL . 88.0 mt -88.93 -6.74 57.06 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 55.8 17.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.464 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 2.0 m -79.02 130.95 68.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.477 0.179 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.89 148.84 54.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.143 2.562 . . . . 0.0 112.588 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.56 113.74 13.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.374 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.78 131.29 47.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.142 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.53 102.6 8.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.07 115.36 38.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 120.911 0.386 . . . . 0.0 110.571 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.43 -2.03 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.063 2.508 . . . . 0.0 112.183 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -81.55 -26.73 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.642 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.82 30.17 4.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.839 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -80.43 108.99 14.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.983 0.421 . . . . 0.0 110.59 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -112.49 39.16 2.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.427 0.632 . . . . 0.0 110.229 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -124.69 141.45 52.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.52 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.732 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 3.0 m0 -116.31 142.96 46.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -124.9 111.56 15.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.138 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.42 ' CD1' HD22 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -107.57 140.78 40.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.436 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.96 114.74 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.076 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.658 ' HE1' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -102.89 142.25 34.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.28 148.41 47.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.733 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -129.57 167.66 17.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.2 mm-40 -88.1 115.77 64.17 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.2 Cg_exo -70.36 70.09 1.93 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.158 2.572 . . . . 0.0 111.978 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.36 -150.0 17.51 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.444 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.61 3.04 30.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.0 111.871 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.9 -48.23 16.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.31 0.576 . . . . 0.0 110.095 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.66 -39.2 1.51 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.727 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.41 88.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 117.108 0.454 . . . . 0.0 110.798 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -169.69 136.1 1.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.89 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -154.76 130.9 10.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.095 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -75.14 124.56 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 110.536 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.6 110.44 20.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.954 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.517 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.91 106.93 15.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.974 0.416 . . . . 0.0 110.537 -175.516 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 111.3 22.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.853 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.732 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 4.1 mp -106.66 142.6 36.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.002 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -139.74 133.85 31.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -132.2 141.65 49.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.88 0.371 . . . . 0.0 110.442 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.494 ' HB2' HG23 ' A' ' 102' ' ' THR . 5.5 t-20 -78.1 156.56 29.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.247 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -14.14 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.766 0.666 . . . . 0.0 112.245 -176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -15.01 61.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 0.0 110.496 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 97.36 19.55 25.27 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.164 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.957 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.2 t -113.47 126.4 70.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 122.877 0.471 . . . . 0.0 110.564 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 94' ' ' THR . 2.9 mm? -55.46 108.23 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 173.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.08 -31.99 59.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.838 0.351 . . . . 0.0 110.627 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -167.43 149.7 5.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.146 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.1 mt -127.7 138.33 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.73 102.82 10.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.171 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.06 101.45 9.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.27 153.71 44.9 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.188 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 52.2 Cg_exo -56.73 151.49 47.39 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.87 2.38 . . . . 0.0 112.396 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -60.6 -79.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.208 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.541 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.34 0 O-C-N 123.272 0.357 . . . . 0.0 110.817 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 t30 . . . . . 0 CA--C 1.521 -0.153 0 CA-C-O 121.391 0.615 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -154.43 157.34 38.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.535 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.03 141.62 51.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.0 110.72 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.15 145.21 25.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.974 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.94 78.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.59 -35.54 76.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -63.37 -40.68 97.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.434 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.38 -26.4 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 110.382 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m -75.8 -10.65 59.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.315 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -34.02 41.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -81.1 -150.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.711 0.291 . . . . 0.0 110.786 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.902 ' HB3' ' HG3' ' A' ' 50' ' ' MET . 0.6 OUTLIER -156.59 134.47 11.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.651 0.262 . . . . 0.0 110.665 -173.12 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.496 ' HB ' HD12 ' A' ' 104' ' ' ILE . 1.9 p -71.43 122.26 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.884 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 106.98 2.87 36.41 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.449 -175.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.902 ' HG3' ' HB3' ' A' ' 47' ' ' ARG . 3.9 mtt -78.87 151.61 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.78 154.1 36.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.919 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -48.72 -39.33 24.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.708 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -59.91 -46.18 90.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.074 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.53 -40.25 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.717 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.456 HG21 HD21 ' A' ' 101' ' ' LEU . 84.4 t -58.29 -45.85 89.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.236 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -29.93 68.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 111.087 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.18 -57.72 2.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.844 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.36 -20.56 40.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -172.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.2 31.01 32.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.318 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.756 HG23 ' HE2' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -65.52 136.41 96.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.689 -178.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 61' ' ' THR . 57.7 Cg_endo -73.96 151.22 44.78 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.515 2.144 . . . . 0.0 111.945 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.6 106.43 15.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.001 0.429 . . . . 0.0 110.225 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.4 tpt -95.08 120.6 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.735 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.86 117.53 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.735 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.28 112.31 13.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.448 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.89 -2.99 12.89 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.721 2.281 . . . . 0.0 112.574 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -85.61 -25.69 26.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.923 -176.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.78 29.34 4.7 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.948 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -72.92 107.82 5.51 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.165 0.507 . . . . 0.0 110.644 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -103.6 25.89 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.124 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -131.01 127.17 37.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.531 178.501 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -104.01 124.74 49.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -103.78 135.7 44.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.756 ' HE2' HG23 ' A' ' 61' ' ' THR . 0.2 OUTLIER -134.81 151.24 50.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 178.067 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.58 115.34 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.367 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.533 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -93.56 160.26 14.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.693 -178.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 78' ' ' ARG . 4.4 ptm180 -126.16 132.93 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.687 0.279 . . . . 0.0 110.329 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HG3' HE22 ' A' ' 88' ' ' GLN . 0.0 OUTLIER -159.1 -44.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.854 177.318 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.444 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 5.0 mp0 -90.62 120.21 68.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -54.28 4.54 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.885 2.39 . . . . 0.0 112.563 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.79 127.82 1.04 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.864 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 179.24 149.66 0.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.836 0.454 . . . . 0.0 110.137 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 72.62 -41.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.856 0.862 . . . . 0.0 112.321 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.17 -37.78 3.55 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 t -115.2 86.74 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 m -164.37 99.96 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 -174.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -165.48 168.36 16.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.877 171.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.451 ' H ' ' NE2' ' A' ' 88' ' ' GLN . 8.2 tt0 -82.47 142.81 31.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 122.85 47.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.322 175.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.533 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -110.03 119.47 39.42 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.382 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.12 138.57 50.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 110.652 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -116.59 139.18 50.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.304 177.695 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -102.78 146.79 27.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.192 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -125.18 125.37 43.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 111.805 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.778 ' HB2' HG23 ' A' ' 102' ' ' THR . 47.5 t-20 -73.61 157.02 37.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 170.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -19.69 37.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -7.75 57.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 87.06 29.64 22.35 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 49' ' ' GLY . 1.6 t -111.88 135.6 50.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -174.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.884 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 17.6 mt -60.91 105.77 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.341 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.778 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -75.56 -30.51 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.186 0.517 . . . . 0.0 110.631 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -168.25 140.82 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.904 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 48' ' ' VAL . 14.2 mt -103.48 139.11 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -117.52 101.9 8.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.089 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.42 121.48 33.95 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -143.31 129.85 10.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.362 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.88 170.26 2.85 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.273 2.649 . . . . 0.0 112.262 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.28 93.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.76 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.611 -177.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.275 0.56 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -164.42 177.63 8.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.278 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CD2' ' A' ' 75' ' ' TYR . 11.9 tp -118.01 140.71 49.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.77 0.319 . . . . 0.0 110.568 175.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.13 145.97 39.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.072 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -63.49 -42.32 98.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.92 -21.77 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.897 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.642 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -73.45 -34.2 65.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.126 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG21 ' HG ' ' A' ' 91' ' ' LEU . 96.2 t -75.8 -30.77 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 110.091 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.3 m -66.72 -6.56 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.45 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.642 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 13.5 mtpt -70.6 -32.97 70.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.486 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 pp -93.58 179.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.391 . . . . 0.0 111.151 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -144.3 160.03 41.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.89 -175.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 2.8 m -69.55 146.25 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.999 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 84.67 -15.77 39.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.291 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.553 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -70.52 141.08 51.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.377 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.18 145.92 41.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.898 0.38 . . . . 0.0 111.78 -172.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -35.4 29.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.827 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -64.89 -53.87 39.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.625 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.5 72.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.713 HG21 HD23 ' A' ' 101' ' ' LEU . 21.6 t -61.39 -42.19 92.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.607 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -67.13 -37.94 84.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.691 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.21 -34.19 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.645 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.1 -41.07 16.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.507 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -69.73 -43.25 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 111.378 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.9 59.74 0.81 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -71.99 147.33 91.11 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.737 0.303 . . . . 0.0 110.792 -177.426 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 11.5 Cg_exo -71.83 164.64 35.05 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.2 2.6 . . . . 0.0 111.547 175.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.34 85.31 3.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.346 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mtm -143.77 171.24 14.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.444 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -119.9 -178.05 3.55 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.233 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -128.85 53.28 10.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 78.9 Cg_endo -78.23 -4.99 14.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.066 1.844 . . . . 0.0 112.085 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -93.41 -4.59 51.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.262 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.24 35.79 7.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 86.85 2.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.314 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 90.1 m-20 -102.35 7.72 40.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.263 0.554 . . . . 0.0 110.208 176.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.11 123.37 41.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.176 176.346 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.788 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 11.7 m0 -104.79 137.12 43.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.181 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -118.78 115.27 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.051 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 22.6 m-85 -118.44 148.25 42.76 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.08 117.97 31.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.121 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.609 ' HB3' ' HG2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -104.8 114.46 28.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.05 0.453 . . . . 0.0 111.359 -175.449 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -93.28 103.87 16.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -151.3 147.27 26.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 -176.256 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.618 HE22 ' HB3' ' A' ' 108' ' ' PRO . 31.5 mt-30 73.13 147.79 0.12 Allowed Pre-proline 0 N--CA 1.466 0.371 0 O-C-N 123.984 0.803 . . . . 0.0 111.485 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.3 Cg_exo -71.85 -2.35 11.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 112.572 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.408 ' HA2' ' HB ' ' A' ' 87' ' ' THR . . . 95.95 148.59 24.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.967 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.441 ' H ' ' CB ' ' A' ' 87' ' ' THR . 3.0 t-80 -118.89 117.76 29.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 60.98 20.56 10.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.99 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.44 -9.29 42.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.023 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.38 87.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.022 0.411 . . . . 0.0 110.0 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.649 HG23 ' HB3' ' A' ' 109' ' ' ALA . 11.7 m -163.26 121.53 1.99 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.39 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 1.4 tp-100 -176.61 112.26 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.22 0.95 . . . . 0.0 109.156 170.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.609 ' HG2' ' HB3' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -78.47 165.98 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.283 0.563 . . . . 0.0 111.842 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.9 t -123.54 127.21 48.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.726 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HG ' HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -84.56 110.9 19.05 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 1.9 m -109.37 110.99 22.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.353 -177.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.788 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -91.79 142.15 27.9 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.585 177.236 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -135.22 117.79 15.91 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.559 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 1.1 p90 -132.2 157.62 43.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.085 0.469 . . . . 0.0 110.936 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.31 161.73 22.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.17 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -20.0 24.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -9.0 58.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.493 0.663 . . . . 0.0 110.314 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.82 8.73 57.96 Favored Glycine 0 C--O 1.219 -0.783 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.636 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.999 HG13 ' HA2' ' A' ' 49' ' ' GLY . 55.1 t -89.2 110.0 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 122.894 -0.18 . . . . 0.0 111.15 -172.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.713 HD23 HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -55.22 107.5 0.32 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.593 0.558 . . . . 0.0 110.101 174.173 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.36 -25.82 14.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.776 0.322 . . . . 0.0 111.142 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.561 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 18.1 t30 -150.29 143.84 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.87 133.78 66.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' HD22 ' A' ' 91' ' ' LEU . 6.4 t70 -103.28 101.87 11.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.278 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -132.33 102.0 5.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.229 0.538 . . . . 0.0 110.149 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 165.6 21.73 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.618 ' HB3' HE22 ' A' ' 80' ' ' GLN . 23.2 Cg_exo -65.78 158.22 54.81 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.223 1.949 . . . . 0.0 110.778 169.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.649 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -73.33 59.53 0.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 111.467 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.513 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.1 179.48 7.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.753 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 38' ' ' LEU . 5.6 tp -75.05 145.12 42.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.638 0.732 . . . . 0.0 112.968 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 41' ' ' ASN . 4.7 m -116.14 152.6 33.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.187 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -54.84 -38.96 68.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.578 ' H ' HG22 ' A' ' 39' ' ' THR . 9.2 t30 -61.17 -47.05 87.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.384 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.452 ' OD1' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -68.35 -20.4 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.603 -176.046 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.8 -27.01 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.748 0.308 . . . . 0.0 111.256 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.9 -7.14 32.02 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 3.36 55.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.21 -169.03 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.236 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -147.79 143.2 27.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.07 0.462 . . . . 0.0 112.018 -174.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 104' ' ' ILE . 41.1 t -76.05 137.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.87 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.611 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 89.26 -6.46 83.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.902 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.2 mmm -71.04 153.24 42.76 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -77.78 145.66 36.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.89 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -36.31 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.298 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 1.6 mp0 -70.15 -40.81 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.279 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.64 -34.76 60.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.754 -177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.51 -46.49 94.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.589 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -62.67 -41.14 98.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.574 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.438 ' HE1' HD11 ' A' ' 63' ' ' LEU . 1.1 m-85 -60.22 -49.2 78.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.6 -36.35 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.232 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -80.08 -37.62 33.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.4 . . . . 0.0 111.54 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.44 52.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -173.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -122.08 139.85 31.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.45 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.41 138.7 82.34 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.323 2.015 . . . . 0.0 110.716 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD11 ' HE1' ' A' ' 57' ' ' TYR . 91.3 mt -74.07 87.92 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.151 0.501 . . . . 0.0 110.649 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 109.12 12.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.776 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.64 142.05 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.969 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.34 131.64 24.37 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -92.54 -2.97 3.75 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.932 2.422 . . . . 0.0 112.996 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.466 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -103.01 -26.16 13.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.21 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.12 5.54 32.7 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.46 7.34 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.957 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -99.73 51.71 0.92 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.225 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.88 128.85 55.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.373 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.589 ' HH2' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -103.4 141.07 36.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -123.12 119.8 31.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 144.14 47.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.232 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.94 117.13 29.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -94.18 116.88 29.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -175.258 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.15 104.35 12.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.616 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.742 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -165.31 129.15 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.402 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -142.47 117.74 6.7 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.77 0.319 . . . . 0.0 110.801 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.39 -3.19 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.472 2.115 . . . . 0.0 111.927 176.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -11.77 60.11 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.092 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.11 132.79 47.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.671 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER 75.98 -67.44 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 124.106 0.879 . . . . 0.0 112.294 172.241 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 -36.52 4.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.71 86.74 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 109' ' ' ALA . 1.1 m -170.37 131.81 0.97 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.303 -174.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.481 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 28.0 tp60 -143.86 114.01 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.366 0.603 . . . . 0.0 110.782 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.742 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -75.83 135.14 40.21 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.074 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.32 132.5 56.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.635 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -95.93 110.31 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -108.95 138.65 44.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.106 0.479 . . . . 0.0 110.996 -177.471 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.763 ' HG ' HD11 ' A' ' 101' ' ' LEU . 3.4 mp -117.32 131.05 56.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.68 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.88 105.4 9.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.884 0.373 . . . . 0.0 110.087 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.43 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -116.09 135.71 53.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.78 -178.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 164.89 25.81 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.77 -31.4 2.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -170.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -4.51 33.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 111.295 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 93.61 9.86 59.66 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.021 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.611 HG13 ' HA2' ' A' ' 49' ' ' GLY . 21.0 t -93.49 116.22 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -174.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 HD11 ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -54.28 97.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.773 0.671 . . . . 0.0 110.464 176.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.43 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -76.99 -31.51 56.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.909 0.385 . . . . 0.0 110.449 -176.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.68 140.66 9.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.147 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.605 HD12 HG22 ' A' ' 48' ' ' VAL . 1.7 mp -103.45 139.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 171.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 0.5 OUTLIER -107.39 102.03 11.34 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -113.8 102.84 10.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 127.34 10.96 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.039 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.616 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 13.6 Cg_exo -70.9 150.95 62.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.923 2.415 . . . . 0.0 110.554 171.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.714 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -81.44 38.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 110.842 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.531 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.957 0.408 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.47 137.51 33.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.156 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.24 106.04 16.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.266 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.463 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -89.54 93.01 9.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.376 -178.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -108.53 103.96 13.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.961 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.1 85.36 2.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.14 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.8 p -89.53 146.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.635 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.32 121.04 59.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.97 0.414 . . . . 0.0 111.085 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.45 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 3.8 t80 -99.05 139.29 34.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -89.93 113.02 55.51 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.597 0.237 . . . . 0.0 111.46 -176.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 28' ' ' TYR . 5.4 Cg_exo -77.52 45.36 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.285 2.657 . . . . 0.0 111.269 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -136.95 23.68 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.305 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.0 140.45 37.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.296 -173.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -114.89 96.77 5.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.389 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -106.93 67.5 0.71 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.985 0.422 . . . . 0.0 110.972 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.53 -160.56 16.97 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.972 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.2 t30 67.98 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.628 0.771 . . . . 0.0 111.358 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' HD2' ' HD2' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -126.43 167.54 15.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -89.03 140.14 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -73.72 145.03 45.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.601 178.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.28 99.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 110.671 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.71 -27.8 68.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.684 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.2 -41.27 67.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.725 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.718 ' HA ' HD21 ' A' ' 59' ' ' LEU . 11.3 t -68.22 -23.73 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 110.433 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 m -77.0 -5.87 50.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HE3' ' HB1' ' A' ' 58' ' ' ALA . 25.7 mtmt -68.07 -35.43 78.18 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.731 0.3 . . . . 0.0 111.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 pp -84.87 -177.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.402 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.0 175.74 13.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.159 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 104' ' ' ILE . 2.8 t -73.05 143.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.665 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.96 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 84.06 -11.13 58.57 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.342 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.85 133.67 47.64 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -77.42 156.73 30.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.362 -175.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.445 ' HG3' ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.94 -44.57 14.89 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.624 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.494 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.87 -37.64 58.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.926 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 HD23 ' A' ' 101' ' ' LEU . 78.0 t -60.91 -46.93 95.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 109.983 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -67.67 -35.2 78.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.731 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -43.54 97.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.502 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -78.32 -46.47 20.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.718 HD21 ' HA ' ' A' ' 43' ' ' VAL . 7.0 mt -84.05 -16.41 43.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -173.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 17.79 65.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.518 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -68.9 141.05 91.83 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 122.534 0.333 . . . . 0.0 111.457 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.14 158.81 53.98 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.481 2.121 . . . . 0.0 111.417 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.67 135.1 57.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.1 128.6 24.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.536 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -149.78 71.33 1.09 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.541 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.16 121.36 84.91 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.36 -2.93 12.94 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.075 2.517 . . . . 0.0 112.358 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -90.0 -20.05 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.447 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.8 4.66 34.0 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.02 85.29 6.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.344 0.592 . . . . 0.0 110.18 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -101.25 49.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.052 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -112.99 128.11 56.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.714 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -103.62 132.47 49.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.54 125.63 52.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.73 154.57 49.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.63 128.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.995 0.426 . . . . 0.0 110.659 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.53 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 6.7 p90 -127.19 173.47 9.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.606 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HD2' ' HD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -94.07 131.21 39.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.034 0.445 . . . . 0.0 111.115 -177.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.6 -30.74 0.19 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.867 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -125.74 83.26 62.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.72 -42.42 9.07 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.951 2.434 . . . . 0.0 113.469 -172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.18 138.4 4.76 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.884 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -175.2 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.166 0.586 . . . . 0.0 109.581 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -128.11 -2.25 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.539 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.98 -38.35 2.54 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.53 87.64 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.8 m -159.58 98.27 1.37 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.608 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.97 154.96 22.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.012 -175.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.55 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -111.54 131.51 55.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.061 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.24 114.18 25.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.967 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -84.52 105.43 15.33 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.97 124.1 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.592 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -99.68 139.3 35.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.462 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -130.05 108.1 9.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.79 ' HB3' HD22 ' A' ' 101' ' ' LEU . 36.0 p90 -115.35 133.22 56.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.963 0.411 . . . . 0.0 109.976 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.91 162.26 29.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.972 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.29 -22.38 2.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.24 -10.2 59.51 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.776 -0.577 . . . . 0.0 110.94 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 98.83 10.05 50.72 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.213 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.96 HG13 ' HA2' ' A' ' 49' ' ' GLY . 18.0 t -98.93 119.53 47.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 122.343 0.257 . . . . 0.0 110.709 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.79 HD22 ' HB3' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -55.14 105.48 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.423 0.452 . . . . 0.0 109.785 174.268 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.4 -31.95 15.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -150.34 138.02 19.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.888 0.375 . . . . 0.0 110.923 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 HG23 ' A' ' 48' ' ' VAL . 3.8 mt -110.78 133.05 57.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 174.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.04 99.95 11.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.546 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.412 ' C ' ' HG3' ' A' ' 107' ' ' LYS . 28.3 t30 -144.47 101.92 3.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 110.591 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 113' ' ' ASN . 0.7 OUTLIER -142.5 133.75 12.93 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.09 158.61 50.95 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.918 2.412 . . . . 0.0 112.781 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.48 ' HB1' HD23 ' A' ' 114' ' ' LEU . . . -83.08 42.79 0.82 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.02 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.34 59.63 1.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.589 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.559 ' H ' ' HA ' ' A' ' 115' ' ' GLU . 4.6 m 68.95 96.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.312 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.83 -90.38 0.11 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.912 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 1.019 ' HB2' ' HB2' ' A' ' 107' ' ' LYS . 28.2 t30 -77.14 -33.17 56.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.48 HD23 ' HB1' ' A' ' 109' ' ' ALA . 5.3 tp -157.38 155.49 30.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.156 -1.384 . . . . 0.0 107.823 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.559 ' HA ' ' H ' ' A' ' 111' ' ' SER . 0.1 OUTLIER -125.73 -177.52 3.95 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 133.9 56.52 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -69.97 125.28 26.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.304 0.573 . . . . 0.0 112.239 -166.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.34 122.56 0.03 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.535 -1.212 . . . . 0.0 112.547 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -76.62 74.28 3.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.211 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.3 122.24 35.5 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.3 t60 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.687 -176.433 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.808 0.337 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.43 86.36 5.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.179 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 108.35 1.26 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.904 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 tp -155.04 28.55 0.41 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.11 0.481 . . . . 0.0 110.668 -176.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -79.11 92.45 5.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.894 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -169.95 74.89 0.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.731 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.6 t -106.73 109.23 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.148 0.499 . . . . 0.0 110.932 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.04 114.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.823 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -114.12 136.97 52.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.087 0.47 . . . . 0.0 111.002 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 29' ' ' ARG . 3.7 mtt85 -116.12 138.37 24.12 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.092 174.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.61 60.07 2.73 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.059 2.506 . . . . 0.0 112.091 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 9.3 t70 -159.47 -133.15 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.103 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 31' ' ' ASP . 7.2 mt 75.56 134.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.306 0.574 . . . . 0.0 111.308 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.34 94.53 2.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.145 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.87 -167.33 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.93 88.47 0.91 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.371 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -118.46 -68.38 0.92 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -159.3 148.63 18.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -75.2 174.03 10.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.233 0.54 . . . . 0.0 111.216 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -128.05 153.05 47.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.677 176.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.44 -21.23 66.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.974 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -74.17 -34.77 63.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.703 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -70.84 -20.58 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 -176.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.31 -17.1 21.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.224 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -90.73 -8.4 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.703 ' HG3' ' HA ' ' A' ' 42' ' ' ASP . 2.0 mtmt -83.22 -30.6 27.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.217 0.532 . . . . 0.0 110.048 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.636 HD12 HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -86.31 144.83 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.859 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.51 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -127.57 154.35 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.418 -178.33 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -74.36 148.12 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.984 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 80.15 -4.42 67.03 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.084 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 16.1 mmt -74.86 138.6 42.59 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 6.0 t -79.41 154.72 28.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.571 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -36.18 60.3 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.866 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -60.51 -42.64 96.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.088 0.47 . . . . 0.0 110.579 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -77.0 -34.92 57.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.55 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.51 -45.94 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.032 0.444 . . . . 0.0 109.826 175.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.36 83.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.738 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.87 -28.03 65.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.355 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.68 -54.48 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.66 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 46' ' ' ILE . 12.9 mt -81.07 -29.82 34.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.75 0.31 . . . . 0.0 111.812 -174.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.24 24.0 9.98 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.179 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 2.5 m -62.35 131.23 93.72 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.431 -0.385 . . . . 0.0 111.336 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 9.6 Cg_exo -71.2 165.36 32.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.627 2.218 . . . . 0.0 111.508 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.09 116.82 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.36 119.75 40.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.47 -172.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.27 104.09 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.083 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 134.79 19.92 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.3 -5.65 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.44 2.093 . . . . 0.0 113.46 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.17 -26.24 12.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.1 32.23 7.2 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -73.31 114.92 12.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.895 -0.652 . . . . 0.0 111.249 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.596 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 34.2 m-20 -92.41 45.77 1.22 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.262 0.553 . . . . 0.0 110.488 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -148.14 137.08 21.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.618 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -105.51 133.11 50.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.067 0.461 . . . . 0.0 110.592 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -133.78 149.55 51.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.993 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.54 133.87 65.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.454 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 54.5 p90 -163.13 149.8 12.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.53 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 81' ' ' PRO . 2.0 ttm180 -77.58 104.06 7.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.548 HE22 ' HA ' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -67.96 -44.84 75.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.557 -174.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' A' ' 87' ' ' THR . 0.0 OUTLIER -129.49 79.23 74.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 92.6 Cg_endo -83.7 -3.28 10.57 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.729 2.286 . . . . 0.0 112.337 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.23 126.95 8.33 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.735 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.37 -65.72 0.33 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.732 0.813 . . . . 0.0 112.401 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.64 -56.79 8.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.139 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 -36.52 2.95 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.682 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.1 87.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.369 0.604 . . . . 0.0 109.82 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.598 HG23 ' HB3' ' A' ' 109' ' ' ALA . 5.3 m -162.81 115.31 1.6 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.709 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -136.13 124.7 23.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.852 0.358 . . . . 0.0 111.687 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 161.56 14.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.803 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.226 175.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.26 105.04 13.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.32 108.45 13.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.499 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.636 HD21 HD12 ' A' ' 46' ' ' ILE . 4.8 mp -80.9 121.87 26.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.239 175.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 72' ' ' THR . 1.0 OUTLIER -111.3 124.88 53.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.654 ' HB3' HD23 ' A' ' 101' ' ' LEU . 30.9 p90 -135.86 160.18 39.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 111.265 -175.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.36 165.01 18.59 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.3 m -64.43 -4.13 3.65 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -7.37 58.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.578 . . . . 0.0 109.853 172.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 86.84 16.27 61.73 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.407 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.984 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -103.66 116.61 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.187 0.195 . . . . 0.0 110.477 -173.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 95' ' ' PHE . 19.4 mt -55.24 114.98 2.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.345 0.403 . . . . 0.0 110.971 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.57 -35.3 21.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 109.754 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -162.18 153.76 18.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.111 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mt -110.15 136.12 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.21 101.58 13.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -140.55 100.76 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 0.0 110.537 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -144.61 169.05 10.77 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.548 ' HA ' HE22 ' A' ' 79' ' ' GLN . 82.6 Cg_endo -81.5 166.56 17.75 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.831 1.688 . . . . 0.0 111.8 171.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.598 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -68.38 67.7 0.13 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 110.499 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.436 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -138.57 28.38 2.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.863 -177.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.69 10.28 2.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.882 -173.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.42 -105.5 1.58 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.491 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -135.51 -60.75 0.74 Allowed 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.652 -0.322 . . . . 0.0 111.593 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.501 ' HG ' ' HG3' ' A' ' 115' ' ' GLU . 0.4 OUTLIER -69.98 -32.62 70.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.848 0.356 . . . . 0.0 111.282 -174.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.501 ' HG3' ' HG ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -81.86 -162.26 0.52 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.258 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.8 p80 39.16 51.91 2.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.691 0.758 . . . . 0.0 111.719 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 56.25 28.98 14.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.866 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 50.19 57.19 6.84 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.95 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.89 114.81 3.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.258 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -97.11 156.54 16.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.961 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 . . . . . 0 C--O 1.243 0.734 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.297 173.061 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.11 90.05 6.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.984 0.421 . . . . 0.0 110.122 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.26 95.44 4.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.303 0.573 . . . . 0.0 110.548 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.08 147.66 27.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.542 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 143.64 26.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.68 109.07 21.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.321 -174.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 26' ' ' VAL . 2.4 p -74.91 116.81 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.215 0.531 . . . . 0.0 109.837 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -114.61 166.1 8.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.995 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -62.93 112.19 2.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 110.196 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.512 ' HE ' ' HB2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -98.29 116.76 65.46 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.766 177.209 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.92 60.13 2.95 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.849 2.366 . . . . 0.0 111.11 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -88.18 39.06 0.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.722 -176.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.68 171.04 17.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.938 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -85.64 48.41 1.59 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.029 0.442 . . . . 0.0 110.893 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.85 152.89 22.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.101 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.05 -124.26 8.18 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.051 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 69.11 -79.65 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.242 0.617 . . . . 0.0 111.157 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -113.7 165.64 12.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.64 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.041 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.39 143.52 27.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.642 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -21.73 64.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.28 -29.37 31.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.575 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.54 ' HA ' HD21 ' A' ' 59' ' ' LEU . 3.5 t -66.99 -17.06 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.154 0.502 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -69.69 -6.37 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.235 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HE3' ' HB1' ' A' ' 58' ' ' ALA . 11.6 mtmt -75.77 -23.29 55.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.188 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pt -104.91 -179.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.484 0.183 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.9 OUTLIER -154.33 168.4 26.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.543 0.211 . . . . 0.0 110.755 -177.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.61 140.48 18.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.291 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.709 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 81.34 1.74 90.19 Favored Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.999 -0.441 . . . . 0.0 111.999 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.53 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.99 149.05 30.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -75.35 145.63 41.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.717 0.294 . . . . 0.0 110.693 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -58.97 -26.93 64.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.853 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.44 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 10.8 mp0 -63.86 -48.31 77.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.195 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -69.46 -35.55 75.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.383 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.588 ' HA ' HG21 ' A' ' 46' ' ' ILE . 89.0 t -61.28 -47.81 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.39 70.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.082 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.96 -43.23 96.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.551 . . . . 0.0 110.677 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.502 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -76.48 -53.09 8.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.941 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 43' ' ' VAL . 50.4 mt -81.64 -20.42 39.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.18 26.83 35.42 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.405 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -72.11 133.45 83.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.388 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.1 Cg_exo -68.29 152.47 75.74 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.93 2.42 . . . . 0.0 111.515 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.462 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.83 116.44 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 0.0 110.159 -179.424 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 105.25 7.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.798 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.26 69.16 3.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.731 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 75.07 80.72 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -1.78 11.83 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.161 2.574 . . . . 0.0 112.414 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -67.67 -15.32 63.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.751 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.96 16.37 12.74 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.15 83.74 4.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.863 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 50.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.684 0.754 . . . . 0.0 110.125 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 94' ' ' THR . 0.1 OUTLIER -123.37 128.82 50.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.976 176.238 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 122.71 45.44 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -106.44 121.66 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.5 ' HB2' HD12 ' A' ' 91' ' ' LEU . 1.2 m-85 -116.91 137.82 51.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.375 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.76 118.37 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.673 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 65.3 m-85 -117.91 163.22 16.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.883 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -122.85 103.49 8.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 110.342 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -155.25 164.9 38.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.449 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 55.01 74.29 0.75 Allowed Pre-proline 0 C--O 1.234 0.271 0 O-C-N 123.781 0.676 . . . . 0.0 111.365 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.28 86.16 1.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.309 2.006 . . . . 0.0 111.362 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.11 -104.56 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.702 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -134.27 155.86 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.563 -0.375 . . . . 0.0 111.142 -176.219 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.0 mp0 76.6 -45.64 0.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.771 0.828 . . . . 0.0 111.803 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.1 -36.44 4.22 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.988 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 p -85.04 85.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.417 1.103 . . . . 0.0 109.434 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.808 HG23 ' HB1' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -175.53 138.84 0.41 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.175 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -161.1 168.91 23.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.355 . . . . 0.0 111.091 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -84.3 124.23 31.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.236 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.02 104.73 16.69 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.04 0.447 . . . . 0.0 110.56 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.673 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -84.66 104.83 14.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -103.11 104.19 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.588 HD12 HG12 ' A' ' 104' ' ' ILE . 1.8 tp -94.33 119.6 33.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.481 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -118.15 116.0 25.95 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.64 -171.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.709 ' HB3' HD23 ' A' ' 101' ' ' LEU . 1.3 p90 -123.62 142.77 50.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.995 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.45 164.16 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.54 -22.32 3.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -169.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -6.27 45.42 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.991 -0.443 . . . . 0.0 111.252 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 88.0 21.3 46.69 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.425 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG13 ' HA2' ' A' ' 49' ' ' GLY . 24.6 t -112.18 120.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 9.1 mt -55.44 110.36 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.367 0.417 . . . . 0.0 110.383 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.53 -32.05 58.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.83 153.32 10.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.624 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.588 HG12 HD12 ' A' ' 93' ' ' LEU . 5.0 mt -110.54 135.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 170.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -107.96 102.7 11.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -121.85 114.42 21.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.928 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 153.72 78.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.558 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.28 171.43 3.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.111 2.541 . . . . 0.0 111.71 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.808 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -74.5 6.54 3.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.81 113.44 12.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.72 129.68 45.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 172.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.65 149.12 34.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.776 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 t30 71.57 -64.42 0.39 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.638 0.775 . . . . 0.0 112.191 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -23.87 58.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.659 0.266 . . . . 0.0 110.481 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 69.78 160.3 0.2 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.08 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.45 24.37 2.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -89.27 -38.99 13.8 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 172.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -156.52 -57.34 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.345 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 175.57 171.24 0.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.889 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -72.73 -80.35 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.268 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.503 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.703 0.287 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.49 78.77 2.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.481 0.658 . . . . 0.0 112.409 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -150.2 118.48 6.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.835 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.47 80.96 1.4 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.006 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.59 101.79 6.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.859 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.543 ' HB3' ' HE ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -103.68 79.55 1.68 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.469 176.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.92 121.93 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.311 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.7 m -107.23 152.71 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.688 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -85.28 115.88 23.3 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' C ' ' H ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -80.45 120.02 78.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.56 35.88 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.244 2.629 . . . . 0.0 112.611 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 1.5 m-20 -85.27 128.29 34.63 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 31' ' ' ASP . 90.4 mt 72.11 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -171.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.14 84.11 1.01 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.843 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -71.56 168.95 16.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.67 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.34 53.21 5.7 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.6 -178.39 5.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.712 0.291 . . . . 0.0 110.81 -174.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -90.3 156.23 18.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.195 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.517 HD23 ' HE1' ' A' ' 77' ' ' PHE . 15.3 tp -80.15 142.58 34.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 110.281 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -101.84 145.96 28.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 -179.077 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.92 86.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.787 0.327 . . . . 0.0 111.392 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.98 -30.01 70.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -20.0 62.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.153 0.501 . . . . 0.0 111.084 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 39' ' ' THR . 8.2 t -84.06 -17.03 10.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.871 0.367 . . . . 0.0 111.529 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.7 -8.28 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -87.71 -8.47 56.04 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.378 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.85 158.92 9.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.9 mtt85 -135.88 160.39 38.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 111.158 -173.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 3.4 m -73.62 147.54 9.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.473 171.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 1.006 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 82.05 -8.48 60.33 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.559 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.6 mmt -79.29 141.36 37.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -68.0 150.37 48.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.48 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -59.59 -28.11 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.009 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -68.23 -38.96 82.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -70.14 -38.69 75.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.992 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.2 t -59.57 -45.5 93.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.703 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.44 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -66.57 -33.28 75.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.012 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -70.04 -34.45 73.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.915 0.388 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.07 -35.08 24.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.219 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -98.17 -34.82 10.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.58 30.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.25 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -58.87 139.22 86.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 123.23 0.612 . . . . 0.0 112.118 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 7.7 Cg_exo -73.78 140.76 29.58 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.672 2.248 . . . . 0.0 111.501 174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.21 108.58 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.2 tpp -75.88 118.32 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.595 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.61 106.36 11.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.913 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.24 115.2 18.58 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-O 120.928 0.394 . . . . 0.0 109.94 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -91.54 -2.66 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.953 2.435 . . . . 0.0 112.26 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -26.19 15.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.007 -170.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.44 15.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.48 85.43 3.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.227 0.537 . . . . 0.0 109.893 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.14 55.1 1.27 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.443 0.639 . . . . 0.0 110.772 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -132.15 146.16 51.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.84 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 2.0 m0 -124.01 130.6 52.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -120.37 124.58 45.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.309 0.575 . . . . 0.0 111.079 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -124.53 153.92 41.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.453 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.74 130.34 55.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.288 0.566 . . . . 0.0 110.905 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.517 ' HE1' HD23 ' A' ' 38' ' ' LEU . 2.6 m-30 -93.78 -175.61 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.7 ptt85 -128.14 119.47 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 111.451 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB2' ' HA ' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -105.61 -114.82 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.938 174.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.524 ' H ' ' HB3' ' A' ' 79' ' ' GLN . 3.8 mm-40 -126.92 81.41 69.67 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.52 135.04 32.4 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.141 2.561 . . . . 0.0 112.57 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.55 162.18 28.66 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.37 121.88 18.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.366 0.083 . . . . 0.0 110.78 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 69.38 108.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.002 0.814 . . . . 0.0 110.128 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.67 53.73 0.55 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 t -82.93 87.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 0.9 OUTLIER -127.77 113.56 16.13 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.56 -169.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.594 ' H ' ' HB3' ' A' ' 109' ' ' ALA . 2.8 mm100 -150.58 168.68 23.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.087 -168.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.457 ' CD ' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -122.14 136.15 54.88 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 173.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.3 133.15 56.34 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.18 104.56 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 105.39 15.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.658 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.5 mp -94.96 127.88 41.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.66 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -123.02 127.84 49.35 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.55 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -126.21 148.92 49.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.452 ' HB2' HG23 ' A' ' 102' ' ' THR . 6.0 t-20 -76.73 160.48 29.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -0.37 0.64 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.464 0.478 . . . . 0.0 112.237 -175.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -8.57 58.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.558 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.18 15.53 55.6 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.254 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.006 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -111.52 123.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.765 0.426 . . . . 0.0 110.34 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 95' ' ' PHE . 6.5 mt -54.32 110.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.741 0.305 . . . . 0.0 110.486 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -75.51 -42.19 53.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.07 153.61 16.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.708 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.478 HD12 HG13 ' A' ' 48' ' ' VAL . 2.4 mt -107.88 136.31 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.04 101.65 9.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.873 0.368 . . . . 0.0 110.728 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -114.09 100.74 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 116.62 11.02 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.286 -174.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.7 146.09 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.805 2.336 . . . . 0.0 112.117 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.594 ' HB3' ' H ' ' A' ' 88' ' ' GLN . . . -71.61 70.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.186 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.26 -120.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.066 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.75 -66.8 0.17 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.404 0.682 . . . . 0.0 111.629 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 137.9 63.36 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.02 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -122.41 -42.6 2.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.882 0.372 . . . . 0.0 110.908 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 tp -129.18 -65.76 0.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.343 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -71.74 -50.34 30.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.478 -174.238 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 56.91 66.79 1.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.674 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -63.22 101.21 0.28 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -87.23 133.66 33.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.345 0.593 . . . . 0.0 110.988 -174.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -101.62 -39.73 7.34 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -149.18 -70.9 0.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.879 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.247 0.93 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.25 173.55 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 120.812 0.339 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.78 104.64 17.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.17 -176.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.21 97.11 6.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.289 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.436 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -121.28 140.47 52.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.292 -175.372 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.0 93.47 4.52 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.84 87.71 2.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.023 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.67 99.12 8.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.68 -45.51 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.225 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -160.0 119.54 2.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.874 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 2.1 ptp180 -99.19 115.59 65.65 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 7.3 Cg_exo -74.1 43.48 0.86 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.508 2.805 . . . . 0.0 112.13 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.99 -1.82 38.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.442 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.34 136.28 25.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.787 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.9 134.54 46.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -144.5 171.53 14.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.723 0.296 . . . . 0.0 110.652 -175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.21 -83.34 0.32 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.108 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 t30 59.86 -133.43 0.85 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 172.14 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.07 128.13 34.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.232 176.239 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -109.96 177.49 4.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.947 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.87 90.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.308 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -59.29 -38.21 79.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -38.96 91.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.485 ' HA ' HD11 ' A' ' 46' ' ' ILE . 43.1 t -70.64 -30.9 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.272 0.558 . . . . 0.0 110.385 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 m -75.15 -9.25 58.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.815 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.7 -20.39 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.507 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.558 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -87.11 173.85 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.114 177.204 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.1 mmp_? -131.56 153.6 49.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.938 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.92 136.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.988 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 92.95 -4.08 74.51 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.791 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.535 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.39 144.19 49.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -81.16 145.05 31.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.759 0.314 . . . . 0.0 110.603 -175.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -54.65 -36.13 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.675 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -68.75 -43.02 76.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.138 0.494 . . . . 0.0 110.426 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -74.9 -34.84 62.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.9 -46.32 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.65 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -64.52 -41.59 96.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.705 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.55 -35.93 81.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.632 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.86 -43.71 35.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.203 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.54 1.83 55.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.81 46.25 90.2 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.293 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' A' ' 56' ' ' ALA . 13.6 m -102.87 136.58 19.24 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.48 -0.36 . . . . 0.0 111.068 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.56 132.29 34.95 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.605 2.203 . . . . 0.0 111.46 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.92 87.88 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 110.545 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.7 tpt -79.98 93.68 5.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.205 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.12 109.32 22.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.0 152.45 40.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.465 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.63 -3.27 9.94 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.737 2.291 . . . . 0.0 113.78 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -98.79 -26.22 14.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.829 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.64 27.76 5.35 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.22 83.52 6.94 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.272 0.558 . . . . 0.0 109.755 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -82.34 63.61 6.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.496 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.67 126.65 20.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.012 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.65 ' HH2' ' HB2' ' A' ' 56' ' ' ALA . 7.1 m0 -105.89 135.53 47.17 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.498 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -111.2 122.07 46.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.548 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 159.89 20.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.15 125.08 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 1.7 m-30 -97.64 162.97 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.51 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -139.7 105.12 5.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 175.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.427 HE22 ' HD2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -150.83 11.18 0.65 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.122 -176.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -134.54 144.73 52.11 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.005 -173.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 3.0 Cg_exo -76.39 -165.41 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.192 2.594 . . . . 0.0 112.149 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.76 -14.33 12.64 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.138 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -75.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.944 0.372 . . . . 0.0 111.125 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 2.3 mm-40 -115.41 145.17 42.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.61 34.67 13.12 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.2 88.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.974 HG23 ' HB1' ' A' ' 109' ' ' ALA . 10.5 t -172.23 176.2 3.48 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -151.18 178.96 8.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.765 0.317 . . . . 0.0 110.366 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -128.68 164.06 23.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 -176.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 104.92 15.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.497 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -82.46 105.03 13.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 109.94 19.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.031 -171.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.2 mt -89.51 120.36 30.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.55 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.486 HG23 HG23 ' A' ' 72' ' ' THR . 1.3 m -110.2 123.96 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.608 0.242 . . . . 0.0 110.356 -175.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 0.8 OUTLIER -119.2 148.0 43.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.88 168.29 18.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 m -58.42 -16.37 14.62 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.661 0.384 . . . . 0.0 111.985 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -5.29 42.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.547 175.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 80.15 21.89 64.28 Favored Glycine 0 C--O 1.219 -0.826 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.988 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -106.26 127.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 -172.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HA ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -54.66 101.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.799 175.171 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -39.44 30.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.087 0.47 . . . . 0.0 110.015 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -161.19 153.21 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.255 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.402 HD11 ' HG ' ' A' ' 101' ' ' LEU . 2.4 mp -118.59 133.24 66.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.18 101.93 13.71 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -135.38 100.88 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 0.0 111.139 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.84 111.52 6.23 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.189 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 54.3 Cg_exo -54.58 121.53 9.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.511 2.14 . . . . 0.0 112.443 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.974 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -6.43 77.11 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.514 1.759 . . . . 0.0 114.123 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER 174.93 59.69 0.0 OUTLIER 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -175.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.23 45.01 1.24 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.405 -174.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 129.21 -152.12 19.37 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.404 175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -87.73 69.4 9.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.222 -0.489 . . . . 0.0 111.396 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.4 tp -160.9 -72.46 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.68 ' HB3' HG21 ' A' ' 87' ' ' THR . 11.9 mp0 -40.72 -66.35 0.33 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -170.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.486 ' HB3' HD11 ' A' ' 110' ' ' LEU . 68.2 t60 -144.11 59.4 1.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.525 0.679 . . . . 0.0 109.898 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.33 140.58 15.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.017 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 60.69 55.33 3.34 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.728 0.642 . . . . 0.0 110.21 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -98.51 112.17 24.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.791 -176.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -83.57 141.68 31.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.074 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.763 177.265 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.59 49.0 2.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.13 0.491 . . . . 0.0 110.178 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.37 88.78 7.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.639 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.79 145.14 24.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.216 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.37 150.29 36.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.469 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -153.24 -12.26 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.91 62.91 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.327 0.584 . . . . 0.0 110.759 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.98 148.75 33.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.612 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -63.29 121.74 14.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.877 0.37 . . . . 0.0 110.668 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.492 ' HG3' ' H ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -83.16 127.1 70.39 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.378 172.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 19.1 Cg_exo -67.86 60.98 0.91 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.391 2.727 . . . . 0.0 112.756 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -133.91 150.45 51.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.835 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt 56.73 80.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 123.492 0.495 . . . . 0.0 109.915 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -54.71 -39.23 67.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.288 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 72.45 -72.14 0.12 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.267 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.43 136.42 13.37 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.473 -172.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -119.42 -40.32 2.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -109.57 -171.33 1.82 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.475 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -116.98 134.66 54.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.841 0.353 . . . . 0.0 110.444 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 145.23 44.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.22 96.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.38 -27.88 68.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.989 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -72.72 -39.05 67.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.532 ' HA ' HD11 ' A' ' 59' ' ' LEU . 61.1 t -67.62 -25.15 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.38 0.609 . . . . 0.0 109.952 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -74.59 -6.48 48.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.091 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 16.7 mtpt -71.0 -33.45 70.4 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.531 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.81 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pp -93.84 -178.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.4 OUTLIER -157.31 172.27 18.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.737 0.304 . . . . 0.0 111.08 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 1.4 m -66.31 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.279 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.915 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 90.27 -10.59 73.75 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.095 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -75.03 137.45 41.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -73.89 146.5 43.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.328 -175.065 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -52.52 -32.43 40.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.721 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 mp0 -62.46 -44.21 96.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.165 0.507 . . . . 0.0 109.837 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -73.57 -36.37 65.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.81 ' HA ' HG21 ' A' ' 46' ' ' ILE . 93.9 t -61.04 -48.76 87.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -71.45 -30.62 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.012 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -37.91 87.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.81 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.11 -39.51 17.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.999 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.532 HD11 ' HA ' ' A' ' 43' ' ' VAL . 6.9 mp -86.23 -49.5 7.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 0.0 111.939 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.18 29.25 5.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.224 -172.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -60.89 141.75 92.97 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.247 -0.476 . . . . 0.0 111.293 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.54 ' HD2' HG22 ' A' ' 61' ' ' THR . 50.1 Cg_exo -57.31 165.57 5.46 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.15 2.567 . . . . 0.0 113.351 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 104.58 2.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.365 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.25 93.17 5.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.108 0.48 . . . . 0.0 110.594 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.87 62.12 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.196 0.522 . . . . 0.0 109.865 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -127.88 80.22 72.43 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.48 -175.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.98 -1.5 11.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.339 2.693 . . . . 0.0 112.497 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -74.43 13.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.323 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.84 13.28 20.5 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.344 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 66' ' ' ASP . 8.7 m -83.99 87.22 7.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.261 0.553 . . . . 0.0 110.619 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -113.73 24.04 12.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.742 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.38 55.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.101 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -112.79 121.92 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.0 p90 -111.22 147.25 35.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 111.569 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.836 ' HB2' HD12 ' A' ' 91' ' ' LEU . 1.5 m-85 -147.96 160.75 42.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.066 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.29 115.99 50.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.311 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.417 ' HZ ' HG21 ' A' ' 43' ' ' VAL . 12.2 m-30 -94.0 124.75 38.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -78.4 106.09 10.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.178 0.513 . . . . 0.0 109.815 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.579 HE22 ' HB3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -158.24 41.91 0.27 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.117 -178.672 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 27.7 mp0 -107.99 120.39 47.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.821 -171.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.1 Cg_exo -69.72 176.06 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 123.084 2.523 . . . . 0.0 112.523 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.85 11.31 72.46 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.746 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -86.67 109.75 19.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.9 mp0 72.34 -52.62 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.16 0.912 . . . . 0.0 111.144 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.94 76.58 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.936 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -111.93 84.84 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.616 HG22 ' HB1' ' A' ' 109' ' ' ALA . 55.4 m -171.44 101.43 0.2 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.908 -174.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.33 169.0 17.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.93 0.395 . . . . 0.0 111.16 -173.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.463 ' HB3' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -130.04 166.31 20.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.799 -175.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 117.57 17.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.849 0.357 . . . . 0.0 111.429 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.836 HD12 ' HB2' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -84.26 112.02 19.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.28 118.95 32.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.333 0.587 . . . . 0.0 111.277 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.728 ' HG ' HD11 ' A' ' 101' ' ' LEU . 2.2 mp -102.93 142.55 33.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.447 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.56 123.17 27.4 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.708 ' HB3' HD22 ' A' ' 101' ' ' LEU . 11.1 p90 -131.3 145.38 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.895 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -69.15 159.79 32.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.359 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -19.04 12.72 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -174.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -15.67 61.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.708 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 101.56 11.73 37.42 Favored Glycine 0 C--O 1.221 -0.706 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.754 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.915 HG13 ' HA2' ' A' ' 49' ' ' GLY . 43.0 t -94.32 114.0 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.856 -0.202 . . . . 0.0 110.733 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -54.77 102.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.393 0.433 . . . . 0.0 110.542 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.37 -29.43 24.45 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.99 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -156.7 143.41 18.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.415 HG13 HD12 ' A' ' 101' ' ' LEU . 18.7 mt -121.07 141.74 40.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -129.6 102.89 6.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.623 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.729 ' HB2' HD23 ' A' ' 91' ' ' LEU . 34.8 t30 -135.45 100.13 4.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 110.137 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -121.01 131.6 24.44 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.428 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.579 ' HB3' HE22 ' A' ' 79' ' ' GLN . 46.0 Cg_exo -56.42 146.25 74.84 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.067 2.511 . . . . 0.0 112.983 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -45.93 -41.98 12.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.244 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 87' ' ' THR . 0.1 OUTLIER -78.56 90.36 4.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.067 0.46 . . . . 0.0 110.15 178.239 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -71.4 148.04 47.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.483 178.18 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.12 -65.72 1.98 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.57 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -66.45 -67.87 0.42 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.762 0.315 . . . . 0.0 110.675 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 111' ' ' SER . 0.1 OUTLIER -112.45 116.29 30.06 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.539 ' HG3' ' H ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -89.79 157.83 17.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.205 0.526 . . . . 0.0 111.695 -171.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.52 47.81 0.98 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.034 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -88.6 60.18 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.057 -170.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 16.7 t60 55.67 85.75 0.07 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.267 0.556 . . . . 0.0 111.654 174.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -107.61 91.2 3.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.003 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -89.52 63.75 6.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.681 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 117.892 -1.052 . . . . 0.0 109.574 176.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.82 0.343 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -78.75 69.03 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.178 0.513 . . . . 0.0 110.656 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 80.47 9.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.682 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.71 116.89 10.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.622 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.91 150.4 26.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.141 0.496 . . . . 0.0 111.011 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.78 67.82 1.35 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.087 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG13 ' H ' ' A' ' 27' ' ' VAL . 2.0 p -70.37 -57.54 7.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.421 -173.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.44 ' H ' HG13 ' A' ' 26' ' ' VAL . 3.2 t 47.2 72.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.09 0.472 . . . . 0.0 110.982 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -89.41 126.86 35.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.123 0.487 . . . . 0.0 110.967 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -132.52 131.76 22.4 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.009 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 8.6 Cg_exo -72.54 51.63 1.88 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 123.011 2.474 . . . . 0.0 111.682 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.06 -30.2 17.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.009 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.542 HG12 ' HG2' ' A' ' 34' ' ' GLN . 0.1 OUTLIER -77.92 148.66 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.591 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.89 62.74 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.331 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.542 ' HG2' HG12 ' A' ' 32' ' ' ILE . 5.4 pt20 -104.36 132.29 50.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.721 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.72 38.0 92.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.99 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -94.5 122.98 37.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.694 0.283 . . . . 0.0 110.679 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -104.61 166.76 10.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.48 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD11 HD22 ' A' ' 59' ' ' LEU . 7.5 tp -74.52 137.62 42.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.556 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -90.68 144.99 25.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 178.055 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.87 75.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -74.11 -29.91 62.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 111.194 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -72.96 -20.26 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.408 -175.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 39' ' ' THR . 2.2 t -74.54 -16.47 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.166 0.507 . . . . 0.0 110.654 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -83.91 -6.94 59.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' A' ' 42' ' ' ASP . 4.6 pttt -82.23 -8.0 59.64 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.377 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -102.87 162.41 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -132.81 168.79 17.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.145 0.498 . . . . 0.0 112.241 -169.207 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -76.96 137.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.38 171.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.921 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 83.49 5.36 88.59 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.56 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -89.15 136.35 33.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.25 145.17 51.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.849 0.356 . . . . 0.0 111.272 -176.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.41 -29.3 61.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.639 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.17 -42.15 89.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.2 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.124 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.416 HG21 HD23 ' A' ' 101' ' ' LEU . 72.3 t -60.43 -46.58 95.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.223 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.99 78.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -45.71 93.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.211 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.69 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -80.43 -39.39 28.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.144 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 38' ' ' LEU . 70.0 mt -86.09 -18.67 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.22 40.71 13.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.46 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.4 m -95.58 133.84 25.12 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.104 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.4 Cg_exo -69.68 157.48 60.39 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.904 2.403 . . . . 0.0 111.111 173.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 tp -86.47 87.64 7.48 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.248 0.546 . . . . 0.0 110.367 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.3 115.06 29.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.669 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 140.07 47.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.498 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -91.46 123.74 63.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.96 -2.16 12.28 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.822 2.348 . . . . 0.0 113.284 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -99.61 -20.59 16.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.77 10.66 26.3 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.94 90.15 5.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.111 0.481 . . . . 0.0 109.796 177.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.24 61.35 4.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.484 HG23 HG23 ' A' ' 94' ' ' THR . 0.2 OUTLIER -126.01 123.04 37.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 177.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.551 ' HB2' ' HZ ' ' A' ' 95' ' ' PHE . 1.5 m0 -103.89 122.57 45.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -108.37 121.91 45.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.703 0.763 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.38 153.66 21.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.057 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.9 t -123.48 107.67 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.801 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 55.1 p90 -142.17 146.97 35.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.76 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 106.45 18.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.547 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -113.7 -0.3 14.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -105.4 138.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.303 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 23.6 Cg_exo -63.78 145.04 90.35 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.828 2.352 . . . . 0.0 111.996 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.23 71.43 1.49 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.836 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -119.49 136.73 54.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.3 mt-10 74.41 -17.37 0.47 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.946 0.779 . . . . 0.0 111.016 -176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 83' ' ' HIS . . . 89.88 -36.39 3.55 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.924 169.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.08 88.82 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.374 -0.486 . . . . 0.0 110.309 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -157.69 121.61 4.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.406 0.622 . . . . 0.0 111.197 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -170.58 150.49 3.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.421 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.77 156.2 44.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.997 0.427 . . . . 0.0 111.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -93.71 129.04 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.969 174.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.801 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -85.62 103.96 14.92 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.708 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -102.0 105.9 16.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -174.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.3 mt -93.79 125.25 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.677 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.484 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -115.7 123.45 48.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.113 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.551 ' HZ ' ' HB2' ' A' ' 73' ' ' TRP . 0.1 OUTLIER -118.88 151.67 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -88.93 167.78 12.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -23.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -171.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -3.64 47.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.32 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 84.16 28.17 34.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.296 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.921 HG13 ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -112.85 130.75 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 122.274 0.229 . . . . 0.0 110.436 -177.011 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -55.72 103.06 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.632 0.583 . . . . 0.0 111.263 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.37 -18.5 24.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.0 110.643 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -162.67 138.72 7.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.562 HD12 HG13 ' A' ' 48' ' ' VAL . 3.0 mt -113.61 136.48 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.708 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 28.7 t70 -117.79 103.34 9.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.673 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -131.38 100.65 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.145 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.02 119.54 10.58 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.756 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.74 155.96 20.44 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.436 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 88' ' ' GLN . . . -64.7 92.31 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.033 0.444 . . . . 0.0 110.561 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -157.33 136.16 11.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.1 -178.278 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.8 m 73.88 148.57 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 124.208 0.942 . . . . 0.0 112.303 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.2 -99.65 1.83 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.933 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -64.05 -34.1 77.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.071 0.462 . . . . 0.0 110.235 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.78 107.78 5.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.328 177.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -81.3 111.09 17.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.418 ' HB2' ' HG ' ' A' ' 110' ' ' LEU . 45.3 t-80 -71.84 104.87 3.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.696 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.52 -58.8 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.388 -174.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.18 59.29 0.65 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.695 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 1.4 m-70 -101.46 126.67 48.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.4 -5.55 6.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.315 0.579 . . . . 0.0 109.933 172.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.574 179.344 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.838 0.351 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.77 73.65 2.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.412 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.98 94.74 4.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.484 174.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 mt -81.41 152.01 27.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.58 -171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -83.71 133.93 34.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 -178.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -105.35 125.55 51.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.949 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.8 143.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.836 0.351 . . . . 0.0 111.063 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -168.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.985 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.816 ' HE2' ' HG3' ' A' ' 34' ' ' GLN . 2.1 p90 -96.95 163.31 13.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.814 0.34 . . . . 0.0 110.783 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.669 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 1.4 ptp180 -123.21 138.53 30.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.96 51.61 1.65 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.766 2.311 . . . . 0.0 112.656 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.669 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 19.5 t70 -97.82 37.48 1.4 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.632 0.73 . . . . 0.0 110.303 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.49 -66.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.909 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.37 -70.91 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.414 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.816 ' HG3' ' HE2' ' A' ' 28' ' ' TYR . 6.6 mm100 46.3 53.6 9.36 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.972 0.795 . . . . 0.0 112.335 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.7 166.44 22.5 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.652 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.72 -19.16 45.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.514 0.673 . . . . 0.0 109.591 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -131.86 -169.48 2.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.966 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.718 HD13 ' HE1' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -112.02 155.36 23.91 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.045 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.68 142.56 49.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.915 0.388 . . . . 0.0 111.569 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.64 -38.44 23.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.404 0.621 . . . . 0.0 110.192 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.37 -17.78 64.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 1.2 t0 -77.65 -20.38 53.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.33 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.48 ' HA ' HD13 ' A' ' 59' ' ' LEU . 14.5 t -71.29 -28.1 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.935 0.397 . . . . 0.0 111.147 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -7.21 22.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.696 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -77.92 -15.32 59.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.089 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.474 HG21 HG13 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -100.87 172.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.161 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.5 160.86 39.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.875 -178.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.55 152.03 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 1.008 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 79.42 -4.72 62.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.211 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.9 mtp -85.1 141.84 29.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.56 146.43 50.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.802 -175.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -31.9 62.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.984 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -69.31 -39.52 78.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.032 0.444 . . . . 0.0 110.043 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.03 -34.74 64.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.199 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG13 HG21 ' A' ' 46' ' ' ILE . 76.1 t -61.71 -48.03 90.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.763 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HB2' ' CH2' ' A' ' 73' ' ' TRP . . . -67.87 -29.66 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.151 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -41.8 72.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.094 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.05 -59.6 2.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -91.51 -2.18 57.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.277 0.561 . . . . 0.0 111.39 -171.304 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 46.27 9.86 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.753 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -89.9 136.41 29.19 Favored Pre-proline 0 C--N 1.317 -0.81 0 O-C-N 122.818 -0.225 . . . . 0.0 111.121 177.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.2 Cg_exo -68.58 132.02 24.32 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.37 2.047 . . . . 0.0 111.284 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.86 118.16 19.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.0 ttp -92.15 119.98 32.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.389 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.13 109.35 13.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -114.46 93.19 31.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.615 0.722 . . . . 0.0 111.066 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.92 -9.12 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.04 1.827 . . . . 0.0 111.22 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -96.31 -21.99 17.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.115 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 12.07 25.81 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.19 83.4 2.37 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.146 0.498 . . . . 0.0 110.757 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -94.51 67.57 3.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.236 -177.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -135.61 147.28 48.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.721 -178.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -127.44 148.49 50.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.965 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -133.82 133.59 41.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 0.0 110.594 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.718 ' HE1' HD13 ' A' ' 38' ' ' LEU . 2.4 m-85 -117.2 134.6 54.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.523 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.98 107.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.93 114.29 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -91.17 103.01 15.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.523 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 1.7 pt20 -127.34 37.65 4.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 8.4 pm0 -116.23 136.68 23.07 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.418 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 4.5 Cg_exo -78.11 165.21 26.28 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.788 2.326 . . . . 0.0 111.631 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.23 67.08 3.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.122 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.413 ' HB3' ' H ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -168.71 -99.5 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 mp0 -93.94 149.74 20.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.797 0.332 . . . . 0.0 110.445 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.85 45.32 17.11 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.275 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.81 88.44 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 109' ' ' ALA . 1.9 t -164.72 176.18 9.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.572 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -114.07 109.99 19.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.535 1.061 . . . . 0.0 113.67 -162.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.722 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -76.58 128.87 35.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.76 172.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 120.7 22.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -174.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.15 112.26 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.719 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.52 111.11 23.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.83 134.55 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.811 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -131.23 117.76 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -124.8 136.21 53.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.932 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -73.24 165.68 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.863 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.32 -13.89 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -5.85 42.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 175.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 83.99 12.77 76.19 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.008 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -105.54 122.47 58.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.995 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 55' ' ' VAL . 1.6 mm? -55.42 107.27 0.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.098 174.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.67 -36.04 10.38 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.956 0.408 . . . . 0.0 110.879 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 41.2 t30 -137.06 135.97 37.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.654 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.28 132.2 71.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.81 100.94 11.68 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.7 99.6 7.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 1.3 mtmt -156.4 141.6 12.42 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.079 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.722 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 16.9 Cg_exo -68.25 169.46 16.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.664 2.243 . . . . 0.0 111.536 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.651 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -71.66 -22.22 61.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.578 0.704 . . . . 0.0 110.257 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -96.74 92.17 6.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.258 -177.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -86.78 163.54 17.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.86 172.117 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.51 -48.01 56.06 Favored Glycine 0 C--N 1.332 0.318 0 O-C-N 123.485 0.49 . . . . 0.0 113.487 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -127.91 56.74 1.57 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.28 0.562 . . . . 0.0 110.722 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 6.5 tp -122.07 -134.86 0.3 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.944 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -60.71 -51.57 68.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 30.7 m80 61.84 -131.5 0.64 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -174.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -147.44 18.8 1.19 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.677 0.751 . . . . 0.0 109.114 169.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.52 103.96 0.94 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.357 -174.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -78.04 106.78 10.14 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -79.45 52.21 1.35 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.023 0.44 . . . . 0.0 110.87 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.881 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 120.802 0.334 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.01 160.69 15.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.724 0.297 . . . . 0.0 110.958 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 t -127.77 150.56 49.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.982 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.16 -94.48 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.592 0.234 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.72 69.42 1.07 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.701 0.286 . . . . 0.0 111.18 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.672 ' HG3' HG23 ' A' ' 26' ' ' VAL . 9.7 ptp180 -174.97 172.49 2.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.066 177.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.672 HG23 ' HG3' ' A' ' 25' ' ' ARG . 73.3 t 79.28 108.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 124.086 0.867 . . . . 0.0 111.293 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.66 94.18 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.064 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.15 137.64 56.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.659 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -87.27 116.23 65.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.256 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 23.2 Cg_exo -65.19 -21.76 61.93 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.916 2.411 . . . . 0.0 112.377 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -124.21 118.67 27.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.218 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.27 -171.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.428 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -120.6 81.38 1.75 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -115.6 146.27 41.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.038 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.71 130.71 5.61 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.09 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -89.18 46.75 1.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -162.72 154.96 18.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.078 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 38' ' ' LEU . 13.6 tp -76.7 127.13 32.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.958 0.408 . . . . 0.0 110.234 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 m -87.4 144.72 26.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.48 93.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.211 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -60.64 -33.58 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.241 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.603 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -71.48 -25.43 62.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 -176.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 46' ' ' ILE . 46.7 t -74.49 -32.3 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.209 0.528 . . . . 0.0 110.27 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -6.82 47.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.111 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.603 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -74.82 -20.23 59.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -110.71 -173.43 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 176.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.58 171.52 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.794 0.33 . . . . 0.0 111.018 -174.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 48' ' ' VAL . 1.1 m -71.58 149.6 9.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.739 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 72.35 6.64 65.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.206 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.33 148.05 24.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.766 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -74.82 142.87 44.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.85 0.357 . . . . 0.0 110.731 -175.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -27.43 69.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.612 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -71.81 -35.31 69.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.362 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.11 -36.35 48.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.299 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 83.0 t -58.41 -47.85 86.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB1' ' OG1' ' A' ' 61' ' ' THR . . . -61.42 -39.14 89.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.326 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.92 55.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.585 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.74 -58.66 3.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.595 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -95.26 -16.58 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 95.31 0.77 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.748 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' HB1' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -78.51 155.2 78.91 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.82 148.33 40.88 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.566 2.177 . . . . 0.0 110.585 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 87.11 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.298 0.57 . . . . 0.0 110.624 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -104.93 120.39 41.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.806 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.61 133.18 34.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.31 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -160.26 94.79 1.56 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 110.482 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.45 -3.03 7.66 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.812 2.341 . . . . 0.0 111.919 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.67 -27.52 22.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.213 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.14 35.25 4.55 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.451 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.0 m -76.2 89.62 3.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.355 0.597 . . . . 0.0 110.021 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 8.5 m120 -88.09 51.76 2.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.335 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.71 13.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.71 176.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.6 m0 -103.56 121.63 43.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.917 0.389 . . . . 0.0 110.299 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -104.88 115.06 29.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.885 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -119.39 140.81 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.889 0.376 . . . . 0.0 110.609 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.82 129.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.95 -176.14 2.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.186 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.4 123.65 36.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.983 0.42 . . . . 0.0 110.375 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.519 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -77.82 167.29 21.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.793 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -102.23 93.82 4.23 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 92.7 Cg_endo -93.44 164.77 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.048 2.499 . . . . 0.0 114.22 -169.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.65 -107.85 1.02 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -107.59 -7.36 16.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.214 0.531 . . . . 0.0 109.651 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -178.88 5.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.916 172.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.45 36.95 11.35 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.21 86.58 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.652 HG22 ' HB1' ' A' ' 109' ' ' ALA . 53.3 m -164.95 170.02 15.74 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -170.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.412 ' N ' HG22 ' A' ' 87' ' ' THR . 22.9 tp60 -123.35 129.06 50.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.774 0.715 . . . . 0.0 112.119 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 4.1 pm0 -94.84 137.97 33.22 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.96 129.41 56.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.99 104.61 14.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 m -105.2 109.37 21.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.279 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 3.0 mp -88.31 130.7 35.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.498 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.16 118.4 26.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.686 ' HB3' ' HA ' ' A' ' 101' ' ' LEU . 40.6 p90 -144.04 151.99 40.4 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.645 -173.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -77.81 154.55 31.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.672 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.26 -14.23 24.64 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.868 0.467 . . . . 0.0 111.936 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -73.49 -3.38 27.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.166 0.507 . . . . 0.0 110.577 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.59 6.26 59.73 Favored Glycine 0 C--O 1.22 -0.774 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.551 175.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 49' ' ' GLY . 93.9 t -97.42 112.1 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.666 0.233 . . . . 0.0 111.097 -172.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.686 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -55.34 103.35 0.09 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.584 0.552 . . . . 0.0 110.016 174.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.643 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -75.71 -30.98 59.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.727 0.298 . . . . 0.0 110.587 -175.395 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.05 152.71 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.368 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.4 mt -112.7 134.11 56.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -91.53 101.36 14.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.157 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -119.08 100.32 7.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -142.61 146.94 40.51 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.178 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 10.3 Cg_exo -72.07 166.97 28.04 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.507 2.138 . . . . 0.0 112.31 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.652 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -72.81 66.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.672 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 115' ' ' GLU . 0.3 OUTLIER -156.81 108.93 2.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.351 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.79 144.33 56.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.775 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.96 64.2 3.41 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.467 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 17.4 t30 -159.09 83.54 0.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER 73.28 -73.75 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.994 0.809 . . . . 0.0 110.84 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.484 ' HA ' HD11 ' A' ' 110' ' ' LEU . 1.4 tt0 179.48 170.78 1.02 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -67.44 -20.16 65.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 110.52 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -137.87 172.0 13.59 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -17.87 26.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.763 0.316 . . . . 0.0 110.4 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 m80 61.19 -89.15 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.297 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -147.78 47.04 1.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.017 0.437 . . . . 0.0 111.599 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.962 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.613 -0.143 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m 64.09 179.29 0.17 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.833 0.708 . . . . 0.0 111.176 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.51 130.61 40.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.678 0.275 . . . . 0.0 110.828 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB2' HH21 ' A' ' 25' ' ' ARG . 1.4 mp -120.64 99.83 6.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.891 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.14 131.69 41.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.512 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.505 HH21 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -101.04 141.31 34.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.197 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.01 88.46 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.025 0.44 . . . . 0.0 110.507 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.614 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.6 p -89.51 178.38 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.393 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.614 ' H ' HG22 ' A' ' 27' ' ' VAL . 23.7 t80 -55.14 131.11 44.41 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.737 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.521 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -97.57 132.33 25.39 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HD2' ' HG2' ' A' ' 29' ' ' ARG . 11.9 Cg_endo -55.35 99.3 0.07 OUTLIER 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.016 2.477 . . . . 0.0 111.989 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.633 ' HB3' ' HG2' ' A' ' 34' ' ' GLN . 30.0 t0 -65.8 155.47 36.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.535 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.6 ' H ' HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -98.15 142.24 14.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.348 -173.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 t30 69.62 -67.06 0.24 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.428 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.633 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 13.7 mm-40 56.48 36.54 27.73 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.588 0.555 . . . . 0.0 111.948 173.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.92 70.93 3.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.517 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -119.35 141.63 48.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.835 0.35 . . . . 0.0 111.256 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -100.13 -174.72 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.407 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.622 HD12 ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -90.53 127.42 36.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.114 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' H ' ' A' ' 41' ' ' ASN . 72.5 m -96.93 144.67 26.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.437 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.94 -24.52 67.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.27 0.557 . . . . 0.0 110.881 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.93 ' H ' HG22 ' A' ' 39' ' ' THR . 12.9 t-20 -74.01 -20.95 60.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.43 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 39' ' ' THR . 7.5 m-20 -74.66 -31.28 61.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.533 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.574 HG21 ' HZ ' ' A' ' 77' ' ' PHE . 2.0 t -64.85 -24.97 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.824 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -10.8 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.724 0.297 . . . . 0.0 111.46 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -73.87 -34.35 64.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.188 0.518 . . . . 0.0 109.841 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -108.97 -178.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.91 157.3 31.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.72 0.295 . . . . 0.0 110.758 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.29 130.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.149 0.5 . . . . 0.0 109.818 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.908 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 96.93 -8.79 65.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.902 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 148.72 39.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.99 146.18 37.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.084 -175.361 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.39 -40.29 17.34 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.851 0.72 . . . . 0.0 111.999 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.444 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 7.1 mp0 -67.77 -42.29 81.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.546 -175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -78.39 -33.33 48.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.393 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.47 -46.96 94.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 61' ' ' THR . . . -68.9 -38.74 79.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.726 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -40.12 83.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.66 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -40.61 55.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.582 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.25 -38.93 23.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.665 0.269 . . . . 0.0 111.659 -176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.21 19.87 11.09 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.48 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 2.5 m -80.5 135.19 53.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.956 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.55 131.68 32.59 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.481 2.121 . . . . 0.0 111.074 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mt -72.83 125.04 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.813 0.339 . . . . 0.0 110.526 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.401 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 4.9 ttm -102.23 148.16 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.634 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.483 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -84.18 -177.11 6.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.868 176.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.574 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 11.0 p-10 -134.87 49.79 4.14 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 66' ' ' ASP . 13.3 Cg_exo -68.16 -27.42 35.34 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.822 1.681 . . . . 0.0 111.072 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.23 -2.08 24.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.25 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.41 37.57 5.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.225 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.574 ' OG1' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.49 103.79 3.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.029 0.442 . . . . 0.0 111.585 -172.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -115.18 12.88 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.956 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -134.68 145.31 48.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 -178.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.3 m0 -123.72 140.26 53.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -112.32 111.45 22.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.21 141.84 42.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.632 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -89.07 111.96 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.483 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.622 ' HE1' HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -96.68 170.98 8.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.156 -177.414 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -155.66 151.35 27.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.096 175.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HB2' ' H ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -129.2 -138.87 0.23 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.128 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.466 ' H ' ' HB2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.3 104.89 25.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.368 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 24.0 Cg_exo -63.59 137.26 58.46 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.254 2.636 . . . . 0.0 112.669 -176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.79 150.14 16.93 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -64.84 115.96 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 3.2 mm-40 73.11 134.66 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.045 0.841 . . . . 0.0 110.315 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.82 54.15 1.15 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -170.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.67 100.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.407 0.622 . . . . 0.0 110.093 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -162.64 158.96 23.93 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.463 -175.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -136.03 170.07 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 111.275 -172.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' OE1' ' HG3' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -95.42 130.97 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.036 177.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -99.86 115.05 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.48 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -83.52 104.85 13.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 109.884 -176.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -97.93 110.55 23.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.646 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -98.79 130.93 45.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.957 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -121.81 129.31 52.54 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.475 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -127.38 132.37 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 0.0 110.29 177.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB2' HG23 ' A' ' 102' ' ' THR . 20.3 t-20 -74.68 163.61 27.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.809 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -14.7 9.24 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.591 0.557 . . . . 0.0 112.137 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -10.96 60.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.243 0.544 . . . . 0.0 110.65 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.49 15.2 55.75 Favored Glycine 0 C--O 1.22 -0.743 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.862 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.908 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.4 t -112.42 130.2 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 122.432 0.293 . . . . 0.0 110.712 -172.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.805 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 2.3 mt -55.21 115.14 2.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -84.98 -33.19 22.64 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.033 0.444 . . . . 0.0 110.538 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -168.13 144.8 4.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.088 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.36 134.46 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 169.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.73 103.03 12.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.776 0.322 . . . . 0.0 110.386 176.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -125.31 104.81 8.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.262 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.75 133.84 23.59 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.11 132.87 38.32 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.943 2.429 . . . . 0.0 113.182 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.38 -41.47 63.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.235 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -79.61 41.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 111.097 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -165.3 -60.76 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 58.49 -119.32 16.84 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.048 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -102.78 -37.51 7.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.074 0.464 . . . . 0.0 110.574 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.2 26.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.949 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -86.87 -112.74 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.094 -174.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.447 ' H ' ' HB3' ' A' ' 115' ' ' GLU . 1.0 OUTLIER 71.7 -51.04 0.69 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -172.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 84' ' ' GLU . 0.9 OUTLIER 177.48 93.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.308 0.643 . . . . 0.0 110.204 171.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -55.43 144.83 24.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.088 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.47 55.75 0.9 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -81.25 114.01 19.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.311 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.511 0.196 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.74 74.04 0.44 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.12 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.2 m -74.7 109.94 8.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.412 175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.45 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -118.31 162.93 17.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.877 178.422 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.2 163.99 12.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.35 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.36 116.17 29.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.426 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 t -78.25 83.91 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.42 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 t -74.6 138.94 20.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -110.92 148.97 31.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.508 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -89.26 109.76 33.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.639 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 28' ' ' TYR . 3.3 Cg_exo -76.75 52.82 3.84 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.241 2.627 . . . . 0.0 111.951 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -95.05 -159.98 0.75 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.883 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.496 ' HB ' ' H ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER 37.67 -117.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 124.015 0.822 . . . . 0.0 111.35 -177.503 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.496 ' H ' ' HB ' ' A' ' 32' ' ' ILE . 37.7 t-20 -167.97 -57.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.491 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 21.7 mm-40 61.23 -148.16 0.42 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.386 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' H ' ' HB3' ' A' ' 34' ' ' GLN . . . 77.11 13.56 83.53 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.249 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -84.36 -109.49 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -163.48 -177.78 5.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 38' ' ' LEU . 2.0 tp -75.0 158.71 32.79 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 41' ' ' ASN . 11.0 t -129.15 -179.85 5.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.603 0.239 . . . . 0.0 110.384 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.49 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.071 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.501 ' H ' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.9 -31.99 73.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.787 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -68.08 -34.29 76.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 110.371 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.408 HG13 HD21 ' A' ' 91' ' ' LEU . 6.8 t -63.19 -34.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.34 0.591 . . . . 0.0 110.33 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -6.79 59.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.196 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -29.93 45.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.404 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.47 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -96.84 -177.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.056 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -140.44 144.96 36.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.599 0.238 . . . . 0.0 110.699 -175.239 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 m -68.23 138.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.502 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.807 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 85.34 3.17 87.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.975 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.534 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -82.25 154.36 25.42 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.011 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.53 145.99 38.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HG3' ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -53.98 -31.78 51.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.424 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.546 ' HA ' HD21 ' A' ' 63' ' ' LEU . 23.7 mm-40 -59.57 -44.72 93.21 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 110.426 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -76.65 -35.58 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.228 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 101' ' ' LEU . 84.1 t -61.03 -43.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.973 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 61' ' ' THR . . . -71.66 -34.49 69.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.834 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -37.48 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.85 -52.44 7.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.96 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.1 mt -79.97 -12.28 59.73 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.08 32.44 69.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.519 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 3.2 t -100.95 146.4 32.06 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.8 Cg_exo -64.32 132.71 34.69 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.462 2.108 . . . . 0.0 112.009 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 53' ' ' GLN . 13.3 mt -70.15 99.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.096 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.1 ttp -136.71 100.29 4.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -104.01 146.32 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.96 126.1 75.87 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.429 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.42 -5.42 9.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.402 2.735 . . . . 0.0 113.658 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.53 -12.82 55.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.156 0.503 . . . . 0.0 110.184 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.76 2.19 34.55 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 104.46 4.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.249 0.547 . . . . 0.0 110.437 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -108.39 53.89 0.67 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.727 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -128.08 140.89 51.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.46 176.362 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.71 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 6.8 m0 -117.29 142.86 46.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.695 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 38.6 p90 -129.73 119.62 23.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.356 0.598 . . . . 0.0 110.428 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.99 159.17 26.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.54 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.0 121.86 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.0 0.429 . . . . 0.0 110.82 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.519 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 3.6 p90 -118.39 -174.95 2.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HD2' ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.93 138.74 48.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.864 0.364 . . . . 0.0 111.362 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HG3' ' HG2' ' A' ' 89' ' ' GLN . 1.6 mt-30 -91.85 -128.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.245 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.416 ' H ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -116.92 105.25 49.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.53 143.34 87.58 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.865 2.377 . . . . 0.0 112.396 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.02 -136.22 2.37 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.41 15.0 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.553 0.216 . . . . 0.0 111.083 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 76.01 -60.01 0.5 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.785 0.834 . . . . 0.0 111.119 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.98 -13.32 61.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.026 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 t -109.33 88.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 109' ' ' ALA . 7.0 m -165.67 112.85 0.93 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.275 -174.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.4 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -163.54 117.49 1.56 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.271 176.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 13.5 pt20 -80.28 131.56 35.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.863 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.96 157.45 16.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.395 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -98.05 104.02 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -104.01 107.8 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.1 mp -101.24 124.18 46.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -117.76 122.23 42.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.46 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -127.14 148.07 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.964 0.412 . . . . 0.0 110.362 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -81.15 161.61 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -8.45 1.85 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.72 -13.34 60.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.27 14.39 48.37 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.915 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.5 t -112.16 126.94 69.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.59 0.356 . . . . 0.0 110.43 -173.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.807 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 8.2 mt -56.76 108.42 0.5 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.321 0.388 . . . . 0.0 110.179 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.46 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -74.71 -32.97 62.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.49 140.06 4.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.974 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.6 mt -102.38 134.51 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 3.2 t70 -111.04 101.8 10.31 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.394 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -133.32 102.17 5.45 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.06 0.457 . . . . 0.0 109.779 175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.22 131.56 24.39 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.763 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.07 146.01 13.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.363 2.708 . . . . 0.0 112.361 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.582 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -74.55 51.58 0.47 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.164 0.506 . . . . 0.0 111.485 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -15.94 60.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -19.25 63.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.116 173.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 113' ' ' ASN . . . -67.57 113.44 5.5 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 173.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.536 ' HB3' ' O ' ' A' ' 112' ' ' GLY . 11.8 t-20 72.64 -71.31 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 tp 156.64 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.681 1.192 . . . . 0.0 108.601 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -135.88 81.95 1.92 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.667 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -65.08 -39.49 93.27 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -149.74 74.59 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -175.35 159.52 2.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.937 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.35 137.72 52.04 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.34 173.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -63.63 136.16 57.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.592 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 34.7 t60 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.719 176.645 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 121.194 0.521 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.7 m -143.17 33.5 1.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 109.685 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.09 125.11 25.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.482 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.7 tp -145.98 81.26 1.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.004 0.431 . . . . 0.0 110.744 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.36 71.48 8.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.432 0.634 . . . . 0.0 110.155 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.97 63.35 1.31 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.228 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.15 132.78 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.778 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.85 93.66 4.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.808 0.814 . . . . 0.0 110.953 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -91.56 115.98 28.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.381 174.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -120.55 139.03 28.16 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 7.9 Cg_exo -72.33 54.09 2.25 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.916 2.411 . . . . 0.0 111.105 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -127.42 7.29 6.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.106 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -85.31 143.82 10.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.651 -176.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -87.0 75.2 9.56 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.463 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -133.11 114.01 13.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.29 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.5 32.19 67.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.047 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -103.14 155.12 18.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.628 0.252 . . . . 0.0 110.429 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.8 ' HE2' ' HA ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -159.12 179.35 9.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.59 151.45 40.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.953 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.3 145.97 43.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.126 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.85 80.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.75 -18.54 63.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.154 0.502 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.73 -23.35 45.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 t -67.77 -18.38 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.045 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -7.4 51.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.669 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -17.23 38.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.42 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.516 HG21 HG13 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -115.02 165.6 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 0.0 111.471 -177.208 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.506 ' O ' HD12 ' A' ' 101' ' ' LEU . 15.4 mmt-85 -142.08 166.17 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.014 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.47 145.44 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.88 0.372 . . . . 0.0 110.189 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.652 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 79.16 1.84 86.25 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.261 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.404 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 28.4 mmt -82.09 137.31 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.82 146.09 53.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.624 0.249 . . . . 0.0 111.051 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.699 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 4.6 pt20 -57.28 -26.84 61.47 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.286 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -43.04 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 0.0 109.983 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -76.02 -32.72 59.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.52 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG13 HG21 ' A' ' 46' ' ' ILE . 59.0 t -64.59 -44.33 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.443 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -65.96 -38.02 87.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.668 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.3 -49.5 75.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.495 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.38 -47.34 34.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.3 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 5.0 mp -76.17 -43.53 42.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -175.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.13 50.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.935 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 18.9 m -77.19 134.3 67.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 120.679 0.275 . . . . 0.0 111.151 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.3 Cg_exo -66.66 146.47 79.19 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.888 2.392 . . . . 0.0 111.578 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -69.66 123.97 22.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.217 0.532 . . . . 0.0 110.179 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.75 157.54 44.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.289 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.74 126.97 47.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.125 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.93 121.54 21.94 Favored Pre-proline 0 N--CA 1.447 -0.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -86.47 -3.5 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.672 2.248 . . . . 0.0 113.522 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -102.3 -27.0 13.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.91 34.04 3.88 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.063 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -77.17 84.81 3.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.36 52.94 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.886 0.85 . . . . 0.0 110.3 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.54 119.87 15.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.548 175.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 m0 -104.26 128.33 52.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.762 -174.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.78 131.66 55.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.776 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 23.1 m-85 -136.47 139.84 42.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.931 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 121.44 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.8 ' HA ' ' HE2' ' A' ' 37' ' ' TYR . 7.4 p90 -140.29 150.37 43.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.302 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.684 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -105.35 114.21 28.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.9 0.857 . . . . 0.0 110.137 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -107.94 -130.15 0.29 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.259 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -65.81 129.99 94.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 5.9 Cg_exo -75.61 -161.86 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.261 2.641 . . . . 0.0 112.381 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.91 -67.33 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.565 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 1.4 t-80 -163.55 158.11 20.36 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.6 OUTLIER 81.36 -19.83 0.4 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.064 0.852 . . . . 0.0 111.915 172.202 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 -37.09 1.56 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.238 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.53 86.07 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.644 0.735 . . . . 0.0 109.18 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.912 HG22 ' HB1' ' A' ' 109' ' ' ALA . 11.4 m -167.66 119.37 0.87 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.48 172.44 12.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -165.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -117.71 137.8 52.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.103 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.11 136.97 54.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.925 0.393 . . . . 0.0 111.766 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.559 HD13 HD11 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -86.98 105.68 17.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.356 174.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.8 104.71 14.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.952 0.406 . . . . 0.0 110.311 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.559 HD11 HD13 ' A' ' 91' ' ' LEU . 1.2 mp -98.32 118.43 34.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.438 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.89 111.96 23.28 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.739 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -126.28 146.09 50.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.247 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 168.03 18.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -20.54 8.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -171.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.66 -5.18 56.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.971 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.699 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 87.93 22.19 43.27 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.164 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.652 HG13 ' HA2' ' A' ' 49' ' ' GLY . 53.2 t -100.28 111.52 30.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 95' ' ' PHE . 13.9 mt -54.88 101.85 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.054 0.454 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.72 42.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.454 0.645 . . . . 0.0 109.728 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 136.19 6.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.023 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.7 mt -106.84 134.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -109.01 101.18 10.28 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -133.91 104.44 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.924 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 145.03 54.08 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 31.1 Cg_exo -59.63 162.16 16.04 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.376 2.05 . . . . 0.0 111.08 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.912 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -58.9 -21.45 57.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.527 HD21 ' HG3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -86.41 -9.34 56.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.198 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.1 m 68.26 -56.95 0.49 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.373 0.669 . . . . 0.0 112.245 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -168.25 -132.93 1.48 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.02 58.57 5.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.962 0.41 . . . . 0.0 110.528 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -163.09 140.63 7.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.942 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HG3' HD21 ' A' ' 110' ' ' LEU . 2.4 mp0 -102.0 117.44 34.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.347 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.52 179.46 0.21 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.777 0.673 . . . . 0.0 110.797 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.31 91.87 0.18 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -37.01 77.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 110.427 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -103.8 113.97 27.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 170.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -67.82 129.38 39.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.836 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.757 -1.116 . . . . 0.0 108.718 173.287 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.778 0.323 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.92 133.41 46.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.062 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.2 m -116.22 111.63 20.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.235 0.54 . . . . 0.0 111.298 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 120.73 40.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.35 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.2 150.7 25.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.84 0.352 . . . . 0.0 110.408 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -108.04 132.7 53.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.132 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.53 66.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.374 0.607 . . . . 0.0 109.563 175.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.579 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.4 p -104.08 177.56 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.311 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.579 ' H ' HG22 ' A' ' 27' ' ' VAL . 29.8 t80 -61.94 120.34 10.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.092 0.472 . . . . 0.0 110.801 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.475 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -105.64 137.55 19.34 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 173.601 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 4.5 Cg_exo -75.88 18.99 0.59 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 123.048 2.499 . . . . 0.0 113.192 -177.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -125.06 81.61 1.98 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.872 0.368 . . . . 0.0 110.785 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.454 HD13 ' CG ' ' A' ' 34' ' ' GLN . 0.3 OUTLIER -153.0 162.4 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.014 -179.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -85.48 61.84 7.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.159 0.504 . . . . 0.0 111.107 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.454 ' CG ' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -148.18 13.6 0.99 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.295 175.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.76 170.31 13.6 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.232 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 179.89 -179.26 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -79.83 -174.89 4.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -72.61 155.46 40.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.976 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 162.95 25.68 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.87 69.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.998 0.428 . . . . 0.0 110.637 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -68.19 -23.62 64.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.059 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -84.61 -22.35 30.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.74 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 46' ' ' ILE . 39.6 t -71.02 -27.16 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.309 0.576 . . . . 0.0 110.436 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -5.05 12.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.797 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HB2' ' HE2' ' A' ' 45' ' ' LYS . 9.1 mtmt -78.24 -13.25 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.533 HG21 HG13 ' A' ' 55' ' ' VAL . 1.1 pp -110.84 -176.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.7 ' HB2' ' HG3' ' A' ' 50' ' ' MET . 84.3 mmt-85 -141.64 159.03 43.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.446 -173.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.9 121.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.916 174.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.624 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 103.22 -2.68 47.19 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -175.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.7 ' HG3' ' HB2' ' A' ' 47' ' ' ARG . 5.6 mtt -65.98 147.11 53.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -79.16 151.72 31.13 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.286 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -49.65 -43.24 46.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.596 0.56 . . . . 0.0 111.435 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -68.86 -37.29 78.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.28 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -73.23 -33.34 65.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.533 HG13 HG21 ' A' ' 46' ' ' ILE . 59.0 t -61.77 -51.11 76.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.572 174.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.95 82.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.715 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -45.66 88.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.391 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . -76.74 -51.97 10.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.506 HD21 HD11 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -73.5 -35.37 65.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.298 -175.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.1 27.42 10.96 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -71.64 135.95 83.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.311 -0.445 . . . . 0.0 111.769 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.64 137.97 52.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 110.917 171.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.65 134.24 53.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.51 155.53 16.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.102 0.477 . . . . 0.0 111.319 -172.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.91 81.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.254 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.79 75.14 68.32 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.189 0.518 . . . . 0.0 110.003 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.92 -3.44 13.86 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.696 2.931 . . . . 0.0 112.208 -173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -19.68 63.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.38 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.6 18.76 10.47 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.016 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.09 105.64 4.63 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.705 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 5.4 m-80 -92.13 36.14 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.435 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.98 128.49 34.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.301 177.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.1 m0 -103.7 141.39 36.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.759 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -113.49 111.38 21.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.458 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' CE1' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -106.55 129.12 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.994 178.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 t -108.77 107.26 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 20.7 p90 -123.52 153.71 40.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.057 0.456 . . . . 0.0 110.645 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 139.24 58.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.946 -172.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.422 ' CD ' HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.18 -169.52 2.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.515 174.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -74.83 139.2 73.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 16.9 Cg_exo -68.03 68.44 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.196 2.598 . . . . 0.0 113.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 161.2 -96.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.829 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 87' ' ' THR . 0.4 OUTLIER 57.43 -100.7 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.861 0.465 . . . . 0.0 111.527 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.501 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 8.3 tp10 -123.27 -14.66 7.41 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.19 -37.75 3.32 Favored Glycine 0 C--N 1.322 -0.218 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.4 89.02 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 164.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 83' ' ' HIS . 3.5 m -156.03 113.62 3.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.896 -161.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.632 ' H ' ' HB3' ' A' ' 109' ' ' ALA . 4.1 tp-100 -170.19 -178.43 2.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -161.71 155.08 21.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.546 0.612 . . . . 0.0 111.198 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -126.72 125.51 41.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.875 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.517 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -84.75 111.17 19.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.138 -177.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.64 107.04 18.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.651 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.4 mp -100.63 121.46 41.65 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -113.59 127.57 56.12 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -127.17 158.08 38.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -88.73 171.75 9.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.33 -25.49 24.35 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -13.13 60.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.007 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.606 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.06 22.79 24.34 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.624 HG13 ' HA2' ' A' ' 49' ' ' GLY . 42.0 t -99.42 115.87 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.109 0.164 . . . . 0.0 110.674 -174.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.4 HD12 HG13 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -53.96 107.38 0.26 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 110.606 177.537 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.45 -13.77 17.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.771 -176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.554 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 22.3 t-20 -159.85 127.84 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.237 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.4 HG13 HD12 ' A' ' 101' ' ' LEU . 5.0 mt -108.44 142.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -144.53 103.05 3.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.848 0.356 . . . . 0.0 111.143 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.408 ' HB2' HD23 ' A' ' 91' ' ' LEU . 21.9 t30 -115.51 109.31 17.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 2.2 mmtt -121.94 107.0 36.0 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.279 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 8.3 Cg_exo -72.22 143.45 39.67 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.021 2.48 . . . . 0.0 112.352 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.632 ' HB3' ' H ' ' A' ' 88' ' ' GLN . . . -60.08 92.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.552 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.485 ' HG ' ' NE2' ' A' ' 83' ' ' HIS . 0.3 OUTLIER 177.21 -47.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.559 177.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.25 133.53 48.18 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.23 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.81 -49.28 0.52 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -177.04 -33.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -20.1 63.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.771 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 18.02 77.83 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.822 1.249 . . . . 0.0 113.748 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 68.8 -80.28 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.215 0.606 . . . . 0.0 110.776 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -141.64 70.68 1.34 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.492 0.663 . . . . 0.0 109.395 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.88 120.33 42.21 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.88 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -96.68 -153.95 0.43 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.406 ' HB3' ' H ' ' A' ' 121' ' ' HIS . 0.3 OUTLIER -121.22 -155.47 0.64 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.393 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.406 ' H ' ' HB3' ' A' ' 120' ' ' HIS . 15.6 t-80 . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.749 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.916 0.389 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -140.06 48.59 1.78 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.064 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.52 109.18 16.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.835 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.86 116.01 21.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.114 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -95.71 117.9 31.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.638 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.68 118.72 3.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.29 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.6 144.72 20.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.31 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.93 89.92 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.163 0.506 . . . . 0.0 110.276 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -107.94 135.74 48.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.828 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.4 108.55 59.51 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.935 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.75 63.47 7.44 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.487 2.125 . . . . 0.0 111.508 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 1.1 t0 -153.51 169.8 22.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.945 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 31' ' ' ASP . 1.3 mp 76.92 138.06 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 123.906 0.754 . . . . 0.0 111.252 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -75.52 82.63 2.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.129 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.93 74.89 7.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.767 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.13 -143.93 5.33 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.324 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.5 t30 71.25 -94.22 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.233 0.613 . . . . 0.0 110.62 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -169.35 0.49 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.71 159.03 19.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 41' ' ' ASN . 12.3 t -127.78 170.57 12.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 0.0 110.597 175.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.82 -23.71 67.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.169 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.44 ' H ' HG23 ' A' ' 39' ' ' THR . 35.1 t30 -65.17 -30.12 71.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.986 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.95 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 42.3 m-20 -74.87 -31.15 61.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.04 -27.64 38.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.24 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -12.09 60.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.769 0.318 . . . . 0.0 111.289 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.95 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 mttt -78.01 -46.23 21.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.748 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pp -70.25 154.39 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.989 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.635 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -123.75 156.64 35.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -174.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG13 HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -68.36 131.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 1.007 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 85.18 4.09 86.82 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.195 -176.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -72.21 142.45 49.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.535 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -83.93 151.1 25.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 111.121 -176.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.662 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 1.1 pt20 -51.37 -35.3 37.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.055 -172.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.535 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 2.3 mp0 -64.66 -50.32 67.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.841 0.353 . . . . 0.0 110.106 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -68.37 -36.56 79.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 51' ' ' THR . 96.9 t -59.59 -47.32 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.288 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.551 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -74.68 -23.94 58.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.149 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 -41.85 10.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.543 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.37 -10.94 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.764 0.316 . . . . 0.0 111.549 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.85 40.83 57.14 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.412 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.7 m -67.98 128.6 93.32 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.507 0.194 . . . . 0.0 111.217 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 20.9 Cg_exo -66.85 173.93 7.44 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.266 2.644 . . . . 0.0 112.289 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.88 116.66 2.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.06 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.59 127.19 46.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.375 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.38 81.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.01 115.16 64.53 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 109.268 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 -2.44 12.61 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.7 2.266 . . . . 0.0 112.647 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -100.71 -26.9 13.64 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.5 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.49 4.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.348 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -71.28 99.26 1.89 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.387 0.613 . . . . 0.0 110.546 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 95' ' ' PHE . 5.4 p30 -90.88 43.24 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.258 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.03 129.38 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.87 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 13.5 m0 -116.81 142.76 46.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -120.8 127.06 51.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.992 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.83 153.85 49.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.823 0.344 . . . . 0.0 110.305 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.89 132.76 29.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 2.6 p90 -125.81 138.1 53.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.996 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.12 116.95 13.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.793 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HB3' ' H ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -120.39 -92.5 0.54 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.543 -171.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.461 ' H ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -128.03 117.78 20.65 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.836 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 8.1 Cg_exo -71.97 -95.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.871 2.381 . . . . 0.0 111.992 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 111.17 157.36 14.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.081 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -101.85 -40.33 6.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -110.81 119.96 40.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.795 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.68 55.21 0.95 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.999 -172.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -74.88 89.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.422 0.63 . . . . 0.0 109.456 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.825 HG23 ' HB1' ' A' ' 109' ' ' ALA . 14.2 t -159.54 162.33 35.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.801 -171.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 88' ' ' GLN . 1.4 tp60 -136.35 179.82 6.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.439 0.638 . . . . 0.0 111.976 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.715 ' HG3' ' HA ' ' A' ' 108' ' ' PRO . 3.5 mp0 -78.94 148.23 32.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.258 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.94 118.36 27.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -112.46 105.37 13.6 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 110.406 178.015 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -115.55 126.35 54.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.641 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.1 mp -111.43 131.04 55.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.975 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.89 131.24 53.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.767 ' HE1' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -118.73 130.46 55.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.919 0.39 . . . . 0.0 110.784 -174.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.499 ' HB2' HG23 ' A' ' 102' ' ' THR . 66.1 t30 -77.54 162.4 27.15 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.18 45.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -2.51 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.662 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 85.05 22.3 52.85 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.007 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -94.15 130.16 43.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.516 0.198 . . . . 0.0 110.919 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.767 HD22 ' HE1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -58.96 96.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.506 174.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.52 -32.9 58.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.179 0.514 . . . . 0.0 110.762 -178.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -164.38 142.57 6.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.838 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.456 HD12 HG13 ' A' ' 48' ' ' VAL . 3.3 mt -111.54 129.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.34 101.14 12.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.68 115.39 18.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.12 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -145.56 136.93 12.72 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.613 -177.184 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.715 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . 18.0 Cg_exo -66.84 169.88 13.85 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.154 2.569 . . . . 0.0 112.114 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.825 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -74.08 -28.11 61.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.085 0.469 . . . . 0.0 110.606 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -94.41 115.28 27.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.738 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 m -90.35 175.24 7.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.791 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.79 -28.3 67.33 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.681 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -64.94 -84.07 0.02 OUTLIER 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.63 123.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.744 175.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 60.04 15.41 5.08 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 170.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.465 ' HB2' HG21 ' A' ' 87' ' ' THR . 1.0 OUTLIER 70.01 -54.8 0.61 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.953 0.501 . . . . 0.0 110.174 -173.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -92.33 106.47 18.46 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -65.13 122.47 17.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.527 -177.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -134.41 116.21 14.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.66 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.27 -175.14 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.821 -173.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.656 -0.687 . . . . 0.0 109.457 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.549 0.214 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 m -74.23 116.97 15.49 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.35 129.54 34.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.226 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 23' ' ' LEU . 1.1 mt -142.97 46.5 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.513 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.428 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -71.82 104.17 3.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.753 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.65 92.4 3.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.112 0.482 . . . . 0.0 111.383 -176.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.82 69.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.88 126.39 40.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.767 -171.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -92.8 131.52 37.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.221 -0.899 . . . . 0.0 108.901 171.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -102.92 122.38 45.86 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.155 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 8.8 Cg_exo -72.58 43.36 0.64 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 123.33 2.686 . . . . 0.0 112.223 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.68 28.14 1.59 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.494 0.664 . . . . 0.0 110.002 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.19 144.43 31.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.428 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.97 108.01 3.85 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -142.0 108.78 5.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.01 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.93 -142.17 15.97 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.775 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.7 t30 71.45 -86.64 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.309 0.644 . . . . 0.0 111.673 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -102.81 175.08 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.999 0.428 . . . . 0.0 110.93 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -129.6 152.37 49.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.884 175.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -125.27 174.09 8.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.696 0.284 . . . . 0.0 110.331 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.36 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.966 0.412 . . . . 0.0 111.337 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.42 -29.12 70.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.21 -27.4 68.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.508 ' CG2' ' HZ ' ' A' ' 77' ' ' PHE . 2.3 t -79.98 -18.65 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -75.99 -12.21 60.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.161 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -82.11 -29.29 31.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.612 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.25 -167.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 50' ' ' MET . 1.4 ptt85 -154.85 164.52 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.385 . . . . 0.0 111.601 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.28 141.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.793 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.677 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 86.4 -5.3 84.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.761 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -68.22 131.37 45.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.702 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -69.59 146.64 51.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.519 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -50.04 -37.5 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.48 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -68.53 -38.5 80.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.525 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -77.46 -31.54 53.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.359 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.09 -49.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.675 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.73 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -57.26 8.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.0 -42.66 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.26 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 38' ' ' LEU . 26.1 tp -85.88 -28.97 24.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 0.0 110.696 -175.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.06 79.67 1.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.724 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.2 m -105.62 134.32 19.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.458 0.171 . . . . 0.0 111.28 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 36.0 Cg_exo -61.42 134.96 54.53 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.833 2.355 . . . . 0.0 112.05 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 138.11 51.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.159 -175.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -140.27 170.81 15.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.277 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.7 13.32 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -155.92 90.27 2.79 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.83 -8.15 5.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.948 2.432 . . . . 0.0 112.325 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.25 -27.36 11.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -173.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.2 31.0 6.72 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -83.89 88.5 7.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.657 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.94 64.63 7.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.369 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.536 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -141.36 137.35 32.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.455 176.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -125.43 155.41 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.381 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.55 134.42 33.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.725 0.298 . . . . 0.0 110.468 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -122.38 146.63 47.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.272 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.68 114.38 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HZ ' ' CG2' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -94.13 128.44 40.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.114 -170.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 78' ' ' ARG . 2.8 mmt85 -77.66 103.42 7.59 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 169.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HB3' HE21 ' A' ' 89' ' ' GLN . 1.5 tp-100 -140.84 168.17 20.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 -171.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.516 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -70.87 127.47 91.73 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.246 0.546 . . . . 0.0 110.923 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 36.7 Cg_endo -93.35 -37.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.012 2.474 . . . . 0.0 113.495 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.89 -149.15 27.95 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.999 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.96 52.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.528 0.664 . . . . 0.0 111.665 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.44 -30.67 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.171 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.29 -33.64 6.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.69 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.72 86.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -161.32 98.37 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.748 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.438 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -147.0 107.36 4.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.943 178.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.613 HE21 ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -90.88 123.64 34.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.485 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.55 44.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -84.13 115.31 22.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -106.08 132.78 51.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.177 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.5 mp -111.41 122.15 47.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.881 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.536 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -114.6 114.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -176.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.34 158.57 20.41 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.401 ' OD1' ' HB ' ' A' ' 100' ' ' VAL . 24.2 p30 -86.99 169.07 12.76 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.2 -23.42 47.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -173.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -11.63 60.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.5 27.05 12.2 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.246 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.677 HG13 ' HA2' ' A' ' 49' ' ' GLY . 30.7 t -111.78 125.1 69.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.865 0.333 . . . . 0.0 111.127 -174.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.667 ' HB3' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -53.68 111.11 0.67 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -24.74 13.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.915 0.388 . . . . 0.0 110.343 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -155.5 131.49 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.95 140.17 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 170.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 10.7 t70 -117.04 109.97 17.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.9 101.35 3.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.157 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 140.9 29.67 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.648 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 11.3 Cg_endo -56.14 133.37 57.59 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.514 2.143 . . . . 0.0 111.815 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.438 ' CB ' ' H ' ' A' ' 88' ' ' GLN . . . -60.67 -24.92 65.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.129 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -84.22 10.76 9.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.2 m -126.24 -173.03 2.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.159 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 117.87 109.56 2.48 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 71.32 -49.46 0.68 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.319 0.647 . . . . 0.0 110.697 -174.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.527 ' HG ' ' HG3' ' A' ' 115' ' ' GLU . 6.7 tp -168.71 -74.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HG3' ' HG ' ' A' ' 114' ' ' LEU . 92.4 mt-10 -131.3 149.38 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.778 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -102.95 -36.29 8.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.42 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -169.33 99.06 0.35 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.261 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -166.56 -42.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.869 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 74.79 74.03 0.1 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 124.11 0.881 . . . . 0.0 111.38 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -56.85 -43.98 81.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.665 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 . . . . . 0 C--O 1.243 0.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.01 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m 58.84 37.44 24.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.37 0.605 . . . . 0.0 110.699 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 76.81 5.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.362 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -126.83 143.42 51.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.592 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -134.15 118.87 18.16 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.971 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HB3' ' H ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -152.28 -96.88 0.05 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.109 178.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.465 ' H ' ' HB3' ' A' ' 25' ' ' ARG . 2.2 t 47.94 59.55 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 O-C-N 123.606 0.566 . . . . 0.0 111.126 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG22 ' HG2' ' A' ' 25' ' ' ARG . 2.3 m -112.79 163.66 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.812 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -78.76 135.51 37.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.855 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 2.0 mpp_? -109.36 128.93 24.53 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.454 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 23.8 Cg_exo -63.69 -29.0 69.02 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.655 2.237 . . . . 0.0 111.867 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -103.8 103.42 13.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.59 HG12 ' HB2' ' A' ' 34' ' ' GLN . 0.1 OUTLIER -136.57 -158.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.698 178.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -81.44 47.58 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.726 0.774 . . . . 0.0 110.196 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.59 ' HB2' HG12 ' A' ' 32' ' ' ILE . 1.2 tp-100 -90.54 90.41 7.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.918 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.08 175.82 14.64 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.663 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -127.7 -59.53 1.2 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -123.78 -169.47 1.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.84 HD21 HD11 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -113.51 150.98 32.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.909 0.385 . . . . 0.0 111.528 -175.002 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.05 145.25 35.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.52 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -74.27 -41.89 60.52 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.012 0.434 . . . . 0.0 110.329 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.04 -22.44 66.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.661 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 8.1 m-20 -69.49 -37.22 77.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.977 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' HA ' HD13 ' A' ' 59' ' ' LEU . 9.2 t -76.1 -16.9 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.529 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 -7.38 56.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 4.7 mtpt -82.49 -34.03 28.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.625 HG21 HG13 ' A' ' 55' ' ' VAL . 1.2 pp -80.5 160.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.579 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -136.92 165.51 25.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.85 -171.439 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -72.3 145.38 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.997 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 75.93 2.77 72.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.38 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.532 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.1 mmm -83.9 137.06 33.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.2 OUTLIER -78.17 152.39 32.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 -176.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -32.74 62.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.313 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -64.66 -45.34 87.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -72.63 -33.74 66.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.051 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.625 HG13 HG21 ' A' ' 46' ' ' ILE . 56.0 t -62.23 -49.68 83.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.632 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.5 69.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.78 -54.43 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.815 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.83 34.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.814 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.84 HD11 HD21 ' A' ' 38' ' ' LEU . 8.3 tp -84.79 -40.27 17.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.22 -176.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.08 63.47 0.81 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.178 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 5.7 m -101.81 133.37 20.79 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -80.19 172.45 13.78 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.136 2.557 . . . . 0.0 111.649 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 138.94 56.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.818 0.342 . . . . 0.0 110.657 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.1 ttp -142.21 178.7 7.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.052 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -121.51 152.34 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.76 0.314 . . . . 0.0 111.418 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.75 46.13 0.35 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.172 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.24 -34.08 88.93 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.0 113.449 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -104.26 7.73 35.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.797 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.03 21.13 9.18 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.425 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.84 85.61 3.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.247 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.86 27.87 9.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.298 0.57 . . . . 0.0 111.374 -172.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -102.76 129.57 49.45 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.258 170.529 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -103.46 121.58 43.13 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.53 114.67 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.365 -176.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.513 ' HE2' HD13 ' A' ' 38' ' ' LEU . 11.1 m-85 -106.12 130.99 53.91 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.884 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.05 108.76 16.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.545 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -115.28 116.47 28.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 102.35 11.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.923 165.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -118.9 -37.68 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.184 0.516 . . . . 0.0 110.697 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.477 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -147.57 141.47 15.76 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.572 175.239 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 1.3 Cg_endo -85.4 -104.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.136 2.557 . . . . 0.0 111.987 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 116.19 165.94 14.39 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.9 97.2 9.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.929 0.365 . . . . 0.0 110.787 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -159.23 -63.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.02 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 -35.76 4.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.453 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -106.42 87.18 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.555 HG23 ' HB3' ' A' ' 109' ' ' ALA . 27.2 m -159.41 101.24 1.53 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.559 -168.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -151.69 144.48 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.55 173.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.71 147.01 44.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.482 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.05 127.98 47.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.389 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.02 114.73 21.93 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.97 105.41 14.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.331 0.586 . . . . 0.0 111.515 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 6.6 mp -87.34 148.04 25.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.815 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -137.19 116.24 12.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.616 ' HB3' HD22 ' A' ' 101' ' ' LEU . 26.6 p90 -129.2 145.03 51.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.63 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.528 ' ND2' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.41 163.01 28.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.892 177.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.08 -38.49 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -3.51 25.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.63 17.82 47.36 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.182 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.997 HG13 ' HA2' ' A' ' 49' ' ' GLY . 14.3 t -97.08 114.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 95' ' ' PHE . 1.4 mm? -54.82 106.21 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.552 0.533 . . . . 0.0 110.837 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.41 -28.22 19.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.146 0.498 . . . . 0.0 110.891 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -158.8 149.65 20.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.696 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 mp -124.02 130.03 73.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.13 101.65 13.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.599 174.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -125.11 106.53 9.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.223 0.535 . . . . 0.0 110.376 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 144.59 35.68 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 159.64 40.71 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.299 1.999 . . . . 0.0 111.274 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -66.37 -34.92 79.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 116.54 31.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.18 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m 69.92 124.44 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.076 0.86 . . . . 0.0 110.935 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.27 -77.86 0.23 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.442 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -73.4 -35.69 65.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.46 0.648 . . . . 0.0 109.703 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.0 132.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.35 176.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -80.55 148.37 30.39 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.235 175.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -49.62 127.56 15.92 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.746 0.654 . . . . 0.0 112.263 -176.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 75.47 161.13 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.454 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -69.61 120.32 15.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.787 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -67.04 103.26 1.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.469 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.54 144.44 25.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.377 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.5 p80 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.426 -176.68 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.592 0.234 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.4 156.11 40.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.948 0.404 . . . . 0.0 110.997 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.1 133.13 34.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.873 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -85.6 49.66 1.81 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.419 0.628 . . . . 0.0 110.267 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.97 126.42 33.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.549 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -174.43 126.41 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.386 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.57 123.54 19.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.177 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.7 p -146.05 -47.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.759 0.314 . . . . 0.0 111.138 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -159.09 139.64 12.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.918 0.39 . . . . 0.0 110.742 -176.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.9 ttt85 -111.11 113.05 54.86 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.676 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.54 75.86 0.77 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.564 2.176 . . . . 0.0 110.855 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.32 -133.95 0.34 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.221 -173.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 33' ' ' ASN . 2.1 pp -92.08 -20.39 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.619 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.536 ' N ' HD12 ' A' ' 32' ' ' ILE . 17.2 t-20 -77.21 67.5 3.18 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.353 0.597 . . . . 0.0 110.477 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.98 -35.3 0.09 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.369 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.33 84.87 0.38 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.08 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -118.26 169.32 9.81 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 -179.74 3.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.658 HD23 ' HE1' ' A' ' 77' ' ' PHE . 12.4 tp -78.87 131.81 36.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.414 . . . . 0.0 110.772 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 145.84 27.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.302 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.01 81.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.969 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.91 -22.15 65.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.493 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -42.3 89.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.866 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' HG13 ' A' ' 46' ' ' ILE . 6.3 t -74.98 -17.06 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.747 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -73.86 -7.36 51.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.854 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -76.06 -37.9 57.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.061 0.457 . . . . 0.0 110.165 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -91.0 179.13 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.874 177.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.602 ' O ' ' HB2' ' A' ' 50' ' ' MET . 7.7 ptp180 -157.81 167.66 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.769 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.36 128.96 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.785 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.957 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 95.51 -4.7 66.84 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.01 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.602 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -81.26 161.84 23.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -79.29 144.67 34.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.069 0.462 . . . . 0.0 111.518 -169.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -61.31 -36.32 79.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.728 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.686 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -79.52 -30.54 41.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.154 -172.426 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.26 -37.68 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HA ' HG21 ' A' ' 46' ' ' ILE . 38.4 t -60.44 -46.24 95.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.796 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -68.5 -31.88 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.873 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -37.62 83.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.153 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.7 -44.8 13.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.989 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.419 HD21 ' HA ' ' A' ' 43' ' ' VAL . 88.0 mt -88.93 -6.74 57.06 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 55.8 17.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.464 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 2.0 m -79.02 130.95 68.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.477 0.179 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.89 148.84 54.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.143 2.562 . . . . 0.0 112.588 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.56 113.74 13.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.374 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.78 131.29 47.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.142 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.53 102.6 8.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.07 115.36 38.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 120.911 0.386 . . . . 0.0 110.571 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.43 -2.03 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.063 2.508 . . . . 0.0 112.183 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -81.55 -26.73 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.642 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.82 30.17 4.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.839 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -80.43 108.99 14.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.983 0.421 . . . . 0.0 110.59 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -112.49 39.16 2.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.427 0.632 . . . . 0.0 110.229 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -124.69 141.45 52.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.52 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.732 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 3.0 m0 -116.31 142.96 46.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -124.9 111.56 15.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.138 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.42 ' CD1' HD22 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -107.57 140.78 40.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.436 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.96 114.74 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.076 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.658 ' HE1' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -102.89 142.25 34.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.28 148.41 47.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.733 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -129.57 167.66 17.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.2 mm-40 -88.1 115.77 64.17 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.2 Cg_exo -70.36 70.09 1.93 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.158 2.572 . . . . 0.0 111.978 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.36 -150.0 17.51 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.444 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.61 3.04 30.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.0 111.871 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.9 -48.23 16.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.31 0.576 . . . . 0.0 110.095 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.66 -39.2 1.51 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.727 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.41 88.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 117.108 0.454 . . . . 0.0 110.798 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -169.69 136.1 1.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.89 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -154.76 130.9 10.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.095 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -75.14 124.56 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 110.536 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.6 110.44 20.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.954 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.517 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.91 106.93 15.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.974 0.416 . . . . 0.0 110.537 -175.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 111.3 22.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.853 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.732 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 4.1 mp -106.66 142.6 36.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.002 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -139.74 133.85 31.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -132.2 141.65 49.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.88 0.371 . . . . 0.0 110.442 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.494 ' HB2' HG23 ' A' ' 102' ' ' THR . 5.5 t-20 -78.1 156.56 29.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.247 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -14.14 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.766 0.666 . . . . 0.0 112.245 -176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -15.01 61.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 0.0 110.496 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 97.36 19.55 25.27 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.164 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.957 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.2 t -113.47 126.4 70.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 122.877 0.471 . . . . 0.0 110.564 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 94' ' ' THR . 2.9 mm? -55.46 108.23 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 173.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.08 -31.99 59.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.838 0.351 . . . . 0.0 110.627 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -167.43 149.7 5.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.146 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.1 mt -127.7 138.33 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.73 102.82 10.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.171 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.06 101.45 9.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.27 153.71 44.9 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.188 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 52.2 Cg_exo -56.73 151.49 47.39 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.87 2.38 . . . . 0.0 112.396 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -60.6 -79.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.208 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.541 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER 55.42 -99.66 0.1 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.272 0.357 . . . . 0.0 110.817 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.537 ' H ' ' HB3' ' A' ' 110' ' ' LEU . 1.2 m 57.72 57.71 4.09 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.278 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.42 -167.56 14.55 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.965 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.96 7.24 43.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.095 0.474 . . . . 0.0 110.712 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tp -171.97 -56.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.441 ' HB3' ' H ' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -120.82 -149.84 0.44 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.085 175.11 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.441 ' H ' ' HB3' ' A' ' 115' ' ' GLU . 20.7 p-80 -57.01 148.58 21.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -44.25 131.23 6.22 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.816 0.698 . . . . 0.0 111.771 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -130.15 85.58 2.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.566 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -110.82 122.78 48.68 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.878 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -142.76 126.33 16.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.371 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 C--O 1.246 0.875 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.323 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m 54.54 52.93 11.46 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.534 0.521 . . . . 0.0 111.184 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.62 147.84 27.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.789 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.11 134.07 36.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.953 0.406 . . . . 0.0 111.066 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.84 123.42 4.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.387 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -168.72 110.38 0.52 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.76 0.314 . . . . 0.0 111.347 -178.698 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.97 83.93 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 171.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.49 126.83 40.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.195 -175.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -69.05 123.22 20.46 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.88 115.37 57.35 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.722 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.13 51.11 2.37 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.749 2.299 . . . . 0.0 111.574 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.76 9.89 41.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.712 -175.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HB ' ' HG2' ' A' ' 34' ' ' GLN . 0.3 OUTLIER -132.05 144.98 35.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.334 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -98.49 51.15 1.0 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.286 0.565 . . . . 0.0 110.976 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.672 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 7.1 mm100 -78.36 -7.9 57.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.174 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.89 90.0 0.28 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.665 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -128.38 38.46 3.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.391 0.615 . . . . 0.0 109.714 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -154.43 157.34 38.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.535 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.03 141.62 51.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.0 110.72 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.15 145.21 25.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.974 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.94 78.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.59 -35.54 76.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -63.37 -40.68 97.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.434 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.38 -26.4 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 110.382 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m -75.8 -10.65 59.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.315 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -34.02 41.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -81.1 -150.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.711 0.291 . . . . 0.0 110.786 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.902 ' HB3' ' HG3' ' A' ' 50' ' ' MET . 0.6 OUTLIER -156.59 134.47 11.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.651 0.262 . . . . 0.0 110.665 -173.12 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.496 ' HB ' HD12 ' A' ' 104' ' ' ILE . 1.9 p -71.43 122.26 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.884 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 106.98 2.87 36.41 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.449 -175.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.902 ' HG3' ' HB3' ' A' ' 47' ' ' ARG . 3.9 mtt -78.87 151.61 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.78 154.1 36.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.919 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -48.72 -39.33 24.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.708 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -59.91 -46.18 90.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.074 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.53 -40.25 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.717 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.456 HG21 HD21 ' A' ' 101' ' ' LEU . 84.4 t -58.29 -45.85 89.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.236 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -29.93 68.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 111.087 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.18 -57.72 2.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.844 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.36 -20.56 40.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -172.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.2 31.01 32.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.318 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.756 HG23 ' HE2' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -65.52 136.41 96.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.689 -178.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 61' ' ' THR . 57.7 Cg_endo -73.96 151.22 44.78 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.515 2.144 . . . . 0.0 111.945 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.6 106.43 15.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.001 0.429 . . . . 0.0 110.225 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.4 tpt -95.08 120.6 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.735 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.86 117.53 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.735 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.28 112.31 13.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.448 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.89 -2.99 12.89 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.721 2.281 . . . . 0.0 112.574 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -85.61 -25.69 26.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.923 -176.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.78 29.34 4.7 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.948 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -72.92 107.82 5.51 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.165 0.507 . . . . 0.0 110.644 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -103.6 25.89 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.124 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -131.01 127.17 37.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.531 178.501 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -104.01 124.74 49.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -103.78 135.7 44.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.756 ' HE2' HG23 ' A' ' 61' ' ' THR . 0.2 OUTLIER -134.81 151.24 50.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 178.067 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.58 115.34 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.367 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.533 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -93.56 160.26 14.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.693 -178.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 78' ' ' ARG . 4.4 ptm180 -126.16 132.93 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.687 0.279 . . . . 0.0 110.329 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HG3' HE22 ' A' ' 88' ' ' GLN . 0.0 OUTLIER -159.1 -44.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.854 177.318 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.444 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 5.0 mp0 -90.62 120.21 68.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -54.28 4.54 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.885 2.39 . . . . 0.0 112.563 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.79 127.82 1.04 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.864 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 179.24 149.66 0.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.836 0.454 . . . . 0.0 110.137 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 72.62 -41.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.856 0.862 . . . . 0.0 112.321 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.17 -37.78 3.55 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 t -115.2 86.74 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 m -164.37 99.96 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 -174.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -165.48 168.36 16.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.877 171.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.451 ' H ' ' NE2' ' A' ' 88' ' ' GLN . 8.2 tt0 -82.47 142.81 31.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 122.85 47.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.322 175.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.533 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -110.03 119.47 39.42 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.382 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.12 138.57 50.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 110.652 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -116.59 139.18 50.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.304 177.695 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -102.78 146.79 27.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.192 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -125.18 125.37 43.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 111.805 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.778 ' HB2' HG23 ' A' ' 102' ' ' THR . 47.5 t-20 -73.61 157.02 37.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 170.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -19.69 37.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -7.75 57.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 87.06 29.64 22.35 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 49' ' ' GLY . 1.6 t -111.88 135.6 50.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -174.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.884 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 17.6 mt -60.91 105.77 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.341 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.778 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -75.56 -30.51 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.186 0.517 . . . . 0.0 110.631 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -168.25 140.82 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.904 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 48' ' ' VAL . 14.2 mt -103.48 139.11 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -117.52 101.9 8.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.089 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.42 121.48 33.95 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -143.31 129.85 10.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.362 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.88 170.26 2.85 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.273 2.649 . . . . 0.0 112.262 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.28 93.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.76 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.24 97.82 8.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.611 -177.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.95 172.21 11.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.236 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.85 -60.59 6.35 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.952 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 8.7 t30 -99.37 109.69 22.27 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.48 ' HG ' ' N ' ' A' ' 115' ' ' GLU . 2.9 tp 70.21 144.16 0.05 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.736 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.48 ' N ' ' HG ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -79.17 171.97 14.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.361 178.586 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -78.53 72.85 5.08 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -30.19 15.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.64 147.45 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.465 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.03 -45.2 10.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.734 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -177.39 -33.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 38.8 t60 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 117.958 -1.02 . . . . 0.0 108.834 175.243 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 121.278 0.561 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.6 74.02 9.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.134 -176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -120.18 58.15 0.92 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.987 0.898 . . . . 0.0 109.489 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.1 39.22 2.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.187 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -71.96 111.91 7.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.144 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.25 91.66 3.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.231 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.44 112.84 37.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.214 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.96 126.38 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.517 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -116.5 126.58 53.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.818 0.342 . . . . 0.0 110.355 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.653 ' HG3' HD11 ' A' ' 32' ' ' ILE . 4.0 ptm180 -117.42 112.0 39.61 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.73 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.38 55.38 4.65 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.161 2.574 . . . . 0.0 112.161 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 29' ' ' ARG . 2.7 p-10 -132.59 -10.79 3.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.593 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.653 HD11 ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -124.73 131.51 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.987 0.423 . . . . 0.0 111.909 -178.494 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 69.4 11.22 8.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.963 170.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.66 87.1 3.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.539 0.685 . . . . 0.0 110.274 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.08 131.55 1.56 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.117 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.34 18.07 12.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.275 0.56 . . . . 0.0 109.919 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -164.42 177.63 8.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.278 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CD2' ' A' ' 75' ' ' TYR . 11.9 tp -118.01 140.71 49.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.77 0.319 . . . . 0.0 110.568 175.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.13 145.97 39.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.072 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -63.49 -42.32 98.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.92 -21.77 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.897 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.642 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -73.45 -34.2 65.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.126 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG21 ' HG ' ' A' ' 91' ' ' LEU . 96.2 t -75.8 -30.77 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 110.091 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.3 m -66.72 -6.56 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.45 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.642 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 13.5 mtpt -70.6 -32.97 70.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.486 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 pp -93.58 179.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.391 . . . . 0.0 111.151 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -144.3 160.03 41.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.89 -175.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 2.8 m -69.55 146.25 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.999 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 84.67 -15.77 39.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.291 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.553 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -70.52 141.08 51.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.18 145.92 41.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.898 0.38 . . . . 0.0 111.78 -172.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -35.4 29.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.827 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -64.89 -53.87 39.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.625 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.5 72.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.713 HG21 HD23 ' A' ' 101' ' ' LEU . 21.6 t -61.39 -42.19 92.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.607 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -67.13 -37.94 84.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.691 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.21 -34.19 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.645 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.1 -41.07 16.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.507 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -69.73 -43.25 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 111.378 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.9 59.74 0.81 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -71.99 147.33 91.11 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.737 0.303 . . . . 0.0 110.792 -177.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 11.5 Cg_exo -71.83 164.64 35.05 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.2 2.6 . . . . 0.0 111.547 175.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.34 85.31 3.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.346 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mtm -143.77 171.24 14.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.444 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -119.9 -178.05 3.55 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.233 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -128.85 53.28 10.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 78.9 Cg_endo -78.23 -4.99 14.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.066 1.844 . . . . 0.0 112.085 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -93.41 -4.59 51.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.262 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.24 35.79 7.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 86.85 2.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.314 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 90.1 m-20 -102.35 7.72 40.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.263 0.554 . . . . 0.0 110.208 176.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.11 123.37 41.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.176 176.346 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.788 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 11.7 m0 -104.79 137.12 43.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.181 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -118.78 115.27 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.051 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 22.6 m-85 -118.44 148.25 42.76 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.08 117.97 31.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.121 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.609 ' HB3' ' HG2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -104.8 114.46 28.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.05 0.453 . . . . 0.0 111.359 -175.449 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -93.28 103.87 16.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -151.3 147.27 26.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 -176.256 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.618 HE22 ' HB3' ' A' ' 108' ' ' PRO . 31.5 mt-30 73.13 147.79 0.12 Allowed Pre-proline 0 N--CA 1.466 0.371 0 O-C-N 123.984 0.803 . . . . 0.0 111.485 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.3 Cg_exo -71.85 -2.35 11.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 112.572 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.408 ' HA2' ' HB ' ' A' ' 87' ' ' THR . . . 95.95 148.59 24.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.967 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.441 ' H ' ' CB ' ' A' ' 87' ' ' THR . 3.0 t-80 -118.89 117.76 29.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 60.98 20.56 10.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.99 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.44 -9.29 42.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.023 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.38 87.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.022 0.411 . . . . 0.0 110.0 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.649 HG23 ' HB3' ' A' ' 109' ' ' ALA . 11.7 m -163.26 121.53 1.99 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.39 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 1.4 tp-100 -176.61 112.26 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.22 0.95 . . . . 0.0 109.156 170.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.609 ' HG2' ' HB3' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -78.47 165.98 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.283 0.563 . . . . 0.0 111.842 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.9 t -123.54 127.21 48.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.726 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HG ' HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -84.56 110.9 19.05 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 1.9 m -109.37 110.99 22.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.353 -177.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.788 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -91.79 142.15 27.9 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.585 177.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -135.22 117.79 15.91 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.559 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 1.1 p90 -132.2 157.62 43.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.085 0.469 . . . . 0.0 110.936 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.31 161.73 22.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.17 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -20.0 24.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -9.0 58.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.493 0.663 . . . . 0.0 110.314 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.82 8.73 57.96 Favored Glycine 0 C--O 1.219 -0.783 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.636 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.999 HG13 ' HA2' ' A' ' 49' ' ' GLY . 55.1 t -89.2 110.0 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 122.894 -0.18 . . . . 0.0 111.15 -172.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.713 HD23 HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -55.22 107.5 0.32 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.593 0.558 . . . . 0.0 110.101 174.173 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.36 -25.82 14.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.776 0.322 . . . . 0.0 111.142 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.561 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 18.1 t30 -150.29 143.84 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.87 133.78 66.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' HD22 ' A' ' 91' ' ' LEU . 6.4 t70 -103.28 101.87 11.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.278 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -132.33 102.0 5.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.229 0.538 . . . . 0.0 110.149 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 165.6 21.73 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.618 ' HB3' HE22 ' A' ' 80' ' ' GLN . 23.2 Cg_exo -65.78 158.22 54.81 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.223 1.949 . . . . 0.0 110.778 169.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.649 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -73.33 59.53 0.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 111.467 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.817 ' HA ' ' HG2' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -163.55 82.85 0.46 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.513 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m -81.63 63.56 5.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.155 0.502 . . . . 0.0 110.731 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.79 -157.18 41.37 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.634 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -74.61 -11.16 60.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 14.8 tp -77.7 -10.21 59.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.772 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.817 ' HG2' ' HA ' ' A' ' 110' ' ' LEU . 4.3 tp10 -89.17 -127.25 0.06 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.801 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 64.74 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.019 0.528 . . . . 0.0 109.595 -173.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -164.27 111.14 1.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.21 109.73 0.21 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.939 0.775 . . . . 0.0 111.155 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -165.71 148.44 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.26 -176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -138.53 115.75 11.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.242 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.777 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.959 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.867 0.365 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -109.59 132.92 53.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.393 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 143.42 53.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.592 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.85 116.07 21.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.399 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.88 132.41 49.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.145 0.498 . . . . 0.0 109.977 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -96.44 82.51 3.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.498 -176.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p -71.79 123.81 26.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.388 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.38 156.61 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.562 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -76.01 135.24 39.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.122 0.487 . . . . 0.0 110.715 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.82 131.87 24.13 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.283 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.32 98.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.588 2.192 . . . . 0.0 111.247 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -135.79 -44.9 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.419 -172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -75.31 -32.43 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.229 -173.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.7 t30 56.64 57.73 4.6 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.801 0.81 . . . . 0.0 109.983 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -95.66 156.62 16.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.629 -175.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.85 39.48 7.53 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.558 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -154.08 140.56 18.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.1 179.48 7.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.753 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 38' ' ' LEU . 5.6 tp -75.05 145.12 42.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.638 0.732 . . . . 0.0 112.968 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 41' ' ' ASN . 4.7 m -116.14 152.6 33.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.187 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -54.84 -38.96 68.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.578 ' H ' HG22 ' A' ' 39' ' ' THR . 9.2 t30 -61.17 -47.05 87.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.384 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.452 ' OD1' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -68.35 -20.4 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.603 -176.046 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.8 -27.01 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.748 0.308 . . . . 0.0 111.256 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.9 -7.14 32.02 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 3.36 55.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.21 -169.03 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.236 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -147.79 143.2 27.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.07 0.462 . . . . 0.0 112.018 -174.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 104' ' ' ILE . 41.1 t -76.05 137.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.87 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.611 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 89.26 -6.46 83.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.902 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.2 mmm -71.04 153.24 42.76 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -77.78 145.66 36.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.89 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -36.31 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.298 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 1.6 mp0 -70.15 -40.81 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.279 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.64 -34.76 60.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.754 -177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.51 -46.49 94.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.589 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -62.67 -41.14 98.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.574 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.438 ' HE1' HD11 ' A' ' 63' ' ' LEU . 1.1 m-85 -60.22 -49.2 78.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.6 -36.35 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.232 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -80.08 -37.62 33.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.4 . . . . 0.0 111.54 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.44 52.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -173.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -122.08 139.85 31.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.45 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.41 138.7 82.34 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.323 2.015 . . . . 0.0 110.716 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD11 ' HE1' ' A' ' 57' ' ' TYR . 91.3 mt -74.07 87.92 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.151 0.501 . . . . 0.0 110.649 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 109.12 12.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.776 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.64 142.05 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.969 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.34 131.64 24.37 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -92.54 -2.97 3.75 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.932 2.422 . . . . 0.0 112.996 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.466 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -103.01 -26.16 13.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.12 5.54 32.7 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.46 7.34 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.957 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -99.73 51.71 0.92 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.225 -174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.88 128.85 55.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.373 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.589 ' HH2' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -103.4 141.07 36.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -123.12 119.8 31.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 144.14 47.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.232 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.94 117.13 29.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -94.18 116.88 29.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -175.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.15 104.35 12.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.616 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.742 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -165.31 129.15 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.402 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -142.47 117.74 6.7 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.77 0.319 . . . . 0.0 110.801 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.39 -3.19 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.472 2.115 . . . . 0.0 111.927 176.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -11.77 60.11 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.092 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.11 132.79 47.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.671 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.832 ' HG2' ' HB3' ' A' ' 116' ' ' HIS . 0.3 OUTLIER 75.98 -67.44 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 124.106 0.879 . . . . 0.0 112.294 172.241 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 -36.52 4.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.71 86.74 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 109' ' ' ALA . 1.1 m -170.37 131.81 0.97 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.303 -174.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.481 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 28.0 tp60 -143.86 114.01 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.366 0.603 . . . . 0.0 110.782 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.742 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -75.83 135.14 40.21 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.074 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.32 132.5 56.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.635 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -95.93 110.31 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -108.95 138.65 44.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.106 0.479 . . . . 0.0 110.996 -177.471 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.763 ' HG ' HD11 ' A' ' 101' ' ' LEU . 3.4 mp -117.32 131.05 56.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.68 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.88 105.4 9.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.884 0.373 . . . . 0.0 110.087 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.43 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -116.09 135.71 53.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.78 -178.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 164.89 25.81 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.77 -31.4 2.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -170.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -4.51 33.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 111.295 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 93.61 9.86 59.66 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.021 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.611 HG13 ' HA2' ' A' ' 49' ' ' GLY . 21.0 t -93.49 116.22 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -174.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 HD11 ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -54.28 97.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.773 0.671 . . . . 0.0 110.464 176.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.43 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -76.99 -31.51 56.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.909 0.385 . . . . 0.0 110.449 -176.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.68 140.66 9.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.147 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.605 HD12 HG22 ' A' ' 48' ' ' VAL . 1.7 mp -103.45 139.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 171.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 0.5 OUTLIER -107.39 102.03 11.34 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -113.8 102.84 10.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 127.34 10.96 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.039 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.616 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 13.6 Cg_exo -70.9 150.95 62.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.923 2.415 . . . . 0.0 110.554 171.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.714 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -81.44 38.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 110.842 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.41 141.97 25.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.531 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 11.0 m -125.55 131.71 52.71 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.77 -52.68 50.9 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.862 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -85.68 55.3 3.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.096 0.474 . . . . 0.0 110.63 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 111' ' ' SER . 0.3 OUTLIER -165.99 -57.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.86 179.209 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.28 112.45 0.03 OUTLIER 'General case' 0 C--O 1.233 0.188 0 O-C-N 124.135 0.897 . . . . 0.0 110.992 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.832 ' HB3' ' HG2' ' A' ' 84' ' ' GLU . 6.0 t-160 -72.88 -6.34 44.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.802 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.79 -39.24 77.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.768 174.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -90.18 122.79 33.44 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.167 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -70.52 -33.79 71.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 173.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.76 168.99 15.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.185 175.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.278 175.892 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.61 0.243 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' HD2' ' HD2' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -126.43 167.54 15.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -89.03 140.14 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -73.72 145.03 45.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.601 178.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.28 99.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 110.671 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.71 -27.8 68.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.684 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.2 -41.27 67.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.725 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.718 ' HA ' HD21 ' A' ' 59' ' ' LEU . 11.3 t -68.22 -23.73 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 110.433 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 m -77.0 -5.87 50.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HE3' ' HB1' ' A' ' 58' ' ' ALA . 25.7 mtmt -68.07 -35.43 78.18 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.731 0.3 . . . . 0.0 111.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 pp -84.87 -177.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.402 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.0 175.74 13.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.159 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 104' ' ' ILE . 2.8 t -73.05 143.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.665 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.96 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 84.06 -11.13 58.57 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.342 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.85 133.67 47.64 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -77.42 156.73 30.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.362 -175.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.445 ' HG3' ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.94 -44.57 14.89 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.624 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.494 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.87 -37.64 58.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.926 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 HD23 ' A' ' 101' ' ' LEU . 78.0 t -60.91 -46.93 95.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 109.983 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -67.67 -35.2 78.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.731 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -43.54 97.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.502 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -78.32 -46.47 20.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.718 HD21 ' HA ' ' A' ' 43' ' ' VAL . 7.0 mt -84.05 -16.41 43.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -173.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 17.79 65.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.518 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -68.9 141.05 91.83 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 122.534 0.333 . . . . 0.0 111.457 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.14 158.81 53.98 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.481 2.121 . . . . 0.0 111.417 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.67 135.1 57.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.1 128.6 24.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.536 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -149.78 71.33 1.09 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.541 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.16 121.36 84.91 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.36 -2.93 12.94 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.075 2.517 . . . . 0.0 112.358 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -90.0 -20.05 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.447 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.8 4.66 34.0 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.02 85.29 6.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.344 0.592 . . . . 0.0 110.18 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -101.25 49.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.052 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -112.99 128.11 56.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.714 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -103.62 132.47 49.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.54 125.63 52.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.73 154.57 49.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.63 128.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.995 0.426 . . . . 0.0 110.659 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.53 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 6.7 p90 -127.19 173.47 9.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.606 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HD2' ' HD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -94.07 131.21 39.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.034 0.445 . . . . 0.0 111.115 -177.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.6 -30.74 0.19 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.867 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -125.74 83.26 62.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.72 -42.42 9.07 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.951 2.434 . . . . 0.0 113.469 -172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.18 138.4 4.76 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.884 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -175.2 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.166 0.586 . . . . 0.0 109.581 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -128.11 -2.25 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.539 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.98 -38.35 2.54 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.53 87.64 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.8 m -159.58 98.27 1.37 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.608 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.97 154.96 22.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.012 -175.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.55 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -111.54 131.51 55.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.24 114.18 25.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.967 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.53 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -84.52 105.43 15.33 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.97 124.1 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.592 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -99.68 139.3 35.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.462 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -130.05 108.1 9.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.79 ' HB3' HD22 ' A' ' 101' ' ' LEU . 36.0 p90 -115.35 133.22 56.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.963 0.411 . . . . 0.0 109.976 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.91 162.26 29.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.972 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.29 -22.38 2.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.24 -10.2 59.51 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.776 -0.577 . . . . 0.0 110.94 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 98.83 10.05 50.72 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.213 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.96 HG13 ' HA2' ' A' ' 49' ' ' GLY . 18.0 t -98.93 119.53 47.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 122.343 0.257 . . . . 0.0 110.709 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.79 HD22 ' HB3' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -55.14 105.48 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.423 0.452 . . . . 0.0 109.785 174.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.4 -31.95 15.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -150.34 138.02 19.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.888 0.375 . . . . 0.0 110.923 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 HG23 ' A' ' 48' ' ' VAL . 3.8 mt -110.78 133.05 57.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 174.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.04 99.95 11.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.546 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.412 ' C ' ' HG3' ' A' ' 107' ' ' LYS . 28.3 t30 -144.47 101.92 3.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 110.591 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -142.5 133.75 12.93 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.09 158.61 50.95 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.918 2.412 . . . . 0.0 112.781 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.08 42.79 0.82 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.02 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.589 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -159.3 148.63 18.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -75.2 174.03 10.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.233 0.54 . . . . 0.0 111.216 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -128.05 153.05 47.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.677 176.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.44 -21.23 66.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.974 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -74.17 -34.77 63.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.703 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -70.84 -20.58 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 -176.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.31 -17.1 21.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.224 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -90.73 -8.4 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.703 ' HG3' ' HA ' ' A' ' 42' ' ' ASP . 2.0 mtmt -83.22 -30.6 27.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.217 0.532 . . . . 0.0 110.048 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.636 HD12 HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -86.31 144.83 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.859 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.51 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -127.57 154.35 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.418 -178.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -74.36 148.12 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.984 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 80.15 -4.42 67.03 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.084 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 16.1 mmt -74.86 138.6 42.59 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 6.0 t -79.41 154.72 28.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.571 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -36.18 60.3 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.866 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -60.51 -42.64 96.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.088 0.47 . . . . 0.0 110.579 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -77.0 -34.92 57.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.55 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.51 -45.94 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.032 0.444 . . . . 0.0 109.826 175.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.36 83.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.738 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.87 -28.03 65.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.355 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.68 -54.48 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.66 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 46' ' ' ILE . 12.9 mt -81.07 -29.82 34.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.75 0.31 . . . . 0.0 111.812 -174.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.24 24.0 9.98 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.179 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 2.5 m -62.35 131.23 93.72 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.431 -0.385 . . . . 0.0 111.336 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 9.6 Cg_exo -71.2 165.36 32.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.627 2.218 . . . . 0.0 111.508 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.09 116.82 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.36 119.75 40.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.47 -172.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.27 104.09 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.083 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 134.79 19.92 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.3 -5.65 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.44 2.093 . . . . 0.0 113.46 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.17 -26.24 12.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.1 32.23 7.2 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -73.31 114.92 12.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.895 -0.652 . . . . 0.0 111.249 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.596 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 2.2 m120 -92.41 45.77 1.22 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.262 0.553 . . . . 0.0 110.488 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -148.14 137.08 21.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.618 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -105.51 133.11 50.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.067 0.461 . . . . 0.0 110.592 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -133.78 149.55 51.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.993 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.54 133.87 65.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.454 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 54.5 p90 -163.13 149.8 12.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.53 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 81' ' ' PRO . 2.0 ttm180 -77.58 104.06 7.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.548 HE22 ' HA ' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -67.96 -44.84 75.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.557 -174.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' A' ' 87' ' ' THR . 0.0 OUTLIER -129.49 79.23 74.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 92.6 Cg_endo -83.7 -3.28 10.57 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.729 2.286 . . . . 0.0 112.337 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.23 126.95 8.33 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.735 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.37 -65.72 0.33 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.732 0.813 . . . . 0.0 112.401 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.64 -56.79 8.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.139 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 -36.52 2.95 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.682 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.1 87.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.369 0.604 . . . . 0.0 109.82 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.598 HG23 ' HB3' ' A' ' 109' ' ' ALA . 5.3 m -162.81 115.31 1.6 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.709 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -136.13 124.7 23.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.852 0.358 . . . . 0.0 111.687 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 161.56 14.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.803 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.226 175.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.26 105.04 13.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.32 108.45 13.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.499 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.636 HD21 HD12 ' A' ' 46' ' ' ILE . 4.8 mp -80.9 121.87 26.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.239 175.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 72' ' ' THR . 1.0 OUTLIER -111.3 124.88 53.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.654 ' HB3' HD23 ' A' ' 101' ' ' LEU . 30.9 p90 -135.86 160.18 39.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 111.265 -175.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.36 165.01 18.59 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.3 m -64.43 -4.13 3.65 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -7.37 58.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.578 . . . . 0.0 109.853 172.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 86.84 16.27 61.73 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.407 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.984 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -103.66 116.61 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.187 0.195 . . . . 0.0 110.477 -173.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 95' ' ' PHE . 19.4 mt -55.24 114.98 2.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.345 0.403 . . . . 0.0 110.971 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.57 -35.3 21.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 109.754 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -162.18 153.76 18.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.111 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mt -110.15 136.12 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.21 101.58 13.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -140.55 100.76 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 0.0 110.537 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -144.61 169.05 10.77 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.548 ' HA ' HE22 ' A' ' 79' ' ' GLN . 82.6 Cg_endo -81.5 166.56 17.75 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.831 1.688 . . . . 0.0 111.8 171.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.598 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -68.38 67.7 0.13 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 110.499 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.436 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.863 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.514 0.197 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -113.7 165.64 12.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.64 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.041 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.39 143.52 27.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.642 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -21.73 64.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.28 -29.37 31.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.575 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.54 ' HA ' HD21 ' A' ' 59' ' ' LEU . 3.5 t -66.99 -17.06 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.154 0.502 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -69.69 -6.37 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.235 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HE3' ' HB1' ' A' ' 58' ' ' ALA . 11.6 mtmt -75.77 -23.29 55.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.188 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pt -104.91 -179.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.484 0.183 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.9 OUTLIER -154.33 168.4 26.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.543 0.211 . . . . 0.0 110.755 -177.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.61 140.48 18.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.291 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.709 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 81.34 1.74 90.19 Favored Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.999 -0.441 . . . . 0.0 111.999 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.53 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.99 149.05 30.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -75.35 145.63 41.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.717 0.294 . . . . 0.0 110.693 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -58.97 -26.93 64.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.853 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.44 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 10.8 mp0 -63.86 -48.31 77.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.195 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -69.46 -35.55 75.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.383 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.588 ' HA ' HG21 ' A' ' 46' ' ' ILE . 89.0 t -61.28 -47.81 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.39 70.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.082 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.96 -43.23 96.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.551 . . . . 0.0 110.677 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.502 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -76.48 -53.09 8.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.941 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 43' ' ' VAL . 50.4 mt -81.64 -20.42 39.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.18 26.83 35.42 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.405 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -72.11 133.45 83.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.388 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.1 Cg_exo -68.29 152.47 75.74 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.93 2.42 . . . . 0.0 111.515 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.462 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.83 116.44 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 0.0 110.159 -179.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 105.25 7.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.798 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.26 69.16 3.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.731 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 75.07 80.72 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -1.78 11.83 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.161 2.574 . . . . 0.0 112.414 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -67.67 -15.32 63.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.751 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.96 16.37 12.74 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.15 83.74 4.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.863 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 50.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.684 0.754 . . . . 0.0 110.125 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 94' ' ' THR . 0.1 OUTLIER -123.37 128.82 50.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.976 176.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 122.71 45.44 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -106.44 121.66 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.5 ' HB2' HD12 ' A' ' 91' ' ' LEU . 1.2 m-85 -116.91 137.82 51.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.375 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.76 118.37 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.673 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 65.3 m-85 -117.91 163.22 16.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.883 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -122.85 103.49 8.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 110.342 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -155.25 164.9 38.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.449 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 55.01 74.29 0.75 Allowed Pre-proline 0 C--O 1.234 0.271 0 O-C-N 123.781 0.676 . . . . 0.0 111.365 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.28 86.16 1.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.309 2.006 . . . . 0.0 111.362 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.11 -104.56 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.702 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -134.27 155.86 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.563 -0.375 . . . . 0.0 111.142 -176.219 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.0 mp0 76.6 -45.64 0.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.771 0.828 . . . . 0.0 111.803 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.1 -36.44 4.22 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.988 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 p -85.04 85.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.417 1.103 . . . . 0.0 109.434 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.808 HG23 ' HB1' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -175.53 138.84 0.41 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.175 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -161.1 168.91 23.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.355 . . . . 0.0 111.091 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -84.3 124.23 31.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.236 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.02 104.73 16.69 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.04 0.447 . . . . 0.0 110.56 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.673 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -84.66 104.83 14.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -103.11 104.19 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.588 HD12 HG12 ' A' ' 104' ' ' ILE . 1.8 tp -94.33 119.6 33.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.481 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -118.15 116.0 25.95 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.64 -171.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.709 ' HB3' HD23 ' A' ' 101' ' ' LEU . 1.3 p90 -123.62 142.77 50.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.995 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.45 164.16 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.54 -22.32 3.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -169.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -6.27 45.42 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.991 -0.443 . . . . 0.0 111.252 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 88.0 21.3 46.69 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.425 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG13 ' HA2' ' A' ' 49' ' ' GLY . 24.6 t -112.18 120.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 9.1 mt -55.44 110.36 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.367 0.417 . . . . 0.0 110.383 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.53 -32.05 58.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.83 153.32 10.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.624 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.588 HG12 HD12 ' A' ' 93' ' ' LEU . 5.0 mt -110.54 135.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 170.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -107.96 102.7 11.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.606 HD22 HD23 ' A' ' 91' ' ' LEU . 23.3 t-20 -121.85 114.42 21.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.928 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 153.72 78.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.558 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.28 171.43 3.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.111 2.541 . . . . 0.0 111.71 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.808 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -74.5 6.54 3.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 120.712 0.291 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -90.3 156.23 18.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.195 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.517 HD23 ' HE1' ' A' ' 77' ' ' PHE . 15.3 tp -80.15 142.58 34.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 110.281 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -101.84 145.96 28.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 -179.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.92 86.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.787 0.327 . . . . 0.0 111.392 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.98 -30.01 70.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -20.0 62.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.153 0.501 . . . . 0.0 111.084 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 39' ' ' THR . 8.2 t -84.06 -17.03 10.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.871 0.367 . . . . 0.0 111.529 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.7 -8.28 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -87.71 -8.47 56.04 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.378 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.85 158.92 9.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.9 mtt85 -135.88 160.39 38.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 111.158 -173.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 3.4 m -73.62 147.54 9.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.473 171.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 1.006 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 82.05 -8.48 60.33 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.559 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.6 mmt -79.29 141.36 37.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -68.0 150.37 48.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.48 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -59.59 -28.11 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.009 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -68.23 -38.96 82.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -70.14 -38.69 75.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.992 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.2 t -59.57 -45.5 93.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.703 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.44 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -66.57 -33.28 75.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.012 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -70.04 -34.45 73.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.915 0.388 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.07 -35.08 24.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.219 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -98.17 -34.82 10.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.58 30.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.25 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -58.87 139.22 86.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 123.23 0.612 . . . . 0.0 112.118 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 7.7 Cg_exo -73.78 140.76 29.58 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.672 2.248 . . . . 0.0 111.501 174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.21 108.58 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.2 tpp -75.88 118.32 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.595 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.61 106.36 11.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.913 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.24 115.2 18.58 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-O 120.928 0.394 . . . . 0.0 109.94 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -91.54 -2.66 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.953 2.435 . . . . 0.0 112.26 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -26.19 15.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.007 -170.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.44 15.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.48 85.43 3.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.227 0.537 . . . . 0.0 109.893 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.14 55.1 1.27 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.443 0.639 . . . . 0.0 110.772 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -132.15 146.16 51.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.84 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 2.0 m0 -124.01 130.6 52.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -120.37 124.58 45.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.309 0.575 . . . . 0.0 111.079 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -124.53 153.92 41.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.453 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.74 130.34 55.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.288 0.566 . . . . 0.0 110.905 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.517 ' HE1' HD23 ' A' ' 38' ' ' LEU . 2.6 m-30 -93.78 -175.61 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.7 ptt85 -128.14 119.47 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 111.451 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB2' ' HA ' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -105.61 -114.82 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.938 174.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.524 ' H ' ' HB3' ' A' ' 79' ' ' GLN . 3.8 mm-40 -126.92 81.41 69.67 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.52 135.04 32.4 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.141 2.561 . . . . 0.0 112.57 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.55 162.18 28.66 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.37 121.88 18.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.366 0.083 . . . . 0.0 110.78 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 69.38 108.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.002 0.814 . . . . 0.0 110.128 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.67 53.73 0.55 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 t -82.93 87.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 0.9 OUTLIER -127.77 113.56 16.13 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.56 -169.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.594 ' H ' ' HB3' ' A' ' 109' ' ' ALA . 2.8 mm100 -150.58 168.68 23.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.087 -168.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.457 ' CD ' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -122.14 136.15 54.88 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 173.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.3 133.15 56.34 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.18 104.56 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 105.39 15.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.658 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.5 mp -94.96 127.88 41.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.66 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -123.02 127.84 49.35 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.55 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -126.21 148.92 49.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.452 ' HB2' HG23 ' A' ' 102' ' ' THR . 6.0 t-20 -76.73 160.48 29.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -0.37 0.64 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.464 0.478 . . . . 0.0 112.237 -175.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -8.57 58.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.558 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.18 15.53 55.6 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.254 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.006 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -111.52 123.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.765 0.426 . . . . 0.0 110.34 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 95' ' ' PHE . 6.5 mt -54.32 110.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.741 0.305 . . . . 0.0 110.486 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -75.51 -42.19 53.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.07 153.61 16.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.708 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.478 HD12 HG13 ' A' ' 48' ' ' VAL . 2.4 mt -107.88 136.31 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.04 101.65 9.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.873 0.368 . . . . 0.0 110.728 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -114.09 100.74 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 116.62 11.02 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.286 -174.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.7 146.09 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.805 2.336 . . . . 0.0 112.117 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.594 ' HB3' ' H ' ' A' ' 88' ' ' GLN . . . -71.61 70.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.186 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.066 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 t30 . . . . . 0 N--CA 1.465 0.277 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 172.14 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.07 128.13 34.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.232 176.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -109.96 177.49 4.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.947 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.87 90.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.308 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -59.29 -38.21 79.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -38.96 91.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.485 ' HA ' HD11 ' A' ' 46' ' ' ILE . 43.1 t -70.64 -30.9 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.272 0.558 . . . . 0.0 110.385 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 m -75.15 -9.25 58.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.815 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.7 -20.39 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.507 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.558 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -87.11 173.85 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.114 177.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.1 mmp_? -131.56 153.6 49.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.938 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.92 136.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.988 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 92.95 -4.08 74.51 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.791 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.535 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.39 144.19 49.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -81.16 145.05 31.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.759 0.314 . . . . 0.0 110.603 -175.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -54.65 -36.13 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.675 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -68.75 -43.02 76.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.138 0.494 . . . . 0.0 110.426 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -74.9 -34.84 62.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.9 -46.32 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.65 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -64.52 -41.59 96.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.705 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.55 -35.93 81.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.632 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.86 -43.71 35.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.203 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.54 1.83 55.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.81 46.25 90.2 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.293 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' A' ' 56' ' ' ALA . 13.6 m -102.87 136.58 19.24 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.48 -0.36 . . . . 0.0 111.068 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.56 132.29 34.95 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.605 2.203 . . . . 0.0 111.46 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.92 87.88 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 110.545 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.7 tpt -79.98 93.68 5.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.205 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.12 109.32 22.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.0 152.45 40.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.465 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.63 -3.27 9.94 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.737 2.291 . . . . 0.0 113.78 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -98.79 -26.22 14.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.829 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.64 27.76 5.35 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.22 83.52 6.94 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.272 0.558 . . . . 0.0 109.755 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -82.34 63.61 6.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.496 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.67 126.65 20.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.012 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.65 ' HH2' ' HB2' ' A' ' 56' ' ' ALA . 7.1 m0 -105.89 135.53 47.17 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.498 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -111.2 122.07 46.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.548 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 159.89 20.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.15 125.08 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 1.7 m-30 -97.64 162.97 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.51 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -139.7 105.12 5.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 175.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.427 HE22 ' HD2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -150.83 11.18 0.65 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.122 -176.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -134.54 144.73 52.11 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.005 -173.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 3.0 Cg_exo -76.39 -165.41 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.192 2.594 . . . . 0.0 112.149 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.76 -14.33 12.64 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.138 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -75.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.944 0.372 . . . . 0.0 111.125 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -115.41 145.17 42.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.61 34.67 13.12 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.2 88.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.974 HG23 ' HB1' ' A' ' 109' ' ' ALA . 10.5 t -172.23 176.2 3.48 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -151.18 178.96 8.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.765 0.317 . . . . 0.0 110.366 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -128.68 164.06 23.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 -176.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 104.92 15.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.497 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -82.46 105.03 13.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 109.94 19.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.031 -171.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.2 mt -89.51 120.36 30.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.55 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.486 HG23 HG23 ' A' ' 72' ' ' THR . 1.3 m -110.2 123.96 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.608 0.242 . . . . 0.0 110.356 -175.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 0.8 OUTLIER -119.2 148.0 43.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.88 168.29 18.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 m -58.42 -16.37 14.62 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.661 0.384 . . . . 0.0 111.985 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -5.29 42.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.547 175.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 80.15 21.89 64.28 Favored Glycine 0 C--O 1.219 -0.826 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.988 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -106.26 127.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 -172.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HA ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -54.66 101.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.799 175.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -39.44 30.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.087 0.47 . . . . 0.0 110.015 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -161.19 153.21 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.255 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.402 HD11 ' HG ' ' A' ' 101' ' ' LEU . 2.4 mp -118.59 133.24 66.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.18 101.93 13.71 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -135.38 100.88 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 0.0 111.139 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.84 111.52 6.23 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.189 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 54.3 Cg_exo -54.58 121.53 9.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.511 2.14 . . . . 0.0 112.443 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.974 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -6.43 77.11 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.514 1.759 . . . . 0.0 114.123 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.24 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--O 1.232 0.163 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -109.57 -171.33 1.82 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.475 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -116.98 134.66 54.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.841 0.353 . . . . 0.0 110.444 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 145.23 44.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.22 96.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.38 -27.88 68.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.989 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -72.72 -39.05 67.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.532 ' HA ' HD11 ' A' ' 59' ' ' LEU . 61.1 t -67.62 -25.15 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.38 0.609 . . . . 0.0 109.952 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -74.59 -6.48 48.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.091 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 16.7 mtpt -71.0 -33.45 70.4 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.531 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.81 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pp -93.84 -178.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.4 OUTLIER -157.31 172.27 18.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.737 0.304 . . . . 0.0 111.08 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 1.4 m -66.31 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.279 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.915 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 90.27 -10.59 73.75 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.095 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -75.03 137.45 41.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -73.89 146.5 43.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.328 -175.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -52.52 -32.43 40.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.721 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 mp0 -62.46 -44.21 96.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.165 0.507 . . . . 0.0 109.837 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -73.57 -36.37 65.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.81 ' HA ' HG21 ' A' ' 46' ' ' ILE . 93.9 t -61.04 -48.76 87.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -71.45 -30.62 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.012 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -37.91 87.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.81 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.11 -39.51 17.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.999 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.532 HD11 ' HA ' ' A' ' 43' ' ' VAL . 6.9 mp -86.23 -49.5 7.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 0.0 111.939 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.18 29.25 5.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.224 -172.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -60.89 141.75 92.97 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.247 -0.476 . . . . 0.0 111.293 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.54 ' HD2' HG22 ' A' ' 61' ' ' THR . 50.1 Cg_exo -57.31 165.57 5.46 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.15 2.567 . . . . 0.0 113.351 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 104.58 2.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.365 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.25 93.17 5.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.108 0.48 . . . . 0.0 110.594 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.87 62.12 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.196 0.522 . . . . 0.0 109.865 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -127.88 80.22 72.43 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.48 -175.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.98 -1.5 11.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.339 2.693 . . . . 0.0 112.497 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -74.43 13.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.323 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.84 13.28 20.5 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.344 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 66' ' ' ASP . 8.7 m -83.99 87.22 7.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.261 0.553 . . . . 0.0 110.619 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.43 ' HA ' HD22 ' A' ' 71' ' ' ASN . 8.8 m120 -113.73 24.04 12.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.742 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.38 55.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.101 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -112.79 121.92 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.0 p90 -111.22 147.25 35.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 111.569 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.836 ' HB2' HD12 ' A' ' 91' ' ' LEU . 1.5 m-85 -147.96 160.75 42.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.066 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.29 115.99 50.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.311 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.417 ' HZ ' HG21 ' A' ' 43' ' ' VAL . 12.2 m-30 -94.0 124.75 38.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -78.4 106.09 10.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.178 0.513 . . . . 0.0 109.815 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.579 HE22 ' HB3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -158.24 41.91 0.27 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.117 -178.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.492 ' NE2' HE21 ' A' ' 88' ' ' GLN . 27.7 mp0 -107.99 120.39 47.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.821 -171.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.1 Cg_exo -69.72 176.06 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 123.084 2.523 . . . . 0.0 112.523 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.85 11.31 72.46 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.746 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -86.67 109.75 19.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.9 mp0 72.34 -52.62 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.16 0.912 . . . . 0.0 111.144 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.94 76.58 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.936 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.93 84.84 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.616 HG22 ' HB1' ' A' ' 109' ' ' ALA . 55.4 m -171.44 101.43 0.2 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.908 -174.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.492 HE21 ' NE2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -132.33 169.0 17.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.93 0.395 . . . . 0.0 111.16 -173.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.463 ' HB3' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -130.04 166.31 20.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.799 -175.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 117.57 17.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.849 0.357 . . . . 0.0 111.429 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.836 HD12 ' HB2' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -84.26 112.02 19.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.28 118.95 32.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.333 0.587 . . . . 0.0 111.277 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.728 ' HG ' HD11 ' A' ' 101' ' ' LEU . 2.2 mp -102.93 142.55 33.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.447 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.56 123.17 27.4 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.708 ' HB3' HD22 ' A' ' 101' ' ' LEU . 11.1 p90 -131.3 145.38 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.895 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -69.15 159.79 32.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.359 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -19.04 12.72 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -174.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -15.67 61.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.708 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 101.56 11.73 37.42 Favored Glycine 0 C--O 1.221 -0.706 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.754 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.915 HG13 ' HA2' ' A' ' 49' ' ' GLY . 43.0 t -94.32 114.0 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.856 -0.202 . . . . 0.0 110.733 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -54.77 102.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.393 0.433 . . . . 0.0 110.542 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.37 -29.43 24.45 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.99 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -156.7 143.41 18.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.415 HG13 HD12 ' A' ' 101' ' ' LEU . 18.7 mt -121.07 141.74 40.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -129.6 102.89 6.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.623 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.729 ' HB2' HD23 ' A' ' 91' ' ' LEU . 34.8 t30 -135.45 100.13 4.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 110.137 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -121.01 131.6 24.44 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.428 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.579 ' HB3' HE22 ' A' ' 79' ' ' GLN . 46.0 Cg_exo -56.42 146.25 74.84 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.067 2.511 . . . . 0.0 112.983 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -45.93 -41.98 12.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.244 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 87' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 121.067 0.46 . . . . 0.0 110.15 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 t30 . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -104.61 166.76 10.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.48 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD11 HD22 ' A' ' 59' ' ' LEU . 7.5 tp -74.52 137.62 42.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.556 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -90.68 144.99 25.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 178.055 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.87 75.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -74.11 -29.91 62.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 111.194 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -72.96 -20.26 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.408 -175.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 39' ' ' THR . 2.2 t -74.54 -16.47 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.166 0.507 . . . . 0.0 110.654 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -83.91 -6.94 59.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' A' ' 42' ' ' ASP . 4.6 pttt -82.23 -8.0 59.64 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.377 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -102.87 162.41 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -132.81 168.79 17.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.145 0.498 . . . . 0.0 112.241 -169.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -76.96 137.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.38 171.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.921 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 83.49 5.36 88.59 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.56 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -89.15 136.35 33.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.25 145.17 51.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.849 0.356 . . . . 0.0 111.272 -176.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.41 -29.3 61.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.639 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.17 -42.15 89.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.2 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.124 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.416 HG21 HD23 ' A' ' 101' ' ' LEU . 72.3 t -60.43 -46.58 95.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.223 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.99 78.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -45.71 93.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.211 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.69 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -80.43 -39.39 28.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.144 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 38' ' ' LEU . 70.0 mt -86.09 -18.67 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.22 40.71 13.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.46 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.4 m -95.58 133.84 25.12 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.104 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.4 Cg_exo -69.68 157.48 60.39 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.904 2.403 . . . . 0.0 111.111 173.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 tp -86.47 87.64 7.48 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.248 0.546 . . . . 0.0 110.367 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.3 115.06 29.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.669 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 140.07 47.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.498 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -91.46 123.74 63.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.96 -2.16 12.28 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.822 2.348 . . . . 0.0 113.284 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -99.61 -20.59 16.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.77 10.66 26.3 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.94 90.15 5.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.111 0.481 . . . . 0.0 109.796 177.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.42 ' HA ' HD22 ' A' ' 71' ' ' ASN . 0.0 OUTLIER -80.24 61.35 4.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -174.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.484 HG23 HG23 ' A' ' 94' ' ' THR . 0.2 OUTLIER -126.01 123.04 37.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 177.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.551 ' HB2' ' HZ ' ' A' ' 95' ' ' PHE . 1.5 m0 -103.89 122.57 45.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -108.37 121.91 45.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.703 0.763 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.38 153.66 21.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.057 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.9 t -123.48 107.67 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.801 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 55.1 p90 -142.17 146.97 35.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.76 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 106.45 18.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.547 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -113.7 -0.3 14.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -105.4 138.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.303 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 23.6 Cg_exo -63.78 145.04 90.35 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.828 2.352 . . . . 0.0 111.996 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.23 71.43 1.49 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.836 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -119.49 136.73 54.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.3 mt-10 74.41 -17.37 0.47 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.946 0.779 . . . . 0.0 111.016 -176.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 83' ' ' HIS . . . 89.88 -36.39 3.55 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.924 169.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.08 88.82 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.374 -0.486 . . . . 0.0 110.309 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -157.69 121.61 4.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.406 0.622 . . . . 0.0 111.197 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -170.58 150.49 3.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.421 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.77 156.2 44.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.997 0.427 . . . . 0.0 111.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -93.71 129.04 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.969 174.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.801 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -85.62 103.96 14.92 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.708 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -102.0 105.9 16.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -174.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.3 mt -93.79 125.25 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.677 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.484 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -115.7 123.45 48.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.551 ' HZ ' ' HB2' ' A' ' 73' ' ' TRP . 0.1 OUTLIER -118.88 151.67 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -88.93 167.78 12.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -23.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -171.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -3.64 47.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.32 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 84.16 28.17 34.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.296 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.921 HG13 ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -112.85 130.75 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 122.274 0.229 . . . . 0.0 110.436 -177.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -55.72 103.06 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.632 0.583 . . . . 0.0 111.263 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.37 -18.5 24.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.0 110.643 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -162.67 138.72 7.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.562 HD12 HG13 ' A' ' 48' ' ' VAL . 3.0 mt -113.61 136.48 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.708 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 28.7 t70 -117.79 103.34 9.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.673 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -131.38 100.65 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.145 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.02 119.54 10.58 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.756 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.74 155.96 20.44 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.436 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 88' ' ' GLN . . . -64.7 92.31 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.033 0.444 . . . . 0.0 110.561 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.1 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 121.514 0.673 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -131.86 -169.48 2.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.966 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.718 HD13 ' HE1' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -112.02 155.36 23.91 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.68 142.56 49.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.915 0.388 . . . . 0.0 111.569 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.64 -38.44 23.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.404 0.621 . . . . 0.0 110.192 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.37 -17.78 64.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 1.2 t0 -77.65 -20.38 53.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.33 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.48 ' HA ' HD13 ' A' ' 59' ' ' LEU . 14.5 t -71.29 -28.1 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.935 0.397 . . . . 0.0 111.147 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -7.21 22.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.696 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -77.92 -15.32 59.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.089 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.474 HG21 HG13 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -100.87 172.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.161 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.5 160.86 39.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.875 -178.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.55 152.03 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 1.008 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 79.42 -4.72 62.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.211 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.9 mtp -85.1 141.84 29.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.56 146.43 50.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.802 -175.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -31.9 62.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.984 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -69.31 -39.52 78.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.032 0.444 . . . . 0.0 110.043 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.03 -34.74 64.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.199 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG13 HG21 ' A' ' 46' ' ' ILE . 76.1 t -61.71 -48.03 90.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.763 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HB2' ' CH2' ' A' ' 73' ' ' TRP . . . -67.87 -29.66 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.151 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -41.8 72.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.094 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.05 -59.6 2.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -91.51 -2.18 57.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.277 0.561 . . . . 0.0 111.39 -171.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 46.27 9.86 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.753 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -89.9 136.41 29.19 Favored Pre-proline 0 C--N 1.317 -0.81 0 O-C-N 122.818 -0.225 . . . . 0.0 111.121 177.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.2 Cg_exo -68.58 132.02 24.32 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.37 2.047 . . . . 0.0 111.284 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.86 118.16 19.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.0 ttp -92.15 119.98 32.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.389 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.13 109.35 13.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -114.46 93.19 31.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.615 0.722 . . . . 0.0 111.066 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.92 -9.12 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.04 1.827 . . . . 0.0 111.22 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -96.31 -21.99 17.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.115 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 12.07 25.81 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.19 83.4 2.37 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.146 0.498 . . . . 0.0 110.757 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -94.51 67.57 3.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.236 -177.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -135.61 147.28 48.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.721 -178.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -127.44 148.49 50.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.965 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -133.82 133.59 41.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 0.0 110.594 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.718 ' HE1' HD13 ' A' ' 38' ' ' LEU . 2.4 m-85 -117.2 134.6 54.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.523 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.98 107.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.93 114.29 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -91.17 103.01 15.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.523 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 1.7 pt20 -127.34 37.65 4.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 8.4 pm0 -116.23 136.68 23.07 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.418 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 4.5 Cg_exo -78.11 165.21 26.28 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.788 2.326 . . . . 0.0 111.631 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.23 67.08 3.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.122 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.413 ' HB3' ' H ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -168.71 -99.5 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 mp0 -93.94 149.74 20.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.797 0.332 . . . . 0.0 110.445 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.85 45.32 17.11 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.275 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.81 88.44 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 109' ' ' ALA . 1.9 t -164.72 176.18 9.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.572 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -114.07 109.99 19.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.535 1.061 . . . . 0.0 113.67 -162.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.722 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -76.58 128.87 35.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.76 172.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 120.7 22.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -174.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.433 HD11 HD22 ' A' ' 106' ' ' ASN . 0.5 OUTLIER -85.15 112.26 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.719 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.52 111.11 23.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.83 134.55 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.811 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -131.23 117.76 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -124.8 136.21 53.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.932 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -73.24 165.68 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.863 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.32 -13.89 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -5.85 42.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 175.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 83.99 12.77 76.19 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.008 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -105.54 122.47 58.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.995 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 55' ' ' VAL . 1.6 mm? -55.42 107.27 0.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.098 174.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.67 -36.04 10.38 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.956 0.408 . . . . 0.0 110.879 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 41.2 t30 -137.06 135.97 37.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.654 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.28 132.2 71.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.81 100.94 11.68 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.433 HD22 HD11 ' A' ' 91' ' ' LEU . 21.9 t-20 -116.7 99.6 7.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 1.3 mtmt -156.4 141.6 12.42 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.079 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.722 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 16.9 Cg_exo -68.25 169.46 16.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.664 2.243 . . . . 0.0 111.536 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.651 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -71.66 -22.22 61.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.578 0.704 . . . . 0.0 110.257 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.258 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -162.72 154.96 18.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.078 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 38' ' ' LEU . 13.6 tp -76.7 127.13 32.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.958 0.408 . . . . 0.0 110.234 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 m -87.4 144.72 26.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.48 93.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.211 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -60.64 -33.58 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.241 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.603 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -71.48 -25.43 62.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 -176.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 46' ' ' ILE . 46.7 t -74.49 -32.3 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.209 0.528 . . . . 0.0 110.27 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -6.82 47.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.111 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.603 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -74.82 -20.23 59.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -110.71 -173.43 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 176.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.58 171.52 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.794 0.33 . . . . 0.0 111.018 -174.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 48' ' ' VAL . 1.1 m -71.58 149.6 9.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.739 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 72.35 6.64 65.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.206 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.33 148.05 24.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.766 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -74.82 142.87 44.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.85 0.357 . . . . 0.0 110.731 -175.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -27.43 69.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.612 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -71.81 -35.31 69.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.362 -178.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.11 -36.35 48.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.299 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 83.0 t -58.41 -47.85 86.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB1' ' OG1' ' A' ' 61' ' ' THR . . . -61.42 -39.14 89.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.326 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.92 55.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.585 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.74 -58.66 3.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.595 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -95.26 -16.58 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 95.31 0.77 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.748 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' HB1' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -78.51 155.2 78.91 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.82 148.33 40.88 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.566 2.177 . . . . 0.0 110.585 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 87.11 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.298 0.57 . . . . 0.0 110.624 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -104.93 120.39 41.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.806 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.61 133.18 34.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.31 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -160.26 94.79 1.56 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 110.482 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.45 -3.03 7.66 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.812 2.341 . . . . 0.0 111.919 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.67 -27.52 22.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.213 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.14 35.25 4.55 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.451 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.0 m -76.2 89.62 3.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.355 0.597 . . . . 0.0 110.021 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 8.5 m120 -88.09 51.76 2.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.335 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.71 13.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.71 176.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.6 m0 -103.56 121.63 43.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.917 0.389 . . . . 0.0 110.299 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -104.88 115.06 29.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.885 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -119.39 140.81 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.889 0.376 . . . . 0.0 110.609 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.82 129.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.95 -176.14 2.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.186 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.4 123.65 36.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.983 0.42 . . . . 0.0 110.375 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.519 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -77.82 167.29 21.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.793 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -102.23 93.82 4.23 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 92.7 Cg_endo -93.44 164.77 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.048 2.499 . . . . 0.0 114.22 -169.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.65 -107.85 1.02 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -107.59 -7.36 16.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.214 0.531 . . . . 0.0 109.651 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -178.88 5.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.916 172.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.45 36.95 11.35 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.21 86.58 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.652 HG22 ' HB1' ' A' ' 109' ' ' ALA . 53.3 m -164.95 170.02 15.74 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -170.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.412 ' N ' HG22 ' A' ' 87' ' ' THR . 22.9 tp60 -123.35 129.06 50.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.774 0.715 . . . . 0.0 112.119 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 4.1 pm0 -94.84 137.97 33.22 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.96 129.41 56.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.99 104.61 14.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 m -105.2 109.37 21.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.279 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 3.0 mp -88.31 130.7 35.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.498 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.16 118.4 26.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.686 ' HB3' ' HA ' ' A' ' 101' ' ' LEU . 40.6 p90 -144.04 151.99 40.4 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.645 -173.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -77.81 154.55 31.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.672 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.26 -14.23 24.64 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.868 0.467 . . . . 0.0 111.936 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -73.49 -3.38 27.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.166 0.507 . . . . 0.0 110.577 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.59 6.26 59.73 Favored Glycine 0 C--O 1.22 -0.774 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.551 175.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 49' ' ' GLY . 93.9 t -97.42 112.1 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.666 0.233 . . . . 0.0 111.097 -172.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.686 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -55.34 103.35 0.09 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.584 0.552 . . . . 0.0 110.016 174.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.643 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -75.71 -30.98 59.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.727 0.298 . . . . 0.0 110.587 -175.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.05 152.71 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.368 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.4 mt -112.7 134.11 56.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -91.53 101.36 14.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.157 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -119.08 100.32 7.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -142.61 146.94 40.51 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.178 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 10.3 Cg_exo -72.07 166.97 28.04 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.507 2.138 . . . . 0.0 112.31 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.652 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -72.81 66.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.672 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.351 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.9 t30 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -100.13 -174.72 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.407 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.622 HD12 ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -90.53 127.42 36.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.114 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' H ' ' A' ' 41' ' ' ASN . 72.5 m -96.93 144.67 26.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.437 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.94 -24.52 67.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.27 0.557 . . . . 0.0 110.881 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.93 ' H ' HG22 ' A' ' 39' ' ' THR . 12.9 t-20 -74.01 -20.95 60.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.43 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 39' ' ' THR . 7.5 m-20 -74.66 -31.28 61.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.533 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.574 HG21 ' HZ ' ' A' ' 77' ' ' PHE . 2.0 t -64.85 -24.97 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.824 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -10.8 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.724 0.297 . . . . 0.0 111.46 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -73.87 -34.35 64.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.188 0.518 . . . . 0.0 109.841 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -108.97 -178.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.91 157.3 31.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.72 0.295 . . . . 0.0 110.758 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.29 130.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.149 0.5 . . . . 0.0 109.818 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.908 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 96.93 -8.79 65.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.902 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 148.72 39.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.99 146.18 37.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.084 -175.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.39 -40.29 17.34 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.851 0.72 . . . . 0.0 111.999 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.444 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 7.1 mp0 -67.77 -42.29 81.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.546 -175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -78.39 -33.33 48.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.393 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.47 -46.96 94.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 61' ' ' THR . . . -68.9 -38.74 79.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.726 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -40.12 83.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.66 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -40.61 55.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.582 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.25 -38.93 23.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.665 0.269 . . . . 0.0 111.659 -176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.21 19.87 11.09 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.48 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 2.5 m -80.5 135.19 53.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.956 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.55 131.68 32.59 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.481 2.121 . . . . 0.0 111.074 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mt -72.83 125.04 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.813 0.339 . . . . 0.0 110.526 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.401 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 4.9 ttm -102.23 148.16 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.634 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.483 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -84.18 -177.11 6.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.868 176.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.574 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 11.0 p-10 -134.87 49.79 4.14 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 66' ' ' ASP . 13.3 Cg_exo -68.16 -27.42 35.34 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.822 1.681 . . . . 0.0 111.072 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.23 -2.08 24.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.25 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.41 37.57 5.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.225 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.574 ' OG1' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.49 103.79 3.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.029 0.442 . . . . 0.0 111.585 -172.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -115.18 12.88 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.956 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -134.68 145.31 48.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 -178.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.3 m0 -123.72 140.26 53.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -112.32 111.45 22.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.21 141.84 42.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.632 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -89.07 111.96 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.483 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.622 ' HE1' HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -96.68 170.98 8.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.156 -177.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -155.66 151.35 27.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.096 175.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HB2' ' H ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -129.2 -138.87 0.23 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.466 ' H ' ' HB2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.3 104.89 25.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 24.0 Cg_exo -63.59 137.26 58.46 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.254 2.636 . . . . 0.0 112.669 -176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.79 150.14 16.93 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -64.84 115.96 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 73.11 134.66 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.045 0.841 . . . . 0.0 110.315 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.82 54.15 1.15 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -170.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.67 100.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.407 0.622 . . . . 0.0 110.093 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -162.64 158.96 23.93 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.463 -175.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -136.03 170.07 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 111.275 -172.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' OE1' ' HG3' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -95.42 130.97 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.036 177.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -99.86 115.05 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.48 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -83.52 104.85 13.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 109.884 -176.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -97.93 110.55 23.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.646 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -98.79 130.93 45.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.957 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -121.81 129.31 52.54 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.475 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -127.38 132.37 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 0.0 110.29 177.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB2' HG23 ' A' ' 102' ' ' THR . 20.3 t-20 -74.68 163.61 27.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.809 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -14.7 9.24 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.591 0.557 . . . . 0.0 112.137 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -10.96 60.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.243 0.544 . . . . 0.0 110.65 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.49 15.2 55.75 Favored Glycine 0 C--O 1.22 -0.743 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.862 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.908 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.4 t -112.42 130.2 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 122.432 0.293 . . . . 0.0 110.712 -172.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.805 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 2.3 mt -55.21 115.14 2.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -84.98 -33.19 22.64 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.033 0.444 . . . . 0.0 110.538 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -168.13 144.8 4.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.088 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.36 134.46 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 169.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.73 103.03 12.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.776 0.322 . . . . 0.0 110.386 176.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -125.31 104.81 8.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.262 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.75 133.84 23.59 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.11 132.87 38.32 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.943 2.429 . . . . 0.0 113.182 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.38 -41.47 63.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.235 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 111.097 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.3 t30 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -163.48 -177.78 5.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 38' ' ' LEU . 2.0 tp -75.0 158.71 32.79 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 41' ' ' ASN . 11.0 t -129.15 -179.85 5.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.603 0.239 . . . . 0.0 110.384 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.49 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.071 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.501 ' H ' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.9 -31.99 73.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.787 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -68.08 -34.29 76.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 110.371 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.408 HG13 HD21 ' A' ' 91' ' ' LEU . 6.8 t -63.19 -34.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.34 0.591 . . . . 0.0 110.33 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -6.79 59.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.196 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -29.93 45.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.404 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.47 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -96.84 -177.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.056 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -140.44 144.96 36.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.599 0.238 . . . . 0.0 110.699 -175.239 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 m -68.23 138.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.502 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.807 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 85.34 3.17 87.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.975 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.534 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -82.25 154.36 25.42 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.53 145.99 38.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HG3' ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -53.98 -31.78 51.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.424 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.546 ' HA ' HD21 ' A' ' 63' ' ' LEU . 23.7 mm-40 -59.57 -44.72 93.21 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 110.426 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -76.65 -35.58 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.228 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 101' ' ' LEU . 84.1 t -61.03 -43.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.973 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 61' ' ' THR . . . -71.66 -34.49 69.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.834 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -37.48 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.85 -52.44 7.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.96 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.1 mt -79.97 -12.28 59.73 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.08 32.44 69.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.519 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 3.2 t -100.95 146.4 32.06 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.8 Cg_exo -64.32 132.71 34.69 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.462 2.108 . . . . 0.0 112.009 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 53' ' ' GLN . 13.3 mt -70.15 99.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.096 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.1 ttp -136.71 100.29 4.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -104.01 146.32 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.96 126.1 75.87 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.429 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.42 -5.42 9.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.402 2.735 . . . . 0.0 113.658 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.53 -12.82 55.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.156 0.503 . . . . 0.0 110.184 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.76 2.19 34.55 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 104.46 4.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.249 0.547 . . . . 0.0 110.437 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -108.39 53.89 0.67 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.727 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -128.08 140.89 51.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.46 176.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.71 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 6.8 m0 -117.29 142.86 46.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.695 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 38.6 p90 -129.73 119.62 23.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.356 0.598 . . . . 0.0 110.428 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.99 159.17 26.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.54 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.0 121.86 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.0 0.429 . . . . 0.0 110.82 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.529 ' HZ ' ' ND2' ' A' ' 106' ' ' ASN . 3.6 p90 -118.39 -174.95 2.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HD2' ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.93 138.74 48.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.864 0.364 . . . . 0.0 111.362 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.58 HE21 ' NE2' ' A' ' 80' ' ' GLN . 1.6 mt-30 -91.85 -128.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.245 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.58 ' NE2' HE21 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -116.92 105.25 49.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.53 143.34 87.58 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.865 2.377 . . . . 0.0 112.396 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.02 -136.22 2.37 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.41 15.0 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.553 0.216 . . . . 0.0 111.083 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 76.01 -60.01 0.5 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.785 0.834 . . . . 0.0 111.119 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.98 -13.32 61.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.026 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 t -109.33 88.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 109' ' ' ALA . 7.0 m -165.67 112.85 0.93 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.275 -174.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.4 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -163.54 117.49 1.56 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.271 176.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 13.5 pt20 -80.28 131.56 35.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.863 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.96 157.45 16.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.395 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -98.05 104.02 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -104.01 107.8 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.1 mp -101.24 124.18 46.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -117.76 122.23 42.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.46 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -127.14 148.07 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.964 0.412 . . . . 0.0 110.362 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -81.15 161.61 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -8.45 1.85 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.72 -13.34 60.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.27 14.39 48.37 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.915 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.5 t -112.16 126.94 69.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.59 0.356 . . . . 0.0 110.43 -173.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.807 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 8.2 mt -56.76 108.42 0.5 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.321 0.388 . . . . 0.0 110.179 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.46 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -74.71 -32.97 62.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.49 140.06 4.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.974 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.6 mt -102.38 134.51 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 3.2 t70 -111.04 101.8 10.31 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.394 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.529 ' ND2' ' HZ ' ' A' ' 77' ' ' PHE . 9.4 t-20 -133.32 102.17 5.45 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.06 0.457 . . . . 0.0 109.779 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.22 131.56 24.39 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.763 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.07 146.01 13.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.363 2.708 . . . . 0.0 112.361 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.582 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -74.55 51.58 0.47 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.164 0.506 . . . . 0.0 111.485 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.628 0.252 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.8 ' HE2' ' HA ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -159.12 179.35 9.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.59 151.45 40.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.953 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.3 145.97 43.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.126 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.85 80.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.75 -18.54 63.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.154 0.502 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.73 -23.35 45.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 t -67.77 -18.38 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.045 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -7.4 51.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.669 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -17.23 38.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.42 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.516 HG21 HG13 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -115.02 165.6 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 0.0 111.471 -177.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.506 ' O ' HD12 ' A' ' 101' ' ' LEU . 15.4 mmt-85 -142.08 166.17 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.014 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.47 145.44 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.88 0.372 . . . . 0.0 110.189 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.652 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 79.16 1.84 86.25 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.261 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.404 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 28.4 mmt -82.09 137.31 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.82 146.09 53.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.624 0.249 . . . . 0.0 111.051 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.699 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 4.6 pt20 -57.28 -26.84 61.47 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.286 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -43.04 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 0.0 109.983 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -76.02 -32.72 59.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.52 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG13 HG21 ' A' ' 46' ' ' ILE . 59.0 t -64.59 -44.33 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.443 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -65.96 -38.02 87.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.668 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.3 -49.5 75.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.495 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.38 -47.34 34.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.3 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 5.0 mp -76.17 -43.53 42.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -175.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.13 50.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.935 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 18.9 m -77.19 134.3 67.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 120.679 0.275 . . . . 0.0 111.151 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.3 Cg_exo -66.66 146.47 79.19 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.888 2.392 . . . . 0.0 111.578 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -69.66 123.97 22.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.217 0.532 . . . . 0.0 110.179 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.75 157.54 44.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.289 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.74 126.97 47.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.125 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.93 121.54 21.94 Favored Pre-proline 0 N--CA 1.447 -0.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -86.47 -3.5 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.672 2.248 . . . . 0.0 113.522 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -102.3 -27.0 13.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.91 34.04 3.88 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.063 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -77.17 84.81 3.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.36 52.94 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.886 0.85 . . . . 0.0 110.3 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.54 119.87 15.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.548 175.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 m0 -104.26 128.33 52.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.762 -174.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.78 131.66 55.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.776 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 23.1 m-85 -136.47 139.84 42.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.931 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 121.44 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.8 ' HA ' ' HE2' ' A' ' 37' ' ' TYR . 7.4 p90 -140.29 150.37 43.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.302 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.684 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -105.35 114.21 28.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.9 0.857 . . . . 0.0 110.137 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -107.94 -130.15 0.29 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.259 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -65.81 129.99 94.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 5.9 Cg_exo -75.61 -161.86 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.261 2.641 . . . . 0.0 112.381 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.91 -67.33 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.565 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -163.55 158.11 20.36 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -178.09 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.6 OUTLIER 81.36 -19.83 0.4 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.064 0.852 . . . . 0.0 111.915 172.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 -37.09 1.56 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.238 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.53 86.07 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.644 0.735 . . . . 0.0 109.18 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.912 HG22 ' HB1' ' A' ' 109' ' ' ALA . 11.4 m -167.66 119.37 0.87 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.57 HE22 ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -131.48 172.44 12.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -165.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -117.71 137.8 52.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.103 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.11 136.97 54.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.925 0.393 . . . . 0.0 111.766 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.559 HD13 HD11 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -86.98 105.68 17.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.356 174.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.8 104.71 14.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.952 0.406 . . . . 0.0 110.311 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.559 HD11 HD13 ' A' ' 91' ' ' LEU . 1.2 mp -98.32 118.43 34.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.438 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.89 111.96 23.28 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.739 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -126.28 146.09 50.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.247 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 168.03 18.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -20.54 8.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -171.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.66 -5.18 56.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.971 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.699 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 87.93 22.19 43.27 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.164 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.652 HG13 ' HA2' ' A' ' 49' ' ' GLY . 53.2 t -100.28 111.52 30.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 95' ' ' PHE . 13.9 mt -54.88 101.85 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.054 0.454 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.72 42.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.454 0.645 . . . . 0.0 109.728 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 136.19 6.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.023 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.7 mt -106.84 134.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -109.01 101.18 10.28 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -133.91 104.44 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.924 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 145.03 54.08 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 31.1 Cg_exo -59.63 162.16 16.04 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.376 2.05 . . . . 0.0 111.08 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.912 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -58.9 -21.45 57.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.198 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 . . . . . 0 CA--C 1.519 -0.241 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -79.83 -174.89 4.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -72.61 155.46 40.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.976 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 162.95 25.68 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.87 69.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.998 0.428 . . . . 0.0 110.637 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -68.19 -23.62 64.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.059 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -84.61 -22.35 30.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.74 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 46' ' ' ILE . 39.6 t -71.02 -27.16 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.309 0.576 . . . . 0.0 110.436 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -5.05 12.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.797 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HB2' ' HE2' ' A' ' 45' ' ' LYS . 9.1 mtmt -78.24 -13.25 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.533 HG21 HG13 ' A' ' 55' ' ' VAL . 1.1 pp -110.84 -176.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.7 ' HB2' ' HG3' ' A' ' 50' ' ' MET . 84.3 mmt-85 -141.64 159.03 43.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.446 -173.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.9 121.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.916 174.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.624 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 103.22 -2.68 47.19 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -175.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.7 ' HG3' ' HB2' ' A' ' 47' ' ' ARG . 5.6 mtt -65.98 147.11 53.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -79.16 151.72 31.13 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -49.65 -43.24 46.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.596 0.56 . . . . 0.0 111.435 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -68.86 -37.29 78.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.28 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -73.23 -33.34 65.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.533 HG13 HG21 ' A' ' 46' ' ' ILE . 59.0 t -61.77 -51.11 76.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.572 174.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.95 82.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.715 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -45.66 88.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.391 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . -76.74 -51.97 10.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.506 HD21 HD11 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -73.5 -35.37 65.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.298 -175.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.1 27.42 10.96 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -71.64 135.95 83.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.311 -0.445 . . . . 0.0 111.769 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.64 137.97 52.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 110.917 171.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.65 134.24 53.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.51 155.53 16.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.102 0.477 . . . . 0.0 111.319 -172.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.91 81.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.254 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.79 75.14 68.32 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.189 0.518 . . . . 0.0 110.003 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.92 -3.44 13.86 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.696 2.931 . . . . 0.0 112.208 -173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -19.68 63.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.38 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.6 18.76 10.47 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.016 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.09 105.64 4.63 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.705 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 5.4 m-80 -92.13 36.14 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.435 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.98 128.49 34.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.301 177.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.1 m0 -103.7 141.39 36.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.759 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -113.49 111.38 21.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.458 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.4 ' CE1' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -106.55 129.12 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.994 178.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 t -108.77 107.26 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 20.7 p90 -123.52 153.71 40.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.057 0.456 . . . . 0.0 110.645 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 139.24 58.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.946 -172.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.422 ' CD ' HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.18 -169.52 2.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.515 174.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.454 ' N ' HE21 ' A' ' 80' ' ' GLN . 0.0 OUTLIER -74.83 139.2 73.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 16.9 Cg_exo -68.03 68.44 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.196 2.598 . . . . 0.0 113.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 161.2 -96.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.829 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 87' ' ' THR . 0.4 OUTLIER 57.43 -100.7 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.861 0.465 . . . . 0.0 111.527 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.501 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 8.3 tp10 -123.27 -14.66 7.41 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.19 -37.75 3.32 Favored Glycine 0 C--N 1.322 -0.218 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.4 89.02 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 164.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 83' ' ' HIS . 3.5 m -156.03 113.62 3.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.896 -161.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.632 ' H ' ' HB3' ' A' ' 109' ' ' ALA . 4.1 tp-100 -170.19 -178.43 2.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -161.71 155.08 21.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.546 0.612 . . . . 0.0 111.198 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -126.72 125.51 41.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.875 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.517 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -84.75 111.17 19.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.138 -177.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.64 107.04 18.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.651 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.4 mp -100.63 121.46 41.65 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -113.59 127.57 56.12 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -127.17 158.08 38.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -88.73 171.75 9.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.33 -25.49 24.35 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -13.13 60.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.007 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.606 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.06 22.79 24.34 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.624 HG13 ' HA2' ' A' ' 49' ' ' GLY . 42.0 t -99.42 115.87 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.109 0.164 . . . . 0.0 110.674 -174.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.4 HD12 HG13 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -53.96 107.38 0.26 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 110.606 177.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.45 -13.77 17.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.771 -176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.554 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 22.3 t-20 -159.85 127.84 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.237 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.4 HG13 HD12 ' A' ' 101' ' ' LEU . 5.0 mt -108.44 142.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -144.53 103.05 3.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.848 0.356 . . . . 0.0 111.143 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.408 ' HB2' HD23 ' A' ' 91' ' ' LEU . 21.9 t30 -115.51 109.31 17.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 2.2 mmtt -121.94 107.0 36.0 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.279 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 8.3 Cg_exo -72.22 143.45 39.67 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.021 2.48 . . . . 0.0 112.352 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.632 ' HB3' ' H ' ' A' ' 88' ' ' GLN . . . -60.08 92.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.552 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.485 ' HG ' ' NE2' ' A' ' 83' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.559 177.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.5 t30 . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -169.35 0.49 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.71 159.03 19.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 41' ' ' ASN . 12.3 t -127.78 170.57 12.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 0.0 110.597 175.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.82 -23.71 67.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.169 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.44 ' H ' HG23 ' A' ' 39' ' ' THR . 35.1 t30 -65.17 -30.12 71.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.986 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.95 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 42.3 m-20 -74.87 -31.15 61.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.04 -27.64 38.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.24 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -12.09 60.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.769 0.318 . . . . 0.0 111.289 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.95 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 mttt -78.01 -46.23 21.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.748 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pp -70.25 154.39 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.989 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.635 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -123.75 156.64 35.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -174.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG13 HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -68.36 131.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 1.007 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 85.18 4.09 86.82 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.195 -176.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -72.21 142.45 49.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.535 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -83.93 151.1 25.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 111.121 -176.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.662 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 1.1 pt20 -51.37 -35.3 37.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.055 -172.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.535 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 2.3 mp0 -64.66 -50.32 67.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.841 0.353 . . . . 0.0 110.106 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -68.37 -36.56 79.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 51' ' ' THR . 96.9 t -59.59 -47.32 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.288 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.551 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -74.68 -23.94 58.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.149 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 -41.85 10.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.543 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.37 -10.94 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.764 0.316 . . . . 0.0 111.549 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.85 40.83 57.14 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.412 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.7 m -67.98 128.6 93.32 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.507 0.194 . . . . 0.0 111.217 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 20.9 Cg_exo -66.85 173.93 7.44 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.266 2.644 . . . . 0.0 112.289 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.88 116.66 2.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.06 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.59 127.19 46.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.375 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.38 81.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.01 115.16 64.53 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 109.268 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 -2.44 12.61 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.7 2.266 . . . . 0.0 112.647 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -100.71 -26.9 13.64 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.5 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.49 4.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.348 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -71.28 99.26 1.89 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.387 0.613 . . . . 0.0 110.546 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 95' ' ' PHE . 5.4 p30 -90.88 43.24 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.258 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.03 129.38 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.87 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 13.5 m0 -116.81 142.76 46.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -120.8 127.06 51.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.992 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.83 153.85 49.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.823 0.344 . . . . 0.0 110.305 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.89 132.76 29.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 2.6 p90 -125.81 138.1 53.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.996 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.12 116.95 13.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.793 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HB3' ' H ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -120.39 -92.5 0.54 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.543 -171.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.461 ' H ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -128.03 117.78 20.65 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.836 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 8.1 Cg_exo -71.97 -95.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.871 2.381 . . . . 0.0 111.992 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 111.17 157.36 14.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.081 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -101.85 -40.33 6.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -110.81 119.96 40.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.795 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.68 55.21 0.95 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.999 -172.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -74.88 89.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.422 0.63 . . . . 0.0 109.456 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.825 HG23 ' HB1' ' A' ' 109' ' ' ALA . 14.2 t -159.54 162.33 35.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.801 -171.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 88' ' ' GLN . 1.4 tp60 -136.35 179.82 6.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.439 0.638 . . . . 0.0 111.976 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.715 ' HG3' ' HA ' ' A' ' 108' ' ' PRO . 3.5 mp0 -78.94 148.23 32.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.258 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.94 118.36 27.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -112.46 105.37 13.6 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 110.406 178.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -115.55 126.35 54.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.641 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.1 mp -111.43 131.04 55.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.975 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.89 131.24 53.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.767 ' HE1' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -118.73 130.46 55.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.919 0.39 . . . . 0.0 110.784 -174.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.499 ' HB2' HG23 ' A' ' 102' ' ' THR . 66.1 t30 -77.54 162.4 27.15 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.18 45.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -2.51 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.662 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 85.05 22.3 52.85 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.007 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -94.15 130.16 43.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.516 0.198 . . . . 0.0 110.919 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.767 HD22 ' HE1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -58.96 96.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.506 174.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.52 -32.9 58.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.179 0.514 . . . . 0.0 110.762 -178.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -164.38 142.57 6.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.838 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.456 HD12 HG13 ' A' ' 48' ' ' VAL . 3.3 mt -111.54 129.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.34 101.14 12.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.68 115.39 18.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.12 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -145.56 136.93 12.72 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.613 -177.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.715 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . 18.0 Cg_exo -66.84 169.88 13.85 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.154 2.569 . . . . 0.0 112.114 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.825 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -74.08 -28.11 61.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.085 0.469 . . . . 0.0 110.606 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.738 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -102.81 175.08 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.999 0.428 . . . . 0.0 110.93 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -129.6 152.37 49.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.884 175.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -125.27 174.09 8.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.696 0.284 . . . . 0.0 110.331 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.36 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.966 0.412 . . . . 0.0 111.337 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.42 -29.12 70.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.21 -27.4 68.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.508 ' CG2' ' HZ ' ' A' ' 77' ' ' PHE . 2.3 t -79.98 -18.65 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -75.99 -12.21 60.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.161 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -82.11 -29.29 31.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.612 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.25 -167.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 50' ' ' MET . 1.4 ptt85 -154.85 164.52 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.385 . . . . 0.0 111.601 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.28 141.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.793 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.677 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 86.4 -5.3 84.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.761 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -68.22 131.37 45.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -69.59 146.64 51.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.519 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -50.04 -37.5 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.48 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -68.53 -38.5 80.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.525 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -77.46 -31.54 53.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.359 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.09 -49.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.675 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.73 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -57.26 8.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.0 -42.66 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.26 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 38' ' ' LEU . 26.1 tp -85.88 -28.97 24.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 0.0 110.696 -175.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.06 79.67 1.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.724 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.2 m -105.62 134.32 19.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.458 0.171 . . . . 0.0 111.28 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 36.0 Cg_exo -61.42 134.96 54.53 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.833 2.355 . . . . 0.0 112.05 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 138.11 51.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.159 -175.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -140.27 170.81 15.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.277 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.7 13.32 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -155.92 90.27 2.79 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.83 -8.15 5.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.948 2.432 . . . . 0.0 112.325 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.25 -27.36 11.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -173.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.2 31.0 6.72 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -83.89 88.5 7.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.657 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.94 64.63 7.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.369 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.536 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -141.36 137.35 32.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.455 176.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -125.43 155.41 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.381 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.55 134.42 33.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.725 0.298 . . . . 0.0 110.468 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -122.38 146.63 47.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.272 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.68 114.38 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HZ ' ' CG2' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -94.13 128.44 40.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.114 -170.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 78' ' ' ARG . 2.8 mmt85 -77.66 103.42 7.59 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 169.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HB3' HE21 ' A' ' 89' ' ' GLN . 1.5 tp-100 -140.84 168.17 20.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 -171.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.516 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -70.87 127.47 91.73 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.246 0.546 . . . . 0.0 110.923 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 36.7 Cg_endo -93.35 -37.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.012 2.474 . . . . 0.0 113.495 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.89 -149.15 27.95 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.999 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.96 52.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.528 0.664 . . . . 0.0 111.665 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.44 -30.67 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.171 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.29 -33.64 6.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.69 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.72 86.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -161.32 98.37 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.748 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.438 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -147.0 107.36 4.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.943 178.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.613 HE21 ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -90.88 123.64 34.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.485 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.55 44.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -84.13 115.31 22.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -106.08 132.78 51.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.177 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.5 mp -111.41 122.15 47.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.881 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.536 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -114.6 114.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -176.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.34 158.57 20.41 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.401 ' OD1' ' HB ' ' A' ' 100' ' ' VAL . 24.2 p30 -86.99 169.07 12.76 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.2 -23.42 47.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -173.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -11.63 60.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.5 27.05 12.2 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.246 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.677 HG13 ' HA2' ' A' ' 49' ' ' GLY . 30.7 t -111.78 125.1 69.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.865 0.333 . . . . 0.0 111.127 -174.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.667 ' HB3' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -53.68 111.11 0.67 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -24.74 13.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.915 0.388 . . . . 0.0 110.343 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -155.5 131.49 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.95 140.17 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 170.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 10.7 t70 -117.04 109.97 17.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.9 101.35 3.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.157 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 140.9 29.67 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.648 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 11.3 Cg_endo -56.14 133.37 57.59 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.514 2.143 . . . . 0.0 111.815 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.438 ' CB ' ' H ' ' A' ' 88' ' ' GLN . . . -60.67 -24.92 65.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.129 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 CA--C 1.519 -0.233 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -123.78 -169.47 1.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.84 HD21 HD11 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -113.51 150.98 32.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.909 0.385 . . . . 0.0 111.528 -175.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.05 145.25 35.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.52 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -74.27 -41.89 60.52 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.012 0.434 . . . . 0.0 110.329 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.04 -22.44 66.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.661 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 8.1 m-20 -69.49 -37.22 77.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.977 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' HA ' HD13 ' A' ' 59' ' ' LEU . 9.2 t -76.1 -16.9 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.529 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 -7.38 56.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 4.7 mtpt -82.49 -34.03 28.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.625 HG21 HG13 ' A' ' 55' ' ' VAL . 1.2 pp -80.5 160.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.579 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -136.92 165.51 25.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.85 -171.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -72.3 145.38 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.997 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 75.93 2.77 72.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.38 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.532 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.1 mmm -83.9 137.06 33.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.2 OUTLIER -78.17 152.39 32.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 -176.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -32.74 62.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.313 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -64.66 -45.34 87.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -72.63 -33.74 66.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.051 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.625 HG13 HG21 ' A' ' 46' ' ' ILE . 56.0 t -62.23 -49.68 83.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.632 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.5 69.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.78 -54.43 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.815 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.83 34.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.814 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.84 HD11 HD21 ' A' ' 38' ' ' LEU . 8.3 tp -84.79 -40.27 17.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.22 -176.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.08 63.47 0.81 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.178 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 5.7 m -101.81 133.37 20.79 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -80.19 172.45 13.78 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.136 2.557 . . . . 0.0 111.649 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 138.94 56.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.818 0.342 . . . . 0.0 110.657 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.1 ttp -142.21 178.7 7.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.052 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -121.51 152.34 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.76 0.314 . . . . 0.0 111.418 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.75 46.13 0.35 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.172 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.24 -34.08 88.93 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.0 113.449 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -104.26 7.73 35.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.797 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.03 21.13 9.18 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.425 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.84 85.61 3.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.247 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 71' ' ' ASN . 4.0 m120 -108.86 27.87 9.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.298 0.57 . . . . 0.0 111.374 -172.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -102.76 129.57 49.45 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.258 170.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -103.46 121.58 43.13 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.53 114.67 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.365 -176.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.513 ' HE2' HD13 ' A' ' 38' ' ' LEU . 11.1 m-85 -106.12 130.99 53.91 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.884 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.05 108.76 16.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.545 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -115.28 116.47 28.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 102.35 11.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.923 165.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -118.9 -37.68 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.184 0.516 . . . . 0.0 110.697 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.477 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -147.57 141.47 15.76 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.572 175.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 1.3 Cg_endo -85.4 -104.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.136 2.557 . . . . 0.0 111.987 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 116.19 165.94 14.39 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.9 97.2 9.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.929 0.365 . . . . 0.0 110.787 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -159.23 -63.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.02 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 -35.76 4.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.453 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -106.42 87.18 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.555 HG23 ' HB3' ' A' ' 109' ' ' ALA . 27.2 m -159.41 101.24 1.53 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.559 -168.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -151.69 144.48 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.55 173.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.71 147.01 44.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.482 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.05 127.98 47.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.389 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.02 114.73 21.93 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.97 105.41 14.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.331 0.586 . . . . 0.0 111.515 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 6.6 mp -87.34 148.04 25.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.815 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -137.19 116.24 12.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.616 ' HB3' HD22 ' A' ' 101' ' ' LEU . 26.6 p90 -129.2 145.03 51.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.63 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.528 ' ND2' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.41 163.01 28.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.892 177.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.08 -38.49 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -3.51 25.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.63 17.82 47.36 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.182 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.997 HG13 ' HA2' ' A' ' 49' ' ' GLY . 14.3 t -97.08 114.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 95' ' ' PHE . 1.4 mm? -54.82 106.21 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.552 0.533 . . . . 0.0 110.837 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.41 -28.22 19.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.146 0.498 . . . . 0.0 110.891 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -158.8 149.65 20.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.696 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 mp -124.02 130.03 73.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.13 101.65 13.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.599 174.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -125.11 106.53 9.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.223 0.535 . . . . 0.0 110.376 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 144.59 35.68 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 159.64 40.71 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.299 1.999 . . . . 0.0 111.274 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -66.37 -34.92 79.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.18 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.4 t30 . . . . . 0 C--O 1.23 0.07 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 -179.74 3.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.658 HD23 ' HE1' ' A' ' 77' ' ' PHE . 12.4 tp -78.87 131.81 36.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.414 . . . . 0.0 110.772 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 145.84 27.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.302 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.01 81.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.969 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.91 -22.15 65.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.493 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -42.3 89.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.866 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' HG13 ' A' ' 46' ' ' ILE . 6.3 t -74.98 -17.06 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.747 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -73.86 -7.36 51.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.854 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -76.06 -37.9 57.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.061 0.457 . . . . 0.0 110.165 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -91.0 179.13 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.874 177.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.602 ' O ' ' HB2' ' A' ' 50' ' ' MET . 7.7 ptp180 -157.81 167.66 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.769 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.36 128.96 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.785 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.957 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 95.51 -4.7 66.84 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.01 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.602 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -81.26 161.84 23.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -79.29 144.67 34.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.069 0.462 . . . . 0.0 111.518 -169.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -61.31 -36.32 79.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.728 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.686 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -79.52 -30.54 41.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.154 -172.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.26 -37.68 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HA ' HG21 ' A' ' 46' ' ' ILE . 38.4 t -60.44 -46.24 95.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.796 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -68.5 -31.88 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.873 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -37.62 83.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.153 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.7 -44.8 13.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.989 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.419 HD21 ' HA ' ' A' ' 43' ' ' VAL . 88.0 mt -88.93 -6.74 57.06 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 55.8 17.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.464 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 2.0 m -79.02 130.95 68.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.477 0.179 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.89 148.84 54.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.143 2.562 . . . . 0.0 112.588 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.56 113.74 13.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.374 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.78 131.29 47.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.142 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.53 102.6 8.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.07 115.36 38.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 120.911 0.386 . . . . 0.0 110.571 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.43 -2.03 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.063 2.508 . . . . 0.0 112.183 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -81.55 -26.73 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.642 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.82 30.17 4.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.839 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -80.43 108.99 14.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.983 0.421 . . . . 0.0 110.59 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -112.49 39.16 2.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.427 0.632 . . . . 0.0 110.229 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -124.69 141.45 52.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.52 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.732 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 3.0 m0 -116.31 142.96 46.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -124.9 111.56 15.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.138 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.42 ' CD1' HD22 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -107.57 140.78 40.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.436 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.96 114.74 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.076 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.658 ' HE1' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -102.89 142.25 34.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.28 148.41 47.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.733 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -129.57 167.66 17.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.2 mm-40 -88.1 115.77 64.17 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.2 Cg_exo -70.36 70.09 1.93 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.158 2.572 . . . . 0.0 111.978 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.36 -150.0 17.51 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.444 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.61 3.04 30.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.0 111.871 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.9 -48.23 16.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.31 0.576 . . . . 0.0 110.095 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.66 -39.2 1.51 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.727 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.41 88.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 117.108 0.454 . . . . 0.0 110.798 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -169.69 136.1 1.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.89 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -154.76 130.9 10.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.095 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -75.14 124.56 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 110.536 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.6 110.44 20.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.954 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.517 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.91 106.93 15.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.974 0.416 . . . . 0.0 110.537 -175.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 111.3 22.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.853 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.732 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 4.1 mp -106.66 142.6 36.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.002 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -139.74 133.85 31.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -132.2 141.65 49.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.88 0.371 . . . . 0.0 110.442 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.494 ' HB2' HG23 ' A' ' 102' ' ' THR . 5.5 t-20 -78.1 156.56 29.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.247 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -14.14 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.766 0.666 . . . . 0.0 112.245 -176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -15.01 61.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 0.0 110.496 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 97.36 19.55 25.27 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.164 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.957 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.2 t -113.47 126.4 70.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 122.877 0.471 . . . . 0.0 110.564 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 94' ' ' THR . 2.9 mm? -55.46 108.23 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 173.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.08 -31.99 59.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.838 0.351 . . . . 0.0 110.627 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -167.43 149.7 5.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.146 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.1 mt -127.7 138.33 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.73 102.82 10.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.171 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.06 101.45 9.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.27 153.71 44.9 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.188 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 52.2 Cg_exo -56.73 151.49 47.39 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.87 2.38 . . . . 0.0 112.396 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -60.6 -79.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.208 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.541 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.34 0 O-C-N 123.272 0.357 . . . . 0.0 110.817 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 t30 . . . . . 0 CA--C 1.521 -0.153 0 CA-C-O 121.391 0.615 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -154.43 157.34 38.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.535 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.03 141.62 51.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.0 110.72 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.15 145.21 25.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.974 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.94 78.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.59 -35.54 76.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -63.37 -40.68 97.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.434 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.38 -26.4 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 110.382 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m -75.8 -10.65 59.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.315 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -34.02 41.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -81.1 -150.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.711 0.291 . . . . 0.0 110.786 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.902 ' HB3' ' HG3' ' A' ' 50' ' ' MET . 0.6 OUTLIER -156.59 134.47 11.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.651 0.262 . . . . 0.0 110.665 -173.12 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.496 ' HB ' HD12 ' A' ' 104' ' ' ILE . 1.9 p -71.43 122.26 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.884 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 106.98 2.87 36.41 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.449 -175.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.902 ' HG3' ' HB3' ' A' ' 47' ' ' ARG . 3.9 mtt -78.87 151.61 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.78 154.1 36.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.919 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -48.72 -39.33 24.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.708 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -59.91 -46.18 90.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.074 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.53 -40.25 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.717 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.456 HG21 HD21 ' A' ' 101' ' ' LEU . 84.4 t -58.29 -45.85 89.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.236 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -29.93 68.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 111.087 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.18 -57.72 2.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.844 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.36 -20.56 40.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -172.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.2 31.01 32.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.318 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.756 HG23 ' HE2' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -65.52 136.41 96.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.689 -178.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 61' ' ' THR . 57.7 Cg_endo -73.96 151.22 44.78 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.515 2.144 . . . . 0.0 111.945 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.6 106.43 15.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.001 0.429 . . . . 0.0 110.225 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.4 tpt -95.08 120.6 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.735 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.86 117.53 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.735 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.28 112.31 13.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.448 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.89 -2.99 12.89 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.721 2.281 . . . . 0.0 112.574 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -85.61 -25.69 26.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.923 -176.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.78 29.34 4.7 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.948 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -72.92 107.82 5.51 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.165 0.507 . . . . 0.0 110.644 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -103.6 25.89 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.124 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -131.01 127.17 37.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.531 178.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -104.01 124.74 49.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -103.78 135.7 44.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.756 ' HE2' HG23 ' A' ' 61' ' ' THR . 0.2 OUTLIER -134.81 151.24 50.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 178.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.58 115.34 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.367 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.533 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -93.56 160.26 14.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.693 -178.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 78' ' ' ARG . 4.4 ptm180 -126.16 132.93 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.687 0.279 . . . . 0.0 110.329 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HG3' HE22 ' A' ' 88' ' ' GLN . 0.0 OUTLIER -159.1 -44.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.854 177.318 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.444 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -90.62 120.21 68.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -54.28 4.54 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.885 2.39 . . . . 0.0 112.563 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.79 127.82 1.04 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.864 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 179.24 149.66 0.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.836 0.454 . . . . 0.0 110.137 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 72.62 -41.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.856 0.862 . . . . 0.0 112.321 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.17 -37.78 3.55 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 t -115.2 86.74 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 m -164.37 99.96 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 -174.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -165.48 168.36 16.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.877 171.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.502 HE21 ' HB2' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -82.47 142.81 31.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -176.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 122.85 47.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.322 175.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.533 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -110.03 119.47 39.42 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.12 138.57 50.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 110.652 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -116.59 139.18 50.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.304 177.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -102.78 146.79 27.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -125.18 125.37 43.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 111.805 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.778 ' HB2' HG23 ' A' ' 102' ' ' THR . 47.5 t-20 -73.61 157.02 37.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 170.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -19.69 37.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -7.75 57.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 87.06 29.64 22.35 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 49' ' ' GLY . 1.6 t -111.88 135.6 50.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -174.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.884 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 17.6 mt -60.91 105.77 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.341 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.778 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -75.56 -30.51 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.186 0.517 . . . . 0.0 110.631 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -168.25 140.82 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.904 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 48' ' ' VAL . 14.2 mt -103.48 139.11 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -117.52 101.9 8.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.089 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 121.48 33.95 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -143.31 129.85 10.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.362 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.88 170.26 2.85 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.273 2.649 . . . . 0.0 112.262 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.28 93.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.76 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.611 -177.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.275 0.56 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -164.42 177.63 8.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.278 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CD2' ' A' ' 75' ' ' TYR . 11.9 tp -118.01 140.71 49.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.77 0.319 . . . . 0.0 110.568 175.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.13 145.97 39.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.072 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -63.49 -42.32 98.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.92 -21.77 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.897 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.642 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -73.45 -34.2 65.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.126 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG21 ' HG ' ' A' ' 91' ' ' LEU . 96.2 t -75.8 -30.77 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 110.091 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.3 m -66.72 -6.56 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.45 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.642 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 13.5 mtpt -70.6 -32.97 70.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.486 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 pp -93.58 179.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.391 . . . . 0.0 111.151 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -144.3 160.03 41.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.89 -175.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 2.8 m -69.55 146.25 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.999 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 84.67 -15.77 39.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.291 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.553 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -70.52 141.08 51.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.18 145.92 41.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.898 0.38 . . . . 0.0 111.78 -172.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -35.4 29.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.827 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -64.89 -53.87 39.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.625 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.5 72.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.713 HG21 HD23 ' A' ' 101' ' ' LEU . 21.6 t -61.39 -42.19 92.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.607 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -67.13 -37.94 84.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.691 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.21 -34.19 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.645 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.1 -41.07 16.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.507 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -69.73 -43.25 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 111.378 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.9 59.74 0.81 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -71.99 147.33 91.11 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.737 0.303 . . . . 0.0 110.792 -177.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 11.5 Cg_exo -71.83 164.64 35.05 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.2 2.6 . . . . 0.0 111.547 175.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.34 85.31 3.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.346 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mtm -143.77 171.24 14.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.444 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -119.9 -178.05 3.55 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -128.85 53.28 10.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 78.9 Cg_endo -78.23 -4.99 14.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.066 1.844 . . . . 0.0 112.085 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -93.41 -4.59 51.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.262 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.24 35.79 7.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 86.85 2.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.314 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 17.5 m120 -102.35 7.72 40.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.263 0.554 . . . . 0.0 110.208 176.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.11 123.37 41.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.176 176.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.788 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 11.7 m0 -104.79 137.12 43.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.181 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -118.78 115.27 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.051 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 22.6 m-85 -118.44 148.25 42.76 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.08 117.97 31.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.121 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.609 ' HB3' ' HG2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -104.8 114.46 28.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.05 0.453 . . . . 0.0 111.359 -175.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -93.28 103.87 16.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -151.3 147.27 26.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 -176.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.618 HE22 ' HB3' ' A' ' 108' ' ' PRO . 31.5 mt-30 73.13 147.79 0.12 Allowed Pre-proline 0 N--CA 1.466 0.371 0 O-C-N 123.984 0.803 . . . . 0.0 111.485 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.3 Cg_exo -71.85 -2.35 11.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 112.572 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.408 ' HA2' ' HB ' ' A' ' 87' ' ' THR . . . 95.95 148.59 24.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.967 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.441 ' H ' ' CB ' ' A' ' 87' ' ' THR . 3.0 t-80 -118.89 117.76 29.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 60.98 20.56 10.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.99 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.44 -9.29 42.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.023 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.38 87.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.022 0.411 . . . . 0.0 110.0 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.649 HG23 ' HB3' ' A' ' 109' ' ' ALA . 11.7 m -163.26 121.53 1.99 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.39 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.559 ' NE2' ' HA ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -176.61 112.26 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.22 0.95 . . . . 0.0 109.156 170.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.609 ' HG2' ' HB3' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -78.47 165.98 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.283 0.563 . . . . 0.0 111.842 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.9 t -123.54 127.21 48.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.726 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HG ' HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -84.56 110.9 19.05 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 1.9 m -109.37 110.99 22.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.353 -177.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.788 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -91.79 142.15 27.9 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.585 177.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -135.22 117.79 15.91 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.559 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 1.1 p90 -132.2 157.62 43.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.085 0.469 . . . . 0.0 110.936 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.31 161.73 22.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.17 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -20.0 24.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -9.0 58.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.493 0.663 . . . . 0.0 110.314 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.82 8.73 57.96 Favored Glycine 0 C--O 1.219 -0.783 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.636 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.999 HG13 ' HA2' ' A' ' 49' ' ' GLY . 55.1 t -89.2 110.0 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 122.894 -0.18 . . . . 0.0 111.15 -172.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.713 HD23 HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -55.22 107.5 0.32 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.593 0.558 . . . . 0.0 110.101 174.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.36 -25.82 14.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.776 0.322 . . . . 0.0 111.142 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.561 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 18.1 t30 -150.29 143.84 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.87 133.78 66.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' HD22 ' A' ' 91' ' ' LEU . 6.4 t70 -103.28 101.87 11.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.278 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -132.33 102.0 5.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.229 0.538 . . . . 0.0 110.149 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 165.6 21.73 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.618 ' HB3' HE22 ' A' ' 80' ' ' GLN . 23.2 Cg_exo -65.78 158.22 54.81 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.223 1.949 . . . . 0.0 110.778 169.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.649 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -73.33 59.53 0.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 111.467 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.513 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.1 179.48 7.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.753 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 38' ' ' LEU . 5.6 tp -75.05 145.12 42.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.638 0.732 . . . . 0.0 112.968 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 41' ' ' ASN . 4.7 m -116.14 152.6 33.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.187 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -54.84 -38.96 68.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.578 ' H ' HG22 ' A' ' 39' ' ' THR . 9.2 t30 -61.17 -47.05 87.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.384 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.452 ' OD1' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -68.35 -20.4 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.603 -176.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.8 -27.01 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.748 0.308 . . . . 0.0 111.256 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.9 -7.14 32.02 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 3.36 55.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.21 -169.03 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.236 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -147.79 143.2 27.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.07 0.462 . . . . 0.0 112.018 -174.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 104' ' ' ILE . 41.1 t -76.05 137.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.87 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.611 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 89.26 -6.46 83.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.902 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.2 mmm -71.04 153.24 42.76 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -77.78 145.66 36.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.89 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -36.31 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.298 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 1.6 mp0 -70.15 -40.81 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.279 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.64 -34.76 60.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.754 -177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.51 -46.49 94.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.589 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -62.67 -41.14 98.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.574 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.438 ' HE1' HD11 ' A' ' 63' ' ' LEU . 1.1 m-85 -60.22 -49.2 78.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.6 -36.35 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.232 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -80.08 -37.62 33.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.4 . . . . 0.0 111.54 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.44 52.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -173.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -122.08 139.85 31.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.45 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.41 138.7 82.34 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.323 2.015 . . . . 0.0 110.716 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD11 ' HE1' ' A' ' 57' ' ' TYR . 91.3 mt -74.07 87.92 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.151 0.501 . . . . 0.0 110.649 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 109.12 12.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.776 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.64 142.05 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.969 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.34 131.64 24.37 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -92.54 -2.97 3.75 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.932 2.422 . . . . 0.0 112.996 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.466 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -103.01 -26.16 13.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.12 5.54 32.7 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.46 7.34 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.957 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.463 HD22 ' HA ' ' A' ' 71' ' ' ASN . 3.1 m120 -99.73 51.71 0.92 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.225 -174.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.88 128.85 55.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.373 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.589 ' HH2' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -103.4 141.07 36.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -123.12 119.8 31.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 144.14 47.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.232 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.94 117.13 29.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -94.18 116.88 29.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -175.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.15 104.35 12.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.616 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.742 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -165.31 129.15 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -142.47 117.74 6.7 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.77 0.319 . . . . 0.0 110.801 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.39 -3.19 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.472 2.115 . . . . 0.0 111.927 176.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -11.77 60.11 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.092 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.11 132.79 47.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.671 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER 75.98 -67.44 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 124.106 0.879 . . . . 0.0 112.294 172.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 -36.52 4.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.71 86.74 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 109' ' ' ALA . 1.1 m -170.37 131.81 0.97 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.303 -174.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.481 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 28.0 tp60 -143.86 114.01 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.366 0.603 . . . . 0.0 110.782 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.742 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -75.83 135.14 40.21 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.074 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.32 132.5 56.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.635 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -95.93 110.31 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -108.95 138.65 44.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.106 0.479 . . . . 0.0 110.996 -177.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.763 ' HG ' HD11 ' A' ' 101' ' ' LEU . 3.4 mp -117.32 131.05 56.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.68 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.88 105.4 9.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.884 0.373 . . . . 0.0 110.087 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.43 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -116.09 135.71 53.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.78 -178.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.414 ' ND2' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -72.69 164.89 25.81 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.77 -31.4 2.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -170.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -4.51 33.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 111.295 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 93.61 9.86 59.66 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.021 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.611 HG13 ' HA2' ' A' ' 49' ' ' GLY . 21.0 t -93.49 116.22 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -174.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 HD11 ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -54.28 97.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.773 0.671 . . . . 0.0 110.464 176.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.43 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -76.99 -31.51 56.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.909 0.385 . . . . 0.0 110.449 -176.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.68 140.66 9.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.147 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.605 HD12 HG22 ' A' ' 48' ' ' VAL . 1.7 mp -103.45 139.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 171.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 0.5 OUTLIER -107.39 102.03 11.34 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -113.8 102.84 10.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 127.34 10.96 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.039 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.616 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 13.6 Cg_exo -70.9 150.95 62.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.923 2.415 . . . . 0.0 110.554 171.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.714 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -81.44 38.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 110.842 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.531 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.957 0.408 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.47 137.51 33.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.156 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.24 106.04 16.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.266 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.463 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -89.54 93.01 9.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.376 -178.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -108.53 103.96 13.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.961 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.1 85.36 2.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.14 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.8 p -89.53 146.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.635 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.32 121.04 59.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.97 0.414 . . . . 0.0 111.085 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.45 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 3.8 t80 -99.05 139.29 34.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -89.93 113.02 55.51 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.597 0.237 . . . . 0.0 111.46 -176.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 28' ' ' TYR . 5.4 Cg_exo -77.52 45.36 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.285 2.657 . . . . 0.0 111.269 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -136.95 23.68 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.305 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.0 140.45 37.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.296 -173.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -114.89 96.77 5.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.389 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -106.93 67.5 0.71 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.985 0.422 . . . . 0.0 110.972 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.53 -160.56 16.97 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.972 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.2 t30 67.98 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.628 0.771 . . . . 0.0 111.358 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' HD2' ' HD2' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -126.43 167.54 15.43 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -89.03 140.14 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -73.72 145.03 45.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.601 178.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.28 99.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 110.671 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.71 -27.8 68.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.684 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.2 -41.27 67.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.725 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.718 ' HA ' HD21 ' A' ' 59' ' ' LEU . 11.3 t -68.22 -23.73 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 110.433 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 m -77.0 -5.87 50.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HE3' ' HB1' ' A' ' 58' ' ' ALA . 25.7 mtmt -68.07 -35.43 78.18 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.731 0.3 . . . . 0.0 111.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 pp -84.87 -177.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.402 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.0 175.74 13.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.159 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 104' ' ' ILE . 2.8 t -73.05 143.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.665 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.96 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 84.06 -11.13 58.57 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.342 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.85 133.67 47.64 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -77.42 156.73 30.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.362 -175.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.445 ' HG3' ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.94 -44.57 14.89 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.624 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -57.87 -47.62 82.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.494 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.87 -37.64 58.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.926 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 HD23 ' A' ' 101' ' ' LEU . 78.0 t -60.91 -46.93 95.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 109.983 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -67.67 -35.2 78.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.731 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -43.54 97.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.502 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -78.32 -46.47 20.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.718 HD21 ' HA ' ' A' ' 43' ' ' VAL . 7.0 mt -84.05 -16.41 43.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -173.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 17.79 65.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.518 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -68.9 141.05 91.83 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 122.534 0.333 . . . . 0.0 111.457 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.14 158.81 53.98 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.481 2.121 . . . . 0.0 111.417 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.67 135.1 57.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.1 128.6 24.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.536 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -149.78 71.33 1.09 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.541 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.16 121.36 84.91 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.36 -2.93 12.94 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.075 2.517 . . . . 0.0 112.358 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -90.0 -20.05 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.447 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.8 4.66 34.0 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.02 85.29 6.67 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.344 0.592 . . . . 0.0 110.18 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -101.25 49.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.052 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -112.99 128.11 56.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.714 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -103.62 132.47 49.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.54 125.63 52.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.73 154.57 49.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.63 128.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.995 0.426 . . . . 0.0 110.659 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.53 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 6.7 p90 -127.19 173.47 9.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.606 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HD2' ' HD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -94.07 131.21 39.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.034 0.445 . . . . 0.0 111.115 -177.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.6 -30.74 0.19 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.867 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -125.74 83.26 62.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.72 -42.42 9.07 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.951 2.434 . . . . 0.0 113.469 -172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.18 138.4 4.76 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.884 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -175.2 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.166 0.586 . . . . 0.0 109.581 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -128.11 -2.25 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.539 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.98 -38.35 2.54 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.477 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.53 87.64 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.8 m -159.58 98.27 1.37 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.608 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.97 154.96 22.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.012 -175.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.55 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -111.54 131.51 55.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.24 114.18 25.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.967 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -84.52 105.43 15.33 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.97 124.1 45.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.592 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -99.68 139.3 35.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.462 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -130.05 108.1 9.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.79 ' HB3' HD22 ' A' ' 101' ' ' LEU . 36.0 p90 -115.35 133.22 56.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.963 0.411 . . . . 0.0 109.976 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.91 162.26 29.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.972 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.29 -22.38 2.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.24 -10.2 59.51 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.776 -0.577 . . . . 0.0 110.94 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 98.83 10.05 50.72 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.213 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.96 HG13 ' HA2' ' A' ' 49' ' ' GLY . 18.0 t -98.93 119.53 47.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 122.343 0.257 . . . . 0.0 110.709 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.79 HD22 ' HB3' ' A' ' 95' ' ' PHE . 0.3 OUTLIER -55.14 105.48 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.423 0.452 . . . . 0.0 109.785 174.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.4 -31.95 15.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -150.34 138.02 19.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.888 0.375 . . . . 0.0 110.923 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 HG23 ' A' ' 48' ' ' VAL . 3.8 mt -110.78 133.05 57.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 174.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.04 99.95 11.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.546 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.412 ' C ' ' HG3' ' A' ' 107' ' ' LYS . 28.3 t30 -144.47 101.92 3.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.678 0.275 . . . . 0.0 110.591 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 113' ' ' ASN . 0.7 OUTLIER -142.5 133.75 12.93 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.09 158.61 50.95 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.918 2.412 . . . . 0.0 112.781 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.48 ' HB1' HD23 ' A' ' 114' ' ' LEU . . . -83.08 42.79 0.82 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.02 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.34 59.63 1.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.589 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.559 ' H ' ' HA ' ' A' ' 115' ' ' GLU . 4.6 m 68.95 96.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.312 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.83 -90.38 0.11 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.912 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 1.019 ' HB2' ' HB2' ' A' ' 107' ' ' LYS . 28.2 t30 -77.14 -33.17 56.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.48 HD23 ' HB1' ' A' ' 109' ' ' ALA . 5.3 tp -157.38 155.49 30.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.156 -1.384 . . . . 0.0 107.823 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.559 ' HA ' ' H ' ' A' ' 111' ' ' SER . 0.1 OUTLIER -125.73 -177.52 3.95 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 133.9 56.52 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -69.97 125.28 26.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.304 0.573 . . . . 0.0 112.239 -166.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.34 122.56 0.03 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.535 -1.212 . . . . 0.0 112.547 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -76.62 74.28 3.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.211 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.3 122.24 35.5 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.3 t60 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.687 -176.433 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.808 0.337 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.43 86.36 5.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.179 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 108.35 1.26 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.904 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 tp -155.04 28.55 0.41 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.11 0.481 . . . . 0.0 110.668 -176.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -79.11 92.45 5.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.894 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -169.95 74.89 0.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.731 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.6 t -106.73 109.23 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.148 0.499 . . . . 0.0 110.932 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.04 114.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.823 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -114.12 136.97 52.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.087 0.47 . . . . 0.0 111.002 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 29' ' ' ARG . 3.7 mtt85 -116.12 138.37 24.12 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.092 174.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.61 60.07 2.73 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.059 2.506 . . . . 0.0 112.091 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 9.3 t70 -159.47 -133.15 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.103 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 31' ' ' ASP . 7.2 mt 75.56 134.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.306 0.574 . . . . 0.0 111.308 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.34 94.53 2.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.145 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.87 -167.33 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.93 88.47 0.91 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.371 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -118.46 -68.38 0.92 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -159.3 148.63 18.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -75.2 174.03 10.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.233 0.54 . . . . 0.0 111.216 -174.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -128.05 153.05 47.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.677 176.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.44 -21.23 66.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.974 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -74.17 -34.77 63.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.703 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -70.84 -20.58 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 -176.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.31 -17.1 21.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.224 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -90.73 -8.4 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.703 ' HG3' ' HA ' ' A' ' 42' ' ' ASP . 2.0 mtmt -83.22 -30.6 27.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.217 0.532 . . . . 0.0 110.048 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.636 HD12 HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -86.31 144.83 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.859 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.51 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -127.57 154.35 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.418 -178.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -74.36 148.12 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 177.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.984 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 80.15 -4.42 67.03 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.084 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 16.1 mmt -74.86 138.6 42.59 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 6.0 t -79.41 154.72 28.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.571 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -36.18 60.3 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.866 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -60.51 -42.64 96.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.088 0.47 . . . . 0.0 110.579 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -77.0 -34.92 57.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.55 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.51 -45.94 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.032 0.444 . . . . 0.0 109.826 175.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.36 83.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.738 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.87 -28.03 65.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.355 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.68 -54.48 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.66 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 46' ' ' ILE . 12.9 mt -81.07 -29.82 34.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.75 0.31 . . . . 0.0 111.812 -174.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.24 24.0 9.98 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.179 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 2.5 m -62.35 131.23 93.72 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.431 -0.385 . . . . 0.0 111.336 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 9.6 Cg_exo -71.2 165.36 32.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.627 2.218 . . . . 0.0 111.508 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.09 116.82 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.36 119.75 40.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.47 -172.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.27 104.09 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.083 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.89 134.79 19.92 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.3 -5.65 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.44 2.093 . . . . 0.0 113.46 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.17 -26.24 12.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.1 32.23 7.2 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -73.31 114.92 12.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.895 -0.652 . . . . 0.0 111.249 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.596 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 2.2 m120 -92.41 45.77 1.22 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.262 0.553 . . . . 0.0 110.488 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -148.14 137.08 21.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.618 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -105.51 133.11 50.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.067 0.461 . . . . 0.0 110.592 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -133.78 149.55 51.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.993 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.54 133.87 65.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.454 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 54.5 p90 -163.13 149.8 12.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.53 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 81' ' ' PRO . 2.0 ttm180 -77.58 104.06 7.88 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.548 HE22 ' HA ' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -67.96 -44.84 75.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.557 -174.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' A' ' 87' ' ' THR . 0.0 OUTLIER -129.49 79.23 74.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 92.6 Cg_endo -83.7 -3.28 10.57 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.729 2.286 . . . . 0.0 112.337 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.23 126.95 8.33 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.735 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.37 -65.72 0.33 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.732 0.813 . . . . 0.0 112.401 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.64 -56.79 8.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.139 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 -36.52 2.95 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.682 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.1 87.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.369 0.604 . . . . 0.0 109.82 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.598 HG23 ' HB3' ' A' ' 109' ' ' ALA . 5.3 m -162.81 115.31 1.6 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.709 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -136.13 124.7 23.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.852 0.358 . . . . 0.0 111.687 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 161.56 14.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.803 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.226 175.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.26 105.04 13.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.32 108.45 13.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.499 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.636 HD21 HD12 ' A' ' 46' ' ' ILE . 4.8 mp -80.9 121.87 26.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.239 175.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 72' ' ' THR . 1.0 OUTLIER -111.3 124.88 53.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.654 ' HB3' HD23 ' A' ' 101' ' ' LEU . 30.9 p90 -135.86 160.18 39.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 111.265 -175.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.36 165.01 18.59 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.3 m -64.43 -4.13 3.65 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -7.37 58.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.315 0.578 . . . . 0.0 109.853 172.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 86.84 16.27 61.73 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.407 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.984 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -103.66 116.61 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.187 0.195 . . . . 0.0 110.477 -173.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 95' ' ' PHE . 19.4 mt -55.24 114.98 2.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.345 0.403 . . . . 0.0 110.971 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.57 -35.3 21.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 109.754 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -162.18 153.76 18.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.111 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mt -110.15 136.12 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.21 101.58 13.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 172.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -140.55 100.76 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 0.0 110.537 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -144.61 169.05 10.77 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.548 ' HA ' HE22 ' A' ' 79' ' ' GLN . 82.6 Cg_endo -81.5 166.56 17.75 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.831 1.688 . . . . 0.0 111.8 171.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.598 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -68.38 67.7 0.13 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.225 0.536 . . . . 0.0 110.499 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.436 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -138.57 28.38 2.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.863 -177.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.69 10.28 2.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.882 -173.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.42 -105.5 1.58 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.491 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -135.51 -60.75 0.74 Allowed 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.652 -0.322 . . . . 0.0 111.593 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.501 ' HG ' ' HG3' ' A' ' 115' ' ' GLU . 0.4 OUTLIER -69.98 -32.62 70.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.848 0.356 . . . . 0.0 111.282 -174.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.501 ' HG3' ' HG ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -81.86 -162.26 0.52 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.258 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.8 p80 39.16 51.91 2.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.691 0.758 . . . . 0.0 111.719 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 56.25 28.98 14.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.866 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 50.19 57.19 6.84 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.95 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.89 114.81 3.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.258 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -97.11 156.54 16.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.961 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 . . . . . 0 C--O 1.243 0.734 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.297 173.061 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.11 90.05 6.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.984 0.421 . . . . 0.0 110.122 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.26 95.44 4.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.303 0.573 . . . . 0.0 110.548 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.08 147.66 27.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.542 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 143.64 26.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.68 109.07 21.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.321 -174.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 26' ' ' VAL . 2.4 p -74.91 116.81 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.215 0.531 . . . . 0.0 109.837 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -114.61 166.1 8.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.995 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -62.93 112.19 2.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 110.196 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.512 ' HE ' ' HB2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -98.29 116.76 65.46 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.766 177.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.92 60.13 2.95 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.849 2.366 . . . . 0.0 111.11 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -88.18 39.06 0.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.722 -176.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.68 171.04 17.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.938 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -85.64 48.41 1.59 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.029 0.442 . . . . 0.0 110.893 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.85 152.89 22.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.101 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.05 -124.26 8.18 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.051 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 69.11 -79.65 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.242 0.617 . . . . 0.0 111.157 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -113.7 165.64 12.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.64 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.041 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.39 143.52 27.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.642 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.13 -21.73 64.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.779 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.28 -29.37 31.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.575 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.54 ' HA ' HD21 ' A' ' 59' ' ' LEU . 3.5 t -66.99 -17.06 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.154 0.502 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -69.69 -6.37 31.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.235 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HE3' ' HB1' ' A' ' 58' ' ' ALA . 11.6 mtmt -75.77 -23.29 55.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.188 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pt -104.91 -179.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.484 0.183 . . . . 0.0 110.633 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.9 OUTLIER -154.33 168.4 26.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.543 0.211 . . . . 0.0 110.755 -177.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.61 140.48 18.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.291 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.709 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 81.34 1.74 90.19 Favored Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.999 -0.441 . . . . 0.0 111.999 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.53 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.99 149.05 30.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -75.35 145.63 41.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.717 0.294 . . . . 0.0 110.693 -177.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -58.97 -26.93 64.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.853 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.44 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 10.8 mp0 -63.86 -48.31 77.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.195 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -69.46 -35.55 75.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.383 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.588 ' HA ' HG21 ' A' ' 46' ' ' ILE . 89.0 t -61.28 -47.81 91.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.954 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.39 70.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.082 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.96 -43.23 96.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.258 0.551 . . . . 0.0 110.677 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.502 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -76.48 -53.09 8.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.941 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 43' ' ' VAL . 50.4 mt -81.64 -20.42 39.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.18 26.83 35.42 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.405 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -72.11 133.45 83.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 111.388 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.1 Cg_exo -68.29 152.47 75.74 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.93 2.42 . . . . 0.0 111.515 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.462 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.83 116.44 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 0.0 110.159 -179.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.23 105.25 7.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.798 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.26 69.16 3.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.731 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 75.07 80.72 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -1.78 11.83 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.161 2.574 . . . . 0.0 112.414 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -67.67 -15.32 63.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.751 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.96 16.37 12.74 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.15 83.74 4.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.863 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 50.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.684 0.754 . . . . 0.0 110.125 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 94' ' ' THR . 0.1 OUTLIER -123.37 128.82 50.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.976 176.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.44 122.71 45.44 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -106.44 121.66 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.671 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.5 ' HB2' HD12 ' A' ' 91' ' ' LEU . 1.2 m-85 -116.91 137.82 51.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.375 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.76 118.37 55.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.673 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 65.3 m-85 -117.91 163.22 16.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.883 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -122.85 103.49 8.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 110.342 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -155.25 164.9 38.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.449 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 55.01 74.29 0.75 Allowed Pre-proline 0 C--O 1.234 0.271 0 O-C-N 123.781 0.676 . . . . 0.0 111.365 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.28 86.16 1.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.309 2.006 . . . . 0.0 111.362 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.11 -104.56 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.702 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -134.27 155.86 49.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.563 -0.375 . . . . 0.0 111.142 -176.219 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.0 mp0 76.6 -45.64 0.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.771 0.828 . . . . 0.0 111.803 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.1 -36.44 4.22 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.988 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 p -85.04 85.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.417 1.103 . . . . 0.0 109.434 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.808 HG23 ' HB1' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -175.53 138.84 0.41 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.175 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -161.1 168.91 23.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.355 . . . . 0.0 111.091 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -84.3 124.23 31.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.236 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.02 104.73 16.69 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.04 0.447 . . . . 0.0 110.56 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.673 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -84.66 104.83 14.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -103.11 104.19 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.588 HD12 HG12 ' A' ' 104' ' ' ILE . 1.8 tp -94.33 119.6 33.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.481 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -118.15 116.0 25.95 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.64 -171.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.709 ' HB3' HD23 ' A' ' 101' ' ' LEU . 1.3 p90 -123.62 142.77 50.73 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.995 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.45 164.16 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.54 -22.32 3.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -169.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -6.27 45.42 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.991 -0.443 . . . . 0.0 111.252 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 88.0 21.3 46.69 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.425 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG13 ' HA2' ' A' ' 49' ' ' GLY . 24.6 t -112.18 120.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 9.1 mt -55.44 110.36 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.367 0.417 . . . . 0.0 110.383 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.53 -32.05 58.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.83 153.32 10.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.624 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.588 HG12 HD12 ' A' ' 93' ' ' LEU . 5.0 mt -110.54 135.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 170.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -107.96 102.7 11.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.606 HD22 HD23 ' A' ' 91' ' ' LEU . 23.3 t-20 -121.85 114.42 21.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.928 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 153.72 78.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.558 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.28 171.43 3.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.111 2.541 . . . . 0.0 111.71 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.808 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -74.5 6.54 3.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.81 113.44 12.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.72 129.68 45.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 172.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.65 149.12 34.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.776 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 t30 71.57 -64.42 0.39 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.638 0.775 . . . . 0.0 112.191 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -23.87 58.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.659 0.266 . . . . 0.0 110.481 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 69.78 160.3 0.2 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.08 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.45 24.37 2.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -89.27 -38.99 13.8 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 172.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -156.52 -57.34 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.345 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 175.57 171.24 0.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.889 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -72.73 -80.35 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.268 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.503 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.703 0.287 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.49 78.77 2.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.481 0.658 . . . . 0.0 112.409 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -150.2 118.48 6.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.835 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.47 80.96 1.4 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.006 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.59 101.79 6.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.859 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.543 ' HB3' ' HE ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -103.68 79.55 1.68 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.469 176.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.92 121.93 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.311 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.7 m -107.23 152.71 8.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.688 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -85.28 115.88 23.3 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' C ' ' H ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -80.45 120.02 78.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.56 35.88 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.244 2.629 . . . . 0.0 112.611 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 1.5 m-20 -85.27 128.29 34.63 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 31' ' ' ASP . 90.4 mt 72.11 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -171.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.14 84.11 1.01 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.843 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -71.56 168.95 16.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.67 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.34 53.21 5.7 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.6 -178.39 5.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.712 0.291 . . . . 0.0 110.81 -174.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -90.3 156.23 18.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.195 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.517 HD23 ' HE1' ' A' ' 77' ' ' PHE . 15.3 tp -80.15 142.58 34.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 110.281 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -101.84 145.96 28.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 -179.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.92 86.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.787 0.327 . . . . 0.0 111.392 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.98 -30.01 70.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -20.0 62.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.153 0.501 . . . . 0.0 111.084 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 39' ' ' THR . 8.2 t -84.06 -17.03 10.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.871 0.367 . . . . 0.0 111.529 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.7 -8.28 41.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -87.71 -8.47 56.04 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.378 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.85 158.92 9.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.9 mtt85 -135.88 160.39 38.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.793 0.33 . . . . 0.0 111.158 -173.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 3.4 m -73.62 147.54 9.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.473 171.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 1.006 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 82.05 -8.48 60.33 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.559 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.6 mmt -79.29 141.36 37.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -68.0 150.37 48.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.48 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -59.59 -28.11 66.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.009 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -68.23 -38.96 82.41 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -70.14 -38.69 75.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.992 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.2 t -59.57 -45.5 93.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.703 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.44 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -66.57 -33.28 75.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.012 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -70.04 -34.45 73.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.915 0.388 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.07 -35.08 24.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.219 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -98.17 -34.82 10.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.58 30.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.25 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -58.87 139.22 86.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 123.23 0.612 . . . . 0.0 112.118 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 7.7 Cg_exo -73.78 140.76 29.58 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.672 2.248 . . . . 0.0 111.501 174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.21 108.58 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.2 tpp -75.88 118.32 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.595 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.61 106.36 11.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.913 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.24 115.2 18.58 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-O 120.928 0.394 . . . . 0.0 109.94 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -91.54 -2.66 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.953 2.435 . . . . 0.0 112.26 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -26.19 15.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.007 -170.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.44 15.83 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.48 85.43 3.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.227 0.537 . . . . 0.0 109.893 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.14 55.1 1.27 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.443 0.639 . . . . 0.0 110.772 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -132.15 146.16 51.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.84 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 2.0 m0 -124.01 130.6 52.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -120.37 124.58 45.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.309 0.575 . . . . 0.0 111.079 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -124.53 153.92 41.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.453 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.74 130.34 55.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.288 0.566 . . . . 0.0 110.905 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.517 ' HE1' HD23 ' A' ' 38' ' ' LEU . 2.6 m-30 -93.78 -175.61 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.7 ptt85 -128.14 119.47 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 111.451 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB2' ' HA ' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -105.61 -114.82 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.938 174.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.524 ' H ' ' HB3' ' A' ' 79' ' ' GLN . 3.8 mm-40 -126.92 81.41 69.67 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.52 135.04 32.4 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.141 2.561 . . . . 0.0 112.57 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.55 162.18 28.66 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.37 121.88 18.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.366 0.083 . . . . 0.0 110.78 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 69.38 108.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.002 0.814 . . . . 0.0 110.128 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.67 53.73 0.55 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 t -82.93 87.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 0.9 OUTLIER -127.77 113.56 16.13 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.56 -169.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.594 ' H ' ' HB3' ' A' ' 109' ' ' ALA . 2.8 mm100 -150.58 168.68 23.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.087 -168.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.457 ' CD ' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -122.14 136.15 54.88 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 173.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.3 133.15 56.34 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.18 104.56 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 105.39 15.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.658 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.5 mp -94.96 127.88 41.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.66 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -123.02 127.84 49.35 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.55 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -126.21 148.92 49.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.452 ' HB2' HG23 ' A' ' 102' ' ' THR . 6.0 t-20 -76.73 160.48 29.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -0.37 0.64 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.464 0.478 . . . . 0.0 112.237 -175.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -8.57 58.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.558 173.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.18 15.53 55.6 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.254 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.006 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.6 t -111.52 123.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 122.765 0.426 . . . . 0.0 110.34 -173.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 95' ' ' PHE . 6.5 mt -54.32 110.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.741 0.305 . . . . 0.0 110.486 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -75.51 -42.19 53.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.07 153.61 16.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.708 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.478 HD12 HG13 ' A' ' 48' ' ' VAL . 2.4 mt -107.88 136.31 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.04 101.65 9.21 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.873 0.368 . . . . 0.0 110.728 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -114.09 100.74 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 116.62 11.02 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.286 -174.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.7 146.09 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.805 2.336 . . . . 0.0 112.117 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.594 ' HB3' ' H ' ' A' ' 88' ' ' GLN . . . -71.61 70.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.186 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.26 -120.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.066 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.75 -66.8 0.17 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.404 0.682 . . . . 0.0 111.629 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 137.9 63.36 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.02 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -122.41 -42.6 2.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.882 0.372 . . . . 0.0 110.908 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 tp -129.18 -65.76 0.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.343 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -71.74 -50.34 30.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.478 -174.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 56.91 66.79 1.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.674 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -63.22 101.21 0.28 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -87.23 133.66 33.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.345 0.593 . . . . 0.0 110.988 -174.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -101.62 -39.73 7.34 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -149.18 -70.9 0.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.879 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.247 0.93 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.25 173.55 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 120.812 0.339 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.78 104.64 17.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.17 -176.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.21 97.11 6.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.289 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.436 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -121.28 140.47 52.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.292 -175.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.0 93.47 4.52 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.84 87.71 2.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.023 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.67 99.12 8.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.68 -45.51 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.225 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -160.0 119.54 2.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.874 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 2.1 ptp180 -99.19 115.59 65.65 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 7.3 Cg_exo -74.1 43.48 0.86 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.508 2.805 . . . . 0.0 112.13 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.99 -1.82 38.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.442 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.34 136.28 25.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.787 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.9 134.54 46.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -144.5 171.53 14.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.723 0.296 . . . . 0.0 110.652 -175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.21 -83.34 0.32 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.108 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 t30 59.86 -133.43 0.85 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.96 172.14 13.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.07 128.13 34.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.232 176.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -109.96 177.49 4.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.947 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.87 90.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.308 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -59.29 -38.21 79.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.819 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -38.96 91.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.485 ' HA ' HD11 ' A' ' 46' ' ' ILE . 43.1 t -70.64 -30.9 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.272 0.558 . . . . 0.0 110.385 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 m -75.15 -9.25 58.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.815 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.7 -20.39 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.507 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.558 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -87.11 173.85 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.114 177.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' A' ' 50' ' ' MET . 6.1 mmp_? -131.56 153.6 49.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.938 -174.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.92 136.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.988 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 92.95 -4.08 74.51 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.791 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.535 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.39 144.19 49.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -81.16 145.05 31.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.759 0.314 . . . . 0.0 110.603 -175.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -54.65 -36.13 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.675 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -68.75 -43.02 76.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.138 0.494 . . . . 0.0 110.426 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -74.9 -34.84 62.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.9 -46.32 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.65 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -64.52 -41.59 96.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.705 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.55 -35.93 81.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.632 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.86 -43.71 35.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.203 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.54 1.83 55.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.81 46.25 90.2 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.293 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' A' ' 56' ' ' ALA . 13.6 m -102.87 136.58 19.24 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.48 -0.36 . . . . 0.0 111.068 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.56 132.29 34.95 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.605 2.203 . . . . 0.0 111.46 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.92 87.88 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 110.545 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.7 tpt -79.98 93.68 5.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.205 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.12 109.32 22.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.417 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.0 152.45 40.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.465 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.63 -3.27 9.94 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.737 2.291 . . . . 0.0 113.78 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -98.79 -26.22 14.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.829 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.64 27.76 5.35 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.22 83.52 6.94 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.272 0.558 . . . . 0.0 109.755 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -82.34 63.61 6.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.496 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.67 126.65 20.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.012 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.65 ' HH2' ' HB2' ' A' ' 56' ' ' ALA . 7.1 m0 -105.89 135.53 47.17 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.498 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -111.2 122.07 46.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.548 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 159.89 20.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.15 125.08 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 1.7 m-30 -97.64 162.97 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.51 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -139.7 105.12 5.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 175.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.427 HE22 ' HD2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -150.83 11.18 0.65 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.122 -176.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -134.54 144.73 52.11 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.005 -173.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 3.0 Cg_exo -76.39 -165.41 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.192 2.594 . . . . 0.0 112.149 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.76 -14.33 12.64 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.138 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -75.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.944 0.372 . . . . 0.0 111.125 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 2.3 mm-40 -115.41 145.17 42.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.61 34.67 13.12 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.2 88.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.974 HG23 ' HB1' ' A' ' 109' ' ' ALA . 10.5 t -172.23 176.2 3.48 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -151.18 178.96 8.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.765 0.317 . . . . 0.0 110.366 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -128.68 164.06 23.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.137 -176.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 104.92 15.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.497 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -82.46 105.03 13.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 109.94 19.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.031 -171.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.2 mt -89.51 120.36 30.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.55 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.486 HG23 HG23 ' A' ' 72' ' ' THR . 1.3 m -110.2 123.96 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.608 0.242 . . . . 0.0 110.356 -175.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 0.8 OUTLIER -119.2 148.0 43.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.88 168.29 18.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 m -58.42 -16.37 14.62 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.661 0.384 . . . . 0.0 111.985 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -5.29 42.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.547 175.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 80.15 21.89 64.28 Favored Glycine 0 C--O 1.219 -0.826 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.988 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -106.26 127.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 -172.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HA ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -54.66 101.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.799 175.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -39.44 30.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.087 0.47 . . . . 0.0 110.015 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -161.19 153.21 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.255 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.402 HD11 ' HG ' ' A' ' 101' ' ' LEU . 2.4 mp -118.59 133.24 66.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.18 101.93 13.71 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 173.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -135.38 100.88 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 0.0 111.139 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.84 111.52 6.23 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.189 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 54.3 Cg_exo -54.58 121.53 9.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.511 2.14 . . . . 0.0 112.443 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.974 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -6.43 77.11 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.514 1.759 . . . . 0.0 114.123 173.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER 174.93 59.69 0.0 OUTLIER 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -175.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.23 45.01 1.24 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.405 -174.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 129.21 -152.12 19.37 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.404 175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -87.73 69.4 9.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.222 -0.489 . . . . 0.0 111.396 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.4 tp -160.9 -72.46 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.68 ' HB3' HG21 ' A' ' 87' ' ' THR . 11.9 mp0 -40.72 -66.35 0.33 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -170.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.486 ' HB3' HD11 ' A' ' 110' ' ' LEU . 68.2 t60 -144.11 59.4 1.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.525 0.679 . . . . 0.0 109.898 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.33 140.58 15.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.017 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 60.69 55.33 3.34 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.728 0.642 . . . . 0.0 110.21 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -98.51 112.17 24.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.791 -176.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -83.57 141.68 31.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.074 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.763 177.265 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.59 49.0 2.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.13 0.491 . . . . 0.0 110.178 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.37 88.78 7.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.639 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.79 145.14 24.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.216 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.37 150.29 36.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.469 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -153.24 -12.26 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.91 62.91 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.327 0.584 . . . . 0.0 110.759 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.98 148.75 33.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.612 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -63.29 121.74 14.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.877 0.37 . . . . 0.0 110.668 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.492 ' HG3' ' H ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -83.16 127.1 70.39 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.378 172.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 19.1 Cg_exo -67.86 60.98 0.91 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.391 2.727 . . . . 0.0 112.756 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -133.91 150.45 51.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.835 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt 56.73 80.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 123.492 0.495 . . . . 0.0 109.915 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -54.71 -39.23 67.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.288 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 72.45 -72.14 0.12 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.267 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.43 136.42 13.37 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.473 -172.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -119.42 -40.32 2.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -109.57 -171.33 1.82 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.475 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -116.98 134.66 54.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.841 0.353 . . . . 0.0 110.444 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 145.23 44.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.837 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.22 96.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.38 -27.88 68.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.989 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -72.72 -39.05 67.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.532 ' HA ' HD11 ' A' ' 59' ' ' LEU . 61.1 t -67.62 -25.15 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.38 0.609 . . . . 0.0 109.952 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -74.59 -6.48 48.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.091 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 16.7 mtpt -71.0 -33.45 70.4 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.531 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.81 HG21 ' HA ' ' A' ' 55' ' ' VAL . 1.1 pp -93.84 -178.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.4 OUTLIER -157.31 172.27 18.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.737 0.304 . . . . 0.0 111.08 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 1.4 m -66.31 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.279 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.915 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 90.27 -10.59 73.75 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.095 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -75.03 137.45 41.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -73.89 146.5 43.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.328 -175.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -52.52 -32.43 40.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.721 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 mp0 -62.46 -44.21 96.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.165 0.507 . . . . 0.0 109.837 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -73.57 -36.37 65.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.405 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.81 ' HA ' HG21 ' A' ' 46' ' ' ILE . 93.9 t -61.04 -48.76 87.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -71.45 -30.62 66.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.012 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -37.91 87.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.81 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.11 -39.51 17.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.999 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.532 HD11 ' HA ' ' A' ' 43' ' ' VAL . 6.9 mp -86.23 -49.5 7.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 0.0 111.939 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.18 29.25 5.52 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.224 -172.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -60.89 141.75 92.97 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.247 -0.476 . . . . 0.0 111.293 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.54 ' HD2' HG22 ' A' ' 61' ' ' THR . 50.1 Cg_exo -57.31 165.57 5.46 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.15 2.567 . . . . 0.0 113.351 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 104.58 2.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.365 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.25 93.17 5.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.108 0.48 . . . . 0.0 110.594 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.87 62.12 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.196 0.522 . . . . 0.0 109.865 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -127.88 80.22 72.43 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.48 -175.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.98 -1.5 11.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.339 2.693 . . . . 0.0 112.497 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -74.43 13.76 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.323 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.84 13.28 20.5 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.344 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 66' ' ' ASP . 8.7 m -83.99 87.22 7.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.261 0.553 . . . . 0.0 110.619 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.43 ' HA ' HD22 ' A' ' 71' ' ' ASN . 8.8 m120 -113.73 24.04 12.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.742 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.38 55.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.101 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -112.79 121.92 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.0 p90 -111.22 147.25 35.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 111.569 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.836 ' HB2' HD12 ' A' ' 91' ' ' LEU . 1.5 m-85 -147.96 160.75 42.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.066 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.29 115.99 50.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.311 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.417 ' HZ ' HG21 ' A' ' 43' ' ' VAL . 12.2 m-30 -94.0 124.75 38.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -78.4 106.09 10.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.178 0.513 . . . . 0.0 109.815 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.579 HE22 ' HB3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -158.24 41.91 0.27 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.117 -178.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.492 ' NE2' HE21 ' A' ' 88' ' ' GLN . 27.7 mp0 -107.99 120.39 47.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.821 -171.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.1 Cg_exo -69.72 176.06 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 123.084 2.523 . . . . 0.0 112.523 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.85 11.31 72.46 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.746 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -86.67 109.75 19.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.9 mp0 72.34 -52.62 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.16 0.912 . . . . 0.0 111.144 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.94 76.58 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.936 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -111.93 84.84 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.616 HG22 ' HB1' ' A' ' 109' ' ' ALA . 55.4 m -171.44 101.43 0.2 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.908 -174.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.492 HE21 ' NE2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -132.33 169.0 17.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.93 0.395 . . . . 0.0 111.16 -173.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.463 ' HB3' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -130.04 166.31 20.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.799 -175.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 117.57 17.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.849 0.357 . . . . 0.0 111.429 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.836 HD12 ' HB2' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -84.26 112.02 19.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.28 118.95 32.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.333 0.587 . . . . 0.0 111.277 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.728 ' HG ' HD11 ' A' ' 101' ' ' LEU . 2.2 mp -102.93 142.55 33.85 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.447 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.56 123.17 27.4 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.708 ' HB3' HD22 ' A' ' 101' ' ' LEU . 11.1 p90 -131.3 145.38 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.895 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -69.15 159.79 32.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.359 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -19.04 12.72 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -174.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -15.67 61.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.708 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 101.56 11.73 37.42 Favored Glycine 0 C--O 1.221 -0.706 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.754 -176.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.915 HG13 ' HA2' ' A' ' 49' ' ' GLY . 43.0 t -94.32 114.0 30.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.856 -0.202 . . . . 0.0 110.733 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -54.77 102.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.393 0.433 . . . . 0.0 110.542 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.37 -29.43 24.45 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.99 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -156.7 143.41 18.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.415 HG13 HD12 ' A' ' 101' ' ' LEU . 18.7 mt -121.07 141.74 40.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -129.6 102.89 6.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.623 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.729 ' HB2' HD23 ' A' ' 91' ' ' LEU . 34.8 t30 -135.45 100.13 4.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 110.137 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -121.01 131.6 24.44 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.428 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.579 ' HB3' HE22 ' A' ' 79' ' ' GLN . 46.0 Cg_exo -56.42 146.25 74.84 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.067 2.511 . . . . 0.0 112.983 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -45.93 -41.98 12.22 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.244 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 87' ' ' THR . 0.1 OUTLIER -78.56 90.36 4.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.067 0.46 . . . . 0.0 110.15 178.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -71.4 148.04 47.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.483 178.18 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.12 -65.72 1.98 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.57 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -66.45 -67.87 0.42 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.762 0.315 . . . . 0.0 110.675 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 111' ' ' SER . 0.1 OUTLIER -112.45 116.29 30.06 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.539 ' HG3' ' H ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -89.79 157.83 17.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.205 0.526 . . . . 0.0 111.695 -171.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.52 47.81 0.98 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.034 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -88.6 60.18 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.057 -170.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 16.7 t60 55.67 85.75 0.07 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.267 0.556 . . . . 0.0 111.654 174.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -107.61 91.2 3.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.003 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -89.52 63.75 6.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.681 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 117.892 -1.052 . . . . 0.0 109.574 176.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.82 0.343 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -78.75 69.03 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.178 0.513 . . . . 0.0 110.656 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 80.47 9.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.682 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.71 116.89 10.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.622 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.91 150.4 26.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.141 0.496 . . . . 0.0 111.011 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.78 67.82 1.35 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.087 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG13 ' H ' ' A' ' 27' ' ' VAL . 2.0 p -70.37 -57.54 7.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.421 -173.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.44 ' H ' HG13 ' A' ' 26' ' ' VAL . 3.2 t 47.2 72.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.09 0.472 . . . . 0.0 110.982 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -89.41 126.86 35.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.123 0.487 . . . . 0.0 110.967 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -132.52 131.76 22.4 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 8.6 Cg_exo -72.54 51.63 1.88 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 123.011 2.474 . . . . 0.0 111.682 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.06 -30.2 17.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.009 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.542 HG12 ' HG2' ' A' ' 34' ' ' GLN . 0.1 OUTLIER -77.92 148.66 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.591 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.89 62.74 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.331 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.542 ' HG2' HG12 ' A' ' 32' ' ' ILE . 5.4 pt20 -104.36 132.29 50.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.721 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.72 38.0 92.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.99 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -94.5 122.98 37.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.694 0.283 . . . . 0.0 110.679 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -104.61 166.76 10.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.48 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD11 HD22 ' A' ' 59' ' ' LEU . 7.5 tp -74.52 137.62 42.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.556 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -90.68 144.99 25.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 178.055 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.87 75.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -74.11 -29.91 62.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 0.0 111.194 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -72.96 -20.26 61.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.408 -175.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 39' ' ' THR . 2.2 t -74.54 -16.47 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.166 0.507 . . . . 0.0 110.654 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -83.91 -6.94 59.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' A' ' 42' ' ' ASP . 4.6 pttt -82.23 -8.0 59.64 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.377 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -102.87 162.41 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -132.81 168.79 17.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.145 0.498 . . . . 0.0 112.241 -169.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -76.96 137.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.38 171.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.921 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 83.49 5.36 88.59 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.56 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -89.15 136.35 33.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.25 145.17 51.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.849 0.356 . . . . 0.0 111.272 -176.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -56.41 -29.3 61.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.639 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.17 -42.15 89.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.2 62.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.124 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.416 HG21 HD23 ' A' ' 101' ' ' LEU . 72.3 t -60.43 -46.58 95.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.223 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.99 78.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -45.71 93.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.211 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.69 ' HB1' ' HE3' ' A' ' 45' ' ' LYS . . . -80.43 -39.39 28.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.144 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 38' ' ' LEU . 70.0 mt -86.09 -18.67 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.22 40.71 13.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.46 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.4 m -95.58 133.84 25.12 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.104 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.4 Cg_exo -69.68 157.48 60.39 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.904 2.403 . . . . 0.0 111.111 173.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 tp -86.47 87.64 7.48 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.248 0.546 . . . . 0.0 110.367 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.3 115.06 29.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.669 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 140.07 47.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.498 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -91.46 123.74 63.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.96 -2.16 12.28 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.822 2.348 . . . . 0.0 113.284 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -99.61 -20.59 16.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.77 10.66 26.3 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.94 90.15 5.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.111 0.481 . . . . 0.0 109.796 177.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.42 ' HA ' HD22 ' A' ' 71' ' ' ASN . 0.0 OUTLIER -80.24 61.35 4.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -174.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.484 HG23 HG23 ' A' ' 94' ' ' THR . 0.2 OUTLIER -126.01 123.04 37.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 177.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.551 ' HB2' ' HZ ' ' A' ' 95' ' ' PHE . 1.5 m0 -103.89 122.57 45.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -108.37 121.91 45.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.703 0.763 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.38 153.66 21.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.057 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 78.9 t -123.48 107.67 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.801 ' HE2' ' HG ' ' A' ' 91' ' ' LEU . 55.1 p90 -142.17 146.97 35.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.76 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 106.45 18.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.547 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -113.7 -0.3 14.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -105.4 138.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.303 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 23.6 Cg_exo -63.78 145.04 90.35 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.828 2.352 . . . . 0.0 111.996 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.23 71.43 1.49 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.836 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -119.49 136.73 54.2 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 3.3 mt-10 74.41 -17.37 0.47 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.946 0.779 . . . . 0.0 111.016 -176.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 83' ' ' HIS . . . 89.88 -36.39 3.55 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.924 169.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.08 88.82 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.374 -0.486 . . . . 0.0 110.309 -176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -157.69 121.61 4.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.406 0.622 . . . . 0.0 111.197 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -170.58 150.49 3.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.421 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.77 156.2 44.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.997 0.427 . . . . 0.0 111.204 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -93.71 129.04 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.969 174.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.801 ' HG ' ' HE2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -85.62 103.96 14.92 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.708 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -102.0 105.9 16.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.309 0.576 . . . . 0.0 111.816 -174.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.3 mt -93.79 125.25 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.677 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.484 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -115.7 123.45 48.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.551 ' HZ ' ' HB2' ' A' ' 73' ' ' TRP . 0.1 OUTLIER -118.88 151.67 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -88.93 167.78 12.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.33 -23.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -171.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -3.64 47.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.32 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 84.16 28.17 34.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.296 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.921 HG13 ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -112.85 130.75 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 122.274 0.229 . . . . 0.0 110.436 -177.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -55.72 103.06 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.632 0.583 . . . . 0.0 111.263 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.37 -18.5 24.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.0 110.643 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -162.67 138.72 7.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.562 HD12 HG13 ' A' ' 48' ' ' VAL . 3.0 mt -113.61 136.48 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.708 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 28.7 t70 -117.79 103.34 9.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.673 178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -131.38 100.65 5.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.145 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.02 119.54 10.58 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.756 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.74 155.96 20.44 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.873 2.382 . . . . 0.0 112.436 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 88' ' ' GLN . . . -64.7 92.31 0.09 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.033 0.444 . . . . 0.0 110.561 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -157.33 136.16 11.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.1 -178.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.8 m 73.88 148.57 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 124.208 0.942 . . . . 0.0 112.303 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.2 -99.65 1.83 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.933 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -64.05 -34.1 77.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.071 0.462 . . . . 0.0 110.235 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.78 107.78 5.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.328 177.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -81.3 111.09 17.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.418 ' HB2' ' HG ' ' A' ' 110' ' ' LEU . 45.3 t-80 -71.84 104.87 3.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.696 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.52 -58.8 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.388 -174.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.18 59.29 0.65 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.695 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 1.4 m-70 -101.46 126.67 48.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.4 -5.55 6.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.315 0.579 . . . . 0.0 109.933 172.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 . . . . . 0 C--O 1.254 1.304 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.574 179.344 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.838 0.351 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.77 73.65 2.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.412 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.98 94.74 4.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.484 174.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 mt -81.41 152.01 27.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.58 -171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -83.71 133.93 34.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 -178.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -105.35 125.55 51.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.949 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.8 143.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.836 0.351 . . . . 0.0 111.063 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -168.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.985 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.816 ' HE2' ' HG3' ' A' ' 34' ' ' GLN . 2.1 p90 -96.95 163.31 13.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.814 0.34 . . . . 0.0 110.783 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.669 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 1.4 ptp180 -123.21 138.53 30.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.96 51.61 1.65 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.766 2.311 . . . . 0.0 112.656 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.669 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 19.5 t70 -97.82 37.48 1.4 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.632 0.73 . . . . 0.0 110.303 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.49 -66.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.909 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.37 -70.91 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.414 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.816 ' HG3' ' HE2' ' A' ' 28' ' ' TYR . 6.6 mm100 46.3 53.6 9.36 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.972 0.795 . . . . 0.0 112.335 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.7 166.44 22.5 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.652 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.72 -19.16 45.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.514 0.673 . . . . 0.0 109.591 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -131.86 -169.48 2.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.966 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.718 HD13 ' HE1' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -112.02 155.36 23.91 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.68 142.56 49.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.915 0.388 . . . . 0.0 111.569 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.64 -38.44 23.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.404 0.621 . . . . 0.0 110.192 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.37 -17.78 64.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 1.2 t0 -77.65 -20.38 53.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.33 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.48 ' HA ' HD13 ' A' ' 59' ' ' LEU . 14.5 t -71.29 -28.1 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.935 0.397 . . . . 0.0 111.147 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -7.21 22.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.696 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -77.92 -15.32 59.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.089 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.474 HG21 HG13 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -100.87 172.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.161 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.5 160.86 39.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.875 -178.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.55 152.03 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 1.008 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 79.42 -4.72 62.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.211 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.9 mtp -85.1 141.84 29.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -70.56 146.43 50.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.802 -175.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -31.9 62.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.984 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -69.31 -39.52 78.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.032 0.444 . . . . 0.0 110.043 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.03 -34.74 64.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.199 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG13 HG21 ' A' ' 46' ' ' ILE . 76.1 t -61.71 -48.03 90.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.763 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HB2' ' CH2' ' A' ' 73' ' ' TRP . . . -67.87 -29.66 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.151 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -41.8 72.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.094 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.05 -59.6 2.71 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -91.51 -2.18 57.28 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.277 0.561 . . . . 0.0 111.39 -171.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.72 46.27 9.86 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.753 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -89.9 136.41 29.19 Favored Pre-proline 0 C--N 1.317 -0.81 0 O-C-N 122.818 -0.225 . . . . 0.0 111.121 177.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 16.2 Cg_exo -68.58 132.02 24.32 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.37 2.047 . . . . 0.0 111.284 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.86 118.16 19.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.072 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.0 ttp -92.15 119.98 32.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.389 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.13 109.35 13.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -114.46 93.19 31.13 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.615 0.722 . . . . 0.0 111.066 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.92 -9.12 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.04 1.827 . . . . 0.0 111.22 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -96.31 -21.99 17.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.115 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 12.07 25.81 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.19 83.4 2.37 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.146 0.498 . . . . 0.0 110.757 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -94.51 67.57 3.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.236 -177.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -135.61 147.28 48.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.721 -178.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -127.44 148.49 50.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.965 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -133.82 133.59 41.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 0.0 110.594 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.718 ' HE1' HD13 ' A' ' 38' ' ' LEU . 2.4 m-85 -117.2 134.6 54.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.523 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.98 107.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.93 114.29 22.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -91.17 103.01 15.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.523 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 1.7 pt20 -127.34 37.65 4.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 8.4 pm0 -116.23 136.68 23.07 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.418 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 4.5 Cg_exo -78.11 165.21 26.28 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.788 2.326 . . . . 0.0 111.631 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.23 67.08 3.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.122 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.413 ' HB3' ' H ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -168.71 -99.5 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 mp0 -93.94 149.74 20.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.797 0.332 . . . . 0.0 110.445 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.85 45.32 17.11 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.275 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.81 88.44 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 109' ' ' ALA . 1.9 t -164.72 176.18 9.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.572 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -114.07 109.99 19.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.535 1.061 . . . . 0.0 113.67 -162.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.722 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -76.58 128.87 35.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.76 172.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 120.7 22.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -174.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.433 HD11 HD22 ' A' ' 106' ' ' ASN . 0.5 OUTLIER -85.15 112.26 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.719 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.52 111.11 23.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.83 134.55 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.811 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -131.23 117.76 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -124.8 136.21 53.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.932 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -73.24 165.68 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.863 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.32 -13.89 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -5.85 42.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 175.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 83.99 12.77 76.19 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.008 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -105.54 122.47 58.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.995 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 55' ' ' VAL . 1.6 mm? -55.42 107.27 0.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.098 174.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.67 -36.04 10.38 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.956 0.408 . . . . 0.0 110.879 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 41.2 t30 -137.06 135.97 37.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.654 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.28 132.2 71.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.81 100.94 11.68 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.433 HD22 HD11 ' A' ' 91' ' ' LEU . 21.9 t-20 -116.7 99.6 7.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 1.3 mtmt -156.4 141.6 12.42 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.079 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.722 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 16.9 Cg_exo -68.25 169.46 16.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.664 2.243 . . . . 0.0 111.536 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.651 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -71.66 -22.22 61.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.578 0.704 . . . . 0.0 110.257 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -96.74 92.17 6.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.258 -177.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -86.78 163.54 17.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.86 172.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.51 -48.01 56.06 Favored Glycine 0 C--N 1.332 0.318 0 O-C-N 123.485 0.49 . . . . 0.0 113.487 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -127.91 56.74 1.57 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.28 0.562 . . . . 0.0 110.722 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 6.5 tp -122.07 -134.86 0.3 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.944 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -60.71 -51.57 68.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 30.7 m80 61.84 -131.5 0.64 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -174.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -147.44 18.8 1.19 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.677 0.751 . . . . 0.0 109.114 169.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.52 103.96 0.94 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.357 -174.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -78.04 106.78 10.14 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -79.45 52.21 1.35 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.023 0.44 . . . . 0.0 110.87 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.881 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 120.802 0.334 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.01 160.69 15.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.724 0.297 . . . . 0.0 110.958 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 t -127.77 150.56 49.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.982 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.16 -94.48 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.592 0.234 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.72 69.42 1.07 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.701 0.286 . . . . 0.0 111.18 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.672 ' HG3' HG23 ' A' ' 26' ' ' VAL . 9.7 ptp180 -174.97 172.49 2.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.066 177.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.672 HG23 ' HG3' ' A' ' 25' ' ' ARG . 73.3 t 79.28 108.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 124.086 0.867 . . . . 0.0 111.293 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.66 94.18 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.064 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.15 137.64 56.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.659 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -87.27 116.23 65.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.256 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 23.2 Cg_exo -65.19 -21.76 61.93 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.916 2.411 . . . . 0.0 112.377 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -124.21 118.67 27.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.218 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.27 -171.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.428 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -120.6 81.38 1.75 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -115.6 146.27 41.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.038 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.71 130.71 5.61 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.09 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -89.18 46.75 1.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -162.72 154.96 18.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.078 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 38' ' ' LEU . 13.6 tp -76.7 127.13 32.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.958 0.408 . . . . 0.0 110.234 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 m -87.4 144.72 26.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.48 93.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.211 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -60.64 -33.58 73.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.241 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.603 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -71.48 -25.43 62.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 -176.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 46' ' ' ILE . 46.7 t -74.49 -32.3 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.209 0.528 . . . . 0.0 110.27 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -6.82 47.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.111 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.603 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -74.82 -20.23 59.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -110.71 -173.43 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 176.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -156.58 171.52 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.794 0.33 . . . . 0.0 111.018 -174.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 48' ' ' VAL . 1.1 m -71.58 149.6 9.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.739 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 72.35 6.64 65.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.206 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.33 148.05 24.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.766 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -74.82 142.87 44.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.85 0.357 . . . . 0.0 110.731 -175.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -27.43 69.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.612 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -71.81 -35.31 69.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.362 -178.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.11 -36.35 48.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.299 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 83.0 t -58.41 -47.85 86.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB1' ' OG1' ' A' ' 61' ' ' THR . . . -61.42 -39.14 89.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.326 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.92 55.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.585 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.74 -58.66 3.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.595 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -95.26 -16.58 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.54 95.31 0.77 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.748 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' HB1' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -78.51 155.2 78.91 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.82 148.33 40.88 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.566 2.177 . . . . 0.0 110.585 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.61 87.11 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.298 0.57 . . . . 0.0 110.624 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -104.93 120.39 41.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.806 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.61 133.18 34.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.31 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -160.26 94.79 1.56 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 110.482 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.45 -3.03 7.66 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.812 2.341 . . . . 0.0 111.919 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.67 -27.52 22.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.213 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.14 35.25 4.55 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.451 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.0 m -76.2 89.62 3.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.355 0.597 . . . . 0.0 110.021 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 8.5 m120 -88.09 51.76 2.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.335 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.71 13.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.71 176.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.6 m0 -103.56 121.63 43.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.917 0.389 . . . . 0.0 110.299 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -104.88 115.06 29.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.885 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -119.39 140.81 49.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.889 0.376 . . . . 0.0 110.609 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.82 129.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.95 -176.14 2.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.186 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.4 123.65 36.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.983 0.42 . . . . 0.0 110.375 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.519 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -77.82 167.29 21.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.793 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -102.23 93.82 4.23 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 92.7 Cg_endo -93.44 164.77 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.048 2.499 . . . . 0.0 114.22 -169.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.65 -107.85 1.02 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -107.59 -7.36 16.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.214 0.531 . . . . 0.0 109.651 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -178.88 5.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.916 172.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.45 36.95 11.35 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.21 86.58 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.652 HG22 ' HB1' ' A' ' 109' ' ' ALA . 53.3 m -164.95 170.02 15.74 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -170.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.412 ' N ' HG22 ' A' ' 87' ' ' THR . 22.9 tp60 -123.35 129.06 50.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.774 0.715 . . . . 0.0 112.119 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 4.1 pm0 -94.84 137.97 33.22 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.96 129.41 56.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.99 104.61 14.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 m -105.2 109.37 21.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.279 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 3.0 mp -88.31 130.7 35.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.498 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.16 118.4 26.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.686 ' HB3' ' HA ' ' A' ' 101' ' ' LEU . 40.6 p90 -144.04 151.99 40.4 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.645 -173.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -77.81 154.55 31.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.672 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.26 -14.23 24.64 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.868 0.467 . . . . 0.0 111.936 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -73.49 -3.38 27.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.166 0.507 . . . . 0.0 110.577 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.59 6.26 59.73 Favored Glycine 0 C--O 1.22 -0.774 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.551 175.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 49' ' ' GLY . 93.9 t -97.42 112.1 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.666 0.233 . . . . 0.0 111.097 -172.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.686 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -55.34 103.35 0.09 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.584 0.552 . . . . 0.0 110.016 174.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.643 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -75.71 -30.98 59.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.727 0.298 . . . . 0.0 110.587 -175.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.05 152.71 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.368 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.4 mt -112.7 134.11 56.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -91.53 101.36 14.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.157 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -119.08 100.32 7.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -142.61 146.94 40.51 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.178 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 10.3 Cg_exo -72.07 166.97 28.04 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.507 2.138 . . . . 0.0 112.31 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.652 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -72.81 66.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.672 176.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 115' ' ' GLU . 0.3 OUTLIER -156.81 108.93 2.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.351 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.79 144.33 56.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.775 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.96 64.2 3.41 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.467 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 17.4 t30 -159.09 83.54 0.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER 73.28 -73.75 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.994 0.809 . . . . 0.0 110.84 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.484 ' HA ' HD11 ' A' ' 110' ' ' LEU . 1.4 tt0 179.48 170.78 1.02 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -67.44 -20.16 65.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 110.52 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -137.87 172.0 13.59 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -17.87 26.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.763 0.316 . . . . 0.0 110.4 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 m80 61.19 -89.15 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.297 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -147.78 47.04 1.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.017 0.437 . . . . 0.0 111.599 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.962 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.613 -0.143 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m 64.09 179.29 0.17 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.833 0.708 . . . . 0.0 111.176 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.51 130.61 40.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.678 0.275 . . . . 0.0 110.828 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB2' HH21 ' A' ' 25' ' ' ARG . 1.4 mp -120.64 99.83 6.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.891 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.14 131.69 41.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.512 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.505 HH21 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -101.04 141.31 34.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.197 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.01 88.46 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.025 0.44 . . . . 0.0 110.507 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.614 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.6 p -89.51 178.38 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.393 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.614 ' H ' HG22 ' A' ' 27' ' ' VAL . 23.7 t80 -55.14 131.11 44.41 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.737 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.521 ' HG2' ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -97.57 132.33 25.39 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HD2' ' HG2' ' A' ' 29' ' ' ARG . 11.9 Cg_endo -55.35 99.3 0.07 OUTLIER 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.016 2.477 . . . . 0.0 111.989 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.633 ' HB3' ' HG2' ' A' ' 34' ' ' GLN . 30.0 t0 -65.8 155.47 36.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.535 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.6 ' H ' HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -98.15 142.24 14.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.348 -173.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 t30 69.62 -67.06 0.24 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.428 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.633 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 13.7 mm-40 56.48 36.54 27.73 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.588 0.555 . . . . 0.0 111.948 173.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.92 70.93 3.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.517 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -119.35 141.63 48.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.835 0.35 . . . . 0.0 111.256 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -100.13 -174.72 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.407 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.622 HD12 ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -90.53 127.42 36.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.114 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' H ' ' A' ' 41' ' ' ASN . 72.5 m -96.93 144.67 26.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.437 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.94 -24.52 67.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.27 0.557 . . . . 0.0 110.881 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.93 ' H ' HG22 ' A' ' 39' ' ' THR . 12.9 t-20 -74.01 -20.95 60.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.43 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 39' ' ' THR . 7.5 m-20 -74.66 -31.28 61.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.533 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.574 HG21 ' HZ ' ' A' ' 77' ' ' PHE . 2.0 t -64.85 -24.97 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.824 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -10.8 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.724 0.297 . . . . 0.0 111.46 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -73.87 -34.35 64.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.188 0.518 . . . . 0.0 109.841 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -108.97 -178.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.91 157.3 31.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.72 0.295 . . . . 0.0 110.758 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.29 130.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.149 0.5 . . . . 0.0 109.818 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.908 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 96.93 -8.79 65.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.902 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 148.72 39.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.99 146.18 37.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.084 -175.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -47.39 -40.29 17.34 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.851 0.72 . . . . 0.0 111.999 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.444 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 7.1 mp0 -67.77 -42.29 81.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.546 -175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -78.39 -33.33 48.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.393 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.47 -46.96 94.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 61' ' ' THR . . . -68.9 -38.74 79.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.726 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -40.12 83.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.66 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -40.61 55.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.582 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.25 -38.93 23.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.665 0.269 . . . . 0.0 111.659 -176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.21 19.87 11.09 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.48 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 2.5 m -80.5 135.19 53.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.956 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.55 131.68 32.59 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.481 2.121 . . . . 0.0 111.074 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mt -72.83 125.04 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.813 0.339 . . . . 0.0 110.526 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.401 ' HB2' ' HE1' ' A' ' 73' ' ' TRP . 4.9 ttm -102.23 148.16 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.634 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.483 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -84.18 -177.11 6.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.868 176.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.574 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 11.0 p-10 -134.87 49.79 4.14 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 66' ' ' ASP . 13.3 Cg_exo -68.16 -27.42 35.34 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.822 1.681 . . . . 0.0 111.072 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.23 -2.08 24.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.25 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.41 37.57 5.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.225 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.574 ' OG1' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.49 103.79 3.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.029 0.442 . . . . 0.0 111.585 -172.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -115.18 12.88 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.956 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -134.68 145.31 48.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 -178.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.3 m0 -123.72 140.26 53.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -112.32 111.45 22.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.21 141.84 42.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.632 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -89.07 111.96 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.483 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.622 ' HE1' HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -96.68 170.98 8.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.156 -177.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -155.66 151.35 27.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.096 175.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HB2' ' H ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -129.2 -138.87 0.23 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.466 ' H ' ' HB2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.3 104.89 25.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 24.0 Cg_exo -63.59 137.26 58.46 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.254 2.636 . . . . 0.0 112.669 -176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.79 150.14 16.93 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -64.84 115.96 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 3.2 mm-40 73.11 134.66 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.045 0.841 . . . . 0.0 110.315 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.82 54.15 1.15 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -170.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.67 100.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.407 0.622 . . . . 0.0 110.093 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -162.64 158.96 23.93 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.463 -175.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -136.03 170.07 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 111.275 -172.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' OE1' ' HG3' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -95.42 130.97 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.036 177.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -99.86 115.05 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.48 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -83.52 104.85 13.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 109.884 -176.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -97.93 110.55 23.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.646 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.7 mp -98.79 130.93 45.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.957 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -121.81 129.31 52.54 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.475 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -127.38 132.37 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 0.0 110.29 177.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB2' HG23 ' A' ' 102' ' ' THR . 20.3 t-20 -74.68 163.61 27.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.809 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -14.7 9.24 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.591 0.557 . . . . 0.0 112.137 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -10.96 60.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.243 0.544 . . . . 0.0 110.65 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.49 15.2 55.75 Favored Glycine 0 C--O 1.22 -0.743 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.862 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.908 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.4 t -112.42 130.2 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 122.432 0.293 . . . . 0.0 110.712 -172.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.805 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 2.3 mt -55.21 115.14 2.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -84.98 -33.19 22.64 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.033 0.444 . . . . 0.0 110.538 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -168.13 144.8 4.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.088 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.36 134.46 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 169.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.73 103.03 12.58 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.776 0.322 . . . . 0.0 110.386 176.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -125.31 104.81 8.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.262 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.75 133.84 23.59 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.11 132.87 38.32 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.943 2.429 . . . . 0.0 113.182 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.38 -41.47 63.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.235 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -79.61 41.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 111.097 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -165.3 -60.76 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 58.49 -119.32 16.84 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.048 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -102.78 -37.51 7.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.074 0.464 . . . . 0.0 110.574 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.2 26.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.949 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -86.87 -112.74 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.094 -174.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.447 ' H ' ' HB3' ' A' ' 115' ' ' GLU . 1.0 OUTLIER 71.7 -51.04 0.69 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -172.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 84' ' ' GLU . 0.9 OUTLIER 177.48 93.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.308 0.643 . . . . 0.0 110.204 171.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -55.43 144.83 24.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.088 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.47 55.75 0.9 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -81.25 114.01 19.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.311 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.511 0.196 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.74 74.04 0.44 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.12 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.2 m -74.7 109.94 8.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.412 175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.45 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -118.31 162.93 17.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.877 178.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.2 163.99 12.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.35 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.36 116.17 29.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.426 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 t -78.25 83.91 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.42 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 t -74.6 138.94 20.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -110.92 148.97 31.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -89.26 109.76 33.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.639 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 28' ' ' TYR . 3.3 Cg_exo -76.75 52.82 3.84 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.241 2.627 . . . . 0.0 111.951 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -95.05 -159.98 0.75 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.883 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.496 ' HB ' ' H ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER 37.67 -117.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 124.015 0.822 . . . . 0.0 111.35 -177.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.496 ' H ' ' HB ' ' A' ' 32' ' ' ILE . 37.7 t-20 -167.97 -57.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.491 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 21.7 mm-40 61.23 -148.16 0.42 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.386 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' H ' ' HB3' ' A' ' 34' ' ' GLN . . . 77.11 13.56 83.53 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.249 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -84.36 -109.49 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -163.48 -177.78 5.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 38' ' ' LEU . 2.0 tp -75.0 158.71 32.79 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 41' ' ' ASN . 11.0 t -129.15 -179.85 5.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.603 0.239 . . . . 0.0 110.384 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.49 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.071 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.501 ' H ' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.9 -31.99 73.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.787 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -68.08 -34.29 76.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 110.371 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.408 HG13 HD21 ' A' ' 91' ' ' LEU . 6.8 t -63.19 -34.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.34 0.591 . . . . 0.0 110.33 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -6.79 59.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.196 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -29.93 45.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.404 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.47 ' H ' HG13 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -96.84 -177.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.056 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -140.44 144.96 36.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.599 0.238 . . . . 0.0 110.699 -175.239 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 m -68.23 138.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.502 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.807 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 85.34 3.17 87.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.975 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.534 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -82.25 154.36 25.42 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -76.53 145.99 38.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HG3' ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -53.98 -31.78 51.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.424 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.546 ' HA ' HD21 ' A' ' 63' ' ' LEU . 23.7 mm-40 -59.57 -44.72 93.21 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 110.426 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -76.65 -35.58 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.228 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 101' ' ' LEU . 84.1 t -61.03 -43.83 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.973 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 61' ' ' THR . . . -71.66 -34.49 69.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.834 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -37.48 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.85 -52.44 7.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.96 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.1 mt -79.97 -12.28 59.73 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.08 32.44 69.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.519 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 3.2 t -100.95 146.4 32.06 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.738 0.304 . . . . 0.0 110.723 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.8 Cg_exo -64.32 132.71 34.69 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.462 2.108 . . . . 0.0 112.009 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 53' ' ' GLN . 13.3 mt -70.15 99.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.096 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.1 ttp -136.71 100.29 4.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -104.01 146.32 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.96 126.1 75.87 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.429 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.42 -5.42 9.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.402 2.735 . . . . 0.0 113.658 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.53 -12.82 55.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.156 0.503 . . . . 0.0 110.184 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.76 2.19 34.55 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 104.46 4.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.249 0.547 . . . . 0.0 110.437 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -108.39 53.89 0.67 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.727 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -128.08 140.89 51.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.46 176.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.71 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 6.8 m0 -117.29 142.86 46.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.695 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 38.6 p90 -129.73 119.62 23.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.356 0.598 . . . . 0.0 110.428 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.99 159.17 26.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.54 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.0 121.86 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.0 0.429 . . . . 0.0 110.82 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.529 ' HZ ' ' ND2' ' A' ' 106' ' ' ASN . 3.6 p90 -118.39 -174.95 2.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HD2' ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.93 138.74 48.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.864 0.364 . . . . 0.0 111.362 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.58 HE21 ' NE2' ' A' ' 80' ' ' GLN . 1.6 mt-30 -91.85 -128.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.245 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.58 ' NE2' HE21 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -116.92 105.25 49.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.53 143.34 87.58 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.865 2.377 . . . . 0.0 112.396 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.02 -136.22 2.37 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.41 15.0 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.553 0.216 . . . . 0.0 111.083 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 76.01 -60.01 0.5 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.785 0.834 . . . . 0.0 111.119 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.98 -13.32 61.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.026 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 t -109.33 88.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 109' ' ' ALA . 7.0 m -165.67 112.85 0.93 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.275 -174.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.4 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -163.54 117.49 1.56 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.271 176.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 13.5 pt20 -80.28 131.56 35.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.863 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.96 157.45 16.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.395 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -98.05 104.02 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -104.01 107.8 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.1 mp -101.24 124.18 46.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -117.76 122.23 42.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.46 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -127.14 148.07 50.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.964 0.412 . . . . 0.0 110.362 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -81.15 161.61 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -8.45 1.85 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.72 -13.34 60.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.27 14.39 48.37 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.915 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.5 t -112.16 126.94 69.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.59 0.356 . . . . 0.0 110.43 -173.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.807 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 8.2 mt -56.76 108.42 0.5 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.321 0.388 . . . . 0.0 110.179 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.46 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -74.71 -32.97 62.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.49 140.06 4.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.974 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.6 mt -102.38 134.51 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 3.2 t70 -111.04 101.8 10.31 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.394 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.529 ' ND2' ' HZ ' ' A' ' 77' ' ' PHE . 9.4 t-20 -133.32 102.17 5.45 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.06 0.457 . . . . 0.0 109.779 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.22 131.56 24.39 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.763 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.07 146.01 13.14 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.363 2.708 . . . . 0.0 112.361 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.582 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -74.55 51.58 0.47 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.164 0.506 . . . . 0.0 111.485 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -15.94 60.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -19.25 63.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.116 173.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 113' ' ' ASN . . . -67.57 113.44 5.5 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 173.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.536 ' HB3' ' O ' ' A' ' 112' ' ' GLY . 11.8 t-20 72.64 -71.31 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 tp 156.64 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.681 1.192 . . . . 0.0 108.601 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -135.88 81.95 1.92 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.667 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -65.08 -39.49 93.27 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -149.74 74.59 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -175.35 159.52 2.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.937 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.35 137.72 52.04 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.34 173.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -63.63 136.16 57.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.592 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 34.7 t60 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.719 176.645 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 121.194 0.521 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.7 m -143.17 33.5 1.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 109.685 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.09 125.11 25.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.482 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.7 tp -145.98 81.26 1.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.004 0.431 . . . . 0.0 110.744 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.36 71.48 8.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.432 0.634 . . . . 0.0 110.155 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.97 63.35 1.31 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.228 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.15 132.78 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.778 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.85 93.66 4.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.808 0.814 . . . . 0.0 110.953 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -91.56 115.98 28.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.381 174.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -120.55 139.03 28.16 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 7.9 Cg_exo -72.33 54.09 2.25 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.916 2.411 . . . . 0.0 111.105 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -127.42 7.29 6.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.106 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -85.31 143.82 10.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.651 -176.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -87.0 75.2 9.56 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.463 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -133.11 114.01 13.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.29 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.5 32.19 67.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.047 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -103.14 155.12 18.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.628 0.252 . . . . 0.0 110.429 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.8 ' HE2' ' HA ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -159.12 179.35 9.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.59 151.45 40.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.953 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.3 145.97 43.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.126 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.85 80.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.75 -18.54 63.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.154 0.502 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.73 -23.35 45.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 t -67.77 -18.38 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.045 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -7.4 51.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.669 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -17.23 38.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.42 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.516 HG21 HG13 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -115.02 165.6 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 0.0 111.471 -177.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.506 ' O ' HD12 ' A' ' 101' ' ' LEU . 15.4 mmt-85 -142.08 166.17 25.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.014 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.47 145.44 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.88 0.372 . . . . 0.0 110.189 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.652 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 79.16 1.84 86.25 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.261 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.404 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 28.4 mmt -82.09 137.31 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.82 146.09 53.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.624 0.249 . . . . 0.0 111.051 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.699 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 4.6 pt20 -57.28 -26.84 61.47 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.286 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -43.04 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 0.0 109.983 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -76.02 -32.72 59.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.52 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG13 HG21 ' A' ' 46' ' ' ILE . 59.0 t -64.59 -44.33 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.443 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -65.96 -38.02 87.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.668 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.3 -49.5 75.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.495 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.38 -47.34 34.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.3 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 5.0 mp -76.17 -43.53 42.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -175.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.13 50.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.935 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 18.9 m -77.19 134.3 67.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 120.679 0.275 . . . . 0.0 111.151 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.3 Cg_exo -66.66 146.47 79.19 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.888 2.392 . . . . 0.0 111.578 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -69.66 123.97 22.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.217 0.532 . . . . 0.0 110.179 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.75 157.54 44.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.289 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.74 126.97 47.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.125 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.93 121.54 21.94 Favored Pre-proline 0 N--CA 1.447 -0.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -86.47 -3.5 8.47 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.672 2.248 . . . . 0.0 113.522 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -102.3 -27.0 13.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.91 34.04 3.88 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.063 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -77.17 84.81 3.64 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.36 52.94 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.886 0.85 . . . . 0.0 110.3 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.54 119.87 15.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.548 175.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 5.4 m0 -104.26 128.33 52.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.762 -174.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.78 131.66 55.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.776 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 23.1 m-85 -136.47 139.84 42.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.931 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 121.44 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.8 ' HA ' ' HE2' ' A' ' 37' ' ' TYR . 7.4 p90 -140.29 150.37 43.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.302 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.684 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -105.35 114.21 28.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.9 0.857 . . . . 0.0 110.137 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -107.94 -130.15 0.29 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.259 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -65.81 129.99 94.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 5.9 Cg_exo -75.61 -161.86 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.261 2.641 . . . . 0.0 112.381 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.91 -67.33 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.565 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -163.55 158.11 20.36 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -178.09 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.6 OUTLIER 81.36 -19.83 0.4 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.064 0.852 . . . . 0.0 111.915 172.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 -37.09 1.56 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.238 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.53 86.07 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.644 0.735 . . . . 0.0 109.18 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.912 HG22 ' HB1' ' A' ' 109' ' ' ALA . 11.4 m -167.66 119.37 0.87 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.57 HE22 ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -131.48 172.44 12.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -165.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -117.71 137.8 52.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.103 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.11 136.97 54.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.925 0.393 . . . . 0.0 111.766 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.559 HD13 HD11 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -86.98 105.68 17.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.356 174.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.8 104.71 14.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.952 0.406 . . . . 0.0 110.311 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.559 HD11 HD13 ' A' ' 91' ' ' LEU . 1.2 mp -98.32 118.43 34.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.438 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.89 111.96 23.28 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.739 ' HB3' HD23 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -126.28 146.09 50.15 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.247 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 168.03 18.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -20.54 8.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -171.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.66 -5.18 56.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.971 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.699 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 87.93 22.19 43.27 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.164 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.652 HG13 ' HA2' ' A' ' 49' ' ' GLY . 53.2 t -100.28 111.52 30.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 95' ' ' PHE . 13.9 mt -54.88 101.85 0.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.054 0.454 . . . . 0.0 110.547 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -27.72 42.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.454 0.645 . . . . 0.0 109.728 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 136.19 6.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.023 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.7 mt -106.84 134.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -109.01 101.18 10.28 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -133.91 104.44 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.924 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 145.03 54.08 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 31.1 Cg_exo -59.63 162.16 16.04 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.376 2.05 . . . . 0.0 111.08 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.912 ' HB1' HG22 ' A' ' 87' ' ' THR . . . -58.9 -21.45 57.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.527 HD21 ' HG3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -86.41 -9.34 56.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.198 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.1 m 68.26 -56.95 0.49 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.373 0.669 . . . . 0.0 112.245 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -168.25 -132.93 1.48 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.02 58.57 5.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.962 0.41 . . . . 0.0 110.528 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -163.09 140.63 7.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.942 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HG3' HD21 ' A' ' 110' ' ' LEU . 2.4 mp0 -102.0 117.44 34.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.347 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.52 179.46 0.21 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.777 0.673 . . . . 0.0 110.797 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.31 91.87 0.18 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -37.01 77.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 110.427 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -103.8 113.97 27.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 170.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -67.82 129.38 39.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.836 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 117.757 -1.116 . . . . 0.0 108.718 173.287 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.778 0.323 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.92 133.41 46.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.062 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.2 m -116.22 111.63 20.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.235 0.54 . . . . 0.0 111.298 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 120.73 40.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.35 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.2 150.7 25.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.84 0.352 . . . . 0.0 110.408 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -108.04 132.7 53.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.132 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.53 66.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.374 0.607 . . . . 0.0 109.563 175.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.579 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.4 p -104.08 177.56 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.311 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.579 ' H ' HG22 ' A' ' 27' ' ' VAL . 29.8 t80 -61.94 120.34 10.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.092 0.472 . . . . 0.0 110.801 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.475 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -105.64 137.55 19.34 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 173.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 4.5 Cg_exo -75.88 18.99 0.59 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 123.048 2.499 . . . . 0.0 113.192 -177.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -125.06 81.61 1.98 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.872 0.368 . . . . 0.0 110.785 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.454 HD13 ' CG ' ' A' ' 34' ' ' GLN . 0.3 OUTLIER -153.0 162.4 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.014 -179.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -85.48 61.84 7.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.159 0.504 . . . . 0.0 111.107 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.454 ' CG ' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -148.18 13.6 0.99 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.295 175.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.76 170.31 13.6 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.232 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 179.89 -179.26 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -79.83 -174.89 4.62 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -72.61 155.46 40.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.36 -0.382 . . . . 0.0 109.976 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 162.95 25.68 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.87 69.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.998 0.428 . . . . 0.0 110.637 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -68.19 -23.62 64.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.059 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -84.61 -22.35 30.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.74 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 46' ' ' ILE . 39.6 t -71.02 -27.16 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.309 0.576 . . . . 0.0 110.436 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -5.05 12.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.797 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HB2' ' HE2' ' A' ' 45' ' ' LYS . 9.1 mtmt -78.24 -13.25 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.533 HG21 HG13 ' A' ' 55' ' ' VAL . 1.1 pp -110.84 -176.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.7 ' HB2' ' HG3' ' A' ' 50' ' ' MET . 84.3 mmt-85 -141.64 159.03 43.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.446 -173.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.9 121.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.916 174.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.624 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 103.22 -2.68 47.19 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -175.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.7 ' HG3' ' HB2' ' A' ' 47' ' ' ARG . 5.6 mtt -65.98 147.11 53.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -79.16 151.72 31.13 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -49.65 -43.24 46.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.596 0.56 . . . . 0.0 111.435 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -68.86 -37.29 78.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.28 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -73.23 -33.34 65.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.533 HG13 HG21 ' A' ' 46' ' ' ILE . 59.0 t -61.77 -51.11 76.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.572 174.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.95 82.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.715 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -45.66 88.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.391 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . -76.74 -51.97 10.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.506 HD21 HD11 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -73.5 -35.37 65.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.298 -175.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.1 27.42 10.96 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -71.64 135.95 83.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.311 -0.445 . . . . 0.0 111.769 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.64 137.97 52.24 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 110.917 171.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.65 134.24 53.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.51 155.53 16.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.102 0.477 . . . . 0.0 111.319 -172.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.91 81.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.254 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.79 75.14 68.32 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.189 0.518 . . . . 0.0 110.003 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -75.92 -3.44 13.86 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.696 2.931 . . . . 0.0 112.208 -173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -19.68 63.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.38 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.6 18.76 10.47 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.016 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.09 105.64 4.63 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.705 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 5.4 m-80 -92.13 36.14 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.435 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.98 128.49 34.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.301 177.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 1.1 m0 -103.7 141.39 36.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.759 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -113.49 111.38 21.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.011 0.434 . . . . 0.0 110.458 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' CE1' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -106.55 129.12 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.994 178.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 t -108.77 107.26 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 20.7 p90 -123.52 153.71 40.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.057 0.456 . . . . 0.0 110.645 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 139.24 58.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.946 -172.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.422 ' CD ' HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.18 -169.52 2.68 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.515 174.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' N ' HE21 ' A' ' 80' ' ' GLN . 0.0 OUTLIER -74.83 139.2 73.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 16.9 Cg_exo -68.03 68.44 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.196 2.598 . . . . 0.0 113.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 161.2 -96.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.829 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 87' ' ' THR . 0.4 OUTLIER 57.43 -100.7 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.861 0.465 . . . . 0.0 111.527 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.501 ' H ' ' HB3' ' A' ' 83' ' ' HIS . 8.3 tp10 -123.27 -14.66 7.41 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.19 -37.75 3.32 Favored Glycine 0 C--N 1.322 -0.218 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.4 89.02 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 164.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 83' ' ' HIS . 3.5 m -156.03 113.62 3.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.896 -161.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.632 ' H ' ' HB3' ' A' ' 109' ' ' ALA . 4.1 tp-100 -170.19 -178.43 2.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -161.71 155.08 21.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.546 0.612 . . . . 0.0 111.198 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -126.72 125.51 41.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.875 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.517 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -84.75 111.17 19.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.138 -177.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.64 107.04 18.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.651 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.4 mp -100.63 121.46 41.65 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -113.59 127.57 56.12 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -127.17 158.08 38.04 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -88.73 171.75 9.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.33 -25.49 24.35 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -13.13 60.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.007 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.606 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.06 22.79 24.34 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.624 HG13 ' HA2' ' A' ' 49' ' ' GLY . 42.0 t -99.42 115.87 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.109 0.164 . . . . 0.0 110.674 -174.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.4 HD12 HG13 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -53.96 107.38 0.26 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 110.606 177.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.45 -13.77 17.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.771 -176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.554 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 22.3 t-20 -159.85 127.84 4.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.237 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.4 HG13 HD12 ' A' ' 101' ' ' LEU . 5.0 mt -108.44 142.08 22.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -144.53 103.05 3.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.848 0.356 . . . . 0.0 111.143 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.408 ' HB2' HD23 ' A' ' 91' ' ' LEU . 21.9 t30 -115.51 109.31 17.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 2.2 mmtt -121.94 107.0 36.0 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.279 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 8.3 Cg_exo -72.22 143.45 39.67 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.021 2.48 . . . . 0.0 112.352 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.632 ' HB3' ' H ' ' A' ' 88' ' ' GLN . . . -60.08 92.64 0.02 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.552 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.485 ' HG ' ' NE2' ' A' ' 83' ' ' HIS . 0.3 OUTLIER 177.21 -47.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.559 177.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.25 133.53 48.18 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.23 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.81 -49.28 0.52 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -177.04 -33.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -20.1 63.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.771 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 18.02 77.83 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.822 1.249 . . . . 0.0 113.748 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 68.8 -80.28 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.215 0.606 . . . . 0.0 110.776 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -141.64 70.68 1.34 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.492 0.663 . . . . 0.0 109.395 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.88 120.33 42.21 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.88 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -96.68 -153.95 0.43 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.406 ' HB3' ' H ' ' A' ' 121' ' ' HIS . 0.3 OUTLIER -121.22 -155.47 0.64 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.393 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.406 ' H ' ' HB3' ' A' ' 120' ' ' HIS . 15.6 t-80 . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.749 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.916 0.389 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -140.06 48.59 1.78 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.064 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.52 109.18 16.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.835 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.86 116.01 21.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.114 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -95.71 117.9 31.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.638 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.68 118.72 3.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.29 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.6 144.72 20.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.31 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.93 89.92 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.163 0.506 . . . . 0.0 110.276 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -107.94 135.74 48.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.828 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.4 108.55 59.51 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.935 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.75 63.47 7.44 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.487 2.125 . . . . 0.0 111.508 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 1.1 t0 -153.51 169.8 22.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.945 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 31' ' ' ASP . 1.3 mp 76.92 138.06 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 123.906 0.754 . . . . 0.0 111.252 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -75.52 82.63 2.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.129 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.93 74.89 7.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.767 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.13 -143.93 5.33 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.324 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.5 t30 71.25 -94.22 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.233 0.613 . . . . 0.0 110.62 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -169.35 0.49 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.71 159.03 19.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 41' ' ' ASN . 12.3 t -127.78 170.57 12.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 0.0 110.597 175.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.82 -23.71 67.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.169 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.44 ' H ' HG23 ' A' ' 39' ' ' THR . 35.1 t30 -65.17 -30.12 71.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.986 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.95 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 42.3 m-20 -74.87 -31.15 61.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.04 -27.64 38.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.24 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -12.09 60.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.769 0.318 . . . . 0.0 111.289 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.95 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 mttt -78.01 -46.23 21.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.748 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pp -70.25 154.39 8.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.989 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.635 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.1 OUTLIER -123.75 156.64 35.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -174.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG13 HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -68.36 131.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 1.007 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 85.18 4.09 86.82 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.195 -176.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -72.21 142.45 49.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.535 ' HB ' ' OE1' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -83.93 151.1 25.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 111.121 -176.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.662 ' HG2' ' HA3' ' A' ' 99' ' ' GLY . 1.1 pt20 -51.37 -35.3 37.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.055 -172.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.535 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 2.3 mp0 -64.66 -50.32 67.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.841 0.353 . . . . 0.0 110.106 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -68.37 -36.56 79.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 51' ' ' THR . 96.9 t -59.59 -47.32 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.288 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.551 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -74.68 -23.94 58.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.149 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.25 -41.85 10.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.543 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.37 -10.94 55.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.764 0.316 . . . . 0.0 111.549 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.85 40.83 57.14 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.412 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.7 m -67.98 128.6 93.32 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.507 0.194 . . . . 0.0 111.217 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 20.9 Cg_exo -66.85 173.93 7.44 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.266 2.644 . . . . 0.0 112.289 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.88 116.66 2.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.06 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.59 127.19 46.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.375 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.38 81.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.01 115.16 64.53 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 109.268 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 -2.44 12.61 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.7 2.266 . . . . 0.0 112.647 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -100.71 -26.9 13.64 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.5 -174.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.21 38.49 4.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.348 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 m -71.28 99.26 1.89 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.387 0.613 . . . . 0.0 110.546 -174.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 95' ' ' PHE . 5.4 p30 -90.88 43.24 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.258 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.03 129.38 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.87 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 13.5 m0 -116.81 142.76 46.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -120.8 127.06 51.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.992 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.83 153.85 49.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.823 0.344 . . . . 0.0 110.305 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.89 132.76 29.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 2.6 p90 -125.81 138.1 53.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.996 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.12 116.95 13.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.793 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HB3' ' H ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -120.39 -92.5 0.54 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.543 -171.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.461 ' H ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -128.03 117.78 20.65 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.836 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 8.1 Cg_exo -71.97 -95.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.871 2.381 . . . . 0.0 111.992 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 111.17 157.36 14.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.081 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -101.85 -40.33 6.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -110.81 119.96 40.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.795 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.68 55.21 0.95 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.999 -172.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -74.88 89.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.422 0.63 . . . . 0.0 109.456 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.825 HG23 ' HB1' ' A' ' 109' ' ' ALA . 14.2 t -159.54 162.33 35.41 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.801 -171.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 88' ' ' GLN . 1.4 tp60 -136.35 179.82 6.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.439 0.638 . . . . 0.0 111.976 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.715 ' HG3' ' HA ' ' A' ' 108' ' ' PRO . 3.5 mp0 -78.94 148.23 32.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.258 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.94 118.36 27.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -112.46 105.37 13.6 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.255 0.55 . . . . 0.0 110.406 178.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -115.55 126.35 54.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.641 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 2.1 mp -111.43 131.04 55.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.975 -176.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.89 131.24 53.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.767 ' HE1' HD22 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -118.73 130.46 55.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.919 0.39 . . . . 0.0 110.784 -174.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.499 ' HB2' HG23 ' A' ' 102' ' ' THR . 66.1 t30 -77.54 162.4 27.15 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.18 45.59 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -2.51 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.892 0.377 . . . . 0.0 111.071 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.662 ' HA3' ' HG2' ' A' ' 52' ' ' GLN . . . 85.05 22.3 52.85 Favored Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.007 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.1 t -94.15 130.16 43.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.516 0.198 . . . . 0.0 110.919 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.767 HD22 ' HE1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -58.96 96.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.506 174.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.52 -32.9 58.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.179 0.514 . . . . 0.0 110.762 -178.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -164.38 142.57 6.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.838 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.456 HD12 HG13 ' A' ' 48' ' ' VAL . 3.3 mt -111.54 129.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.34 101.14 12.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.68 115.39 18.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.12 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -145.56 136.93 12.72 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.613 -177.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.715 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . 18.0 Cg_exo -66.84 169.88 13.85 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.154 2.569 . . . . 0.0 112.114 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.825 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -74.08 -28.11 61.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.085 0.469 . . . . 0.0 110.606 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -94.41 115.28 27.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.738 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 m -90.35 175.24 7.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.791 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.79 -28.3 67.33 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.681 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -64.94 -84.07 0.02 OUTLIER 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.63 123.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.744 175.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 60.04 15.41 5.08 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 170.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.465 ' HB2' HG21 ' A' ' 87' ' ' THR . 4.8 t-80 70.01 -54.8 0.61 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.953 0.501 . . . . 0.0 110.174 -173.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -92.33 106.47 18.46 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -65.13 122.47 17.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.527 -177.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -134.41 116.21 14.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.66 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.27 -175.14 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.821 -173.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.656 -0.687 . . . . 0.0 109.457 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.549 0.214 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 m -74.23 116.97 15.49 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.35 129.54 34.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.226 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 23' ' ' LEU . 1.1 mt -142.97 46.5 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.513 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.428 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -71.82 104.17 3.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.753 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.65 92.4 3.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.112 0.482 . . . . 0.0 111.383 -176.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.82 69.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.88 126.39 40.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.767 -171.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -92.8 131.52 37.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.221 -0.899 . . . . 0.0 108.901 171.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -102.92 122.38 45.86 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.155 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 8.8 Cg_exo -72.58 43.36 0.64 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 123.33 2.686 . . . . 0.0 112.223 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.68 28.14 1.59 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.494 0.664 . . . . 0.0 110.002 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.19 144.43 31.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.428 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.97 108.01 3.85 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -142.0 108.78 5.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.01 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.93 -142.17 15.97 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.775 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.7 t30 71.45 -86.64 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.309 0.644 . . . . 0.0 111.673 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -102.81 175.08 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.999 0.428 . . . . 0.0 110.93 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -129.6 152.37 49.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.884 175.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -125.27 174.09 8.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.696 0.284 . . . . 0.0 110.331 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.36 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.966 0.412 . . . . 0.0 111.337 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.42 -29.12 70.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.21 -27.4 68.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.508 ' CG2' ' HZ ' ' A' ' 77' ' ' PHE . 2.3 t -79.98 -18.65 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -75.99 -12.21 60.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.161 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -82.11 -29.29 31.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.612 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.25 -167.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 50' ' ' MET . 1.4 ptt85 -154.85 164.52 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.385 . . . . 0.0 111.601 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.28 141.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.793 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.677 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 86.4 -5.3 84.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.761 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -68.22 131.37 45.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -69.59 146.64 51.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.519 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -50.04 -37.5 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.48 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -68.53 -38.5 80.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.525 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -77.46 -31.54 53.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.359 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.09 -49.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.675 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.73 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -57.26 8.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.409 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.0 -42.66 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.26 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 38' ' ' LEU . 26.1 tp -85.88 -28.97 24.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 0.0 110.696 -175.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.06 79.67 1.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.724 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.2 m -105.62 134.32 19.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.458 0.171 . . . . 0.0 111.28 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 36.0 Cg_exo -61.42 134.96 54.53 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.833 2.355 . . . . 0.0 112.05 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 138.11 51.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.159 -175.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -140.27 170.81 15.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.277 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.7 13.32 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -155.92 90.27 2.79 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.83 -8.15 5.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.948 2.432 . . . . 0.0 112.325 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.25 -27.36 11.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -173.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.2 31.0 6.72 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -83.89 88.5 7.12 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.657 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.94 64.63 7.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.369 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.536 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -141.36 137.35 32.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.455 176.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -125.43 155.41 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.381 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.55 134.42 33.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.725 0.298 . . . . 0.0 110.468 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -122.38 146.63 47.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.272 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.68 114.38 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HZ ' ' CG2' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -94.13 128.44 40.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.114 -170.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 78' ' ' ARG . 2.8 mmt85 -77.66 103.42 7.59 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 169.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HB3' HE21 ' A' ' 89' ' ' GLN . 1.5 tp-100 -140.84 168.17 20.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 -171.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.516 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -70.87 127.47 91.73 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.246 0.546 . . . . 0.0 110.923 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 36.7 Cg_endo -93.35 -37.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.012 2.474 . . . . 0.0 113.495 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.89 -149.15 27.95 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.999 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.96 52.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.528 0.664 . . . . 0.0 111.665 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.44 -30.67 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.171 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.29 -33.64 6.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.69 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.72 86.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -161.32 98.37 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.748 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.438 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -147.0 107.36 4.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.943 178.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.613 HE21 ' HB3' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -90.88 123.64 34.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.485 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.24 138.55 44.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -84.13 115.31 22.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -106.08 132.78 51.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.177 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.5 mp -111.41 122.15 47.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.881 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.536 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -114.6 114.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -176.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.34 158.57 20.41 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.401 ' OD1' ' HB ' ' A' ' 100' ' ' VAL . 24.2 p30 -86.99 169.07 12.76 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.2 -23.42 47.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -173.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -11.63 60.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 94.5 27.05 12.2 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.246 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.677 HG13 ' HA2' ' A' ' 49' ' ' GLY . 30.7 t -111.78 125.1 69.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.865 0.333 . . . . 0.0 111.127 -174.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.667 ' HB3' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -53.68 111.11 0.67 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -24.74 13.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.915 0.388 . . . . 0.0 110.343 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -155.5 131.49 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.95 140.17 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 170.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 10.7 t70 -117.04 109.97 17.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.9 101.35 3.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.157 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 140.9 29.67 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.648 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 11.3 Cg_endo -56.14 133.37 57.59 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.514 2.143 . . . . 0.0 111.815 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.438 ' CB ' ' H ' ' A' ' 88' ' ' GLN . . . -60.67 -24.92 65.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.129 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -84.22 10.76 9.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.2 m -126.24 -173.03 2.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.159 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 117.87 109.56 2.48 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 71.32 -49.46 0.68 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.319 0.647 . . . . 0.0 110.697 -174.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.527 ' HG ' ' HG3' ' A' ' 115' ' ' GLU . 6.7 tp -168.71 -74.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HG3' ' HG ' ' A' ' 114' ' ' LEU . 92.4 mt-10 -131.3 149.38 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.778 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -102.95 -36.29 8.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.42 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -169.33 99.06 0.35 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.261 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -166.56 -42.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.869 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 74.79 74.03 0.1 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 124.11 0.881 . . . . 0.0 111.38 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -56.85 -43.98 81.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.665 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 . . . . . 0 C--O 1.243 0.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.01 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m 58.84 37.44 24.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.37 0.605 . . . . 0.0 110.699 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 76.81 5.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.362 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -126.83 143.42 51.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.592 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -134.15 118.87 18.16 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.971 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HB3' ' H ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -152.28 -96.88 0.05 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.109 178.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.465 ' H ' ' HB3' ' A' ' 25' ' ' ARG . 2.2 t 47.94 59.55 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 O-C-N 123.606 0.566 . . . . 0.0 111.126 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG22 ' HG2' ' A' ' 25' ' ' ARG . 2.3 m -112.79 163.66 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.812 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -78.76 135.51 37.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.855 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 2.0 mpp_? -109.36 128.93 24.53 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.454 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 23.8 Cg_exo -63.69 -29.0 69.02 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.655 2.237 . . . . 0.0 111.867 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -103.8 103.42 13.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.59 HG12 ' HB2' ' A' ' 34' ' ' GLN . 0.1 OUTLIER -136.57 -158.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.698 178.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -81.44 47.58 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.726 0.774 . . . . 0.0 110.196 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.59 ' HB2' HG12 ' A' ' 32' ' ' ILE . 1.2 tp-100 -90.54 90.41 7.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.918 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.08 175.82 14.64 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.663 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -127.7 -59.53 1.2 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -123.78 -169.47 1.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 168.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.84 HD21 HD11 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -113.51 150.98 32.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.909 0.385 . . . . 0.0 111.528 -175.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.05 145.25 35.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.52 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -74.27 -41.89 60.52 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.012 0.434 . . . . 0.0 110.329 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.04 -22.44 66.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.661 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 8.1 m-20 -69.49 -37.22 77.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.977 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' HA ' HD13 ' A' ' 59' ' ' LEU . 9.2 t -76.1 -16.9 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.529 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -77.81 -7.38 56.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 4.7 mtpt -82.49 -34.03 28.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.625 HG21 HG13 ' A' ' 55' ' ' VAL . 1.2 pp -80.5 160.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.157 0.503 . . . . 0.0 110.579 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.2 OUTLIER -136.92 165.51 25.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.85 -171.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -72.3 145.38 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 173.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.997 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 75.93 2.77 72.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.38 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.532 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 2.1 mmm -83.9 137.06 33.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.2 OUTLIER -78.17 152.39 32.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 -176.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -32.74 62.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.313 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -64.66 -45.34 87.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -72.63 -33.74 66.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.051 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.625 HG13 HG21 ' A' ' 46' ' ' ILE . 56.0 t -62.23 -49.68 83.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.632 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.5 69.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.78 -54.43 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.815 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.83 34.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.814 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.84 HD11 HD21 ' A' ' 38' ' ' LEU . 8.3 tp -84.79 -40.27 17.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.22 -176.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.08 63.47 0.81 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.178 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 5.7 m -101.81 133.37 20.79 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -80.19 172.45 13.78 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.136 2.557 . . . . 0.0 111.649 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 138.94 56.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.818 0.342 . . . . 0.0 110.657 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.1 ttp -142.21 178.7 7.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.052 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -121.51 152.34 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.76 0.314 . . . . 0.0 111.418 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.75 46.13 0.35 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.172 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.24 -34.08 88.93 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.0 113.449 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -104.26 7.73 35.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.797 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.03 21.13 9.18 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.425 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.84 85.61 3.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.247 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 71' ' ' ASN . 4.0 m120 -108.86 27.87 9.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.298 0.57 . . . . 0.0 111.374 -172.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -102.76 129.57 49.45 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.258 170.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -103.46 121.58 43.13 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.53 114.67 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.365 -176.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.513 ' HE2' HD13 ' A' ' 38' ' ' LEU . 11.1 m-85 -106.12 130.99 53.91 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.884 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.05 108.76 16.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.545 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -115.28 116.47 28.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 102.35 11.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.923 165.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -118.9 -37.68 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.184 0.516 . . . . 0.0 110.697 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.477 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -147.57 141.47 15.76 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.572 175.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 1.3 Cg_endo -85.4 -104.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.136 2.557 . . . . 0.0 111.987 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 81' ' ' PRO . . . 116.19 165.94 14.39 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -94.9 97.2 9.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.929 0.365 . . . . 0.0 110.787 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -159.23 -63.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.02 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 -35.76 4.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.453 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -106.42 87.18 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.555 HG23 ' HB3' ' A' ' 109' ' ' ALA . 27.2 m -159.41 101.24 1.53 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.559 -168.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -151.69 144.48 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.55 173.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.71 147.01 44.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.482 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.05 127.98 47.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.389 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.02 114.73 21.93 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.97 105.41 14.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.331 0.586 . . . . 0.0 111.515 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 6.6 mp -87.34 148.04 25.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.815 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -137.19 116.24 12.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.616 ' HB3' HD22 ' A' ' 101' ' ' LEU . 26.6 p90 -129.2 145.03 51.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.63 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.528 ' ND2' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.41 163.01 28.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.892 177.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.08 -38.49 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -3.51 25.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 91.63 17.82 47.36 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.182 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.997 HG13 ' HA2' ' A' ' 49' ' ' GLY . 14.3 t -97.08 114.22 33.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 95' ' ' PHE . 1.4 mm? -54.82 106.21 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.552 0.533 . . . . 0.0 110.837 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.41 -28.22 19.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.146 0.498 . . . . 0.0 110.891 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -158.8 149.65 20.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.696 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 mp -124.02 130.03 73.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.13 101.65 13.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.599 174.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -125.11 106.53 9.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.223 0.535 . . . . 0.0 110.376 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 144.59 35.68 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 159.64 40.71 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.299 1.999 . . . . 0.0 111.274 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -66.37 -34.92 79.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.498 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 116.54 31.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.18 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m 69.92 124.44 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.076 0.86 . . . . 0.0 110.935 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.27 -77.86 0.23 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.442 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -73.4 -35.69 65.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.46 0.648 . . . . 0.0 109.703 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.0 132.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.35 176.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -80.55 148.37 30.39 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.235 175.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -49.62 127.56 15.92 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.746 0.654 . . . . 0.0 112.263 -176.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 75.47 161.13 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.454 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -69.61 120.32 15.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.787 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -67.04 103.26 1.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.469 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.54 144.44 25.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.377 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.5 p80 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.426 -176.68 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.592 0.234 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.4 156.11 40.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.948 0.404 . . . . 0.0 110.997 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.1 133.13 34.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.873 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -85.6 49.66 1.81 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.419 0.628 . . . . 0.0 110.267 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.97 126.42 33.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.549 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -174.43 126.41 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.57 123.54 19.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.177 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.7 p -146.05 -47.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.759 0.314 . . . . 0.0 111.138 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -159.09 139.64 12.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.918 0.39 . . . . 0.0 110.742 -176.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.9 ttt85 -111.11 113.05 54.86 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.676 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.54 75.86 0.77 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.564 2.176 . . . . 0.0 110.855 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.32 -133.95 0.34 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.221 -173.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 33' ' ' ASN . 2.1 pp -92.08 -20.39 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.619 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.536 ' N ' HD12 ' A' ' 32' ' ' ILE . 17.2 t-20 -77.21 67.5 3.18 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.353 0.597 . . . . 0.0 110.477 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.98 -35.3 0.09 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.369 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.33 84.87 0.38 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.08 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -118.26 169.32 9.81 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 -179.74 3.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.658 HD23 ' HE1' ' A' ' 77' ' ' PHE . 12.4 tp -78.87 131.81 36.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.968 0.414 . . . . 0.0 110.772 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 145.84 27.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.302 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.01 81.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 110.969 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.91 -22.15 65.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.493 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -42.3 89.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.866 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' HG13 ' A' ' 46' ' ' ILE . 6.3 t -74.98 -17.06 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.747 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -73.86 -7.36 51.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.854 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -76.06 -37.9 57.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.061 0.457 . . . . 0.0 110.165 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 43' ' ' VAL . 1.1 pp -91.0 179.13 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.874 177.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.602 ' O ' ' HB2' ' A' ' 50' ' ' MET . 7.7 ptp180 -157.81 167.66 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.769 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.36 128.96 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.785 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.957 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 95.51 -4.7 66.84 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.01 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.602 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -81.26 161.84 23.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -79.29 144.67 34.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.069 0.462 . . . . 0.0 111.518 -169.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -61.31 -36.32 79.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.728 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.686 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -79.52 -30.54 41.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.154 -172.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.26 -37.68 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HA ' HG21 ' A' ' 46' ' ' ILE . 38.4 t -60.44 -46.24 95.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.796 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -68.5 -31.88 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.873 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -37.62 83.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.153 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.7 -44.8 13.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.989 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.419 HD21 ' HA ' ' A' ' 43' ' ' VAL . 88.0 mt -88.93 -6.74 57.06 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.04 55.8 17.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.464 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 56' ' ' ALA . 2.0 m -79.02 130.95 68.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.477 0.179 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.89 148.84 54.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.143 2.562 . . . . 0.0 112.588 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.2 tp -75.56 113.74 13.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.374 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.78 131.29 47.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.142 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.53 102.6 8.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.07 115.36 38.46 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 120.911 0.386 . . . . 0.0 110.571 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.43 -2.03 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.063 2.508 . . . . 0.0 112.183 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -81.55 -26.73 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.642 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.82 30.17 4.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.839 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -80.43 108.99 14.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.983 0.421 . . . . 0.0 110.59 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -112.49 39.16 2.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.427 0.632 . . . . 0.0 110.229 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -124.69 141.45 52.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.52 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.732 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 3.0 m0 -116.31 142.96 46.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -124.9 111.56 15.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.138 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.42 ' CD1' HD22 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -107.57 140.78 40.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.436 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.96 114.74 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.076 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.658 ' HE1' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -102.89 142.25 34.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.28 148.41 47.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.733 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -129.57 167.66 17.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.2 mm-40 -88.1 115.77 64.17 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 13.2 Cg_exo -70.36 70.09 1.93 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.158 2.572 . . . . 0.0 111.978 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.36 -150.0 17.51 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.444 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.61 3.04 30.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.0 111.871 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.9 -48.23 16.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.31 0.576 . . . . 0.0 110.095 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.66 -39.2 1.51 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.727 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.41 88.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 117.108 0.454 . . . . 0.0 110.798 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -169.69 136.1 1.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.89 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -154.76 130.9 10.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.095 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 108' ' ' PRO . 0.1 OUTLIER -75.14 124.56 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 110.536 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.6 110.44 20.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.954 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.517 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -83.91 106.93 15.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.974 0.416 . . . . 0.0 110.537 -175.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 111.3 22.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.853 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.732 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 4.1 mp -106.66 142.6 36.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.002 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -139.74 133.85 31.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -132.2 141.65 49.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.88 0.371 . . . . 0.0 110.442 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.494 ' HB2' HG23 ' A' ' 102' ' ' THR . 5.5 t-20 -78.1 156.56 29.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.247 176.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -14.14 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.766 0.666 . . . . 0.0 112.245 -176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -15.01 61.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 0.0 110.496 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 97.36 19.55 25.27 Favored Glycine 0 C--O 1.221 -0.716 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.164 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.957 HG13 ' HA2' ' A' ' 49' ' ' GLY . 2.2 t -113.47 126.4 70.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 122.877 0.471 . . . . 0.0 110.564 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 94' ' ' THR . 2.9 mm? -55.46 108.23 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 173.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -76.08 -31.99 59.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.838 0.351 . . . . 0.0 110.627 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -167.43 149.7 5.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.146 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.1 mt -127.7 138.33 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.73 102.82 10.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.171 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.06 101.45 9.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.27 153.71 44.9 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.188 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 89' ' ' GLN . 52.2 Cg_exo -56.73 151.49 47.39 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.87 2.38 . . . . 0.0 112.396 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -60.6 -79.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.208 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.541 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER 55.42 -99.66 0.1 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.272 0.357 . . . . 0.0 110.817 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.537 ' H ' ' HB3' ' A' ' 110' ' ' LEU . 1.2 m 57.72 57.71 4.09 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.278 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.42 -167.56 14.55 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.965 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.96 7.24 43.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.095 0.474 . . . . 0.0 110.712 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tp -171.97 -56.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.441 ' HB3' ' H ' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -120.82 -149.84 0.44 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.085 175.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.441 ' H ' ' HB3' ' A' ' 115' ' ' GLU . 6.4 p80 -57.01 148.58 21.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -44.25 131.23 6.22 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.816 0.698 . . . . 0.0 111.771 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -130.15 85.58 2.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.566 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -110.82 122.78 48.68 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.878 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -142.76 126.33 16.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.371 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 C--O 1.246 0.875 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.323 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m 54.54 52.93 11.46 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.534 0.521 . . . . 0.0 111.184 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.62 147.84 27.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.789 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.11 134.07 36.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.953 0.406 . . . . 0.0 111.066 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.84 123.42 4.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.387 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -168.72 110.38 0.52 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.76 0.314 . . . . 0.0 111.347 -178.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.97 83.93 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 171.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.49 126.83 40.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.195 -175.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -69.05 123.22 20.46 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.88 115.37 57.35 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.722 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.13 51.11 2.37 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.749 2.299 . . . . 0.0 111.574 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.76 9.89 41.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.712 -175.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HB ' ' HG2' ' A' ' 34' ' ' GLN . 0.3 OUTLIER -132.05 144.98 35.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.334 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -98.49 51.15 1.0 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.286 0.565 . . . . 0.0 110.976 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.672 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 7.1 mm100 -78.36 -7.9 57.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.174 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.89 90.0 0.28 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.665 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -128.38 38.46 3.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.391 0.615 . . . . 0.0 109.714 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -154.43 157.34 38.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.535 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.03 141.62 51.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.0 110.72 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.15 145.21 25.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.974 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.94 78.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.59 -35.54 76.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -63.37 -40.68 97.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.434 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.38 -26.4 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.295 0.569 . . . . 0.0 110.382 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m -75.8 -10.65 59.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.315 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -34.02 41.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.989 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -81.1 -150.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.711 0.291 . . . . 0.0 110.786 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.902 ' HB3' ' HG3' ' A' ' 50' ' ' MET . 0.6 OUTLIER -156.59 134.47 11.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.651 0.262 . . . . 0.0 110.665 -173.12 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.496 ' HB ' HD12 ' A' ' 104' ' ' ILE . 1.9 p -71.43 122.26 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.884 ' H ' ' HB2' ' A' ' 101' ' ' LEU . . . 106.98 2.87 36.41 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.449 -175.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.902 ' HG3' ' HB3' ' A' ' 47' ' ' ARG . 3.9 mtt -78.87 151.61 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.78 154.1 36.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.919 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -48.72 -39.33 24.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.708 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -59.91 -46.18 90.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.074 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.53 -40.25 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.717 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.456 HG21 HD21 ' A' ' 101' ' ' LEU . 84.4 t -58.29 -45.85 89.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.236 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' HA ' ' OG1' ' A' ' 61' ' ' THR . . . -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.013 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -29.93 68.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 111.087 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.18 -57.72 2.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.844 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.36 -20.56 40.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -172.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.2 31.01 32.53 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.318 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.756 HG23 ' HE2' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -65.52 136.41 96.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.689 -178.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 61' ' ' THR . 57.7 Cg_endo -73.96 151.22 44.78 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.515 2.144 . . . . 0.0 111.945 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -83.6 106.43 15.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.001 0.429 . . . . 0.0 110.225 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.4 tpt -95.08 120.6 35.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.735 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.86 117.53 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.735 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.28 112.31 13.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.448 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.89 -2.99 12.89 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.721 2.281 . . . . 0.0 112.574 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -85.61 -25.69 26.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.923 -176.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.78 29.34 4.7 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.948 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -72.92 107.82 5.51 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.165 0.507 . . . . 0.0 110.644 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -103.6 25.89 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.124 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -131.01 127.17 37.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.531 178.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -104.01 124.74 49.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -103.78 135.7 44.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.756 ' HE2' HG23 ' A' ' 61' ' ' THR . 0.2 OUTLIER -134.81 151.24 50.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 178.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.58 115.34 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.367 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.533 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -93.56 160.26 14.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.693 -178.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 78' ' ' ARG . 4.4 ptm180 -126.16 132.93 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.687 0.279 . . . . 0.0 110.329 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HG3' HE22 ' A' ' 88' ' ' GLN . 0.0 OUTLIER -159.1 -44.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.854 177.318 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.444 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -90.62 120.21 68.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -54.28 4.54 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.885 2.39 . . . . 0.0 112.563 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.79 127.82 1.04 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.864 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 179.24 149.66 0.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.836 0.454 . . . . 0.0 110.137 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 72.62 -41.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.856 0.862 . . . . 0.0 112.321 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.17 -37.78 3.55 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 t -115.2 86.74 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 m -164.37 99.96 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 -174.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -165.48 168.36 16.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.877 171.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.502 HE21 ' HB2' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -82.47 142.81 31.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -176.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 122.85 47.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.322 175.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.533 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -110.03 119.47 39.42 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.12 138.57 50.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 110.652 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -116.59 139.18 50.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.304 177.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -102.78 146.79 27.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -125.18 125.37 43.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 111.805 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.778 ' HB2' HG23 ' A' ' 102' ' ' THR . 47.5 t-20 -73.61 157.02 37.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 170.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -19.69 37.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -7.75 57.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 87.06 29.64 22.35 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 49' ' ' GLY . 1.6 t -111.88 135.6 50.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -174.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.884 ' HB2' ' H ' ' A' ' 49' ' ' GLY . 17.6 mt -60.91 105.77 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.341 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.778 HG23 ' HB2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -75.56 -30.51 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.186 0.517 . . . . 0.0 110.631 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -168.25 140.82 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.904 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 48' ' ' VAL . 14.2 mt -103.48 139.11 25.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -117.52 101.9 8.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.089 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.42 121.48 33.95 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -143.31 129.85 10.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.362 -177.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.88 170.26 2.85 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.273 2.649 . . . . 0.0 112.262 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.28 93.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.76 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.24 97.82 8.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.611 -177.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.95 172.21 11.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.236 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.85 -60.59 6.35 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.952 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 8.7 t30 -99.37 109.69 22.27 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.48 ' HG ' ' N ' ' A' ' 115' ' ' GLU . 2.9 tp 70.21 144.16 0.05 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.736 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.48 ' N ' ' HG ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -79.17 171.97 14.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.361 178.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -78.53 72.85 5.08 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -30.19 15.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.64 147.45 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.465 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.03 -45.2 10.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.734 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -177.39 -33.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 38.8 t60 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 117.958 -1.02 . . . . 0.0 108.834 175.243 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 121.278 0.561 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.6 74.02 9.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.134 -176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -120.18 58.15 0.92 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.987 0.898 . . . . 0.0 109.489 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.1 39.22 2.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.187 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -71.96 111.91 7.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.144 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.25 91.66 3.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.231 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.44 112.84 37.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.214 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.96 126.38 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.517 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -116.5 126.58 53.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.818 0.342 . . . . 0.0 110.355 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.653 ' HG3' HD11 ' A' ' 32' ' ' ILE . 4.0 ptm180 -117.42 112.0 39.61 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.73 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.38 55.38 4.65 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.161 2.574 . . . . 0.0 112.161 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 29' ' ' ARG . 2.7 p-10 -132.59 -10.79 3.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.593 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.653 HD11 ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -124.73 131.51 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.987 0.423 . . . . 0.0 111.909 -178.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 69.4 11.22 8.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.963 170.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.66 87.1 3.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.539 0.685 . . . . 0.0 110.274 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.08 131.55 1.56 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.117 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.34 18.07 12.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.275 0.56 . . . . 0.0 109.919 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -164.42 177.63 8.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.278 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CD2' ' A' ' 75' ' ' TYR . 11.9 tp -118.01 140.71 49.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.77 0.319 . . . . 0.0 110.568 175.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.13 145.97 39.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.072 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -63.49 -42.32 98.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.92 -21.77 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.897 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.642 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -73.45 -34.2 65.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.126 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG21 ' HG ' ' A' ' 91' ' ' LEU . 96.2 t -75.8 -30.77 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 110.091 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.3 m -66.72 -6.56 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.45 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.642 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 13.5 mtpt -70.6 -32.97 70.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.486 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 pp -93.58 179.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.391 . . . . 0.0 111.151 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -144.3 160.03 41.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.89 -175.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.484 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . 2.8 m -69.55 146.25 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.999 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 84.67 -15.77 39.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.291 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.553 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -70.52 141.08 51.95 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -75.18 145.92 41.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.898 0.38 . . . . 0.0 111.78 -172.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -35.4 29.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.827 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -64.89 -53.87 39.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.625 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.5 72.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.713 HG21 HD23 ' A' ' 101' ' ' LEU . 21.6 t -61.39 -42.19 92.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.607 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -67.13 -37.94 84.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.691 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -69.21 -34.19 74.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.645 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.1 -41.07 16.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.507 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -69.73 -43.25 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 111.378 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.9 59.74 0.81 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -71.99 147.33 91.11 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.737 0.303 . . . . 0.0 110.792 -177.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 11.5 Cg_exo -71.83 164.64 35.05 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.2 2.6 . . . . 0.0 111.547 175.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.34 85.31 3.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.346 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mtm -143.77 171.24 14.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.444 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -119.9 -178.05 3.55 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -128.85 53.28 10.97 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 78.9 Cg_endo -78.23 -4.99 14.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.066 1.844 . . . . 0.0 112.085 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -93.41 -4.59 51.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.262 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.24 35.79 7.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 86.85 2.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.314 -172.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 95' ' ' PHE . 17.5 m120 -102.35 7.72 40.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.263 0.554 . . . . 0.0 110.208 176.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.11 123.37 41.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.176 176.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.788 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 11.7 m0 -104.79 137.12 43.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.181 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -118.78 115.27 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.051 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 22.6 m-85 -118.44 148.25 42.76 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.08 117.97 31.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.121 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.609 ' HB3' ' HG2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -104.8 114.46 28.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.05 0.453 . . . . 0.0 111.359 -175.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -93.28 103.87 16.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -151.3 147.27 26.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 -176.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.618 HE22 ' HB3' ' A' ' 108' ' ' PRO . 31.5 mt-30 73.13 147.79 0.12 Allowed Pre-proline 0 N--CA 1.466 0.371 0 O-C-N 123.984 0.803 . . . . 0.0 111.485 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.3 Cg_exo -71.85 -2.35 11.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 112.572 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.408 ' HA2' ' HB ' ' A' ' 87' ' ' THR . . . 95.95 148.59 24.43 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.967 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.441 ' H ' ' CB ' ' A' ' 87' ' ' THR . 3.0 t-80 -118.89 117.76 29.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 60.98 20.56 10.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.99 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.44 -9.29 42.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.023 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.38 87.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.022 0.411 . . . . 0.0 110.0 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.649 HG23 ' HB3' ' A' ' 109' ' ' ALA . 11.7 m -163.26 121.53 1.99 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.39 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.559 ' NE2' ' HA ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -176.61 112.26 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.22 0.95 . . . . 0.0 109.156 170.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.609 ' HG2' ' HB3' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -78.47 165.98 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.283 0.563 . . . . 0.0 111.842 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.9 t -123.54 127.21 48.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.726 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.514 ' HG ' HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -84.56 110.9 19.05 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 1.9 m -109.37 110.99 22.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.353 -177.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.788 ' HB2' ' HB2' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -91.79 142.15 27.9 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.585 177.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -135.22 117.79 15.91 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.559 ' O ' ' HB3' ' A' ' 71' ' ' ASN . 1.1 p90 -132.2 157.62 43.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.085 0.469 . . . . 0.0 110.936 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.31 161.73 22.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.17 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -20.0 24.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -9.0 58.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.493 0.663 . . . . 0.0 110.314 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 95.82 8.73 57.96 Favored Glycine 0 C--O 1.219 -0.783 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.636 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.999 HG13 ' HA2' ' A' ' 49' ' ' GLY . 55.1 t -89.2 110.0 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 122.894 -0.18 . . . . 0.0 111.15 -172.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.713 HD23 HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -55.22 107.5 0.32 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.593 0.558 . . . . 0.0 110.101 174.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.36 -25.82 14.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.776 0.322 . . . . 0.0 111.142 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.561 ' HB3' ' HB ' ' A' ' 94' ' ' THR . 18.1 t30 -150.29 143.84 25.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.87 133.78 66.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' HD22 ' A' ' 91' ' ' LEU . 6.4 t70 -103.28 101.87 11.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.278 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -132.33 102.0 5.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.229 0.538 . . . . 0.0 110.149 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.89 165.6 21.73 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.618 ' HB3' HE22 ' A' ' 80' ' ' GLN . 23.2 Cg_exo -65.78 158.22 54.81 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.223 1.949 . . . . 0.0 110.778 169.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.649 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -73.33 59.53 0.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 111.467 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.817 ' HA ' ' HG2' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -163.55 82.85 0.46 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.513 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m -81.63 63.56 5.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.155 0.502 . . . . 0.0 110.731 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.79 -157.18 41.37 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.634 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -74.61 -11.16 60.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 14.8 tp -77.7 -10.21 59.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.772 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.817 ' HG2' ' HA ' ' A' ' 110' ' ' LEU . 4.3 tp10 -89.17 -127.25 0.06 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.801 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 64.74 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.019 0.528 . . . . 0.0 109.595 -173.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -164.27 111.14 1.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.21 109.73 0.21 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.939 0.775 . . . . 0.0 111.155 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -165.71 148.44 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.26 -176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -138.53 115.75 11.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.242 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.777 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.959 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.867 0.365 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -109.59 132.92 53.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.393 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 143.42 53.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.592 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.85 116.07 21.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.399 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.88 132.41 49.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.145 0.498 . . . . 0.0 109.977 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -96.44 82.51 3.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.498 -176.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p -71.79 123.81 26.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.388 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.38 156.61 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.562 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -76.01 135.24 39.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.122 0.487 . . . . 0.0 110.715 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.82 131.87 24.13 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.283 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.32 98.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.588 2.192 . . . . 0.0 111.247 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -135.79 -44.9 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.419 -172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -75.31 -32.43 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.229 -173.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.7 t30 56.64 57.73 4.6 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.801 0.81 . . . . 0.0 109.983 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -95.66 156.62 16.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.629 -175.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.85 39.48 7.53 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.558 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -154.08 140.56 18.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.1 179.48 7.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.753 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 38' ' ' LEU . 5.6 tp -75.05 145.12 42.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.638 0.732 . . . . 0.0 112.968 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 41' ' ' ASN . 4.7 m -116.14 152.6 33.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.187 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . . . -54.84 -38.96 68.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.578 ' H ' HG22 ' A' ' 39' ' ' THR . 9.2 t30 -61.17 -47.05 87.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.384 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.452 ' OD1' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -68.35 -20.4 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.603 -176.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.8 -27.01 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.748 0.308 . . . . 0.0 111.256 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.9 -7.14 32.02 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 3.36 55.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.21 -169.03 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.164 -0.214 . . . . 0.0 111.236 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -147.79 143.2 27.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.07 0.462 . . . . 0.0 112.018 -174.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 104' ' ' ILE . 41.1 t -76.05 137.59 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.87 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.611 ' HA2' HG13 ' A' ' 100' ' ' VAL . . . 89.26 -6.46 83.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.902 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.2 mmm -71.04 153.24 42.76 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -77.78 145.66 36.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.89 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -36.31 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.298 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' OE1' ' HB ' ' A' ' 51' ' ' THR . 1.6 mp0 -70.15 -40.81 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.279 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.64 -34.76 60.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.754 -177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.51 -46.49 94.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.589 ' HB2' ' HH2' ' A' ' 73' ' ' TRP . . . -62.67 -41.14 98.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.574 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.438 ' HE1' HD11 ' A' ' 63' ' ' LEU . 1.1 m-85 -60.22 -49.2 78.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.885 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.6 -36.35 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.232 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -80.08 -37.62 33.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.4 . . . . 0.0 111.54 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.44 52.7 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -173.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -122.08 139.85 31.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.45 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.41 138.7 82.34 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.323 2.015 . . . . 0.0 110.716 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD11 ' HE1' ' A' ' 57' ' ' TYR . 91.3 mt -74.07 87.92 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.151 0.501 . . . . 0.0 110.649 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 109.12 12.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.776 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.64 142.05 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.969 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.34 131.64 24.37 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -92.54 -2.97 3.75 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.932 2.422 . . . . 0.0 112.996 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.466 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -103.01 -26.16 13.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -169.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.12 5.54 32.7 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.46 7.34 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.957 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.463 HD22 ' HA ' ' A' ' 71' ' ' ASN . 3.1 m120 -99.73 51.71 0.92 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.225 -174.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.88 128.85 55.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.373 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.589 ' HH2' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -103.4 141.07 36.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -123.12 119.8 31.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 144.14 47.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.232 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.94 117.13 29.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -94.18 116.88 29.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -175.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.15 104.35 12.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.616 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.742 ' CG ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -165.31 129.15 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -142.47 117.74 6.7 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.77 0.319 . . . . 0.0 110.801 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.39 -3.19 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.472 2.115 . . . . 0.0 111.927 176.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -11.77 60.11 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.092 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.11 132.79 47.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.671 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.832 ' HG2' ' HB3' ' A' ' 116' ' ' HIS . 0.3 OUTLIER 75.98 -67.44 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 124.106 0.879 . . . . 0.0 112.294 172.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 -36.52 4.32 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.71 86.74 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 109' ' ' ALA . 1.1 m -170.37 131.81 0.97 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.303 -174.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.481 ' H ' ' CB ' ' A' ' 109' ' ' ALA . 28.0 tp60 -143.86 114.01 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.366 0.603 . . . . 0.0 110.782 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.742 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -75.83 135.14 40.21 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.074 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.32 132.5 56.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.635 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HG ' ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -95.93 110.31 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -108.95 138.65 44.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.106 0.479 . . . . 0.0 110.996 -177.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.763 ' HG ' HD11 ' A' ' 101' ' ' LEU . 3.4 mp -117.32 131.05 56.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.68 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.88 105.4 9.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.884 0.373 . . . . 0.0 110.087 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.43 ' HA ' ' H ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -116.09 135.71 53.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.78 -178.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.414 ' ND2' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -72.69 164.89 25.81 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.77 -31.4 2.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -170.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -4.51 33.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 111.295 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 93.61 9.86 59.66 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.021 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.611 HG13 ' HA2' ' A' ' 49' ' ' GLY . 21.0 t -93.49 116.22 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -174.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 HD11 ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -54.28 97.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.773 0.671 . . . . 0.0 110.464 176.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.43 ' H ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -76.99 -31.51 56.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.909 0.385 . . . . 0.0 110.449 -176.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.68 140.66 9.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.147 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.605 HD12 HG22 ' A' ' 48' ' ' VAL . 1.7 mp -103.45 139.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 171.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 0.5 OUTLIER -107.39 102.03 11.34 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -113.8 102.84 10.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 127.34 10.96 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.039 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.616 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 13.6 Cg_exo -70.9 150.95 62.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.923 2.415 . . . . 0.0 110.554 171.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.714 ' HB3' HG23 ' A' ' 87' ' ' THR . . . -81.44 38.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 110.842 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.41 141.97 25.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.531 -177.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 11.0 m -125.55 131.71 52.71 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.77 -52.68 50.9 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.862 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -85.68 55.3 3.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.096 0.474 . . . . 0.0 110.63 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 111' ' ' SER . 0.3 OUTLIER -165.99 -57.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.86 179.209 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.28 112.45 0.03 OUTLIER 'General case' 0 C--O 1.233 0.188 0 O-C-N 124.135 0.897 . . . . 0.0 110.992 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.832 ' HB3' ' HG2' ' A' ' 84' ' ' GLU . 6.0 t-160 -72.88 -6.34 44.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.802 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.79 -39.24 77.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.768 174.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -90.18 122.79 33.44 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.167 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -70.52 -33.79 71.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 173.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.76 168.99 15.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.185 175.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.278 175.892 . . . . . . . . 0 0 . 1 stop_ save_